|
A06.6
|
Amebic brain abscess
|
|
A17.0
|
Tuberculous meningitis
|
|
A17.1
|
Meningeal tuberculoma
|
|
A17.81
|
Tuberculoma of brain and spinal cord
|
|
A17.82
|
Tuberculous meningoencephalitis
|
|
A17.83
|
Tuberculous neuritis
|
|
A17.89
|
Other tuberculosis of nervous system
|
|
A17.9
|
Tuberculosis of nervous system, unspecified
|
|
A27.81
|
Aseptic meningitis in leptospirosis
|
|
A39.0
|
Meningococcal meningitis
|
|
A39.1
|
Waterhouse-Friderichsen syndrome
|
|
A39.2
|
Acute meningococcemia
|
|
A39.3
|
Chronic meningococcemia
|
|
A39.4
|
Meningococcemia, unspecified
|
|
A39.81
|
Meningococcal encephalitis
|
|
A81.00
|
Creutzfeldt-Jakob disease, unspecified
|
|
A81.01
|
Variant Creutzfeldt-Jakob disease
|
|
A81.09
|
Other Creutzfeldt-Jakob disease
|
|
A81.1
|
Subacute sclerosing panencephalitis
|
|
A81.2
|
Progressive multifocal leukoencephalopathy
|
|
A81.81
|
Kuru
|
|
A81.83
|
Fatal familial insomnia
|
|
A81.89
|
Other atypical virus infections of central nervous system
|
|
A81.9
|
Atypical virus infection of central nervous system, unspecified
|
|
A82.0
|
Sylvatic rabies
|
|
A82.1
|
Urban rabies
|
|
A82.9
|
Rabies, unspecified
|
|
A83.0
|
Japanese encephalitis
|
|
A83.1
|
Western equine encephalitis
|
|
A83.2
|
Eastern equine encephalitis
|
|
A83.3
|
St Louis encephalitis
|
|
A83.4
|
Australian encephalitis
|
|
A83.5
|
California encephalitis
|
|
A83.6
|
Rocio virus disease
|
|
A83.8
|
Other mosquito-borne viral encephalitis
|
|
A83.9
|
Mosquito-borne viral encephalitis, unspecified
|
|
A84.0
|
Far Eastern tick-borne encephalitis [Russian spring-summer encephalitis]
|
|
A84.1
|
Central European tick-borne encephalitis
|
|
A84.9
|
Tick-borne viral encephalitis, unspecified
|
|
A85.0
|
Enteroviral encephalitis
|
|
A85.1
|
Adenoviral encephalitis
|
|
A85.2
|
Arthropod-borne viral encephalitis, unspecified
|
|
A85.8
|
Other specified viral encephalitis
|
|
A86
|
Unspecified viral encephalitis
|
|
A87.0
|
Enteroviral meningitis
|
|
A87.1
|
Adenoviral meningitis
|
|
A87.2
|
Lymphocytic choriomeningitis
|
|
A87.8
|
Other viral meningitis
|
|
A87.9
|
Viral meningitis, unspecified
|
|
A88.0
|
Enteroviral exanthematous fever [Boston exanthem]
|
|
A88.8
|
Other specified viral infections of central nervous system
|
|
A89
|
Unspecified viral infection of central nervous system
|
|
B00.3
|
Herpesviral meningitis
|
|
B00.4
|
Herpesviral encephalitis
|
|
B01.11
|
Varicella encephalitis and encephalomyelitis
|
|
B02.0
|
Zoster encephalitis
|
|
B02.1
|
Zoster meningitis
|
|
B02.21
|
Postherpetic geniculate ganglionitis
|
|
B02.22
|
Postherpetic trigeminal neuralgia
|
|
B02.23
|
Postherpetic polyneuropathy
|
|
B02.29
|
Other postherpetic nervous system involvement
|
|
B05.0
|
Measles complicated by encephalitis
|
|
B06.01
|
Rubella encephalitis
|
|
B20
|
Human immunodeficiency virus [HIV] disease
|
|
B25.0
|
Cytomegaloviral pneumonitis
|
|
B25.1
|
Cytomegaloviral hepatitis
|
|
B25.2
|
Cytomegaloviral pancreatitis
|
|
B25.8
|
Other cytomegaloviral diseases
|
|
B25.9
|
Cytomegaloviral disease, unspecified
|
|
B26.1
|
Mumps meningitis
|
|
B26.2
|
Mumps encephalitis
|
|
B37.5
|
Candidal meningitis
|
|
B38.4
|
Coccidioidomycosis meningitis
|
|
B39.4
|
Histoplasmosis capsulati, unspecified
|
|
B44.0
|
Invasive pulmonary aspergillosis
|
|
B44.1
|
Other pulmonary aspergillosis
|
|
B44.2
|
Tonsillar aspergillosis
|
|
B44.7
|
Disseminated aspergillosis
|
|
B44.89
|
Other forms of aspergillosis
|
|
B44.9
|
Aspergillosis, unspecified
|
|
B45.0
|
Pulmonary cryptococcosis
|
|
B45.1
|
Cerebral cryptococcosis
|
|
B45.2
|
Cutaneous cryptococcosis
|
|
B45.3
|
Osseous cryptococcosis
|
|
B45.7
|
Disseminated cryptococcosis
|
|
B45.8
|
Other forms of cryptococcosis
|
|
B45.9
|
Cryptococcosis, unspecified
|
|
B48.4
|
Penicillosis
|
|
B58.2
|
Toxoplasma meningoencephalitis
|
|
B90.0
|
Sequelae of central nervous system tuberculosis
|
|
B94.1
|
Sequelae of viral encephalitis
|
|
C14.2
|
Malignant neoplasm of Waldeyer's ring
|
|
C18.9
|
Malignant neoplasm of colon, unspecified
|
|
C30.0
|
Malignant neoplasm of nasal cavity
|
|
C30.1
|
Malignant neoplasm of middle ear
|
|
C31.0
|
Malignant neoplasm of maxillary sinus
|
|
C31.1
|
Malignant neoplasm of ethmoidal sinus
|
|
C31.2
|
Malignant neoplasm of frontal sinus
|
|
C31.3
|
Malignant neoplasm of sphenoid sinus
|
|
C31.8
|
Malignant neoplasm of overlapping sites of accessory sinuses
|
|
C31.9
|
Malignant neoplasm of accessory sinus, unspecified
|
|
C33
|
Malignant neoplasm of trachea
|
|
C34.01
|
Malignant neoplasm of right main bronchus
|
|
C34.02
|
Malignant neoplasm of left main bronchus
|
|
C34.11
|
Malignant neoplasm of upper lobe, right bronchus or lung
|
|
C34.12
|
Malignant neoplasm of upper lobe, left bronchus or lung
|
|
C34.2
|
Malignant neoplasm of middle lobe, bronchus or lung
|
|
C34.31
|
Malignant neoplasm of lower lobe, right bronchus or lung
|
|
C34.32
|
Malignant neoplasm of lower lobe, left bronchus or lung
|
|
C34.80
|
Malignant neoplasm of overlapping sites of unspecified bronchus and lung
|
|
C34.81
|
Malignant neoplasm of overlapping sites of right bronchus and lung
|
|
C34.82
|
Malignant neoplasm of overlapping sites of left bronchus and lung
|
|
C34.91
|
Malignant neoplasm of unspecified part of right bronchus or lung
|
|
C34.92
|
Malignant neoplasm of unspecified part of left bronchus or lung
|
|
C41.0
|
Malignant neoplasm of bones of skull and face
|
|
C43.111
|
Malignant melanoma of right upper eyelid, including canthus
|
|
C43.112
|
Malignant melanoma of right lower eyelid, including canthus
|
|
C43.121
|
Malignant melanoma of left upper eyelid, including canthus
|
|
C43.122
|
Malignant melanoma of left lower eyelid, including canthus
|
|
C4A.111
|
Merkel cell carcinoma of right upper eyelid, including canthus
|
|
C4A.112
|
Merkel cell carcinoma of right lower eyelid, including canthus
|
|
C4A.121
|
Merkel cell carcinoma of left upper eyelid, including canthus
|
|
C4A.122
|
Merkel cell carcinoma of left lower eyelid, including canthus
|
|
C4A.4
|
Merkel cell carcinoma of scalp and neck
|
|
C44.00
|
Unspecified malignant neoplasm of skin of lip
|
|
C44.02
|
Squamous cell carcinoma of skin of lip
|
|
C44.09
|
Other specified malignant neoplasm of skin of lip
|
|
C44.1021
|
Unspecified malignant neoplasm of skin of right upper eyelid, including canthus
|
|
C44.1022
|
Unspecified malignant neoplasm of skin of right lower eyelid, including canthus
|
|
C44.1091
|
Unspecified malignant neoplasm of skin of left upper eyelid, including canthus
|
|
C44.1092
|
Unspecified malignant neoplasm of skin of left lower eyelid, including canthus
|
|
C44.1121
|
Basal cell carcinoma of skin of right upper eyelid, including canthus
|
|
C44.1122
|
Basal cell carcinoma of skin of right lower eyelid, including canthus
|
|
C44.1191
|
Basal cell carcinoma of skin of left upper eyelid, including canthus
|
|
C44.1192
|
Basal cell carcinoma of skin of left lower eyelid, including canthus
|
|
C44.1221
|
Squamous cell carcinoma of skin of right upper eyelid, including canthus
|
|
C44.1222
|
Squamous cell carcinoma of skin of right lower eyelid, including canthus
|
|
C44.1291
|
Squamous cell carcinoma of skin of left upper eyelid, including canthus
|
|
C44.1292
|
Squamous cell carcinoma of skin of left lower eyelid, including canthus
|
|
C44.1321
|
Sebaceous cell carcinoma of skin of right upper eyelid, including canthus
|
|
C44.1322
|
Sebaceous cell carcinoma of skin of right lower eyelid, including canthus
|
|
C44.1391
|
Sebaceous cell carcinoma of skin of left upper eyelid, including canthus
|
|
C44.1392
|
Sebaceous cell carcinoma of skin of left lower eyelid, including canthus
|
|
C44.1921
|
Other specified malignant neoplasm of skin of right upper eyelid, including canthus
|
|
C44.1922
|
Other specified malignant neoplasm of skin of right lower eyelid, including canthus
|
|
C44.1991
|
Other specified malignant neoplasm of skin of left upper eyelid, including canthus
|
|
C44.1992
|
Other specified malignant neoplasm of skin of left lower eyelid, including canthus
|
|
C44.202
|
Unspecified malignant neoplasm of skin of right ear and external auricular canal
|
|
C44.209
|
Unspecified malignant neoplasm of skin of left ear and external auricular canal
|
|
C44.222
|
Squamous cell carcinoma of skin of right ear and external auricular canal
|
|
C44.229
|
Squamous cell carcinoma of skin of left ear and external auricular canal
|
|
C44.292
|
Other specified malignant neoplasm of skin of right ear and external auricular canal
|
|
C44.299
|
Other specified malignant neoplasm of skin of left ear and external auricular canal
|
|
C44.300
|
Unspecified malignant neoplasm of skin of unspecified part of face
|
|
C44.301
|
Unspecified malignant neoplasm of skin of nose
|
|
C44.309
|
Unspecified malignant neoplasm of skin of other parts of face
|
|
C44.320
|
Squamous cell carcinoma of skin of unspecified parts of face
|
|
C44.321
|
Squamous cell carcinoma of skin of nose
|
|
C44.329
|
Squamous cell carcinoma of skin of other parts of face
|
|
C44.390
|
Other specified malignant neoplasm of skin of unspecified parts of face
|
|
C44.391
|
Other specified malignant neoplasm of skin of nose
|
|
C44.399
|
Other specified malignant neoplasm of skin of other parts of face
|
|
C44.40
|
Unspecified malignant neoplasm of skin of scalp and neck
|
|
C44.42
|
Squamous cell carcinoma of skin of scalp and neck
|
|
C44.49
|
Other specified malignant neoplasm of skin of scalp and neck
|
|
C44.500
|
Unspecified malignant neoplasm of anal skin
|
|
C44.501
|
Unspecified malignant neoplasm of skin of breast
|
|
C44.509
|
Unspecified malignant neoplasm of skin of other part of trunk
|
|
C44.520
|
Squamous cell carcinoma of anal skin
|
|
C44.521
|
Squamous cell carcinoma of skin of breast
|
|
C44.529
|
Squamous cell carcinoma of skin of other part of trunk
|
|
C44.590
|
Other specified malignant neoplasm of anal skin
|
|
C44.591
|
Other specified malignant neoplasm of skin of breast
|
|
C44.599
|
Other specified malignant neoplasm of skin of other part of trunk
|
|
C44.602
|
Unspecified malignant neoplasm of skin of right upper limb, including shoulder
|
|
C44.609
|
Unspecified malignant neoplasm of skin of left upper limb, including shoulder
|
|
C44.622
|
Squamous cell carcinoma of skin of right upper limb, including shoulder
|
|
C44.629
|
Squamous cell carcinoma of skin of left upper limb, including shoulder
|
|
C44.692
|
Other specified malignant neoplasm of skin of right upper limb, including shoulder
|
|
C44.699
|
Other specified malignant neoplasm of skin of left upper limb, including shoulder
|
|
C44.702
|
Unspecified malignant neoplasm of skin of right lower limb, including hip
|
|
C44.709
|
Unspecified malignant neoplasm of skin of left lower limb, including hip
|
|
C44.722
|
Squamous cell carcinoma of skin of right lower limb, including hip
|
|
C44.729
|
Squamous cell carcinoma of skin of left lower limb, including hip
|
|
C44.792
|
Other specified malignant neoplasm of skin of right lower limb, including hip
|
|
C44.799
|
Other specified malignant neoplasm of skin of left lower limb, including hip
|
|
C44.80
|
Unspecified malignant neoplasm of overlapping sites of skin
|
|
C44.82
|
Squamous cell carcinoma of overlapping sites of skin
|
|
C44.89
|
Other specified malignant neoplasm of overlapping sites of skin
|
|
C44.92
|
Squamous cell carcinoma of skin, unspecified
|
|
C44.99
|
Other specified malignant neoplasm of skin, unspecified
|
|
C45.9
|
Mesothelioma, unspecified
|
|
C47.0
|
Malignant neoplasm of peripheral nerves of head, face and neck
|
|
C49.0
|
Malignant neoplasm of connective and soft tissue of head, face and neck
|
|
C49.A0
|
Gastrointestinal stromal tumor, unspecified site
|
|
C49.A1
|
Gastrointestinal stromal tumor of esophagus
|
|
C49.A2
|
Gastrointestinal stromal tumor of stomach
|
|
C49.A3
|
Gastrointestinal stromal tumor of small intestine
|
|
C49.A4
|
Gastrointestinal stromal tumor of large intestine
|
|
C49.A5
|
Gastrointestinal stromal tumor of rectum
|
|
C49.A9
|
Gastrointestinal stromal tumor of other sites
|
|
C50.011
|
Malignant neoplasm of nipple and areola, right female breast
|
|
C50.012
|
Malignant neoplasm of nipple and areola, left female breast
|
|
C50.021
|
Malignant neoplasm of nipple and areola, right male breast
|
|
C50.022
|
Malignant neoplasm of nipple and areola, left male breast
|
|
C50.111
|
Malignant neoplasm of central portion of right female breast
|
|
C50.112
|
Malignant neoplasm of central portion of left female breast
|
|
C50.121
|
Malignant neoplasm of central portion of right male breast
|
|
C50.122
|
Malignant neoplasm of central portion of left male breast
|
|
C50.211
|
Malignant neoplasm of upper-inner quadrant of right female breast
|
|
C50.212
|
Malignant neoplasm of upper-inner quadrant of left female breast
|
|
C50.221
|
Malignant neoplasm of upper-inner quadrant of right male breast
|
|
C50.222
|
Malignant neoplasm of upper-inner quadrant of left male breast
|
|
C50.311
|
Malignant neoplasm of lower-inner quadrant of right female breast
|
|
C50.312
|
Malignant neoplasm of lower-inner quadrant of left female breast
|
|
C50.321
|
Malignant neoplasm of lower-inner quadrant of right male breast
|
|
C50.322
|
Malignant neoplasm of lower-inner quadrant of left male breast
|
|
C50.411
|
Malignant neoplasm of upper-outer quadrant of right female breast
|
|
C50.412
|
Malignant neoplasm of upper-outer quadrant of left female breast
|
|
C50.421
|
Malignant neoplasm of upper-outer quadrant of right male breast
|
|
C50.422
|
Malignant neoplasm of upper-outer quadrant of left male breast
|
|
C50.511
|
Malignant neoplasm of lower-outer quadrant of right female breast
|
|
C50.512
|
Malignant neoplasm of lower-outer quadrant of left female breast
|
|
C50.521
|
Malignant neoplasm of lower-outer quadrant of right male breast
|
|
C50.522
|
Malignant neoplasm of lower-outer quadrant of left male breast
|
|
C50.611
|
Malignant neoplasm of axillary tail of right female breast
|
|
C50.612
|
Malignant neoplasm of axillary tail of left female breast
|
|
C50.621
|
Malignant neoplasm of axillary tail of right male breast
|
|
C50.622
|
Malignant neoplasm of axillary tail of left male breast
|
|
C50.811
|
Malignant neoplasm of overlapping sites of right female breast
|
|
C50.812
|
Malignant neoplasm of overlapping sites of left female breast
|
|
C50.821
|
Malignant neoplasm of overlapping sites of right male breast
|
|
C50.822
|
Malignant neoplasm of overlapping sites of left male breast
|
|
C50.911
|
Malignant neoplasm of unspecified site of right female breast
|
|
C50.912
|
Malignant neoplasm of unspecified site of left female breast
|
|
C50.921
|
Malignant neoplasm of unspecified site of right male breast
|
|
C50.922
|
Malignant neoplasm of unspecified site of left male breast
|
|
C64.1
|
Malignant neoplasm of right kidney, except renal pelvis
|
|
C64.2
|
Malignant neoplasm of left kidney, except renal pelvis
|
|
C69.01
|
Malignant neoplasm of right conjunctiva
|
|
C69.02
|
Malignant neoplasm of left conjunctiva
|
|
C69.11
|
Malignant neoplasm of right cornea
|
|
C69.12
|
Malignant neoplasm of left cornea
|
|
C69.21
|
Malignant neoplasm of right retina
|
|
C69.22
|
Malignant neoplasm of left retina
|
|
C69.31
|
Malignant neoplasm of right choroid
|
|
C69.32
|
Malignant neoplasm of left choroid
|
|
C69.41
|
Malignant neoplasm of right ciliary body
|
|
C69.42
|
Malignant neoplasm of left ciliary body
|
|
C69.51
|
Malignant neoplasm of right lacrimal gland and duct
|
|
C69.52
|
Malignant neoplasm of left lacrimal gland and duct
|
|
C69.61
|
Malignant neoplasm of right orbit
|
|
C69.62
|
Malignant neoplasm of left orbit
|
|
C69.81
|
Malignant neoplasm of overlapping sites of right eye and adnexa
|
|
C69.82
|
Malignant neoplasm of overlapping sites of left eye and adnexa
|
|
C69.91
|
Malignant neoplasm of unspecified site of right eye
|
|
C69.92
|
Malignant neoplasm of unspecified site of left eye
|
|
C70.0
|
Malignant neoplasm of cerebral meninges
|
|
C70.9
|
Malignant neoplasm of meninges, unspecified
|
|
C71.0
|
Malignant neoplasm of cerebrum, except lobes and ventricles
|
|
C71.1
|
Malignant neoplasm of frontal lobe
|
|
C71.2
|
Malignant neoplasm of temporal lobe
|
|
C71.3
|
Malignant neoplasm of parietal lobe
|
|
C71.4
|
Malignant neoplasm of occipital lobe
|
|
C71.5
|
Malignant neoplasm of cerebral ventricle
|
|
C71.6
|
Malignant neoplasm of cerebellum
|
|
C71.7
|
Malignant neoplasm of brain stem
|
|
C71.8
|
Malignant neoplasm of overlapping sites of brain
|
|
C71.9
|
Malignant neoplasm of brain, unspecified
|
|
C72.21
|
Malignant neoplasm of right olfactory nerve
|
|
C72.22
|
Malignant neoplasm of left olfactory nerve
|
|
C72.31
|
Malignant neoplasm of right optic nerve
|
|
C72.32
|
Malignant neoplasm of left optic nerve
|
|
C72.41
|
Malignant neoplasm of right acoustic nerve
|
|
C72.42
|
Malignant neoplasm of left acoustic nerve
|
|
C72.59
|
Malignant neoplasm of other cranial nerves
|
|
C73
|
Malignant neoplasm of thyroid gland
|
|
C75.1
|
Malignant neoplasm of pituitary gland
|
|
C75.2
|
Malignant neoplasm of craniopharyngeal duct
|
|
C75.3
|
Malignant neoplasm of pineal gland
|
|
C7A.00
|
Malignant carcinoid tumor of unspecified site
|
|
C7A.010
|
Malignant carcinoid tumor of the duodenum
|
|
C7A.011
|
Malignant carcinoid tumor of the jejunum
|
|
C7A.012
|
Malignant carcinoid tumor of the ileum
|
|
C7A.019
|
Malignant carcinoid tumor of the small intestine, unspecified portion
|
|
C7A.020
|
Malignant carcinoid tumor of the appendix
|
|
C7A.021
|
Malignant carcinoid tumor of the cecum
|
|
C7A.022
|
Malignant carcinoid tumor of the ascending colon
|
|
C7A.023
|
Malignant carcinoid tumor of the transverse colon
|
|
C7A.024
|
Malignant carcinoid tumor of the descending colon
|
|
C7A.025
|
Malignant carcinoid tumor of the sigmoid colon
|
|
C7A.026
|
Malignant carcinoid tumor of the rectum
|
|
C7A.029
|
Malignant carcinoid tumor of the large intestine, unspecified portion
|
|
C7A.090
|
Malignant carcinoid tumor of the bronchus and lung
|
|
C7A.091
|
Malignant carcinoid tumor of the thymus
|
|
C7A.092
|
Malignant carcinoid tumor of the stomach
|
|
C7A.093
|
Malignant carcinoid tumor of the kidney
|
|
C7A.094
|
Malignant carcinoid tumor of the foregut, unspecified
|
|
C7A.095
|
Malignant carcinoid tumor of the midgut, unspecified
|
|
C7A.096
|
Malignant carcinoid tumor of the hindgut, unspecified
|
|
C7A.098
|
Malignant carcinoid tumors of other sites
|
|
C7A.1
|
Malignant poorly differentiated neuroendocrine tumors
|
|
C7A.8
|
Other malignant neuroendocrine tumors
|
|
C7B.1
|
Secondary Merkel cell carcinoma
|
|
C76.0
|
Malignant neoplasm of head, face and neck
|
|
C77.0
|
Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck
|
|
C79.31
|
Secondary malignant neoplasm of brain
|
|
C79.32
|
Secondary malignant neoplasm of cerebral meninges
|
|
C79.40
|
Secondary malignant neoplasm of unspecified part of nervous system
|
|
C79.49
|
Secondary malignant neoplasm of other parts of nervous system
|
|
C79.51
|
Secondary malignant neoplasm of bone
|
|
C79.52
|
Secondary malignant neoplasm of bone marrow
|
|
C80.0
|
Disseminated malignant neoplasm, unspecified
|
|
C80.1
|
Malignant (primary) neoplasm, unspecified
|
|
C80.2
|
Malignant neoplasm associated with transplanted organ
|
|
C81.00
|
Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site
|
|
C81.01
|
Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of head, face, and neck
|
|
C81.02
|
Nodular lymphocyte predominant Hodgkin lymphoma, intrathoracic lymph nodes
|
|
C81.03
|
Nodular lymphocyte predominant Hodgkin lymphoma, intra-abdominal lymph nodes
|
|
C81.04
|
Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of axilla and upper limb
|
|
C81.05
|
Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of inguinal region and lower limb
|
|
C81.06
|
Nodular lymphocyte predominant Hodgkin lymphoma, intrapelvic lymph nodes
|
|
C81.07
|
Nodular lymphocyte predominant Hodgkin lymphoma, spleen
|
|
C81.08
|
Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of multiple sites
|
|
C81.09
|
Nodular lymphocyte predominant Hodgkin lymphoma, extranodal and solid organ sites
|
|
C81.10
|
Nodular sclerosis Hodgkin lymphoma, unspecified site
|
|
C81.11
|
Nodular sclerosis Hodgkin lymphoma, lymph nodes of head, face, and neck
|
|
C81.12
|
Nodular sclerosis Hodgkin lymphoma, intrathoracic lymph nodes
|
|
C81.13
|
Nodular sclerosis Hodgkin lymphoma, intra-abdominal lymph nodes
|
|
C81.14
|
Nodular sclerosis Hodgkin lymphoma, lymph nodes of axilla and upper limb
|
|
C81.15
|
Nodular sclerosis Hodgkin lymphoma, lymph nodes of inguinal region and lower limb
|
|
C81.16
|
Nodular sclerosis Hodgkin lymphoma, intrapelvic lymph nodes
|
|
C81.17
|
Nodular sclerosis Hodgkin lymphoma, spleen
|
|
C81.18
|
Nodular sclerosis Hodgkin lymphoma, lymph nodes of multiple sites
|
|
C81.19
|
Nodular sclerosis Hodgkin lymphoma, extranodal and solid organ sites
|
|
C81.20
|
Mixed cellularity Hodgkin lymphoma, unspecified site
|
|
C81.21
|
Mixed cellularity Hodgkin lymphoma, lymph nodes of head, face, and neck
|
|
C81.22
|
Mixed cellularity Hodgkin lymphoma, intrathoracic lymph nodes
|
|
C81.23
|
Mixed cellularity Hodgkin lymphoma, intra-abdominal lymph nodes
|
|
C81.24
|
Mixed cellularity Hodgkin lymphoma, lymph nodes of axilla and upper limb
|
|
C81.25
|
Mixed cellularity Hodgkin lymphoma, lymph nodes of inguinal region and lower limb
|
|
C81.26
|
Mixed cellularity Hodgkin lymphoma, intrapelvic lymph nodes
|
|
C81.27
|
Mixed cellularity Hodgkin lymphoma, spleen
|
|
C81.28
|
Mixed cellularity Hodgkin lymphoma, lymph nodes of multiple sites
|
|
C81.29
|
Mixed cellularity Hodgkin lymphoma, extranodal and solid organ sites
|
|
C81.30
|
Lymphocyte depleted Hodgkin lymphoma, unspecified site
|
|
C81.31
|
Lymphocyte depleted Hodgkin lymphoma, lymph nodes of head, face, and neck
|
|
C81.32
|
Lymphocyte depleted Hodgkin lymphoma, intrathoracic lymph nodes
|
|
C81.33
|
Lymphocyte depleted Hodgkin lymphoma, intra-abdominal lymph nodes
|
|
C81.34
|
Lymphocyte depleted Hodgkin lymphoma, lymph nodes of axilla and upper limb
|
|
C81.35
|
Lymphocyte depleted Hodgkin lymphoma, lymph nodes of inguinal region and lower limb
|
|
C81.36
|
Lymphocyte depleted Hodgkin lymphoma, intrapelvic lymph nodes
|
|
C81.37
|
Lymphocyte depleted Hodgkin lymphoma, spleen
|
|
C81.38
|
Lymphocyte depleted Hodgkin lymphoma, lymph nodes of multiple sites
|
|
C81.39
|
Lymphocyte depleted Hodgkin lymphoma, extranodal and solid organ sites
|
|
C81.40
|
Lymphocyte-rich Hodgkin lymphoma, unspecified site
|
|
C81.41
|
Lymphocyte-rich Hodgkin lymphoma, lymph nodes of head, face, and neck
|
|
C81.42
|
Lymphocyte-rich Hodgkin lymphoma, intrathoracic lymph nodes
|
|
C81.43
|
Lymphocyte-rich Hodgkin lymphoma, intra-abdominal lymph nodes
|
|
C81.44
|
Lymphocyte-rich Hodgkin lymphoma, lymph nodes of axilla and upper limb
|
|
C81.45
|
Lymphocyte-rich Hodgkin lymphoma, lymph nodes of inguinal region and lower limb
|
|
C81.46
|
Lymphocyte-rich Hodgkin lymphoma, intrapelvic lymph nodes
|
|
C81.47
|
Lymphocyte-rich Hodgkin lymphoma, spleen
|
|
C81.48
|
Lymphocyte-rich Hodgkin lymphoma, lymph nodes of multiple sites
|
|
C81.49
|
Lymphocyte-rich Hodgkin lymphoma, extranodal and solid organ sites
|
|
C81.70
|
Other Hodgkin lymphoma, unspecified site
|
|
C81.71
|
Other Hodgkin lymphoma, lymph nodes of head, face, and neck
|
|
C81.72
|
Other Hodgkin lymphoma, intrathoracic lymph nodes
|
|
C81.73
|
Other Hodgkin lymphoma, intra-abdominal lymph nodes
|
|
C81.74
|
Other Hodgkin lymphoma, lymph nodes of axilla and upper limb
|
|
C81.75
|
Other Hodgkin lymphoma, lymph nodes of inguinal region and lower limb
|
|
C81.76
|
Other Hodgkin lymphoma, intrapelvic lymph nodes
|
|
C81.77
|
Other Hodgkin lymphoma, spleen
|
|
C81.78
|
Other Hodgkin lymphoma, lymph nodes of multiple sites
|
|
C81.79
|
Other Hodgkin lymphoma, extranodal and solid organ sites
|
|
C81.90
|
Hodgkin lymphoma, unspecified, unspecified site
|
|
C81.91
|
Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck
|
|
C81.92
|
Hodgkin lymphoma, unspecified, intrathoracic lymph nodes
|
|
C81.93
|
Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes
|
|
C81.94
|
Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb
|
|
C81.95
|
Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb
|
|
C81.96
|
Hodgkin lymphoma, unspecified, intrapelvic lymph nodes
|
|
C81.97
|
Hodgkin lymphoma, unspecified, spleen
|
|
C81.98
|
Hodgkin lymphoma, unspecified, lymph nodes of multiple sites
|
|
C81.99
|
Hodgkin lymphoma, unspecified, extranodal and solid organ sites
|
|
C82.00
|
Follicular lymphoma grade I, unspecified site
|
|
C82.01
|
Follicular lymphoma grade I, lymph nodes of head, face, and neck
|
|
C82.02
|
Follicular lymphoma grade I, intrathoracic lymph nodes
|
|
C82.03
|
Follicular lymphoma grade I, intra-abdominal lymph nodes
|
|
C82.04
|
Follicular lymphoma grade I, lymph nodes of axilla and upper limb
|
|
C82.05
|
Follicular lymphoma grade I, lymph nodes of inguinal region and lower limb
|
|
C82.06
|
Follicular lymphoma grade I, intrapelvic lymph nodes
|
|
C82.07
|
Follicular lymphoma grade I, spleen
|
|
C82.08
|
Follicular lymphoma grade I, lymph nodes of multiple sites
|
|
C82.09
|
Follicular lymphoma grade I, extranodal and solid organ sites
|
|
C82.10
|
Follicular lymphoma grade II, unspecified site
|
|
C82.11
|
Follicular lymphoma grade II, lymph nodes of head, face, and neck
|
|
C82.12
|
Follicular lymphoma grade II, intrathoracic lymph nodes
|
|
C82.13
|
Follicular lymphoma grade II, intra-abdominal lymph nodes
|
|
C82.14
|
Follicular lymphoma grade II, lymph nodes of axilla and upper limb
|
|
C82.15
|
Follicular lymphoma grade II, lymph nodes of inguinal region and lower limb
|
|
C82.16
|
Follicular lymphoma grade II, intrapelvic lymph nodes
|
|
C82.17
|
Follicular lymphoma grade II, spleen
|
|
C82.18
|
Follicular lymphoma grade II, lymph nodes of multiple sites
|
|
C82.19
|
Follicular lymphoma grade II, extranodal and solid organ sites
|
|
C82.20
|
Follicular lymphoma grade III, unspecified, unspecified site
|
|
C82.21
|
Follicular lymphoma grade III, unspecified, lymph nodes of head, face, and neck
|
|
C82.22
|
Follicular lymphoma grade III, unspecified, intrathoracic lymph nodes
|
|
C82.23
|
Follicular lymphoma grade III, unspecified, intra-abdominal lymph nodes
|
|
C82.24
|
Follicular lymphoma grade III, unspecified, lymph nodes of axilla and upper limb
|
|
C82.25
|
Follicular lymphoma grade III, unspecified, lymph nodes of inguinal region and lower limb
|
|
C82.26
|
Follicular lymphoma grade III, unspecified, intrapelvic lymph nodes
|
|
C82.27
|
Follicular lymphoma grade III, unspecified, spleen
|
|
C82.28
|
Follicular lymphoma grade III, unspecified, lymph nodes of multiple sites
|
|
C82.29
|
Follicular lymphoma grade III, unspecified, extranodal and solid organ sites
|
|
C82.30
|
Follicular lymphoma grade IIIa, unspecified site
|
|
C82.31
|
Follicular lymphoma grade IIIa, lymph nodes of head, face, and neck
|
|
C82.32
|
Follicular lymphoma grade IIIa, intrathoracic lymph nodes
|
|
C82.33
|
Follicular lymphoma grade IIIa, intra-abdominal lymph nodes
|
|
C82.34
|
Follicular lymphoma grade IIIa, lymph nodes of axilla and upper limb
|
|
C82.35
|
Follicular lymphoma grade IIIa, lymph nodes of inguinal region and lower limb
|
|
C82.36
|
Follicular lymphoma grade IIIa, intrapelvic lymph nodes
|
|
C82.37
|
Follicular lymphoma grade IIIa, spleen
|
|
C82.38
|
Follicular lymphoma grade IIIa, lymph nodes of multiple sites
|
|
C82.39
|
Follicular lymphoma grade IIIa, extranodal and solid organ sites
|
|
C82.40
|
Follicular lymphoma grade IIIb, unspecified site
|
|
C82.41
|
Follicular lymphoma grade IIIb, lymph nodes of head, face, and neck
|
|
C82.42
|
Follicular lymphoma grade IIIb, intrathoracic lymph nodes
|
|
C82.43
|
Follicular lymphoma grade IIIb, intra-abdominal lymph nodes
|
|
C82.44
|
Follicular lymphoma grade IIIb, lymph nodes of axilla and upper limb
|
|
C82.45
|
Follicular lymphoma grade IIIb, lymph nodes of inguinal region and lower limb
|
|
C82.46
|
Follicular lymphoma grade IIIb, intrapelvic lymph nodes
|
|
C82.47
|
Follicular lymphoma grade IIIb, spleen
|
|
C82.48
|
Follicular lymphoma grade IIIb, lymph nodes of multiple sites
|
|
C82.49
|
Follicular lymphoma grade IIIb, extranodal and solid organ sites
|
|
C82.50
|
Diffuse follicle center lymphoma, unspecified site
|
|
C82.51
|
Diffuse follicle center lymphoma, lymph nodes of head, face, and neck
|
|
C82.52
|
Diffuse follicle center lymphoma, intrathoracic lymph nodes
|
|
C82.53
|
Diffuse follicle center lymphoma, intra-abdominal lymph nodes
|
|
C82.54
|
Diffuse follicle center lymphoma, lymph nodes of axilla and upper limb
|
|
C82.55
|
Diffuse follicle center lymphoma, lymph nodes of inguinal region and lower limb
|
|
C82.56
|
Diffuse follicle center lymphoma, intrapelvic lymph nodes
|
|
C82.57
|
Diffuse follicle center lymphoma, spleen
|
|
C82.58
|
Diffuse follicle center lymphoma, lymph nodes of multiple sites
|
|
C82.59
|
Diffuse follicle center lymphoma, extranodal and solid organ sites
|
|
C82.60
|
Cutaneous follicle center lymphoma, unspecified site
|
|
C82.61
|
Cutaneous follicle center lymphoma, lymph nodes of head, face, and neck
|
|
C82.62
|
Cutaneous follicle center lymphoma, intrathoracic lymph nodes
|
|
C82.63
|
Cutaneous follicle center lymphoma, intra-abdominal lymph nodes
|
|
C82.64
|
Cutaneous follicle center lymphoma, lymph nodes of axilla and upper limb
|
|
C82.65
|
Cutaneous follicle center lymphoma, lymph nodes of inguinal region and lower limb
|
|
C82.66
|
Cutaneous follicle center lymphoma, intrapelvic lymph nodes
|
|
C82.67
|
Cutaneous follicle center lymphoma, spleen
|
|
C82.68
|
Cutaneous follicle center lymphoma, lymph nodes of multiple sites
|
|
C82.69
|
Cutaneous follicle center lymphoma, extranodal and solid organ sites
|
|
C82.80
|
Other types of follicular lymphoma, unspecified site
|
|
C82.81
|
Other types of follicular lymphoma, lymph nodes of head, face, and neck
|
|
C82.82
|
Other types of follicular lymphoma, intrathoracic lymph nodes
|
|
C82.83
|
Other types of follicular lymphoma, intra-abdominal lymph nodes
|
|
C82.84
|
Other types of follicular lymphoma, lymph nodes of axilla and upper limb
|
|
C82.85
|
Other types of follicular lymphoma, lymph nodes of inguinal region and lower limb
|
|
C82.86
|
Other types of follicular lymphoma, intrapelvic lymph nodes
|
|
C82.87
|
Other types of follicular lymphoma, spleen
|
|
C82.88
|
Other types of follicular lymphoma, lymph nodes of multiple sites
|
|
C82.89
|
Other types of follicular lymphoma, extranodal and solid organ sites
|
|
C82.90
|
Follicular lymphoma, unspecified, unspecified site
|
|
C82.91
|
Follicular lymphoma, unspecified, lymph nodes of head, face, and neck
|
|
C82.92
|
Follicular lymphoma, unspecified, intrathoracic lymph nodes
|
|
C82.93
|
Follicular lymphoma, unspecified, intra-abdominal lymph nodes
|
|
C82.94
|
Follicular lymphoma, unspecified, lymph nodes of axilla and upper limb
|
|
C82.95
|
Follicular lymphoma, unspecified, lymph nodes of inguinal region and lower limb
|
|
C82.96
|
Follicular lymphoma, unspecified, intrapelvic lymph nodes
|
|
C82.97
|
Follicular lymphoma, unspecified, spleen
|
|
C82.98
|
Follicular lymphoma, unspecified, lymph nodes of multiple sites
|
|
C82.99
|
Follicular lymphoma, unspecified, extranodal and solid organ sites
|
|
C83.00
|
Small cell B-cell lymphoma, unspecified site
|
|
C83.01
|
Small cell B-cell lymphoma, lymph nodes of head, face, and neck
|
|
C83.02
|
Small cell B-cell lymphoma, intrathoracic lymph nodes
|
|
C83.03
|
Small cell B-cell lymphoma, intra-abdominal lymph nodes
|
|
C83.04
|
Small cell B-cell lymphoma, lymph nodes of axilla and upper limb
|
|
C83.05
|
Small cell B-cell lymphoma, lymph nodes of inguinal region and lower limb
|
|
C83.06
|
Small cell B-cell lymphoma, intrapelvic lymph nodes
|
|
C83.07
|
Small cell B-cell lymphoma, spleen
|
|
C83.08
|
Small cell B-cell lymphoma, lymph nodes of multiple sites
|
|
C83.09
|
Small cell B-cell lymphoma, extranodal and solid organ sites
|
|
C83.10
|
Mantle cell lymphoma, unspecified site
|
|
C83.11
|
Mantle cell lymphoma, lymph nodes of head, face, and neck
|
|
C83.12
|
Mantle cell lymphoma, intrathoracic lymph nodes
|
|
C83.13
|
Mantle cell lymphoma, intra-abdominal lymph nodes
|
|
C83.14
|
Mantle cell lymphoma, lymph nodes of axilla and upper limb
|
|
C83.15
|
Mantle cell lymphoma, lymph nodes of inguinal region and lower limb
|
|
C83.16
|
Mantle cell lymphoma, intrapelvic lymph nodes
|
|
C83.17
|
Mantle cell lymphoma, spleen
|
|
C83.18
|
Mantle cell lymphoma, lymph nodes of multiple sites
|
|
C83.19
|
Mantle cell lymphoma, extranodal and solid organ sites
|
|
C83.30
|
Diffuse large B-cell lymphoma, unspecified site
|
|
C83.31
|
Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck
|
|
C83.32
|
Diffuse large B-cell lymphoma, intrathoracic lymph nodes
|
|
C83.33
|
Diffuse large B-cell lymphoma, intra-abdominal lymph nodes
|
|
C83.34
|
Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb
|
|
C83.35
|
Diffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb
|
|
C83.36
|
Diffuse large B-cell lymphoma, intrapelvic lymph nodes
|
|
C83.37
|
Diffuse large B-cell lymphoma, spleen
|
|
C83.38
|
Diffuse large B-cell lymphoma, lymph nodes of multiple sites
|
|
C83.39
|
Diffuse large B-cell lymphoma, extranodal and solid organ sites
|
|
C83.50
|
Lymphoblastic (diffuse) lymphoma, unspecified site
|
|
C83.51
|
Lymphoblastic (diffuse) lymphoma, lymph nodes of head, face, and neck
|
|
C83.52
|
Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes
|
|
C83.53
|
Lymphoblastic (diffuse) lymphoma, intra-abdominal lymph nodes
|
|
C83.54
|
Lymphoblastic (diffuse) lymphoma, lymph nodes of axilla and upper limb
|
|
C83.55
|
Lymphoblastic (diffuse) lymphoma, lymph nodes of inguinal region and lower limb
|
|
C83.56
|
Lymphoblastic (diffuse) lymphoma, intrapelvic lymph nodes
|
|
C83.57
|
Lymphoblastic (diffuse) lymphoma, spleen
|
|
C83.58
|
Lymphoblastic (diffuse) lymphoma, lymph nodes of multiple sites
|
|
C83.59
|
Lymphoblastic (diffuse) lymphoma, extranodal and solid organ sites
|
|
C83.70
|
Burkitt lymphoma, unspecified site
|
|
C83.71
|
Burkitt lymphoma, lymph nodes of head, face, and neck
|
|
C83.72
|
Burkitt lymphoma, intrathoracic lymph nodes
|
|
C83.73
|
Burkitt lymphoma, intra-abdominal lymph nodes
|
|
C83.74
|
Burkitt lymphoma, lymph nodes of axilla and upper limb
|
|
C83.75
|
Burkitt lymphoma, lymph nodes of inguinal region and lower limb
|
|
C83.76
|
Burkitt lymphoma, intrapelvic lymph nodes
|
|
C83.77
|
Burkitt lymphoma, spleen
|
|
C83.78
|
Burkitt lymphoma, lymph nodes of multiple sites
|
|
C83.79
|
Burkitt lymphoma, extranodal and solid organ sites
|
|
C83.80
|
Other non-follicular lymphoma, unspecified site
|
|
C83.81
|
Other non-follicular lymphoma, lymph nodes of head, face, and neck
|
|
C83.82
|
Other non-follicular lymphoma, intrathoracic lymph nodes
|
|
C83.83
|
Other non-follicular lymphoma, intra-abdominal lymph nodes
|
|
C83.84
|
Other non-follicular lymphoma, lymph nodes of axilla and upper limb
|
|
C83.85
|
Other non-follicular lymphoma, lymph nodes of inguinal region and lower limb
|
|
C83.86
|
Other non-follicular lymphoma, intrapelvic lymph nodes
|
|
C83.87
|
Other non-follicular lymphoma, spleen
|
|
C83.88
|
Other non-follicular lymphoma, lymph nodes of multiple sites
|
|
C83.89
|
Other non-follicular lymphoma, extranodal and solid organ sites
|
|
C83.90
|
Non-follicular (diffuse) lymphoma, unspecified, unspecified site
|
|
C83.91
|
Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of head, face, and neck
|
|
C83.92
|
Non-follicular (diffuse) lymphoma, unspecified, intrathoracic lymph nodes
|
|
C83.93
|
Non-follicular (diffuse) lymphoma, unspecified, intra-abdominal lymph nodes
|
|
C83.94
|
Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of axilla and upper limb
|
|
C83.95
|
Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of inguinal region and lower limb
|
|
C83.96
|
Non-follicular (diffuse) lymphoma, unspecified, intrapelvic lymph nodes
|
|
C83.97
|
Non-follicular (diffuse) lymphoma, unspecified, spleen
|
|
C83.98
|
Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of multiple sites
|
|
C83.99
|
Non-follicular (diffuse) lymphoma, unspecified, extranodal and solid organ sites
|
|
C84.00
|
Mycosis fungoides, unspecified site
|
|
C84.01
|
Mycosis fungoides, lymph nodes of head, face, and neck
|
|
C84.02
|
Mycosis fungoides, intrathoracic lymph nodes
|
|
C84.03
|
Mycosis fungoides, intra-abdominal lymph nodes
|
|
C84.04
|
Mycosis fungoides, lymph nodes of axilla and upper limb
|
|
C84.05
|
Mycosis fungoides, lymph nodes of inguinal region and lower limb
|
|
C84.06
|
Mycosis fungoides, intrapelvic lymph nodes
|
|
C84.07
|
Mycosis fungoides, spleen
|
|
C84.08
|
Mycosis fungoides, lymph nodes of multiple sites
|
|
C84.09
|
Mycosis fungoides, extranodal and solid organ sites
|
|
C84.10
|
Sezary disease, unspecified site
|
|
C84.11
|
Sezary disease, lymph nodes of head, face, and neck
|
|
C84.12
|
Sezary disease, intrathoracic lymph nodes
|
|
C84.13
|
Sezary disease, intra-abdominal lymph nodes
|
|
C84.14
|
Sezary disease, lymph nodes of axilla and upper limb
|
|
C84.15
|
Sezary disease, lymph nodes of inguinal region and lower limb
|
|
C84.16
|
Sezary disease, intrapelvic lymph nodes
|
|
C84.17
|
Sezary disease, spleen
|
|
C84.18
|
Sezary disease, lymph nodes of multiple sites
|
|
C84.19
|
Sezary disease, extranodal and solid organ sites
|
|
C84.40
|
Peripheral T-cell lymphoma, not elsewhere classified, unspecified site
|
|
C84.41
|
Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of head, face, and neck
|
|
C84.42
|
Peripheral T-cell lymphoma, not elsewhere classified, intrathoracic lymph nodes
|
|
C84.43
|
Peripheral T-cell lymphoma, not elsewhere classified, intra-abdominal lymph nodes
|
|
C84.44
|
Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of axilla and upper limb
|
|
C84.45
|
Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of inguinal region and lower limb
|
|
C84.46
|
Peripheral T-cell lymphoma, not elsewhere classified, intrapelvic lymph nodes
|
|
C84.47
|
Peripheral T-cell lymphoma, not elsewhere classified, spleen
|
|
C84.48
|
Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of multiple sites
|
|
C84.49
|
Peripheral T-cell lymphoma, not elsewhere classified, extranodal and solid organ sites
|
|
C84.60
|
Anaplastic large cell lymphoma, ALK-positive, unspecified site
|
|
C84.61
|
Anaplastic large cell lymphoma, ALK-positive, lymph nodes of head, face, and neck
|
|
C84.62
|
Anaplastic large cell lymphoma, ALK-positive, intrathoracic lymph nodes
|
|
C84.63
|
Anaplastic large cell lymphoma, ALK-positive, intra-abdominal lymph nodes
|
|
C84.64
|
Anaplastic large cell lymphoma, ALK-positive, lymph nodes of axilla and upper limb
|
|
C84.65
|
Anaplastic large cell lymphoma, ALK-positive, lymph nodes of inguinal region and lower limb
|
|
C84.66
|
Anaplastic large cell lymphoma, ALK-positive, intrapelvic lymph nodes
|
|
C84.67
|
Anaplastic large cell lymphoma, ALK-positive, spleen
|
|
C84.68
|
Anaplastic large cell lymphoma, ALK-positive, lymph nodes of multiple sites
|
|
C84.69
|
Anaplastic large cell lymphoma, ALK-positive, extranodal and solid organ sites
|
|
C84.70
|
Anaplastic large cell lymphoma, ALK-negative, unspecified site
|
|
C84.71
|
Anaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neck
|
|
C84.72
|
Anaplastic large cell lymphoma, ALK-negative, intrathoracic lymph nodes
|
|
C84.73
|
Anaplastic large cell lymphoma, ALK-negative, intra-abdominal lymph nodes
|
|
C84.74
|
Anaplastic large cell lymphoma, ALK-negative, lymph nodes of axilla and upper limb
|
|
C84.75
|
Anaplastic large cell lymphoma, ALK-negative, lymph nodes of inguinal region and lower limb
|
|
C84.76
|
Anaplastic large cell lymphoma, ALK-negative, intrapelvic lymph nodes
|
|
C84.77
|
Anaplastic large cell lymphoma, ALK-negative, spleen
|
|
C84.78
|
Anaplastic large cell lymphoma, ALK-negative, lymph nodes of multiple sites
|
|
C84.79
|
Anaplastic large cell lymphoma, ALK-negative, extranodal and solid organ sites
|
|
C84.7A
|
Anaplastic large cell lymphoma, ALK-negative, breast
|
|
C84.A0
|
Cutaneous T-cell lymphoma, unspecified, unspecified site
|
|
C84.A1
|
Cutaneous T-cell lymphoma, unspecified lymph nodes of head, face, and neck
|
|
C84.A2
|
Cutaneous T-cell lymphoma, unspecified, intrathoracic lymph nodes
|
|
C84.A3
|
Cutaneous T-cell lymphoma, unspecified, intra-abdominal lymph nodes
|
|
C84.A4
|
Cutaneous T-cell lymphoma, unspecified, lymph nodes of axilla and upper limb
|
|
C84.A5
|
Cutaneous T-cell lymphoma, unspecified, lymph nodes of inguinal region and lower limb
|
|
C84.A6
|
Cutaneous T-cell lymphoma, unspecified, intrapelvic lymph nodes
|
|
C84.A7
|
Cutaneous T-cell lymphoma, unspecified, spleen
|
|
C84.A8
|
Cutaneous T-cell lymphoma, unspecified, lymph nodes of multiple sites
|
|
C84.A9
|
Cutaneous T-cell lymphoma, unspecified, extranodal and solid organ sites
|
|
C84.Z0
|
Other mature T/NK-cell lymphomas, unspecified site
|
|
C84.Z1
|
Other mature T/NK-cell lymphomas, lymph nodes of head, face, and neck
|
|
C84.Z2
|
Other mature T/NK-cell lymphomas, intrathoracic lymph nodes
|
|
C84.Z3
|
Other mature T/NK-cell lymphomas, intra-abdominal lymph nodes
|
|
C84.Z4
|
Other mature T/NK-cell lymphomas, lymph nodes of axilla and upper limb
|
|
C84.Z5
|
Other mature T/NK-cell lymphomas, lymph nodes of inguinal region and lower limb
|
|
C84.Z6
|
Other mature T/NK-cell lymphomas, intrapelvic lymph nodes
|
|
C84.Z7
|
Other mature T/NK-cell lymphomas, spleen
|
|
C84.Z8
|
Other mature T/NK-cell lymphomas, lymph nodes of multiple sites
|
|
C84.Z9
|
Other mature T/NK-cell lymphomas, extranodal and solid organ sites
|
|
C84.90
|
Mature T/NK-cell lymphomas, unspecified, unspecified site
|
|
C84.91
|
Mature T/NK-cell lymphomas, unspecified, lymph nodes of head, face, and neck
|
|
C84.92
|
Mature T/NK-cell lymphomas, unspecified, intrathoracic lymph nodes
|
|
C84.93
|
Mature T/NK-cell lymphomas, unspecified, intra-abdominal lymph nodes
|
|
C84.94
|
Mature T/NK-cell lymphomas, unspecified, lymph nodes of axilla and upper limb
|
|
C84.95
|
Mature T/NK-cell lymphomas, unspecified, lymph nodes of inguinal region and lower limb
|
|
C84.96
|
Mature T/NK-cell lymphomas, unspecified, intrapelvic lymph nodes
|
|
C84.97
|
Mature T/NK-cell lymphomas, unspecified, spleen
|
|
C84.98
|
Mature T/NK-cell lymphomas, unspecified, lymph nodes of multiple sites
|
|
C84.99
|
Mature T/NK-cell lymphomas, unspecified, extranodal and solid organ sites
|
|
C85.10
|
Unspecified B-cell lymphoma, unspecified site
|
|
C85.11
|
Unspecified B-cell lymphoma, lymph nodes of head, face, and neck
|
|
C85.12
|
Unspecified B-cell lymphoma, intrathoracic lymph nodes
|
|
C85.13
|
Unspecified B-cell lymphoma, intra-abdominal lymph nodes
|
|
C85.14
|
Unspecified B-cell lymphoma, lymph nodes of axilla and upper limb
|
|
C85.15
|
Unspecified B-cell lymphoma, lymph nodes of inguinal region and lower limb
|
|
C85.16
|
Unspecified B-cell lymphoma, intrapelvic lymph nodes
|
|
C85.17
|
Unspecified B-cell lymphoma, spleen
|
|
C85.18
|
Unspecified B-cell lymphoma, lymph nodes of multiple sites
|
|
C85.19
|
Unspecified B-cell lymphoma, extranodal and solid organ sites
|
|
C85.20
|
Mediastinal (thymic) large B-cell lymphoma, unspecified site
|
|
C85.21
|
Mediastinal (thymic) large B-cell lymphoma, lymph nodes of head, face, and neck
|
|
C85.22
|
Mediastinal (thymic) large B-cell lymphoma, intrathoracic lymph nodes
|
|
C85.23
|
Mediastinal (thymic) large B-cell lymphoma, intra-abdominal lymph nodes
|
|
C85.24
|
Mediastinal (thymic) large B-cell lymphoma, lymph nodes of axilla and upper limb
|
|
C85.25
|
Mediastinal (thymic) large B-cell lymphoma, lymph nodes of inguinal region and lower limb
|
|
C85.26
|
Mediastinal (thymic) large B-cell lymphoma, intrapelvic lymph nodes
|
|
C85.27
|
Mediastinal (thymic) large B-cell lymphoma, spleen
|
|
C85.28
|
Mediastinal (thymic) large B-cell lymphoma, lymph nodes of multiple sites
|
|
C85.29
|
Mediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites
|
|
C85.80
|
Other specified types of non-Hodgkin lymphoma, unspecified site
|
|
C85.81
|
Other specified types of non-Hodgkin lymphoma, lymph nodes of head, face, and neck
|
|
C85.82
|
Other specified types of non-Hodgkin lymphoma, intrathoracic lymph nodes
|
|
C85.83
|
Other specified types of non-Hodgkin lymphoma, intra-abdominal lymph nodes
|
|
C85.84
|
Other specified types of non-Hodgkin lymphoma, lymph nodes of axilla and upper limb
|
|
C85.85
|
Other specified types of non-Hodgkin lymphoma, lymph nodes of inguinal region and lower limb
|
|
C85.86
|
Other specified types of non-Hodgkin lymphoma, intrapelvic lymph nodes
|
|
C85.87
|
Other specified types of non-Hodgkin lymphoma, spleen
|
|
C85.88
|
Other specified types of non-Hodgkin lymphoma, lymph nodes of multiple sites
|
|
C85.89
|
Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites
|
|
C85.90
|
Non-Hodgkin lymphoma, unspecified, unspecified site
|
|
C85.91
|
Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck
|
|
C85.92
|
Non-Hodgkin lymphoma, unspecified, intrathoracic lymph nodes
|
|
C85.93
|
Non-Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes
|
|
C85.94
|
Non-Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb
|
|
C85.95
|
Non-Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb
|
|
C85.96
|
Non-Hodgkin lymphoma, unspecified, intrapelvic lymph nodes
|
|
C85.97
|
Non-Hodgkin lymphoma, unspecified, spleen
|
|
C85.98
|
Non-Hodgkin lymphoma, unspecified, lymph nodes of multiple sites
|
|
C85.99
|
Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites
|
|
C86.0
|
Extranodal NK/T-cell lymphoma, nasal type
|
|
C86.1
|
Hepatosplenic T-cell lymphoma
|
|
C86.2
|
Enteropathy-type (intestinal) T-cell lymphoma
|
|
C86.3
|
Subcutaneous panniculitis-like T-cell lymphoma
|
|
C86.4
|
Blastic NK-cell lymphoma
|
|
C86.5
|
Angioimmunoblastic T-cell lymphoma
|
|
C86.6
|
Primary cutaneous CD30-positive T-cell proliferations
|
|
C88.2
|
Heavy chain disease
|
|
C88.3
|
Immunoproliferative small intestinal disease
|
|
C88.4
|
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
|
|
C88.8
|
Other malignant immunoproliferative diseases
|
|
C88.9
|
Malignant immunoproliferative disease, unspecified
|
|
C90.00
|
Multiple myeloma not having achieved remission
|
|
C90.01
|
Multiple myeloma in remission
|
|
C90.02
|
Multiple myeloma in relapse
|
|
C90.10
|
Plasma cell leukemia not having achieved remission
|
|
C90.11
|
Plasma cell leukemia in remission
|
|
C90.12
|
Plasma cell leukemia in relapse
|
|
C90.20
|
Extramedullary plasmacytoma not having achieved remission
|
|
C90.21
|
Extramedullary plasmacytoma in remission
|
|
C90.22
|
Extramedullary plasmacytoma in relapse
|
|
C90.30
|
Solitary plasmacytoma not having achieved remission
|
|
C90.31
|
Solitary plasmacytoma in remission
|
|
C90.32
|
Solitary plasmacytoma in relapse
|
|
C91.00
|
Acute lymphoblastic leukemia not having achieved remission
|
|
C91.01
|
Acute lymphoblastic leukemia, in remission
|
|
C91.02
|
Acute lymphoblastic leukemia, in relapse
|
|
C91.10
|
Chronic lymphocytic leukemia of B-cell type not having achieved remission
|
|
C91.11
|
Chronic lymphocytic leukemia of B-cell type in remission
|
|
C91.12
|
Chronic lymphocytic leukemia of B-cell type in relapse
|
|
C91.30
|
Prolymphocytic leukemia of B-cell type not having achieved remission
|
|
C91.31
|
Prolymphocytic leukemia of B-cell type, in remission
|
|
C91.32
|
Prolymphocytic leukemia of B-cell type, in relapse
|
|
C91.40
|
Hairy cell leukemia not having achieved remission
|
|
C91.41
|
Hairy cell leukemia, in remission
|
|
C91.42
|
Hairy cell leukemia, in relapse
|
|
C91.50
|
Adult T-cell lymphoma/leukemia (HTLV-1-associated) not having achieved remission
|
|
C91.51
|
Adult T-cell lymphoma/leukemia (HTLV-1-associated), in remission
|
|
C91.52
|
Adult T-cell lymphoma/leukemia (HTLV-1-associated), in relapse
|
|
C91.60
|
Prolymphocytic leukemia of T-cell type not having achieved remission
|
|
C91.61
|
Prolymphocytic leukemia of T-cell type, in remission
|
|
C91.62
|
Prolymphocytic leukemia of T-cell type, in relapse
|
|
C91.A0
|
Mature B-cell leukemia Burkitt-type not having achieved remission
|
|
C91.A1
|
Mature B-cell leukemia Burkitt-type, in remission
|
|
C91.A2
|
Mature B-cell leukemia Burkitt-type, in relapse
|
|
C91.Z0
|
Other lymphoid leukemia not having achieved remission
|
|
C91.Z1
|
Other lymphoid leukemia, in remission
|
|
C91.Z2
|
Other lymphoid leukemia, in relapse
|
|
C91.90
|
Lymphoid leukemia, unspecified not having achieved remission
|
|
C91.91
|
Lymphoid leukemia, unspecified, in remission
|
|
C91.92
|
Lymphoid leukemia, unspecified, in relapse
|
|
C92.00
|
Acute myeloblastic leukemia, not having achieved remission
|
|
C92.01
|
Acute myeloblastic leukemia, in remission
|
|
C92.02
|
Acute myeloblastic leukemia, in relapse
|
|
C92.10
|
Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission
|
|
C92.11
|
Chronic myeloid leukemia, BCR/ABL-positive, in remission
|
|
C92.12
|
Chronic myeloid leukemia, BCR/ABL-positive, in relapse
|
|
C92.20
|
Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission
|
|
C92.21
|
Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission
|
|
C92.22
|
Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse
|
|
C92.30
|
Myeloid sarcoma, not having achieved remission
|
|
C92.31
|
Myeloid sarcoma, in remission
|
|
C92.32
|
Myeloid sarcoma, in relapse
|
|
C92.40
|
Acute promyelocytic leukemia, not having achieved remission
|
|
C92.41
|
Acute promyelocytic leukemia, in remission
|
|
C92.42
|
Acute promyelocytic leukemia, in relapse
|
|
C92.50
|
Acute myelomonocytic leukemia, not having achieved remission
|
|
C92.51
|
Acute myelomonocytic leukemia, in remission
|
|
C92.52
|
Acute myelomonocytic leukemia, in relapse
|
|
C92.60
|
Acute myeloid leukemia with 11q23-abnormality not having achieved remission
|
|
C92.61
|
Acute myeloid leukemia with 11q23-abnormality in remission
|
|
C92.62
|
Acute myeloid leukemia with 11q23-abnormality in relapse
|
|
C92.A0
|
Acute myeloid leukemia with multilineage dysplasia, not having achieved remission
|
|
C92.A1
|
Acute myeloid leukemia with multilineage dysplasia, in remission
|
|
C92.A2
|
Acute myeloid leukemia with multilineage dysplasia, in relapse
|
|
C92.Z0
|
Other myeloid leukemia not having achieved remission
|
|
C92.Z1
|
Other myeloid leukemia, in remission
|
|
C92.Z2
|
Other myeloid leukemia, in relapse
|
|
C92.90
|
Myeloid leukemia, unspecified, not having achieved remission
|
|
C92.91
|
Myeloid leukemia, unspecified in remission
|
|
C92.92
|
Myeloid leukemia, unspecified in relapse
|
|
C93.00
|
Acute monoblastic/monocytic leukemia, not having achieved remission
|
|
C93.01
|
Acute monoblastic/monocytic leukemia, in remission
|
|
C93.02
|
Acute monoblastic/monocytic leukemia, in relapse
|
|
C93.10
|
Chronic myelomonocytic leukemia not having achieved remission
|
|
C93.11
|
Chronic myelomonocytic leukemia, in remission
|
|
C93.12
|
Chronic myelomonocytic leukemia, in relapse
|
|
C93.30
|
Juvenile myelomonocytic leukemia, not having achieved remission
|
|
C93.31
|
Juvenile myelomonocytic leukemia, in remission
|
|
C93.32
|
Juvenile myelomonocytic leukemia, in relapse
|
|
C93.Z0
|
Other monocytic leukemia, not having achieved remission
|
|
C93.Z1
|
Other monocytic leukemia, in remission
|
|
C93.Z2
|
Other monocytic leukemia, in relapse
|
|
C93.90
|
Monocytic leukemia, unspecified, not having achieved remission
|
|
C93.91
|
Monocytic leukemia, unspecified in remission
|
|
C93.92
|
Monocytic leukemia, unspecified in relapse
|
|
C94.00
|
Acute erythroid leukemia, not having achieved remission
|
|
C94.01
|
Acute erythroid leukemia, in remission
|
|
C94.02
|
Acute erythroid leukemia, in relapse
|
|
C94.20
|
Acute megakaryoblastic leukemia not having achieved remission
|
|
C94.21
|
Acute megakaryoblastic leukemia, in remission
|
|
C94.22
|
Acute megakaryoblastic leukemia, in relapse
|
|
C94.30
|
Mast cell leukemia not having achieved remission
|
|
C94.31
|
Mast cell leukemia, in remission
|
|
C94.32
|
Mast cell leukemia, in relapse
|
|
C94.80
|
Other specified leukemias not having achieved remission
|
|
C94.81
|
Other specified leukemias, in remission
|
|
C94.82
|
Other specified leukemias, in relapse
|
|
C95.00
|
Acute leukemia of unspecified cell type not having achieved remission
|
|
C95.01
|
Acute leukemia of unspecified cell type, in remission
|
|
C95.02
|
Acute leukemia of unspecified cell type, in relapse
|
|
C95.10
|
Chronic leukemia of unspecified cell type not having achieved remission
|
|
C95.11
|
Chronic leukemia of unspecified cell type, in remission
|
|
C95.12
|
Chronic leukemia of unspecified cell type, in relapse
|
|
C95.90
|
Leukemia, unspecified not having achieved remission
|
|
C95.91
|
Leukemia, unspecified, in remission
|
|
C95.92
|
Leukemia, unspecified, in relapse
|
|
C96.0
|
Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis
|
|
C96.4
|
Sarcoma of dendritic cells (accessory cells)
|
|
C96.A
|
Histiocytic sarcoma
|
|
C96.Z
|
Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue
|
|
C96.9
|
Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified
|
|
D14.0
|
Benign neoplasm of middle ear, nasal cavity and accessory sinuses
|
|
D16.4
|
Benign neoplasm of bones of skull and face
|
|
D18.02
|
Hemangioma of intracranial structures
|
|
D21.0
|
Benign neoplasm of connective and other soft tissue of head, face and neck
|
|
D31.60
|
Benign neoplasm of unspecified site of unspecified orbit
|
|
D31.61
|
Benign neoplasm of unspecified site of right orbit
|
|
D31.62
|
Benign neoplasm of unspecified site of left orbit
|
|
D32.0
|
Benign neoplasm of cerebral meninges
|
|
D32.9
|
Benign neoplasm of meninges, unspecified
|
|
D33.0
|
Benign neoplasm of brain, supratentorial
|
|
D33.1
|
Benign neoplasm of brain, infratentorial
|
|
D33.2
|
Benign neoplasm of brain, unspecified
|
|
D33.3
|
Benign neoplasm of cranial nerves
|
|
D35.2
|
Benign neoplasm of pituitary gland
|
|
D35.3
|
Benign neoplasm of craniopharyngeal duct
|
|
D35.4
|
Benign neoplasm of pineal gland
|
|
D3A.00
|
Benign carcinoid tumor of unspecified site
|
|
D3A.010
|
Benign carcinoid tumor of the duodenum
|
|
D3A.011
|
Benign carcinoid tumor of the jejunum
|
|
D3A.012
|
Benign carcinoid tumor of the ileum
|
|
D3A.019
|
Benign carcinoid tumor of the small intestine, unspecified portion
|
|
D3A.020
|
Benign carcinoid tumor of the appendix
|
|
D3A.021
|
Benign carcinoid tumor of the cecum
|
|
D3A.022
|
Benign carcinoid tumor of the ascending colon
|
|
D3A.023
|
Benign carcinoid tumor of the transverse colon
|
|
D3A.024
|
Benign carcinoid tumor of the descending colon
|
|
D3A.025
|
Benign carcinoid tumor of the sigmoid colon
|
|
D3A.026
|
Benign carcinoid tumor of the rectum
|
|
D3A.029
|
Benign carcinoid tumor of the large intestine, unspecified portion
|
|
D3A.090
|
Benign carcinoid tumor of the bronchus and lung
|
|
D3A.091
|
Benign carcinoid tumor of the thymus
|
|
D3A.092
|
Benign carcinoid tumor of the stomach
|
|
D3A.093
|
Benign carcinoid tumor of the kidney
|
|
D3A.094
|
Benign carcinoid tumor of the foregut, unspecified
|
|
D3A.095
|
Benign carcinoid tumor of the midgut, unspecified
|
|
D3A.096
|
Benign carcinoid tumor of the hindgut, unspecified
|
|
D3A.098
|
Benign carcinoid tumors of other sites
|
|
D3A.8
|
Other benign neuroendocrine tumors
|
|
D42.0
|
Neoplasm of uncertain behavior of cerebral meninges
|
|
D42.1
|
Neoplasm of uncertain behavior of spinal meninges
|
|
D42.9
|
Neoplasm of uncertain behavior of meninges, unspecified
|
|
D43.0
|
Neoplasm of uncertain behavior of brain, supratentorial
|
|
D43.1
|
Neoplasm of uncertain behavior of brain, infratentorial
|
|
D43.2
|
Neoplasm of uncertain behavior of brain, unspecified
|
|
D43.3
|
Neoplasm of uncertain behavior of cranial nerves
|
|
D43.4
|
Neoplasm of uncertain behavior of spinal cord
|
|
D43.8
|
Neoplasm of uncertain behavior of other specified parts of central nervous system
|
|
D43.9
|
Neoplasm of uncertain behavior of central nervous system, unspecified
|
|
D44.0
|
Neoplasm of uncertain behavior of thyroid gland
|
|
D44.10
|
Neoplasm of uncertain behavior of unspecified adrenal gland
|
|
D44.11
|
Neoplasm of uncertain behavior of right adrenal gland
|
|
D44.12
|
Neoplasm of uncertain behavior of left adrenal gland
|
|
D44.2
|
Neoplasm of uncertain behavior of parathyroid gland
|
|
D44.3
|
Neoplasm of uncertain behavior of pituitary gland
|
|
D44.4
|
Neoplasm of uncertain behavior of craniopharyngeal duct
|
|
D44.5
|
Neoplasm of uncertain behavior of pineal gland
|
|
D44.6
|
Neoplasm of uncertain behavior of carotid body
|
|
D44.7
|
Neoplasm of uncertain behavior of aortic body and other paraganglia
|
|
D45
|
Polycythemia vera
|
|
D47.Z1
|
Post-transplant lymphoproliferative disorder (PTLD)
|
|
D47.Z2
|
Castleman disease
|
|
D49.511
|
Neoplasm of unspecified behavior of right kidney
|
|
D49.512
|
Neoplasm of unspecified behavior of left kidney
|
|
D49.519
|
Neoplasm of unspecified behavior of unspecified kidney
|
|
D49.59
|
Neoplasm of unspecified behavior of other genitourinary organ
|
|
D49.6
|
Neoplasm of unspecified behavior of brain
|
|
D69.59
|
Other secondary thrombocytopenia
|
|
D86.0
|
Sarcoidosis of lung
|
|
D86.1
|
Sarcoidosis of lymph nodes
|
|
D86.2
|
Sarcoidosis of lung with sarcoidosis of lymph nodes
|
|
D86.3
|
Sarcoidosis of skin
|
|
D86.81
|
Sarcoid meningitis
|
|
D86.82
|
Multiple cranial nerve palsies in sarcoidosis
|
|
D86.83
|
Sarcoid iridocyclitis
|
|
D86.84
|
Sarcoid pyelonephritis
|
|
D86.85
|
Sarcoid myocarditis
|
|
D86.86
|
Sarcoid arthropathy
|
|
D86.87
|
Sarcoid myositis
|
|
D86.89
|
Sarcoidosis of other sites
|
|
D86.9
|
Sarcoidosis, unspecified
|
|
E03.5
|
Myxedema coma
|
|
E15
|
Nondiabetic hypoglycemic coma
|
|
E22.0
|
Acromegaly and pituitary gigantism
|
|
E22.1
|
Hyperprolactinemia
|
|
E22.2
|
Syndrome of inappropriate secretion of antidiuretic hormone
|
|
E22.8
|
Other hyperfunction of pituitary gland
|
|
E22.9
|
Hyperfunction of pituitary gland, unspecified
|
|
E23.0
|
Hypopituitarism
|
|
E23.1
|
Drug-induced hypopituitarism
|
|
E23.2
|
Diabetes insipidus
|
|
E23.3
|
Hypothalamic dysfunction, not elsewhere classified
|
|
E23.6
|
Other disorders of pituitary gland
|
|
E23.7
|
Disorder of pituitary gland, unspecified
|
|
E24.0
|
Pituitary-dependent Cushing's disease
|
|
E24.1
|
Nelson's syndrome
|
|
E24.2
|
Drug-induced Cushing's syndrome
|
|
E24.3
|
Ectopic ACTH syndrome
|
|
E24.4
|
Alcohol-induced pseudo-Cushing's syndrome
|
|
E24.8
|
Other Cushing's syndrome
|
|
E24.9
|
Cushing's syndrome, unspecified
|
|
E31.21
|
Multiple endocrine neoplasia [MEN] type I
|
|
E34.4
|
Constitutional tall stature
|
|
E36.01
|
Intraoperative hemorrhage and hematoma of an endocrine system organ or structure complicating an endocrine system procedure
|
|
E36.02
|
Intraoperative hemorrhage and hematoma of an endocrine system organ or structure complicating other procedure
|
|
E75.00
|
GM2 gangliosidosis, unspecified
|
|
E75.01
|
Sandhoff disease
|
|
E75.02
|
Tay-Sachs disease
|
|
E75.09
|
Other GM2 gangliosidosis
|
|
E75.10
|
Unspecified gangliosidosis
|
|
E75.11
|
Mucolipidosis IV
|
|
E75.19
|
Other gangliosidosis
|
|
E75.23
|
Krabbe disease
|
|
E75.244
|
Niemann-Pick disease type A/B
|
|
E75.25
|
Metachromatic leukodystrophy
|
|
E75.29
|
Other sphingolipidosis
|
|
E75.4
|
Neuronal ceroid lipofuscinosis
|
|
E85.1
|
Neuropathic heredofamilial amyloidosis
|
|
E85.2
|
Heredofamilial amyloidosis, unspecified
|
|
E85.3
|
Secondary systemic amyloidosis
|
|
E85.4
|
Organ-limited amyloidosis
|
|
E85.81
|
Light chain (AL) amyloidosis
|
|
E85.82
|
Wild-type transthyretin-related (ATTR) amyloidosis
|
|
E85.89
|
Other amyloidosis
|
|
E85.9
|
Amyloidosis, unspecified
|
|
E89.3
|
Postprocedural hypopituitarism
|
|
E89.820
|
Postprocedural hematoma of an endocrine system organ or structure following an endocrine system procedure
|
|
E89.821
|
Postprocedural hematoma of an endocrine system organ or structure following other procedure
|
|
E89.822
|
Postprocedural seroma of an endocrine system organ or structure following an endocrine system procedure
|
|
E89.823
|
Postprocedural seroma of an endocrine system organ or structure following other procedure
|
|
F01.50
|
Vascular dementia, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
|
|
F01.511
|
Vascular dementia, unspecified severity, with agitation
|
|
F01.518
|
Vascular dementia, unspecified severity, with other behavioral disturbance
|
|
F01.52
|
Vascular dementia, unspecified severity, with psychotic disturbance
|
|
F01.53
|
Vascular dementia, unspecified severity, with mood disturbance
|
|
F01.54
|
Vascular dementia, unspecified severity, with anxiety
|
|
F01.A0
|
Vascular dementia, mild, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
|
|
F01.A11
|
Vascular dementia, mild, with agitation
|
|
F01.A18
|
Vascular dementia, mild, with other behavioral disturbance
|
|
F01.A2
|
Vascular dementia, mild, with psychotic disturbance
|
|
F01.A3
|
Vascular dementia, mild, with mood disturbance
|
|
F01.A4
|
Vascular dementia, mild, with anxiety
|
|
F01.B0
|
Vascular dementia, moderate, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
|
|
F01.B11
|
Vascular dementia, moderate, with agitation
|
|
F01.B18
|
Vascular dementia, moderate, with other behavioral disturbance
|
|
F01.B2
|
Vascular dementia, moderate, with psychotic disturbance
|
|
F01.B3
|
Vascular dementia, moderate, with mood disturbance
|
|
F01.B4
|
Vascular dementia, moderate, with anxiety
|
|
F01.C0
|
Vascular dementia, severe, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
|
|
F01.C11
|
Vascular dementia, severe, with agitation
|
|
F01.C18
|
Vascular dementia, severe, with other behavioral disturbance
|
|
F01.C2
|
Vascular dementia, severe, with psychotic disturbance
|
|
F01.C3
|
Vascular dementia, severe, with mood disturbance
|
|
F01.C4
|
Vascular dementia, severe, with anxiety
|
|
F02.80
|
Dementia in other diseases classified elsewhere, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
|
|
F02.811
|
Dementia in other diseases classified elsewhere, unspecified severity, with agitation
|
|
F02.818
|
Dementia in other diseases classified elsewhere, unspecified severity, with other behavioral disturbance
|
|
F02.82
|
Dementia in other diseases classified elsewhere, unspecified severity, with psychotic disturbance
|
|
F02.83
|
Dementia in other diseases classified elsewhere, unspecified severity, with mood disturbance
|
|
F02.84
|
Dementia in other diseases classified elsewhere, unspecified severity, with anxiety
|
|
F02.A0
|
Dementia in other diseases classified elsewhere, mild, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
|
|
F02.A11
|
Dementia in other diseases classified elsewhere, mild, with agitation
|
|
F02.A18
|
Dementia in other diseases classified elsewhere, mild, with other behavioral disturbance
|
|
F02.A2
|
Dementia in other diseases classified elsewhere, mild, with psychotic disturbance
|
|
F02.A3
|
Dementia in other diseases classified elsewhere, mild, with mood disturbance
|
|
F02.A4
|
Dementia in other diseases classified elsewhere, mild, with anxiety
|
|
F02.B0
|
Dementia in other diseases classified elsewhere, moderate, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
|
|
F02.B11
|
Dementia in other diseases classified elsewhere, moderate, with agitation
|
|
F02.B18
|
Dementia in other diseases classified elsewhere, moderate, with other behavioral disturbance
|
|
F02.B2
|
Dementia in other diseases classified elsewhere, moderate, with psychotic disturbance
|
|
F02.B3
|
Dementia in other diseases classified elsewhere, moderate, with mood disturbance
|
|
F02.B4
|
Dementia in other diseases classified elsewhere, moderate, with anxiety
|
|
F02.C0
|
Dementia in other diseases classified elsewhere, severe, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
|
|
F02.C11
|
Dementia in other diseases classified elsewhere, severe, with agitation
|
|
F02.C18
|
Dementia in other diseases classified elsewhere, severe, with other behavioral disturbance
|
|
F02.C2
|
Dementia in other diseases classified elsewhere, severe, with psychotic disturbance
|
|
F02.C3
|
Dementia in other diseases classified elsewhere, severe, with mood disturbance
|
|
F02.C4
|
Dementia in other diseases classified elsewhere, severe, with anxiety
|
|
F03.90
|
Unspecified dementia, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
|
|
F05
|
Delirium due to known physiological condition
|
|
F06.0
|
Psychotic disorder with hallucinations due to known physiological condition
|
|
F06.1
|
Catatonic disorder due to known physiological condition
|
|
F06.2
|
Psychotic disorder with delusions due to known physiological condition
|
|
F06.30
|
Mood disorder due to known physiological condition, unspecified
|
|
F06.31
|
Mood disorder due to known physiological condition with depressive features
|
|
F06.32
|
Mood disorder due to known physiological condition with major depressive-like episode
|
|
F06.33
|
Mood disorder due to known physiological condition with manic features
|
|
F06.34
|
Mood disorder due to known physiological condition with mixed features
|
|
F06.4
|
Anxiety disorder due to known physiological condition
|
|
F06.8
|
Other specified mental disorders due to known physiological condition
|
|
F07.0
|
Personality change due to known physiological condition
|
|
F07.81
|
Postconcussional syndrome
|
|
F07.89
|
Other personality and behavioral disorders due to known physiological condition
|
|
F07.9
|
Unspecified personality and behavioral disorder due to known physiological condition
|
|
F09
|
Unspecified mental disorder due to known physiological condition
|
|
F10.11
|
Alcohol abuse, in remission
|
|
F10.121
|
Alcohol abuse with intoxication delirium
|
|
F10.130
|
Alcohol abuse with withdrawal, uncomplicated
|
|
F10.131
|
Alcohol abuse with withdrawal delirium
|
|
F10.132
|
Alcohol abuse with withdrawal with perceptual disturbance
|
|
F10.139
|
Alcohol abuse with withdrawal, unspecified
|
|
F10.221
|
Alcohol dependence with intoxication delirium
|
|
F10.231
|
Alcohol dependence with withdrawal delirium
|
|
F10.26
|
Alcohol dependence with alcohol-induced persisting amnestic disorder
|
|
F10.27
|
Alcohol dependence with alcohol-induced persisting dementia
|
|
F10.921
|
Alcohol use, unspecified with intoxication delirium
|
|
F10.930
|
Alcohol use, unspecified with withdrawal, uncomplicated
|
|
F10.931
|
Alcohol use, unspecified with withdrawal delirium
|
|
F10.932
|
Alcohol use, unspecified with withdrawal with perceptual disturbance
|
|
F10.939
|
Alcohol use, unspecified with withdrawal, unspecified
|
|
F10.96
|
Alcohol use, unspecified with alcohol-induced persisting amnestic disorder
|
|
F10.97
|
Alcohol use, unspecified with alcohol-induced persisting dementia
|
|
F20.81
|
Schizophreniform disorder
|
|
F28
|
Other psychotic disorder not due to a substance or known physiological condition
|
|
F29
|
Unspecified psychosis not due to a substance or known physiological condition
|
|
F44.89
|
Other dissociative and conversion disorders
|
|
F48.2
|
Pseudobulbar affect
|
|
F51.04
|
Psychophysiologic insomnia
|
|
F51.05
|
Insomnia due to other mental disorder
|
|
F51.13
|
Hypersomnia due to other mental disorder
|
|
F51.19
|
Other hypersomnia not due to a substance or known physiological condition
|
|
F53.0
|
Postpartum depression
|
|
F53.1
|
Puerperal psychosis
|
|
F63.81
|
Intermittent explosive disorder
|
|
F84.2
|
Rett's syndrome
|
|
G02
|
Meningitis in other infectious and parasitic diseases classified elsewhere
|
|
G03.2
|
Benign recurrent meningitis [Mollaret]
|
|
G04.1
|
Tropical spastic paraplegia
|
|
G10
|
Huntington's disease
|
|
G11.0
|
Congenital nonprogressive ataxia
|
|
G11.10
|
Early-onset cerebellar ataxia, unspecified
|
|
G11.11
|
Friedreich ataxia
|
|
G11.2
|
Late-onset cerebellar ataxia
|
|
G11.3
|
Cerebellar ataxia with defective DNA repair
|
|
G11.4
|
Hereditary spastic paraplegia
|
|
G11.8
|
Other hereditary ataxias
|
|
G11.9
|
Hereditary ataxia, unspecified
|
|
G12.0
|
Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]
|
|
G12.1
|
Other inherited spinal muscular atrophy
|
|
G12.20
|
Motor neuron disease, unspecified
|
|
G12.21
|
Amyotrophic lateral sclerosis
|
|
G12.22
|
Progressive bulbar palsy
|
|
G12.24
|
Familial motor neuron disease
|
|
G12.29
|
Other motor neuron disease
|
|
G12.8
|
Other spinal muscular atrophies and related syndromes
|
|
G12.9
|
Spinal muscular atrophy, unspecified
|
|
G13.2
|
Systemic atrophy primarily affecting the central nervous system in myxedema
|
|
G13.8
|
Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere
|
|
G20
|
Parkinson's disease
|
|
G21.0
|
Malignant neuroleptic syndrome
|
|
G21.11
|
Neuroleptic induced parkinsonism
|
|
G21.19
|
Other drug induced secondary parkinsonism
|
|
G21.2
|
Secondary parkinsonism due to other external agents
|
|
G21.3
|
Postencephalitic parkinsonism
|
|
G21.4
|
Vascular parkinsonism
|
|
G21.8
|
Other secondary parkinsonism
|
|
G21.9
|
Secondary parkinsonism, unspecified
|
|
G23.0
|
Hallervorden-Spatz disease
|
|
G23.1
|
Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
|
|
G23.2
|
Striatonigral degeneration
|
|
G23.8
|
Other specified degenerative diseases of basal ganglia
|
|
G23.9
|
Degenerative disease of basal ganglia, unspecified
|
|
G24.01
|
Drug induced subacute dyskinesia
|
|
G24.02
|
Drug induced acute dystonia
|
|
G24.09
|
Other drug induced dystonia
|
|
G24.1
|
Genetic torsion dystonia
|
|
G24.2
|
Idiopathic nonfamilial dystonia
|
|
G24.3
|
Spasmodic torticollis
|
|
G24.4
|
Idiopathic orofacial dystonia
|
|
G24.5
|
Blepharospasm
|
|
G24.8
|
Other dystonia
|
|
G24.9
|
Dystonia, unspecified
|
|
G25.0
|
Essential tremor
|
|
G25.1
|
Drug-induced tremor
|
|
G25.2
|
Other specified forms of tremor
|
|
G25.3
|
Myoclonus
|
|
G25.4
|
Drug-induced chorea
|
|
G25.5
|
Other chorea
|
|
G25.61
|
Drug induced tics
|
|
G25.69
|
Other tics of organic origin
|
|
G25.70
|
Drug induced movement disorder, unspecified
|
|
G25.71
|
Drug induced akathisia
|
|
G25.79
|
Other drug induced movement disorders
|
|
G25.81
|
Restless legs syndrome
|
|
G25.82
|
Stiff-man syndrome
|
|
G25.83
|
Benign shuddering attacks
|
|
G25.89
|
Other specified extrapyramidal and movement disorders
|
|
G25.9
|
Extrapyramidal and movement disorder, unspecified
|
|
G26
|
Extrapyramidal and movement disorders in diseases classified elsewhere
|
|
G30.0
|
Alzheimer's disease with early onset
|
|
G30.1
|
Alzheimer's disease with late onset
|
|
G30.8
|
Other Alzheimer's disease
|
|
G30.9
|
Alzheimer's disease, unspecified
|
|
G31.01
|
Pick's disease
|
|
G31.09
|
Other frontotemporal neurocognitive disorder
|
|
G31.1
|
Senile degeneration of brain, not elsewhere classified
|
|
G31.2
|
Degeneration of nervous system due to alcohol
|
|
G31.81
|
Alpers disease
|
|
G31.82
|
Leigh's disease
|
|
G31.85
|
Corticobasal degeneration
|
|
G32.0
|
Subacute combined degeneration of spinal cord in diseases classified elsewhere
|
|
G32.81
|
Cerebellar ataxia in diseases classified elsewhere
|
|
G35
|
Multiple sclerosis
|
|
G36.0
|
Neuromyelitis optica [Devic]
|
|
G36.1
|
Acute and subacute hemorrhagic leukoencephalitis [Hurst]
|
|
G36.8
|
Other specified acute disseminated demyelination
|
|
G36.9
|
Acute disseminated demyelination, unspecified
|
|
G37.0
|
Diffuse sclerosis of central nervous system
|
|
G37.1
|
Central demyelination of corpus callosum
|
|
G37.2
|
Central pontine myelinolysis
|
|
G37.3
|
Acute transverse myelitis in demyelinating disease of central nervous system
|
|
G37.5
|
Concentric sclerosis [Balo] of central nervous system
|
|
G37.9
|
Demyelinating disease of central nervous system, unspecified
|
|
G40.001
|
Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, with status epilepticus
|
|
G40.009
|
Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus
|
|
G40.011
|
Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, with status epilepticus
|
|
G40.019
|
Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status epilepticus
|
|
G40.101
|
Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, with status epilepticus
|
|
G40.109
|
Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus
|
|
G40.111
|
Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, with status epilepticus
|
|
G40.119
|
Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, without status epilepticus
|
|
G40.201
|
Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, with status epilepticus
|
|
G40.209
|
Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus
|
|
G40.211
|
Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, with status epilepticus
|
|
G40.219
|
Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, without status epilepticus
|
|
G40.301
|
Generalized idiopathic epilepsy and epileptic syndromes, not intractable, with status epilepticus
|
|
G40.309
|
Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus
|
|
G40.311
|
Generalized idiopathic epilepsy and epileptic syndromes, intractable, with status epilepticus
|
|
G40.319
|
Generalized idiopathic epilepsy and epileptic syndromes, intractable, without status epilepticus
|
|
G40.A01
|
Absence epileptic syndrome, not intractable, with status epilepticus
|
|
G40.A09
|
Absence epileptic syndrome, not intractable, without status epilepticus
|
|
G40.A11
|
Absence epileptic syndrome, intractable, with status epilepticus
|
|
G40.A19
|
Absence epileptic syndrome, intractable, without status epilepticus
|
|
G40.B01
|
Juvenile myoclonic epilepsy, not intractable, with status epilepticus
|
|
G40.B09
|
Juvenile myoclonic epilepsy, not intractable, without status epilepticus
|
|
G40.B11
|
Juvenile myoclonic epilepsy, intractable, with status epilepticus
|
|
G40.B19
|
Juvenile myoclonic epilepsy, intractable, without status epilepticus
|
|
G40.401
|
Other generalized epilepsy and epileptic syndromes, not intractable, with status epilepticus
|
|
G40.409
|
Other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus
|
|
G40.411
|
Other generalized epilepsy and epileptic syndromes, intractable, with status epilepticus
|
|
G40.419
|
Other generalized epilepsy and epileptic syndromes, intractable, without status epilepticus
|
|
G40.42
|
Cyclin-Dependent Kinase-Like 5 Deficiency Disorder
|
|
G40.501
|
Epileptic seizures related to external causes, not intractable, with status epilepticus
|
|
G40.509
|
Epileptic seizures related to external causes, not intractable, without status epilepticus
|
|
G40.801
|
Other epilepsy, not intractable, with status epilepticus
|
|
G40.802
|
Other epilepsy, not intractable, without status epilepticus
|
|
G40.803
|
Other epilepsy, intractable, with status epilepticus
|
|
G40.804
|
Other epilepsy, intractable, without status epilepticus
|
|
G40.811
|
Lennox-Gastaut syndrome, not intractable, with status epilepticus
|
|
G40.812
|
Lennox-Gastaut syndrome, not intractable, without status epilepticus
|
|
G40.813
|
Lennox-Gastaut syndrome, intractable, with status epilepticus
|
|
G40.814
|
Lennox-Gastaut syndrome, intractable, without status epilepticus
|
|
G40.821
|
Epileptic spasms, not intractable, with status epilepticus
|
|
G40.822
|
Epileptic spasms, not intractable, without status epilepticus
|
|
G40.823
|
Epileptic spasms, intractable, with status epilepticus
|
|
G40.824
|
Epileptic spasms, intractable, without status epilepticus
|
|
G40.833
|
Dravet syndrome, intractable, with status epilepticus
|
|
G40.834
|
Dravet syndrome, intractable, without status epilepticus
|
|
G40.89
|
Other seizures
|
|
G40.901
|
Epilepsy, unspecified, not intractable, with status epilepticus
|
|
G40.909
|
Epilepsy, unspecified, not intractable, without status epilepticus
|
|
G40.911
|
Epilepsy, unspecified, intractable, with status epilepticus
|
|
G40.919
|
Epilepsy, unspecified, intractable, without status epilepticus
|
|
G43.001
|
Migraine without aura, not intractable, with status migrainosus
|
|
G43.009
|
Migraine without aura, not intractable, without status migrainosus
|
|
G43.011
|
Migraine without aura, intractable, with status migrainosus
|
|
G43.019
|
Migraine without aura, intractable, without status migrainosus
|
|
G43.101
|
Migraine with aura, not intractable, with status migrainosus
|
|
G43.109
|
Migraine with aura, not intractable, without status migrainosus
|
|
G43.111
|
Migraine with aura, intractable, with status migrainosus
|
|
G43.119
|
Migraine with aura, intractable, without status migrainosus
|
|
G43.401
|
Hemiplegic migraine, not intractable, with status migrainosus
|
|
G43.409
|
Hemiplegic migraine, not intractable, without status migrainosus
|
|
G43.411
|
Hemiplegic migraine, intractable, with status migrainosus
|
|
G43.419
|
Hemiplegic migraine, intractable, without status migrainosus
|
|
G43.501
|
Persistent migraine aura without cerebral infarction, not intractable, with status migrainosus
|
|
G43.509
|
Persistent migraine aura without cerebral infarction, not intractable, without status migrainosus
|
|
G43.511
|
Persistent migraine aura without cerebral infarction, intractable, with status migrainosus
|
|
G43.519
|
Persistent migraine aura without cerebral infarction, intractable, without status migrainosus
|
|
G43.601
|
Persistent migraine aura with cerebral infarction, not intractable, with status migrainosus
|
|
G43.609
|
Persistent migraine aura with cerebral infarction, not intractable, without status migrainosus
|
|
G43.611
|
Persistent migraine aura with cerebral infarction, intractable, with status migrainosus
|
|
G43.619
|
Persistent migraine aura with cerebral infarction, intractable, without status migrainosus
|
|
G43.701
|
Chronic migraine without aura, not intractable, with status migrainosus
|
|
G43.709
|
Chronic migraine without aura, not intractable, without status migrainosus
|
|
G43.711
|
Chronic migraine without aura, intractable, with status migrainosus
|
|
G43.719
|
Chronic migraine without aura, intractable, without status migrainosus
|
|
G43.A0
|
Cyclical vomiting, in migraine, not intractable
|
|
G43.A1
|
Cyclical vomiting, in migraine, intractable
|
|
G43.B0
|
Ophthalmoplegic migraine, not intractable
|
|
G43.B1
|
Ophthalmoplegic migraine, intractable
|
|
G43.C0
|
Periodic headache syndromes in child or adult, not intractable
|
|
G43.C1
|
Periodic headache syndromes in child or adult, intractable
|
|
G43.D0
|
Abdominal migraine, not intractable
|
|
G43.D1
|
Abdominal migraine, intractable
|
|
G43.801
|
Other migraine, not intractable, with status migrainosus
|
|
G43.809
|
Other migraine, not intractable, without status migrainosus
|
|
G43.811
|
Other migraine, intractable, with status migrainosus
|
|
G43.819
|
Other migraine, intractable, without status migrainosus
|
|
G43.821
|
Menstrual migraine, not intractable, with status migrainosus
|
|
G43.829
|
Menstrual migraine, not intractable, without status migrainosus
|
|
G43.831
|
Menstrual migraine, intractable, with status migrainosus
|
|
G43.839
|
Menstrual migraine, intractable, without status migrainosus
|
|
G43.901
|
Migraine, unspecified, not intractable, with status migrainosus
|
|
G43.909
|
Migraine, unspecified, not intractable, without status migrainosus
|
|
G43.911
|
Migraine, unspecified, intractable, with status migrainosus
|
|
G43.919
|
Migraine, unspecified, intractable, without status migrainosus
|
|
G44.001
|
Cluster headache syndrome, unspecified, intractable
|
|
G44.009
|
Cluster headache syndrome, unspecified, not intractable
|
|
G44.011
|
Episodic cluster headache, intractable
|
|
G44.019
|
Episodic cluster headache, not intractable
|
|
G44.021
|
Chronic cluster headache, intractable
|
|
G44.029
|
Chronic cluster headache, not intractable
|
|
G44.031
|
Episodic paroxysmal hemicrania, intractable
|
|
G44.039
|
Episodic paroxysmal hemicrania, not intractable
|
|
G44.041
|
Chronic paroxysmal hemicrania, intractable
|
|
G44.049
|
Chronic paroxysmal hemicrania, not intractable
|
|
G44.051
|
Short lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT), intractable
|
|
G44.059
|
Short lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT), not intractable
|
|
G44.091
|
Other trigeminal autonomic cephalgias (TAC), intractable
|
|
G44.099
|
Other trigeminal autonomic cephalgias (TAC), not intractable
|
|
G44.1
|
Vascular headache, not elsewhere classified
|
|
G44.201
|
Tension-type headache, unspecified, intractable
|
|
G44.209
|
Tension-type headache, unspecified, not intractable
|
|
G44.211
|
Episodic tension-type headache, intractable
|
|
G44.219
|
Episodic tension-type headache, not intractable
|
|
G44.221
|
Chronic tension-type headache, intractable
|
|
G44.229
|
Chronic tension-type headache, not intractable
|
|
G44.301
|
Post-traumatic headache, unspecified, intractable
|
|
G44.309
|
Post-traumatic headache, unspecified, not intractable
|
|
G44.311
|
Acute post-traumatic headache, intractable
|
|
G44.319
|
Acute post-traumatic headache, not intractable
|
|
G44.321
|
Chronic post-traumatic headache, intractable
|
|
G44.329
|
Chronic post-traumatic headache, not intractable
|
|
G44.40
|
Drug-induced headache, not elsewhere classified, not intractable
|
|
G44.41
|
Drug-induced headache, not elsewhere classified, intractable
|
|
G44.51
|
Hemicrania continua
|
|
G44.52
|
New daily persistent headache (NDPH)
|
|
G44.53
|
Primary thunderclap headache
|
|
G44.59
|
Other complicated headache syndrome
|
|
G44.81
|
Hypnic headache
|
|
G44.82
|
Headache associated with sexual activity
|
|
G44.83
|
Primary cough headache
|
|
G44.84
|
Primary exertional headache
|
|
G44.85
|
Primary stabbing headache
|
|
G44.86
|
Cervicogenic headache
|
|
G44.89
|
Other headache syndrome
|
|
G45.0
|
Vertebro-basilar artery syndrome
|
|
G45.1
|
Carotid artery syndrome (hemispheric)
|
|
G45.2
|
Multiple and bilateral precerebral artery syndromes
|
|
G45.4
|
Transient global amnesia
|
|
G45.8
|
Other transient cerebral ischemic attacks and related syndromes
|
|
G45.9
|
Transient cerebral ischemic attack, unspecified
|
|
G46.0
|
Middle cerebral artery syndrome
|
|
G46.1
|
Anterior cerebral artery syndrome
|
|
G46.2
|
Posterior cerebral artery syndrome
|
|
G46.3
|
Brain stem stroke syndrome
|
|
G46.4
|
Cerebellar stroke syndrome
|
|
G46.5
|
Pure motor lacunar syndrome
|
|
G46.6
|
Pure sensory lacunar syndrome
|
|
G46.7
|
Other lacunar syndromes
|
|
G46.8
|
Other vascular syndromes of brain in cerebrovascular diseases
|
|
G47.01
|
Insomnia due to medical condition
|
|
G47.09
|
Other insomnia
|
|
G47.10
|
Hypersomnia, unspecified
|
|
G47.11
|
Idiopathic hypersomnia with long sleep time
|
|
G47.12
|
Idiopathic hypersomnia without long sleep time
|
|
G47.13
|
Recurrent hypersomnia
|
|
G47.14
|
Hypersomnia due to medical condition
|
|
G47.19
|
Other hypersomnia
|
|
G47.30
|
Sleep apnea, unspecified
|
|
G47.31
|
Primary central sleep apnea
|
|
G47.34
|
Idiopathic sleep related nonobstructive alveolar hypoventilation
|
|
G47.35
|
Congenital central alveolar hypoventilation syndrome
|
|
G47.36
|
Sleep related hypoventilation in conditions classified elsewhere
|
|
G47.37
|
Central sleep apnea in conditions classified elsewhere
|
|
G47.39
|
Other sleep apnea
|
|
G47.411
|
Narcolepsy with cataplexy
|
|
G47.419
|
Narcolepsy without cataplexy
|
|
G47.421
|
Narcolepsy in conditions classified elsewhere with cataplexy
|
|
G47.429
|
Narcolepsy in conditions classified elsewhere without cataplexy
|
|
G47.50
|
Parasomnia, unspecified
|
|
G47.51
|
Confusional arousals
|
|
G47.54
|
Parasomnia in conditions classified elsewhere
|
|
G47.59
|
Other parasomnia
|
|
G47.8
|
Other sleep disorders
|
|
G50.0
|
Trigeminal neuralgia
|
|
G50.1
|
Atypical facial pain
|
|
G50.8
|
Other disorders of trigeminal nerve
|
|
G50.9
|
Disorder of trigeminal nerve, unspecified
|
|
G51.0
|
Bell's palsy
|
|
G51.1
|
Geniculate ganglionitis
|
|
G51.2
|
Melkersson's syndrome
|
|
G51.31
|
Clonic hemifacial spasm, right
|
|
G51.32
|
Clonic hemifacial spasm, left
|
|
G51.33
|
Clonic hemifacial spasm, bilateral
|
|
G51.39
|
Clonic hemifacial spasm, unspecified
|
|
G51.4
|
Facial myokymia
|
|
G51.8
|
Other disorders of facial nerve
|
|
G51.9
|
Disorder of facial nerve, unspecified
|
|
G52.0
|
Disorders of olfactory nerve
|
|
G52.1
|
Disorders of glossopharyngeal nerve
|
|
G52.2
|
Disorders of vagus nerve
|
|
G52.3
|
Disorders of hypoglossal nerve
|
|
G52.7
|
Disorders of multiple cranial nerves
|
|
G52.8
|
Disorders of other specified cranial nerves
|
|
G52.9
|
Cranial nerve disorder, unspecified
|
|
G53
|
Cranial nerve disorders in diseases classified elsewhere
|
|
G80.0
|
Spastic quadriplegic cerebral palsy
|
|
G80.1
|
Spastic diplegic cerebral palsy
|
|
G80.2
|
Spastic hemiplegic cerebral palsy
|
|
G80.3
|
Athetoid cerebral palsy
|
|
G80.4
|
Ataxic cerebral palsy
|
|
G80.8
|
Other cerebral palsy
|
|
G80.9
|
Cerebral palsy, unspecified
|
|
G81.01
|
Flaccid hemiplegia affecting right dominant side
|
|
G81.02
|
Flaccid hemiplegia affecting left dominant side
|
|
G81.03
|
Flaccid hemiplegia affecting right nondominant side
|
|
G81.04
|
Flaccid hemiplegia affecting left nondominant side
|
|
G81.11
|
Spastic hemiplegia affecting right dominant side
|
|
G81.12
|
Spastic hemiplegia affecting left dominant side
|
|
G81.13
|
Spastic hemiplegia affecting right nondominant side
|
|
G81.14
|
Spastic hemiplegia affecting left nondominant side
|
|
G81.91
|
Hemiplegia, unspecified affecting right dominant side
|
|
G81.92
|
Hemiplegia, unspecified affecting left dominant side
|
|
G81.93
|
Hemiplegia, unspecified affecting right nondominant side
|
|
G81.94
|
Hemiplegia, unspecified affecting left nondominant side
|
|
G82.21
|
Paraplegia, complete
|
|
G82.22
|
Paraplegia, incomplete
|
|
G82.51
|
Quadriplegia, C1-C4 complete
|
|
G82.52
|
Quadriplegia, C1-C4 incomplete
|
|
G82.53
|
Quadriplegia, C5-C7 complete
|
|
G82.54
|
Quadriplegia, C5-C7 incomplete
|
|
G83.0
|
Diplegia of upper limbs
|
|
G83.11
|
Monoplegia of lower limb affecting right dominant side
|
|
G83.12
|
Monoplegia of lower limb affecting left dominant side
|
|
G83.13
|
Monoplegia of lower limb affecting right nondominant side
|
|
G83.14
|
Monoplegia of lower limb affecting left nondominant side
|
|
G83.21
|
Monoplegia of upper limb affecting right dominant side
|
|
G83.22
|
Monoplegia of upper limb affecting left dominant side
|
|
G83.24
|
Monoplegia of upper limb affecting left nondominant side
|
|
G83.31
|
Monoplegia, unspecified affecting right dominant side
|
|
G83.32
|
Monoplegia, unspecified affecting left dominant side
|
|
G83.33
|
Monoplegia, unspecified affecting right nondominant side
|
|
G83.34
|
Monoplegia, unspecified affecting left nondominant side
|
|
G83.5
|
Locked-in state
|
|
G83.81
|
Brown-Sequard syndrome
|
|
G83.84
|
Todd's paralysis (postepileptic)
|
|
G83.89
|
Other specified paralytic syndromes
|
|
G89.0
|
Central pain syndrome
|
|
G89.11
|
Acute pain due to trauma
|
|
G89.12
|
Acute post-thoracotomy pain
|
|
G89.18
|
Other acute postprocedural pain
|
|
G89.21
|
Chronic pain due to trauma
|
|
G89.22
|
Chronic post-thoracotomy pain
|
|
G89.28
|
Other chronic postprocedural pain
|
|
G89.29
|
Other chronic pain
|
|
G89.3
|
Neoplasm related pain (acute) (chronic)
|
|
G89.4
|
Chronic pain syndrome
|
|
G90.01
|
Carotid sinus syncope
|
|
G90.09
|
Other idiopathic peripheral autonomic neuropathy
|
|
G90.1
|
Familial dysautonomia [Riley-Day]
|
|
G90.2
|
Horner's syndrome
|
|
G90.3
|
Multi-system degeneration of the autonomic nervous system
|
|
G90.4
|
Autonomic dysreflexia
|
|
G90.59
|
Complex regional pain syndrome I of other specified site
|
|
G90.8
|
Other disorders of autonomic nervous system
|
|
G90.9
|
Disorder of the autonomic nervous system, unspecified
|
|
G91.0
|
Communicating hydrocephalus
|
|
G91.1
|
Obstructive hydrocephalus
|
|
G91.2
|
(Idiopathic) normal pressure hydrocephalus
|
|
G91.3
|
Post-traumatic hydrocephalus, unspecified
|
|
G91.4
|
Hydrocephalus in diseases classified elsewhere
|
|
G91.8
|
Other hydrocephalus
|
|
G91.9
|
Hydrocephalus, unspecified
|
|
G92.8
|
Other toxic encephalopathy
|
|
G93.0
|
Cerebral cysts
|
|
G93.1
|
Anoxic brain damage, not elsewhere classified
|
|
G93.2
|
Benign intracranial hypertension
|
|
G93.40
|
Encephalopathy, unspecified
|
|
G93.41
|
Metabolic encephalopathy
|
|
G93.49
|
Other encephalopathy
|
|
G93.5
|
Compression of brain
|
|
G93.6
|
Cerebral edema
|
|
G93.81
|
Temporal sclerosis
|
|
G93.89
|
Other specified disorders of brain
|
|
G94
|
Other disorders of brain in diseases classified elsewhere
|
|
G95.0
|
Syringomyelia and syringobulbia
|
|
G95.11
|
Acute infarction of spinal cord (embolic) (nonembolic)
|
|
G95.19
|
Other vascular myelopathies
|
|
G95.81
|
Conus medullaris syndrome
|
|
G95.89
|
Other specified diseases of spinal cord
|
|
G96.00
|
Cerebrospinal fluid leak, unspecified
|
|
G96.01
|
Cranial cerebrospinal fluid leak, spontaneous
|
|
G96.02
|
Spinal cerebrospinal fluid leak, spontaneous
|
|
G96.08
|
Other cranial cerebrospinal fluid leak
|
|
G96.09
|
Other spinal cerebrospinal fluid leak
|
|
G96.11
|
Dural tear
|
|
G96.12
|
Meningeal adhesions (cerebral) (spinal)
|
|
G96.191
|
Perineural cyst
|
|
G96.198
|
Other disorders of meninges, not elsewhere classified
|
|
G96.810
|
Intracranial hypotension, unspecified
|
|
G96.819
|
Other intracranial hypotension
|
|
G96.9
|
Disorder of central nervous system, unspecified
|
|
G97.1
|
Other reaction to spinal and lumbar puncture
|
|
G97.31
|
Intraoperative hemorrhage and hematoma of a nervous system organ or structure complicating a nervous system procedure
|
|
G97.32
|
Intraoperative hemorrhage and hematoma of a nervous system organ or structure complicating other procedure
|
|
G97.41
|
Accidental puncture or laceration of dura during a procedure
|
|
G97.51
|
Postprocedural hemorrhage of a nervous system organ or structure following a nervous system procedure
|
|
G97.52
|
Postprocedural hemorrhage of a nervous system organ or structure following other procedure
|
|
G97.61
|
Postprocedural hematoma of a nervous system organ or structure following a nervous system procedure
|
|
G97.62
|
Postprocedural hematoma of a nervous system organ or structure following other procedure
|
|
G97.63
|
Postprocedural seroma of a nervous system organ or structure following a nervous system procedure
|
|
G97.64
|
Postprocedural seroma of a nervous system organ or structure following other procedure
|
|
G97.82
|
Other postprocedural complications and disorders of nervous system
|
|
G97.83
|
Intracranial hypotension following lumbar cerebrospinal fluid shunting
|
|
G97.84
|
Intracranial hypotension following other procedure
|
|
G98.8
|
Other disorders of nervous system
|
|
G99.0
|
Autonomic neuropathy in diseases classified elsewhere
|
|
G99.2
|
Myelopathy in diseases classified elsewhere
|
|
H02.23A
|
Paralytic lagophthalmos right eye, upper and lower eyelids
|
|
H02.23B
|
Paralytic lagophthalmos left eye, upper and lower eyelids
|
|
H02.23C
|
Paralytic lagophthalmos, bilateral, upper and lower eyelids
|
|
H05.011
|
Cellulitis of right orbit
|
|
H05.012
|
Cellulitis of left orbit
|
|
H05.013
|
Cellulitis of bilateral orbits
|
|
H05.261
|
Pulsating exophthalmos, right eye
|
|
H05.262
|
Pulsating exophthalmos, left eye
|
|
H05.263
|
Pulsating exophthalmos, bilateral
|
|
H34.8110
|
Central retinal vein occlusion, right eye, with macular edema
|
|
H34.8111
|
Central retinal vein occlusion, right eye, with retinal neovascularization
|
|
H34.8112
|
Central retinal vein occlusion, right eye, stable
|
|
H34.8120
|
Central retinal vein occlusion, left eye, with macular edema
|
|
H34.8121
|
Central retinal vein occlusion, left eye, with retinal neovascularization
|
|
H34.8122
|
Central retinal vein occlusion, left eye, stable
|
|
H34.8130
|
Central retinal vein occlusion, bilateral, with macular edema
|
|
H34.8131
|
Central retinal vein occlusion, bilateral, with retinal neovascularization
|
|
H34.8132
|
Central retinal vein occlusion, bilateral, stable
|
|
H34.8310
|
Tributary (branch) retinal vein occlusion, right eye, with macular edema
|
|
H34.8311
|
Tributary (branch) retinal vein occlusion, right eye, with retinal neovascularization
|
|
H34.8312
|
Tributary (branch) retinal vein occlusion, right eye, stable
|
|
H34.8320
|
Tributary (branch) retinal vein occlusion, left eye, with macular edema
|
|
H34.8321
|
Tributary (branch) retinal vein occlusion, left eye, with retinal neovascularization
|
|
H34.8322
|
Tributary (branch) retinal vein occlusion, left eye, stable
|
|
H34.8330
|
Tributary (branch) retinal vein occlusion, bilateral, with macular edema
|
|
H34.8331
|
Tributary (branch) retinal vein occlusion, bilateral, with retinal neovascularization
|
|
H34.8332
|
Tributary (branch) retinal vein occlusion, bilateral, stable
|
|
H46.01
|
Optic papillitis, right eye
|
|
H46.02
|
Optic papillitis, left eye
|
|
H46.03
|
Optic papillitis, bilateral
|
|
H46.11
|
Retrobulbar neuritis, right eye
|
|
H46.12
|
Retrobulbar neuritis, left eye
|
|
H46.13
|
Retrobulbar neuritis, bilateral
|
|
H47.10
|
Unspecified papilledema
|
|
H47.11
|
Papilledema associated with increased intracranial pressure
|
|
H47.211
|
Primary optic atrophy, right eye
|
|
H47.212
|
Primary optic atrophy, left eye
|
|
H47.213
|
Primary optic atrophy, bilateral
|
|
H47.291
|
Other optic atrophy, right eye
|
|
H47.292
|
Other optic atrophy, left eye
|
|
H47.293
|
Other optic atrophy, bilateral
|
|
H47.43
|
Disorders of optic chiasm in (due to) vascular disorders
|
|
H47.49
|
Disorders of optic chiasm in (due to) other disorders
|
|
H47.531
|
Disorders of visual pathways in (due to) vascular disorders, right side
|
|
H47.532
|
Disorders of visual pathways in (due to) vascular disorders, left side
|
|
H47.611
|
Cortical blindness, right side of brain
|
|
H47.612
|
Cortical blindness, left side of brain
|
|
H47.631
|
Disorders of visual cortex in (due to) neoplasm, right side of brain
|
|
H47.632
|
Disorders of visual cortex in (due to) neoplasm, left side of brain
|
|
H47.641
|
Disorders of visual cortex in (due to) vascular disorders, right side of brain
|
|
H47.642
|
Disorders of visual cortex in (due to) vascular disorders, left side of brain
|
|
H47.9
|
Unspecified disorder of visual pathways
|
|
H49.01
|
Third [oculomotor] nerve palsy, right eye
|
|
H49.02
|
Third [oculomotor] nerve palsy, left eye
|
|
H49.03
|
Third [oculomotor] nerve palsy, bilateral
|
|
H49.11
|
Fourth [trochlear] nerve palsy, right eye
|
|
H49.12
|
Fourth [trochlear] nerve palsy, left eye
|
|
H49.13
|
Fourth [trochlear] nerve palsy, bilateral
|
|
H49.21
|
Sixth [abducent] nerve palsy, right eye
|
|
H49.22
|
Sixth [abducent] nerve palsy, left eye
|
|
H49.23
|
Sixth [abducent] nerve palsy, bilateral
|
|
H49.31
|
Total (external) ophthalmoplegia, right eye
|
|
H49.32
|
Total (external) ophthalmoplegia, left eye
|
|
H49.33
|
Total (external) ophthalmoplegia, bilateral
|
|
H49.41
|
Progressive external ophthalmoplegia, right eye
|
|
H49.42
|
Progressive external ophthalmoplegia, left eye
|
|
H49.43
|
Progressive external ophthalmoplegia, bilateral
|
|
H49.881
|
Other paralytic strabismus, right eye
|
|
H49.882
|
Other paralytic strabismus, left eye
|
|
H49.883
|
Other paralytic strabismus, bilateral
|
|
H49.9
|
Unspecified paralytic strabismus
|
|
H51.0
|
Palsy (spasm) of conjugate gaze
|
|
H51.21
|
Internuclear ophthalmoplegia, right eye
|
|
H51.22
|
Internuclear ophthalmoplegia, left eye
|
|
H51.23
|
Internuclear ophthalmoplegia, bilateral
|
|
H53.121
|
Transient visual loss, right eye
|
|
H53.122
|
Transient visual loss, left eye
|
|
H53.123
|
Transient visual loss, bilateral
|
|
H53.131
|
Sudden visual loss, right eye
|
|
H53.132
|
Sudden visual loss, left eye
|
|
H53.133
|
Sudden visual loss, bilateral
|
|
H53.2
|
Diplopia
|
|
H53.30
|
Unspecified disorder of binocular vision
|
|
H53.31
|
Abnormal retinal correspondence
|
|
H53.32
|
Fusion with defective stereopsis
|
|
H53.33
|
Simultaneous visual perception without fusion
|
|
H53.34
|
Suppression of binocular vision
|
|
H53.40
|
Unspecified visual field defects
|
|
H53.411
|
Scotoma involving central area, right eye
|
|
H53.412
|
Scotoma involving central area, left eye
|
|
H53.413
|
Scotoma involving central area, bilateral
|
|
H53.421
|
Scotoma of blind spot area, right eye
|
|
H53.422
|
Scotoma of blind spot area, left eye
|
|
H53.423
|
Scotoma of blind spot area, bilateral
|
|
H53.431
|
Sector or arcuate defects, right eye
|
|
H53.432
|
Sector or arcuate defects, left eye
|
|
H53.433
|
Sector or arcuate defects, bilateral
|
|
H53.451
|
Other localized visual field defect, right eye
|
|
H53.452
|
Other localized visual field defect, left eye
|
|
H53.453
|
Other localized visual field defect, bilateral
|
|
H53.461
|
Homonymous bilateral field defects, right side
|
|
H53.462
|
Homonymous bilateral field defects, left side
|
|
H53.47
|
Heteronymous bilateral field defects
|
|
H53.481
|
Generalized contraction of visual field, right eye
|
|
H53.482
|
Generalized contraction of visual field, left eye
|
|
H53.483
|
Generalized contraction of visual field, bilateral
|
|
H53.50
|
Unspecified color vision deficiencies
|
|
H53.51
|
Achromatopsia
|
|
H53.52
|
Acquired color vision deficiency
|
|
H53.55
|
Tritanomaly
|
|
H53.59
|
Other color vision deficiencies
|
|
H53.71
|
Glare sensitivity
|
|
H53.72
|
Impaired contrast sensitivity
|
|
H53.8
|
Other visual disturbances
|
|
H55.09
|
Other forms of nystagmus
|
|
H55.81
|
Deficient saccadic eye movements
|
|
H55.82
|
Deficient smooth pursuit eye movements
|
|
H55.89
|
Other irregular eye movements
|
|
H59.111
|
Intraoperative hemorrhage and hematoma of right eye and adnexa complicating an ophthalmic procedure
|
|
H59.112
|
Intraoperative hemorrhage and hematoma of left eye and adnexa complicating an ophthalmic procedure
|
|
H59.113
|
Intraoperative hemorrhage and hematoma of eye and adnexa complicating an ophthalmic procedure, bilateral
|
|
H59.121
|
Intraoperative hemorrhage and hematoma of right eye and adnexa complicating other procedure
|
|
H59.122
|
Intraoperative hemorrhage and hematoma of left eye and adnexa complicating other procedure
|
|
H59.123
|
Intraoperative hemorrhage and hematoma of eye and adnexa complicating other procedure, bilateral
|
|
H59.311
|
Postprocedural hemorrhage of right eye and adnexa following an ophthalmic procedure
|
|
H59.312
|
Postprocedural hemorrhage of left eye and adnexa following an ophthalmic procedure
|
|
H59.313
|
Postprocedural hemorrhage of eye and adnexa following an ophthalmic procedure, bilateral
|
|
H59.321
|
Postprocedural hemorrhage of right eye and adnexa following other procedure
|
|
H59.322
|
Postprocedural hemorrhage of left eye and adnexa following other procedure
|
|
H59.323
|
Postprocedural hemorrhage of eye and adnexa following other procedure, bilateral
|
|
H59.331
|
Postprocedural hematoma of right eye and adnexa following an ophthalmic procedure
|
|
H59.332
|
Postprocedural hematoma of left eye and adnexa following an ophthalmic procedure
|
|
H59.333
|
Postprocedural hematoma of eye and adnexa following an ophthalmic procedure, bilateral
|
|
H59.341
|
Postprocedural hematoma of right eye and adnexa following other procedure
|
|
H59.342
|
Postprocedural hematoma of left eye and adnexa following other procedure
|
|
H59.343
|
Postprocedural hematoma of eye and adnexa following other procedure, bilateral
|
|
H59.351
|
Postprocedural seroma of right eye and adnexa following an ophthalmic procedure
|
|
H59.352
|
Postprocedural seroma of left eye and adnexa following an ophthalmic procedure
|
|
H59.353
|
Postprocedural seroma of eye and adnexa following an ophthalmic procedure, bilateral
|
|
H59.361
|
Postprocedural seroma of right eye and adnexa following other procedure
|
|
H59.362
|
Postprocedural seroma of left eye and adnexa following other procedure
|
|
H59.363
|
Postprocedural seroma of eye and adnexa following other procedure, bilateral
|
|
H83.2X1
|
Labyrinthine dysfunction, right ear
|
|
H83.2X2
|
Labyrinthine dysfunction, left ear
|
|
H83.2X3
|
Labyrinthine dysfunction, bilateral
|
|
H90.0
|
Conductive hearing loss, bilateral
|
|
H90.11
|
Conductive hearing loss, unilateral, right ear, with unrestricted hearing on the contralateral side
|
|
H90.12
|
Conductive hearing loss, unilateral, left ear, with unrestricted hearing on the contralateral side
|
|
H90.3
|
Sensorineural hearing loss, bilateral
|
|
H90.41
|
Sensorineural hearing loss, unilateral, right ear, with unrestricted hearing on the contralateral side
|
|
H90.42
|
Sensorineural hearing loss, unilateral, left ear, with unrestricted hearing on the contralateral side
|
|
H90.6
|
Mixed conductive and sensorineural hearing loss, bilateral
|
|
H90.71
|
Mixed conductive and sensorineural hearing loss, unilateral, right ear, with unrestricted hearing on the contralateral side
|
|
H90.72
|
Mixed conductive and sensorineural hearing loss, unilateral, left ear, with unrestricted hearing on the contralateral side
|
|
H90.A11
|
Conductive hearing loss, unilateral, right ear with restricted hearing on the contralateral side
|
|
H90.A12
|
Conductive hearing loss, unilateral, left ear with restricted hearing on the contralateral side
|
|
H90.A31
|
Mixed conductive and sensorineural hearing loss, unilateral, right ear with restricted hearing on the contralateral side
|
|
H90.A32
|
Mixed conductive and sensorineural hearing loss, unilateral, left ear with restricted hearing on the contralateral side
|
|
H93.A1
|
Pulsatile tinnitus, right ear
|
|
H93.A2
|
Pulsatile tinnitus, left ear
|
|
H93.A3
|
Pulsatile tinnitus, bilateral
|
|
H93.3X1
|
Disorders of right acoustic nerve
|
|
H93.3X2
|
Disorders of left acoustic nerve
|
|
H93.3X3
|
Disorders of bilateral acoustic nerves
|
|
H94.01
|
Acoustic neuritis in infectious and parasitic diseases classified elsewhere, right ear
|
|
H94.02
|
Acoustic neuritis in infectious and parasitic diseases classified elsewhere, left ear
|
|
H94.03
|
Acoustic neuritis in infectious and parasitic diseases classified elsewhere, bilateral
|
|
H95.21
|
Intraoperative hemorrhage and hematoma of ear and mastoid process complicating a procedure on the ear and mastoid process
|
|
H95.22
|
Intraoperative hemorrhage and hematoma of ear and mastoid process complicating other procedure
|
|
H95.41
|
Postprocedural hemorrhage of ear and mastoid process following a procedure on the ear and mastoid process
|
|
H95.42
|
Postprocedural hemorrhage of ear and mastoid process following other procedure
|
|
H95.51
|
Postprocedural hematoma of ear and mastoid process following a procedure on the ear and mastoid process
|
|
H95.52
|
Postprocedural hematoma of ear and mastoid process following other procedure
|
|
H95.53
|
Postprocedural seroma of ear and mastoid process following a procedure on the ear and mastoid process
|
|
H95.54
|
Postprocedural seroma of ear and mastoid process following other procedure
|
|
I60.01
|
Nontraumatic subarachnoid hemorrhage from right carotid siphon and bifurcation
|
|
I60.02
|
Nontraumatic subarachnoid hemorrhage from left carotid siphon and bifurcation
|
|
I60.11
|
Nontraumatic subarachnoid hemorrhage from right middle cerebral artery
|
|
I60.12
|
Nontraumatic subarachnoid hemorrhage from left middle cerebral artery
|
|
I60.2
|
Nontraumatic subarachnoid hemorrhage from anterior communicating artery
|
|
I60.31
|
Nontraumatic subarachnoid hemorrhage from right posterior communicating artery
|
|
I60.32
|
Nontraumatic subarachnoid hemorrhage from left posterior communicating artery
|
|
I60.4
|
Nontraumatic subarachnoid hemorrhage from basilar artery
|
|
I60.51
|
Nontraumatic subarachnoid hemorrhage from right vertebral artery
|
|
I60.52
|
Nontraumatic subarachnoid hemorrhage from left vertebral artery
|
|
I60.6
|
Nontraumatic subarachnoid hemorrhage from other intracranial arteries
|
|
I60.8
|
Other nontraumatic subarachnoid hemorrhage
|
|
I60.9
|
Nontraumatic subarachnoid hemorrhage, unspecified
|
|
I61.0
|
Nontraumatic intracerebral hemorrhage in hemisphere, subcortical
|
|
I61.1
|
Nontraumatic intracerebral hemorrhage in hemisphere, cortical
|
|
I61.2
|
Nontraumatic intracerebral hemorrhage in hemisphere, unspecified
|
|
I61.3
|
Nontraumatic intracerebral hemorrhage in brain stem
|
|
I61.4
|
Nontraumatic intracerebral hemorrhage in cerebellum
|
|
I61.5
|
Nontraumatic intracerebral hemorrhage, intraventricular
|
|
I61.6
|
Nontraumatic intracerebral hemorrhage, multiple localized
|
|
I61.8
|
Other nontraumatic intracerebral hemorrhage
|
|
I61.9
|
Nontraumatic intracerebral hemorrhage, unspecified
|
|
I62.00
|
Nontraumatic subdural hemorrhage, unspecified
|
|
I62.01
|
Nontraumatic acute subdural hemorrhage
|
|
I62.02
|
Nontraumatic subacute subdural hemorrhage
|
|
I62.03
|
Nontraumatic chronic subdural hemorrhage
|
|
I62.1
|
Nontraumatic extradural hemorrhage
|
|
I62.9
|
Nontraumatic intracranial hemorrhage, unspecified
|
|
I63.00
|
Cerebral infarction due to thrombosis of unspecified precerebral artery
|
|
I63.011
|
Cerebral infarction due to thrombosis of right vertebral artery
|
|
I63.012
|
Cerebral infarction due to thrombosis of left vertebral artery
|
|
I63.013
|
Cerebral infarction due to thrombosis of bilateral vertebral arteries
|
|
I63.02
|
Cerebral infarction due to thrombosis of basilar artery
|
|
I63.031
|
Cerebral infarction due to thrombosis of right carotid artery
|
|
I63.032
|
Cerebral infarction due to thrombosis of left carotid artery
|
|
I63.033
|
Cerebral infarction due to thrombosis of bilateral carotid arteries
|
|
I63.09
|
Cerebral infarction due to thrombosis of other precerebral artery
|
|
I63.10
|
Cerebral infarction due to embolism of unspecified precerebral artery
|
|
I63.111
|
Cerebral infarction due to embolism of right vertebral artery
|
|
I63.112
|
Cerebral infarction due to embolism of left vertebral artery
|
|
I63.113
|
Cerebral infarction due to embolism of bilateral vertebral arteries
|
|
I63.12
|
Cerebral infarction due to embolism of basilar artery
|
|
I63.131
|
Cerebral infarction due to embolism of right carotid artery
|
|
I63.132
|
Cerebral infarction due to embolism of left carotid artery
|
|
I63.133
|
Cerebral infarction due to embolism of bilateral carotid arteries
|
|
I63.19
|
Cerebral infarction due to embolism of other precerebral artery
|
|
I63.20
|
Cerebral infarction due to unspecified occlusion or stenosis of unspecified precerebral arteries
|
|
I63.211
|
Cerebral infarction due to unspecified occlusion or stenosis of right vertebral artery
|
|
I63.212
|
Cerebral infarction due to unspecified occlusion or stenosis of left vertebral artery
|
|
I63.213
|
Cerebral infarction due to unspecified occlusion or stenosis of bilateral vertebral arteries
|
|
I63.22
|
Cerebral infarction due to unspecified occlusion or stenosis of basilar artery
|
|
I63.231
|
Cerebral infarction due to unspecified occlusion or stenosis of right carotid arteries
|
|
I63.232
|
Cerebral infarction due to unspecified occlusion or stenosis of left carotid arteries
|
|
I63.233
|
Cerebral infarction due to unspecified occlusion or stenosis of bilateral carotid arteries
|
|
I63.29
|
Cerebral infarction due to unspecified occlusion or stenosis of other precerebral arteries
|
|
I63.30
|
Cerebral infarction due to thrombosis of unspecified cerebral artery
|
|
I63.311
|
Cerebral infarction due to thrombosis of right middle cerebral artery
|
|
I63.312
|
Cerebral infarction due to thrombosis of left middle cerebral artery
|
|
I63.313
|
Cerebral infarction due to thrombosis of bilateral middle cerebral arteries
|
|
I63.321
|
Cerebral infarction due to thrombosis of right anterior cerebral artery
|
|
I63.322
|
Cerebral infarction due to thrombosis of left anterior cerebral artery
|
|
I63.323
|
Cerebral infarction due to thrombosis of bilateral anterior cerebral arteries
|
|
I63.331
|
Cerebral infarction due to thrombosis of right posterior cerebral artery
|
|
I63.332
|
Cerebral infarction due to thrombosis of left posterior cerebral artery
|
|
I63.333
|
Cerebral infarction due to thrombosis of bilateral posterior cerebral arteries
|
|
I63.341
|
Cerebral infarction due to thrombosis of right cerebellar artery
|
|
I63.342
|
Cerebral infarction due to thrombosis of left cerebellar artery
|
|
I63.343
|
Cerebral infarction due to thrombosis of bilateral cerebellar arteries
|
|
I63.39
|
Cerebral infarction due to thrombosis of other cerebral artery
|
|
I63.411
|
Cerebral infarction due to embolism of right middle cerebral artery
|
|
I63.412
|
Cerebral infarction due to embolism of left middle cerebral artery
|
|
I63.413
|
Cerebral infarction due to embolism of bilateral middle cerebral arteries
|
|
I63.421
|
Cerebral infarction due to embolism of right anterior cerebral artery
|
|
I63.422
|
Cerebral infarction due to embolism of left anterior cerebral artery
|
|
I63.423
|
Cerebral infarction due to embolism of bilateral anterior cerebral arteries
|
|
I63.431
|
Cerebral infarction due to embolism of right posterior cerebral artery
|
|
I63.432
|
Cerebral infarction due to embolism of left posterior cerebral artery
|
|
I63.433
|
Cerebral infarction due to embolism of bilateral posterior cerebral arteries
|
|
I63.441
|
Cerebral infarction due to embolism of right cerebellar artery
|
|
I63.442
|
Cerebral infarction due to embolism of left cerebellar artery
|
|
I63.443
|
Cerebral infarction due to embolism of bilateral cerebellar arteries
|
|
I63.49
|
Cerebral infarction due to embolism of other cerebral artery
|
|
I63.511
|
Cerebral infarction due to unspecified occlusion or stenosis of right middle cerebral artery
|
|
I63.512
|
Cerebral infarction due to unspecified occlusion or stenosis of left middle cerebral artery
|
|
I63.513
|
Cerebral infarction due to unspecified occlusion or stenosis of bilateral middle cerebral arteries
|
|
I63.521
|
Cerebral infarction due to unspecified occlusion or stenosis of right anterior cerebral artery
|
|
I63.522
|
Cerebral infarction due to unspecified occlusion or stenosis of left anterior cerebral artery
|
|
I63.523
|
Cerebral infarction due to unspecified occlusion or stenosis of bilateral anterior cerebral arteries
|
|
I63.531
|
Cerebral infarction due to unspecified occlusion or stenosis of right posterior cerebral artery
|
|
I63.532
|
Cerebral infarction due to unspecified occlusion or stenosis of left posterior cerebral artery
|
|
I63.533
|
Cerebral infarction due to unspecified occlusion or stenosis of bilateral posterior cerebral arteries
|
|
I63.541
|
Cerebral infarction due to unspecified occlusion or stenosis of right cerebellar artery
|
|
I63.542
|
Cerebral infarction due to unspecified occlusion or stenosis of left cerebellar artery
|
|
I63.543
|
Cerebral infarction due to unspecified occlusion or stenosis of bilateral cerebellar arteries
|
|
I63.59
|
Cerebral infarction due to unspecified occlusion or stenosis of other cerebral artery
|
|
I63.6
|
Cerebral infarction due to cerebral venous thrombosis, nonpyogenic
|
|
I63.81
|
Other cerebral infarction due to occlusion or stenosis of small artery
|
|
I63.89
|
Other cerebral infarction
|
|
I63.9
|
Cerebral infarction, unspecified
|
|
I65.01
|
Occlusion and stenosis of right vertebral artery
|
|
I65.02
|
Occlusion and stenosis of left vertebral artery
|
|
I65.03
|
Occlusion and stenosis of bilateral vertebral arteries
|
|
I65.1
|
Occlusion and stenosis of basilar artery
|
|
I65.21
|
Occlusion and stenosis of right carotid artery
|
|
I65.22
|
Occlusion and stenosis of left carotid artery
|
|
I65.23
|
Occlusion and stenosis of bilateral carotid arteries
|
|
I65.8
|
Occlusion and stenosis of other precerebral arteries
|
|
I66.01
|
Occlusion and stenosis of right middle cerebral artery
|
|
I66.02
|
Occlusion and stenosis of left middle cerebral artery
|
|
I66.03
|
Occlusion and stenosis of bilateral middle cerebral arteries
|
|
I66.11
|
Occlusion and stenosis of right anterior cerebral artery
|
|
I66.12
|
Occlusion and stenosis of left anterior cerebral artery
|
|
I66.13
|
Occlusion and stenosis of bilateral anterior cerebral arteries
|
|
I66.21
|
Occlusion and stenosis of right posterior cerebral artery
|
|
I66.22
|
Occlusion and stenosis of left posterior cerebral artery
|
|
I66.23
|
Occlusion and stenosis of bilateral posterior cerebral arteries
|
|
I66.3
|
Occlusion and stenosis of cerebellar arteries
|
|
I66.8
|
Occlusion and stenosis of other cerebral arteries
|
|
I67.1
|
Cerebral aneurysm, nonruptured
|
|
I67.2
|
Cerebral atherosclerosis
|
|
I67.3
|
Progressive vascular leukoencephalopathy
|
|
I67.4
|
Hypertensive encephalopathy
|
|
I67.5
|
Moyamoya disease
|
|
I67.6
|
Nonpyogenic thrombosis of intracranial venous system
|
|
I67.7
|
Cerebral arteritis, not elsewhere classified
|
|
I67.81
|
Acute cerebrovascular insufficiency
|
|
I67.82
|
Cerebral ischemia
|
|
I67.83
|
Posterior reversible encephalopathy syndrome
|
|
I67.841
|
Reversible cerebrovascular vasoconstriction syndrome
|
|
I67.848
|
Other cerebrovascular vasospasm and vasoconstriction
|
|
I67.850
|
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
|
|
I67.858
|
Other hereditary cerebrovascular disease
|
|
I67.89
|
Other cerebrovascular disease
|
|
I67.9
|
Cerebrovascular disease, unspecified
|
|
I68.0
|
Cerebral amyloid angiopathy
|
|
I68.2
|
Cerebral arteritis in other diseases classified elsewhere
|
|
I68.8
|
Other cerebrovascular disorders in diseases classified elsewhere
|
|
I69.010
|
Attention and concentration deficit following nontraumatic subarachnoid hemorrhage
|
|
I69.011
|
Memory deficit following nontraumatic subarachnoid hemorrhage
|
|
I69.012
|
Visuospatial deficit and spatial neglect following nontraumatic subarachnoid hemorrhage
|
|
I69.013
|
Psychomotor deficit following nontraumatic subarachnoid hemorrhage
|
|
I69.014
|
Frontal lobe and executive function deficit following nontraumatic subarachnoid hemorrhage
|
|
I69.015
|
Cognitive social or emotional deficit following nontraumatic subarachnoid hemorrhage
|
|
I69.018
|
Other symptoms and signs involving cognitive functions following nontraumatic subarachnoid hemorrhage
|
|
I69.019
|
Unspecified symptoms and signs involving cognitive functions following nontraumatic subarachnoid hemorrhage
|
|
I69.022
|
Dysarthria following nontraumatic subarachnoid hemorrhage
|
|
I69.023
|
Fluency disorder following nontraumatic subarachnoid hemorrhage
|
|
I69.110
|
Attention and concentration deficit following nontraumatic intracerebral hemorrhage
|
|
I69.111
|
Memory deficit following nontraumatic intracerebral hemorrhage
|
|
I69.112
|
Visuospatial deficit and spatial neglect following nontraumatic intracerebral hemorrhage
|
|
I69.113
|
Psychomotor deficit following nontraumatic intracerebral hemorrhage
|
|
I69.114
|
Frontal lobe and executive function deficit following nontraumatic intracerebral hemorrhage
|
|
I69.115
|
Cognitive social or emotional deficit following nontraumatic intracerebral hemorrhage
|
|
I69.118
|
Other symptoms and signs involving cognitive functions following nontraumatic intracerebral hemorrhage
|
|
I69.119
|
Unspecified symptoms and signs involving cognitive functions following nontraumatic intracerebral hemorrhage
|
|
I69.122
|
Dysarthria following nontraumatic intracerebral hemorrhage
|
|
I69.123
|
Fluency disorder following nontraumatic intracerebral hemorrhage
|
|
I69.210
|
Attention and concentration deficit following other nontraumatic intracranial hemorrhage
|
|
I69.211
|
Memory deficit following other nontraumatic intracranial hemorrhage
|
|
I69.212
|
Visuospatial deficit and spatial neglect following other nontraumatic intracranial hemorrhage
|
|
I69.213
|
Psychomotor deficit following other nontraumatic intracranial hemorrhage
|
|
I69.214
|
Frontal lobe and executive function deficit following other nontraumatic intracranial hemorrhage
|
|
I69.215
|
Cognitive social or emotional deficit following other nontraumatic intracranial hemorrhage
|
|
I69.218
|
Other symptoms and signs involving cognitive functions following other nontraumatic intracranial hemorrhage
|
|
I69.219
|
Unspecified symptoms and signs involving cognitive functions following other nontraumatic intracranial hemorrhage
|
|
I69.222
|
Dysarthria following other nontraumatic intracranial hemorrhage
|
|
I69.223
|
Fluency disorder following other nontraumatic intracranial hemorrhage
|
|
I69.310
|
Attention and concentration deficit following cerebral infarction
|
|
I69.311
|
Memory deficit following cerebral infarction
|
|
I69.312
|
Visuospatial deficit and spatial neglect following cerebral infarction
|
|
I69.313
|
Psychomotor deficit following cerebral infarction
|
|
I69.314
|
Frontal lobe and executive function deficit following cerebral infarction
|
|
I69.315
|
Cognitive social or emotional deficit following cerebral infarction
|
|
I69.318
|
Other symptoms and signs involving cognitive functions following cerebral infarction
|
|
I69.319
|
Unspecified symptoms and signs involving cognitive functions following cerebral infarction
|
|
I69.322
|
Dysarthria following cerebral infarction
|
|
I69.323
|
Fluency disorder following cerebral infarction
|
|
I69.810
|
Attention and concentration deficit following other cerebrovascular disease
|
|
I69.811
|
Memory deficit following other cerebrovascular disease
|
|
I69.812
|
Visuospatial deficit and spatial neglect following other cerebrovascular disease
|
|
I69.813
|
Psychomotor deficit following other cerebrovascular disease
|
|
I69.814
|
Frontal lobe and executive function deficit following other cerebrovascular disease
|
|
I69.815
|
Cognitive social or emotional deficit following other cerebrovascular disease
|
|
I69.818
|
Other symptoms and signs involving cognitive functions following other cerebrovascular disease
|
|
I69.819
|
Unspecified symptoms and signs involving cognitive functions following other cerebrovascular disease
|
|
I69.822
|
Dysarthria following other cerebrovascular disease
|
|
I69.823
|
Fluency disorder following other cerebrovascular disease
|
|
I69.910
|
Attention and concentration deficit following unspecified cerebrovascular disease
|
|
I69.911
|
Memory deficit following unspecified cerebrovascular disease
|
|
I69.912
|
Visuospatial deficit and spatial neglect following unspecified cerebrovascular disease
|
|
I69.913
|
Psychomotor deficit following unspecified cerebrovascular disease
|
|
I69.914
|
Frontal lobe and executive function deficit following unspecified cerebrovascular disease
|
|
I69.915
|
Cognitive social or emotional deficit following unspecified cerebrovascular disease
|
|
I69.918
|
Other symptoms and signs involving cognitive functions following unspecified cerebrovascular disease
|
|
I69.919
|
Unspecified symptoms and signs involving cognitive functions following unspecified cerebrovascular disease
|
|
I69.922
|
Dysarthria following unspecified cerebrovascular disease
|
|
I69.923
|
Fluency disorder following unspecified cerebrovascular disease
|
|
I72.5
|
Aneurysm of other precerebral arteries
|
|
I72.6
|
Aneurysm of vertebral artery
|
|
I77.75
|
Dissection of other precerebral arteries
|
|
I77.76
|
Dissection of artery of upper extremity
|
|
I97.410
|
Intraoperative hemorrhage and hematoma of a circulatory system organ or structure complicating a cardiac catheterization
|
|
I97.411
|
Intraoperative hemorrhage and hematoma of a circulatory system organ or structure complicating a cardiac bypass
|
|
I97.418
|
Intraoperative hemorrhage and hematoma of a circulatory system organ or structure complicating other circulatory system procedure
|
|
I97.42
|
Intraoperative hemorrhage and hematoma of a circulatory system organ or structure complicating other procedure
|
|
I97.610
|
Postprocedural hemorrhage of a circulatory system organ or structure following a cardiac catheterization
|
|
I97.611
|
Postprocedural hemorrhage of a circulatory system organ or structure following cardiac bypass
|
|
I97.618
|
Postprocedural hemorrhage of a circulatory system organ or structure following other circulatory system procedure
|
|
J10.81
|
Influenza due to other identified influenza virus with encephalopathy
|
|
J10.83
|
Influenza due to other identified influenza virus with otitis media
|
|
J10.89
|
Influenza due to other identified influenza virus with other manifestations
|
|
J11.81
|
Influenza due to unidentified influenza virus with encephalopathy
|
|
J11.83
|
Influenza due to unidentified influenza virus with otitis media
|
|
J11.89
|
Influenza due to unidentified influenza virus with other manifestations
|
|
K70.41
|
Alcoholic hepatic failure with coma
|
|
K71.11
|
Toxic liver disease with hepatic necrosis, with coma
|
|
K72.01
|
Acute and subacute hepatic failure with coma
|
|
K72.11
|
Chronic hepatic failure with coma
|
|
K72.91
|
Hepatic failure, unspecified with coma
|
|
L03.213
|
Periorbital cellulitis
|
|
O14.04
|
Mild to moderate pre-eclampsia, complicating childbirth
|
|
O14.05
|
Mild to moderate pre-eclampsia, complicating the puerperium
|
|
O14.14
|
Severe pre-eclampsia complicating childbirth
|
|
O14.15
|
Severe pre-eclampsia, complicating the puerperium
|
|
O14.24
|
HELLP syndrome, complicating childbirth
|
|
O14.25
|
HELLP syndrome, complicating the puerperium
|
|
O14.94
|
Unspecified pre-eclampsia, complicating childbirth
|
|
O14.95
|
Unspecified pre-eclampsia, complicating the puerperium
|
|
O74.3
|
Central nervous system complications of anesthesia during labor and delivery
|
|
P10.0
|
Subdural hemorrhage due to birth injury
|
|
P10.1
|
Cerebral hemorrhage due to birth injury
|
|
P10.2
|
Intraventricular hemorrhage due to birth injury
|
|
P10.4
|
Tentorial tear due to birth injury
|
|
P10.8
|
Other intracranial lacerations and hemorrhages due to birth injury
|
|
P10.9
|
Unspecified intracranial laceration and hemorrhage due to birth injury
|
|
P11.0
|
Cerebral edema due to birth injury
|
|
P11.2
|
Unspecified brain damage due to birth injury
|
|
P11.9
|
Birth injury to central nervous system, unspecified
|
|
P12.2
|
Epicranial subaponeurotic hemorrhage due to birth injury
|
|
P13.0
|
Fracture of skull due to birth injury
|
|
P13.1
|
Other birth injuries to skull
|
|
P52.0
|
Intraventricular (nontraumatic) hemorrhage, grade 1, of newborn
|
|
P52.1
|
Intraventricular (nontraumatic) hemorrhage, grade 2, of newborn
|
|
P52.21
|
Intraventricular (nontraumatic) hemorrhage, grade 3, of newborn
|
|
P52.22
|
Intraventricular (nontraumatic) hemorrhage, grade 4, of newborn
|
|
P52.3
|
Unspecified intraventricular (nontraumatic) hemorrhage of newborn
|
|
P52.4
|
Intracerebral (nontraumatic) hemorrhage of newborn
|
|
P52.6
|
Cerebellar (nontraumatic) and posterior fossa hemorrhage of newborn
|
|
P52.8
|
Other intracranial (nontraumatic) hemorrhages of newborn
|
|
P52.9
|
Intracranial (nontraumatic) hemorrhage of newborn, unspecified
|
|
Q01.0
|
Frontal encephalocele
|
|
Q01.1
|
Nasofrontal encephalocele
|
|
Q01.2
|
Occipital encephalocele
|
|
Q01.8
|
Encephalocele of other sites
|
|
Q01.9
|
Encephalocele, unspecified
|
|
Q02
|
Microcephaly
|
|
Q03.0
|
Malformations of aqueduct of Sylvius
|
|
Q03.1
|
Atresia of foramina of Magendie and Luschka
|
|
Q03.8
|
Other congenital hydrocephalus
|
|
Q03.9
|
Congenital hydrocephalus, unspecified
|
|
Q04.0
|
Congenital malformations of corpus callosum
|
|
Q04.1
|
Arhinencephaly
|
|
Q04.2
|
Holoprosencephaly
|
|
Q04.3
|
Other reduction deformities of brain
|
|
Q04.4
|
Septo-optic dysplasia of brain
|
|
Q04.5
|
Megalencephaly
|
|
Q04.6
|
Congenital cerebral cysts
|
|
Q04.8
|
Other specified congenital malformations of brain
|
|
Q04.9
|
Congenital malformation of brain, unspecified
|
|
Q06.0
|
Amyelia
|
|
Q06.1
|
Hypoplasia and dysplasia of spinal cord
|
|
Q06.2
|
Diastematomyelia
|
|
Q06.3
|
Other congenital cauda equina malformations
|
|
Q06.4
|
Hydromyelia
|
|
Q06.8
|
Other specified congenital malformations of spinal cord
|
|
Q07.8
|
Other specified congenital malformations of nervous system
|
|
Q28.2
|
Arteriovenous malformation of cerebral vessels
|
|
Q28.3
|
Other malformations of cerebral vessels
|
|
Q75.0
|
Craniosynostosis
|
|
Q75.1
|
Craniofacial dysostosis
|
|
Q75.2
|
Hypertelorism
|
|
Q75.3
|
Macrocephaly
|
|
Q75.4
|
Mandibulofacial dysostosis
|
|
Q75.5
|
Oculomandibular dysostosis
|
|
Q75.8
|
Other specified congenital malformations of skull and face bones
|
|
Q75.9
|
Congenital malformation of skull and face bones, unspecified
|
|
Q85.00
|
Neurofibromatosis, unspecified
|
|
Q85.01
|
Neurofibromatosis, type 1
|
|
Q85.02
|
Neurofibromatosis, type 2
|
|
Q85.03
|
Schwannomatosis
|
|
Q85.09
|
Other neurofibromatosis
|
|
Q87.0
|
Congenital malformation syndromes predominantly affecting facial appearance
|
|
Q87.82
|
Arterial tortuosity syndrome
|
|
R13.10
|
Dysphagia, unspecified
|
|
R20.0
|
Anesthesia of skin
|
|
R20.1
|
Hypoesthesia of skin
|
|
R20.2
|
Paresthesia of skin
|
|
R20.3
|
Hyperesthesia
|
|
R20.8
|
Other disturbances of skin sensation
|
|
R20.9
|
Unspecified disturbances of skin sensation
|
|
R22.0
|
Localized swelling, mass and lump, head
|
|
R22.1
|
Localized swelling, mass and lump, neck
|
|
R25.0
|
Abnormal head movements
|
|
R25.1
|
Tremor, unspecified
|
|
R25.2
|
Cramp and spasm
|
|
R25.3
|
Fasciculation
|
|
R25.8
|
Other abnormal involuntary movements
|
|
R25.9
|
Unspecified abnormal involuntary movements
|
|
R26.0
|
Ataxic gait
|
|
R26.1
|
Paralytic gait
|
|
R26.2
|
Difficulty in walking, not elsewhere classified
|
|
R26.81
|
Unsteadiness on feet
|
|
R26.89
|
Other abnormalities of gait and mobility
|
|
R26.9
|
Unspecified abnormalities of gait and mobility
|
|
R27.0
|
Ataxia, unspecified
|
|
R27.8
|
Other lack of coordination
|
|
R27.9
|
Unspecified lack of coordination
|
|
R29.5
|
Transient paralysis
|
|
R29.6
|
Repeated falls
|
|
R29.700
|
NIHSS score 0
|
|
R29.701
|
NIHSS score 1
|
|
R29.702
|
NIHSS score 2
|
|
R29.703
|
NIHSS score 3
|
|
R29.704
|
NIHSS score 4
|
|
R29.705
|
NIHSS score 5
|
|
R29.706
|
NIHSS score 6
|
|
R29.707
|
NIHSS score 7
|
|
R29.708
|
NIHSS score 8
|
|
R29.709
|
NIHSS score 9
|
|
R29.710
|
NIHSS score 10
|
|
R29.711
|
NIHSS score 11
|
|
R29.712
|
NIHSS score 12
|
|
R29.713
|
NIHSS score 13
|
|
R29.714
|
NIHSS score 14
|
|
R29.715
|
NIHSS score 15
|
|
R29.716
|
NIHSS score 16
|
|
R29.717
|
NIHSS score 17
|
|
R29.718
|
NIHSS score 18
|
|
R29.719
|
NIHSS score 19
|
|
R29.720
|
NIHSS score 20
|
|
R29.721
|
NIHSS score 21
|
|
R29.722
|
NIHSS score 22
|
|
R29.723
|
NIHSS score 23
|
|
R29.724
|
NIHSS score 24
|
|
R29.725
|
NIHSS score 25
|
|
R29.726
|
NIHSS score 26
|
|
R29.727
|
NIHSS score 27
|
|
R29.728
|
NIHSS score 28
|
|
R29.729
|
NIHSS score 29
|
|
R29.730
|
NIHSS score 30
|
|
R29.731
|
NIHSS score 31
|
|
R29.732
|
NIHSS score 32
|
|
R29.733
|
NIHSS score 33
|
|
R29.734
|
NIHSS score 34
|
|
R29.735
|
NIHSS score 35
|
|
R29.736
|
NIHSS score 36
|
|
R29.737
|
NIHSS score 37
|
|
R29.738
|
NIHSS score 38
|
|
R29.739
|
NIHSS score 39
|
|
R29.740
|
NIHSS score 40
|
|
R29.741
|
NIHSS score 41
|
|
R29.742
|
NIHSS score 42
|
|
R29.810
|
Facial weakness
|
|
R29.818
|
Other symptoms and signs involving the nervous system
|
|
R29.898
|
Other symptoms and signs involving the musculoskeletal system
|
|
R40.0
|
Somnolence
|
|
R40.1
|
Stupor
|
|
R40.20
|
Unspecified coma
|
|
R40.2110
|
Coma scale, eyes open, never, unspecified time
|
|
R40.2111
|
Coma scale, eyes open, never, in the field [EMT or ambulance]
|
|
R40.2112
|
Coma scale, eyes open, never, at arrival to emergency department
|
|
R40.2113
|
Coma scale, eyes open, never, at hospital admission
|
|
R40.2114
|
Coma scale, eyes open, never, 24 hours or more after hospital admission
|
|
R40.2120
|
Coma scale, eyes open, to pain, unspecified time
|
|
R40.2121
|
Coma scale, eyes open, to pain, in the field [EMT or ambulance]
|
|
R40.2122
|
Coma scale, eyes open, to pain, at arrival to emergency department
|
|
R40.2123
|
Coma scale, eyes open, to pain, at hospital admission
|
|
R40.2124
|
Coma scale, eyes open, to pain, 24 hours or more after hospital admission
|
|
R40.2210
|
Coma scale, best verbal response, none, unspecified time
|
|
R40.2211
|
Coma scale, best verbal response, none, in the field [EMT or ambulance]
|
|
R40.2212
|
Coma scale, best verbal response, none, at arrival to emergency department
|
|
R40.2213
|
Coma scale, best verbal response, none, at hospital admission
|
|
R40.2214
|
Coma scale, best verbal response, none, 24 hours or more after hospital admission
|
|
R40.2220
|
Coma scale, best verbal response, incomprehensible words, unspecified time
|
|
R40.2221
|
Coma scale, best verbal response, incomprehensible words, in the field [EMT or ambulance]
|
|
R40.2222
|
Coma scale, best verbal response, incomprehensible words, at arrival to emergency department
|
|
R40.2223
|
Coma scale, best verbal response, incomprehensible words, at hospital admission
|
|
R40.2224
|
Coma scale, best verbal response, incomprehensible words, 24 hours or more after hospital admission
|
|
R40.2310
|
Coma scale, best motor response, none, unspecified time
|
|
R40.2311
|
Coma scale, best motor response, none, in the field [EMT or ambulance]
|
|
R40.2312
|
Coma scale, best motor response, none, at arrival to emergency department
|
|
R40.2313
|
Coma scale, best motor response, none, at hospital admission
|
|
R40.2314
|
Coma scale, best motor response, none, 24 hours or more after hospital admission
|
|
R40.2320
|
Coma scale, best motor response, extension, unspecified time
|
|
R40.2321
|
Coma scale, best motor response, extension, in the field [EMT or ambulance]
|
|
R40.2322
|
Coma scale, best motor response, extension, at arrival to emergency department
|
|
R40.2323
|
Coma scale, best motor response, extension, at hospital admission
|
|
R40.2324
|
Coma scale, best motor response, extension, 24 hours or more after hospital admission
|
|
R40.2340
|
Coma scale, best motor response, flexion withdrawal, unspecified time
|
|
R40.2341
|
Coma scale, best motor response, flexion withdrawal, in the field [EMT or ambulance]
|
|
R40.2342
|
Coma scale, best motor response, flexion withdrawal, at arrival to emergency department
|
|
R40.2343
|
Coma scale, best motor response, flexion withdrawal, at hospital admission
|
|
R40.2344
|
Coma scale, best motor response, flexion withdrawal, 24 hours or more after hospital admission
|
|
R40.2410
|
Glasgow coma scale score 13-15, unspecified time
|
|
R40.2411
|
Glasgow coma scale score 13-15, in the field [EMT or ambulance]
|
|
R40.2412
|
Glasgow coma scale score 13-15, at arrival to emergency department
|
|
R40.2413
|
Glasgow coma scale score 13-15, at hospital admission
|
|
R40.2414
|
Glasgow coma scale score 13-15, 24 hours or more after hospital admission
|
|
R40.2420
|
Glasgow coma scale score 9-12, unspecified time
|
|
R40.2421
|
Glasgow coma scale score 9-12, in the field [EMT or ambulance]
|
|
R40.2422
|
Glasgow coma scale score 9-12, at arrival to emergency department
|
|
R40.2423
|
Glasgow coma scale score 9-12, at hospital admission
|
|
R40.2424
|
Glasgow coma scale score 9-12, 24 hours or more after hospital admission
|
|
R40.2430
|
Glasgow coma scale score 3-8, unspecified time
|
|
R40.2431
|
Glasgow coma scale score 3-8, in the field [EMT or ambulance]
|
|
R40.2432
|
Glasgow coma scale score 3-8, at arrival to emergency department
|
|
R40.2433
|
Glasgow coma scale score 3-8, at hospital admission
|
|
R40.2434
|
Glasgow coma scale score 3-8, 24 hours or more after hospital admission
|
|
R40.2440
|
Other coma, without documented Glasgow coma scale score, or with partial score reported, unspecified time
|
|
R40.2441
|
Other coma, without documented Glasgow coma scale score, or with partial score reported, in the field [EMT or ambulance]
|
|
R40.2442
|
Other coma, without documented Glasgow coma scale score, or with partial score reported, at arrival to emergency department
|
|
R40.2443
|
Other coma, without documented Glasgow coma scale score, or with partial score reported, at hospital admission
|
|
R40.2444
|
Other coma, without documented Glasgow coma scale score, or with partial score reported, 24 hours or more after hospital admission
|
|
R40.3
|
Persistent vegetative state
|
|
R40.4
|
Transient alteration of awareness
|
|
R41.0
|
Disorientation, unspecified
|
|
R41.1
|
Anterograde amnesia
|
|
R41.2
|
Retrograde amnesia
|
|
R41.3
|
Other amnesia
|
|
R41.82
|
Altered mental status, unspecified
|
|
R41.844
|
Frontal lobe and executive function deficit
|
|
R42
|
Dizziness and giddiness
|
|
R43.0
|
Anosmia
|
|
R43.1
|
Parosmia
|
|
R43.2
|
Parageusia
|
|
R43.8
|
Other disturbances of smell and taste
|
|
R43.9
|
Unspecified disturbances of smell and taste
|
|
R44.0
|
Auditory hallucinations
|
|
R44.2
|
Other hallucinations
|
|
R44.3
|
Hallucinations, unspecified
|
|
R47.01
|
Aphasia
|
|
R47.02
|
Dysphasia
|
|
R47.1
|
Dysarthria and anarthria
|
|
R47.81
|
Slurred speech
|
|
R47.82
|
Fluency disorder in conditions classified elsewhere
|
|
R47.89
|
Other speech disturbances
|
|
R47.9
|
Unspecified speech disturbances
|
|
R49.0
|
Dysphonia
|
|
R51.9
|
Headache, unspecified
|
|
R53.1
|
Weakness
|
|
R55
|
Syncope and collapse
|
|
R56.00
|
Simple febrile convulsions
|
|
R56.01
|
Complex febrile convulsions
|
|
R56.1
|
Post traumatic seizures
|
|
R56.9
|
Unspecified convulsions
|
|
R90.0
|
Intracranial space-occupying lesion found on diagnostic imaging of central nervous system
|
|
R90.82
|
White matter disease, unspecified
|
|
R91.1
|
Solitary pulmonary nodule
|
|
R91.8
|
Other nonspecific abnormal finding of lung field
|
|
R93.0
|
Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified
|
|
R94.01
|
Abnormal electroencephalogram [EEG]
|
|
S00.02XA
|
Blister (nonthermal) of scalp, initial encounter
|
|
S00.03XA
|
Contusion of scalp, initial encounter
|
|
S00.83XA
|
Contusion of other part of head, initial encounter
|
|
S01.01XA
|
Laceration without foreign body of scalp, initial encounter
|
|
S01.03XA
|
Puncture wound without foreign body of scalp, initial encounter
|
|
S01.04XA
|
Puncture wound with foreign body of scalp, initial encounter
|
|
S01.81XA
|
Laceration without foreign body of other part of head, initial encounter
|
|
S01.81XD
|
Laceration without foreign body of other part of head, subsequent encounter
|
|
S01.81XS
|
Laceration without foreign body of other part of head, sequela
|
|
S01.82XA
|
Laceration with foreign body of other part of head, initial encounter
|
|
S01.82XD
|
Laceration with foreign body of other part of head, subsequent encounter
|
|
S01.82XS
|
Laceration with foreign body of other part of head, sequela
|
|
S02.0XXA
|
Fracture of vault of skull, initial encounter for closed fracture
|
|
S02.0XXB
|
Fracture of vault of skull, initial encounter for open fracture
|
|
S02.0XXD
|
Fracture of vault of skull, subsequent encounter for fracture with routine healing
|
|
S02.0XXG
|
Fracture of vault of skull, subsequent encounter for fracture with delayed healing
|
|
S02.0XXK
|
Fracture of vault of skull, subsequent encounter for fracture with nonunion
|
|
S02.0XXS
|
Fracture of vault of skull, sequela
|
|
S02.101A
|
Fracture of base of skull, right side, initial encounter for closed fracture
|
|
S02.101B
|
Fracture of base of skull, right side, initial encounter for open fracture
|
|
S02.101D
|
Fracture of base of skull, right side, subsequent encounter for fracture with routine healing
|
|
S02.101G
|
Fracture of base of skull, right side, subsequent encounter for fracture with delayed healing
|
|
S02.101K
|
Fracture of base of skull, right side, subsequent encounter for fracture with nonunion
|
|
S02.101S
|
Fracture of base of skull, right side, sequela
|
|
S02.102A
|
Fracture of base of skull, left side, initial encounter for closed fracture
|
|
S02.102B
|
Fracture of base of skull, left side, initial encounter for open fracture
|
|
S02.102D
|
Fracture of base of skull, left side, subsequent encounter for fracture with routine healing
|
|
S02.102G
|
Fracture of base of skull, left side, subsequent encounter for fracture with delayed healing
|
|
S02.102K
|
Fracture of base of skull, left side, subsequent encounter for fracture with nonunion
|
|
S02.102S
|
Fracture of base of skull, left side, sequela
|
|
S02.109A
|
Fracture of base of skull, unspecified side, initial encounter for closed fracture
|
|
S02.109B
|
Fracture of base of skull, unspecified side, initial encounter for open fracture
|
|
S02.109D
|
Fracture of base of skull, unspecified side, subsequent encounter for fracture with routine healing
|
|
S02.109G
|
Fracture of base of skull, unspecified side, subsequent encounter for fracture with delayed healing
|
|
S02.109K
|
Fracture of base of skull, unspecified side, subsequent encounter for fracture with nonunion
|
|
S02.109S
|
Fracture of base of skull, unspecified side, sequela
|
|
S02.110A
|
Type I occipital condyle fracture, unspecified side, initial encounter for closed fracture
|
|
S02.110B
|
Type I occipital condyle fracture, unspecified side, initial encounter for open fracture
|
|
S02.110D
|
Type I occipital condyle fracture, unspecified side, subsequent encounter for fracture with routine healing
|
|
S02.110G
|
Type I occipital condyle fracture, unspecified side, subsequent encounter for fracture with delayed healing
|
|
S02.110K
|
Type I occipital condyle fracture, unspecified side, subsequent encounter for fracture with nonunion
|
|
S02.110S
|
Type I occipital condyle fracture, unspecified side, sequela
|
|
S02.111A
|
Type II occipital condyle fracture, unspecified side, initial encounter for closed fracture
|
|
S02.111B
|
Type II occipital condyle fracture, unspecified side, initial encounter for open fracture
|
|
S02.111D
|
Type II occipital condyle fracture, unspecified side, subsequent encounter for fracture with routine healing
|
|
S02.111G
|
Type II occipital condyle fracture, unspecified side, subsequent encounter for fracture with delayed healing
|
|
S02.111K
|
Type II occipital condyle fracture, unspecified side, subsequent encounter for fracture with nonunion
|
|
S02.111S
|
Type II occipital condyle fracture, unspecified side, sequela
|
|
S02.112A
|
Type III occipital condyle fracture, unspecified side, initial encounter for closed fracture
|
|
S02.112B
|
Type III occipital condyle fracture, unspecified side, initial encounter for open fracture
|
|
S02.112D
|
Type III occipital condyle fracture, unspecified side, subsequent encounter for fracture with routine healing
|
|
S02.112G
|
Type III occipital condyle fracture, unspecified side, subsequent encounter for fracture with delayed healing
|
|
S02.112K
|
Type III occipital condyle fracture, unspecified side, subsequent encounter for fracture with nonunion
|
|
S02.112S
|
Type III occipital condyle fracture, unspecified side, sequela
|
|
S02.113A
|
Unspecified occipital condyle fracture, initial encounter for closed fracture
|
|
S02.113B
|
Unspecified occipital condyle fracture, initial encounter for open fracture
|
|
S02.113D
|
Unspecified occipital condyle fracture, subsequent encounter for fracture with routine healing
|
|
S02.113G
|
Unspecified occipital condyle fracture, subsequent encounter for fracture with delayed healing
|
|
S02.113K
|
Unspecified occipital condyle fracture, subsequent encounter for fracture with nonunion
|
|
S02.113S
|
Unspecified occipital condyle fracture, sequela
|
|
S02.118A
|
Other fracture of occiput, unspecified side, initial encounter for closed fracture
|
|
S02.118B
|
Other fracture of occiput, unspecified side, initial encounter for open fracture
|
|
S02.118D
|
Other fracture of occiput, unspecified side, subsequent encounter for fracture with routine healing
|
|
S02.118G
|
Other fracture of occiput, unspecified side, subsequent encounter for fracture with delayed healing
|
|
S02.118K
|
Other fracture of occiput, unspecified side, subsequent encounter for fracture with nonunion
|
|
S02.118S
|
Other fracture of occiput, unspecified side, sequela
|
|
S02.119A
|
Unspecified fracture of occiput, initial encounter for closed fracture
|
|
S02.119B
|
Unspecified fracture of occiput, initial encounter for open fracture
|
|
S02.119D
|
Unspecified fracture of occiput, subsequent encounter for fracture with routine healing
|
|
S02.119G
|
Unspecified fracture of occiput, subsequent encounter for fracture with delayed healing
|
|
S02.119K
|
Unspecified fracture of occiput, subsequent encounter for fracture with nonunion
|
|
S02.119S
|
Unspecified fracture of occiput, sequela
|
|
S02.11AA
|
Type I occipital condyle fracture, right side, initial encounter for closed fracture
|
|
S02.11AB
|
Type I occipital condyle fracture, right side, initial encounter for open fracture
|
|
S02.11AD
|
Type I occipital condyle fracture, right side, subsequent encounter for fracture with routine healing
|
|
S02.11AG
|
Type I occipital condyle fracture, right side, subsequent encounter for fracture with delayed healing
|
|
S02.11AK
|
Type I occipital condyle fracture, right side, subsequent encounter for fracture with nonunion
|
|
S02.11AS
|
Type I occipital condyle fracture, right side, sequela
|
|
S02.11BA
|
Type I occipital condyle fracture, left side, initial encounter for closed fracture
|
|
S02.11BB
|
Type I occipital condyle fracture, left side, initial encounter for open fracture
|
|
S02.11BD
|
Type I occipital condyle fracture, left side, subsequent encounter for fracture with routine healing
|
|
S02.11BG
|
Type I occipital condyle fracture, left side, subsequent encounter for fracture with delayed healing
|
|
S02.11BK
|
Type I occipital condyle fracture, left side, subsequent encounter for fracture with nonunion
|
|
S02.11BS
|
Type I occipital condyle fracture, left side, sequela
|
|
S02.11CA
|
Type II occipital condyle fracture, right side, initial encounter for closed fracture
|
|
S02.11CB
|
Type II occipital condyle fracture, right side, initial encounter for open fracture
|
|
S02.11CD
|
Type II occipital condyle fracture, right side, subsequent encounter for fracture with routine healing
|
|
S02.11CG
|
Type II occipital condyle fracture, right side, subsequent encounter for fracture with delayed healing
|
|
S02.11CK
|
Type II occipital condyle fracture, right side, subsequent encounter for fracture with nonunion
|
|
S02.11CS
|
Type II occipital condyle fracture, right side, sequela
|
|
S02.11DA
|
Type II occipital condyle fracture, left side, initial encounter for closed fracture
|
|
S02.11DB
|
Type II occipital condyle fracture, left side, initial encounter for open fracture
|
|
S02.11DD
|
Type II occipital condyle fracture, left side, subsequent encounter for fracture with routine healing
|
|
S02.11DG
|
Type II occipital condyle fracture, left side, subsequent encounter for fracture with delayed healing
|
|
S02.11DK
|
Type II occipital condyle fracture, left side, subsequent encounter for fracture with nonunion
|
|
S02.11DS
|
Type II occipital condyle fracture, left side, sequela
|
|
S02.11EA
|
Type III occipital condyle fracture, right side, initial encounter for closed fracture
|
|
S02.11EB
|
Type III occipital condyle fracture, right side, initial encounter for open fracture
|
|
S02.11ED
|
Type III occipital condyle fracture, right side, subsequent encounter for fracture with routine healing
|
|
S02.11EG
|
Type III occipital condyle fracture, right side, subsequent encounter for fracture with delayed healing
|
|
S02.11EK
|
Type III occipital condyle fracture, right side, subsequent encounter for fracture with nonunion
|
|
S02.11ES
|
Type III occipital condyle fracture, right side, sequela
|
|
S02.11FA
|
Type III occipital condyle fracture, left side, initial encounter for closed fracture
|
|
S02.11FB
|
Type III occipital condyle fracture, left side, initial encounter for open fracture
|
|
S02.11FD
|
Type III occipital condyle fracture, left side, subsequent encounter for fracture with routine healing
|
|
S02.11FG
|
Type III occipital condyle fracture, left side, subsequent encounter for fracture with delayed healing
|
|
S02.11FK
|
Type III occipital condyle fracture, left side, subsequent encounter for fracture with nonunion
|
|
S02.11FS
|
Type III occipital condyle fracture, left side, sequela
|
|
S02.11GA
|
Other fracture of occiput, right side, initial encounter for closed fracture
|
|
S02.11GB
|
Other fracture of occiput, right side, initial encounter for open fracture
|
|
S02.11GD
|
Other fracture of occiput, right side, subsequent encounter for fracture with routine healing
|
|
S02.11GG
|
Other fracture of occiput, right side, subsequent encounter for fracture with delayed healing
|
|
S02.11GK
|
Other fracture of occiput, right side, subsequent encounter for fracture with nonunion
|
|
S02.11GS
|
Other fracture of occiput, right side, sequela
|
|
S02.11HA
|
Other fracture of occiput, left side, initial encounter for closed fracture
|
|
S02.11HB
|
Other fracture of occiput, left side, initial encounter for open fracture
|
|
S02.11HD
|
Other fracture of occiput, left side, subsequent encounter for fracture with routine healing
|
|
S02.11HG
|
Other fracture of occiput, left side, subsequent encounter for fracture with delayed healing
|
|
S02.11HK
|
Other fracture of occiput, left side, subsequent encounter for fracture with nonunion
|
|
S02.11HS
|
Other fracture of occiput, left side, sequela
|
|
S02.19XA
|
Other fracture of base of skull, initial encounter for closed fracture
|
|
S02.19XB
|
Other fracture of base of skull, initial encounter for open fracture
|
|
S02.19XD
|
Other fracture of base of skull, subsequent encounter for fracture with routine healing
|
|
S02.19XG
|
Other fracture of base of skull, subsequent encounter for fracture with delayed healing
|
|
S02.19XK
|
Other fracture of base of skull, subsequent encounter for fracture with nonunion
|
|
S02.19XS
|
Other fracture of base of skull, sequela
|
|
S02.2XXA
|
Fracture of nasal bones, initial encounter for closed fracture
|
|
S02.2XXB
|
Fracture of nasal bones, initial encounter for open fracture
|
|
S02.2XXD
|
Fracture of nasal bones, subsequent encounter for fracture with routine healing
|
|
S02.2XXG
|
Fracture of nasal bones, subsequent encounter for fracture with delayed healing
|
|
S02.2XXK
|
Fracture of nasal bones, subsequent encounter for fracture with nonunion
|
|
S02.2XXS
|
Fracture of nasal bones, sequela
|
|
S02.30XA
|
Fracture of orbital floor, unspecified side, initial encounter for closed fracture
|
|
S02.30XB
|
Fracture of orbital floor, unspecified side, initial encounter for open fracture
|
|
S02.30XD
|
Fracture of orbital floor, unspecified side, subsequent encounter for fracture with routine healing
|
|
S02.30XG
|
Fracture of orbital floor, unspecified side, subsequent encounter for fracture with delayed healing
|
|
S02.30XK
|
Fracture of orbital floor, unspecified side, subsequent encounter for fracture with nonunion
|
|
S02.30XS
|
Fracture of orbital floor, unspecified side, sequela
|
|
S02.31XA
|
Fracture of orbital floor, right side, initial encounter for closed fracture
|
|
S02.31XB
|
Fracture of orbital floor, right side, initial encounter for open fracture
|
|
S02.32XA
|
Fracture of orbital floor, left side, initial encounter for closed fracture
|
|
S02.32XB
|
Fracture of orbital floor, left side, initial encounter for open fracture
|
|
S02.32XD
|
Fracture of orbital floor, left side, subsequent encounter for fracture with routine healing
|
|
S02.32XG
|
Fracture of orbital floor, left side, subsequent encounter for fracture with delayed healing
|
|
S02.32XK
|
Fracture of orbital floor, left side, subsequent encounter for fracture with nonunion
|
|
S02.32XS
|
Fracture of orbital floor, left side, sequela
|
|
S02.400A
|
Malar fracture, unspecified side, initial encounter for closed fracture
|
|
S02.400B
|
Malar fracture, unspecified side, initial encounter for open fracture
|
|
S02.400D
|
Malar fracture, unspecified side, subsequent encounter for fracture with routine healing
|
|
S02.400G
|
Malar fracture, unspecified side, subsequent encounter for fracture with delayed healing
|
|
S02.400K
|
Malar fracture, unspecified side, subsequent encounter for fracture with nonunion
|
|
S02.400S
|
Malar fracture, unspecified side, sequela
|
|
S02.401A
|
Maxillary fracture, unspecified side, initial encounter for closed fracture
|
|
S02.401B
|
Maxillary fracture, unspecified side, initial encounter for open fracture
|
|
S02.401D
|
Maxillary fracture, unspecified side, subsequent encounter for fracture with routine healing
|
|
S02.401G
|
Maxillary fracture, unspecified side, subsequent encounter for fracture with delayed healing
|
|
S02.401K
|
Maxillary fracture, unspecified side, subsequent encounter for fracture with nonunion
|
|
S02.401S
|
Maxillary fracture, unspecified side, sequela
|
|
S02.402A
|
Zygomatic fracture, unspecified side, initial encounter for closed fracture
|
|
S02.402B
|
Zygomatic fracture, unspecified side, initial encounter for open fracture
|
|
S02.402D
|
Zygomatic fracture, unspecified side, subsequent encounter for fracture with routine healing
|
|
S02.402G
|
Zygomatic fracture, unspecified side, subsequent encounter for fracture with delayed healing
|
|
S02.402K
|
Zygomatic fracture, unspecified side, subsequent encounter for fracture with nonunion
|
|
S02.402S
|
Zygomatic fracture, unspecified side, sequela
|
|
S02.40AA
|
Malar fracture, right side, initial encounter for closed fracture
|
|
S02.40AB
|
Malar fracture, right side, initial encounter for open fracture
|
|
S02.40AD
|
Malar fracture, right side, subsequent encounter for fracture with routine healing
|
|
S02.40AG
|
Malar fracture, right side, subsequent encounter for fracture with delayed healing
|
|
S02.40AK
|
Malar fracture, right side, subsequent encounter for fracture with nonunion
|
|
S02.40AS
|
Malar fracture, right side, sequela
|
|
S02.40BA
|
Malar fracture, left side, initial encounter for closed fracture
|
|
S02.40BB
|
Malar fracture, left side, initial encounter for open fracture
|
|
S02.40BD
|
Malar fracture, left side, subsequent encounter for fracture with routine healing
|
|
S02.40BG
|
Malar fracture, left side, subsequent encounter for fracture with delayed healing
|
|
S02.40BK
|
Malar fracture, left side, subsequent encounter for fracture with nonunion
|
|
S02.40BS
|
Malar fracture, left side, sequela
|
|
S02.40CA
|
Maxillary fracture, right side, initial encounter for closed fracture
|
|
S02.40CB
|
Maxillary fracture, right side, initial encounter for open fracture
|
|
S02.40CD
|
Maxillary fracture, right side, subsequent encounter for fracture with routine healing
|
|
S02.40CG
|
Maxillary fracture, right side, subsequent encounter for fracture with delayed healing
|
|
S02.40CK
|
Maxillary fracture, right side, subsequent encounter for fracture with nonunion
|
|
S02.40CS
|
Maxillary fracture, right side, sequela
|
|
S02.40DA
|
Maxillary fracture, left side, initial encounter for closed fracture
|
|
S02.40DB
|
Maxillary fracture, left side, initial encounter for open fracture
|
|
S02.40DD
|
Maxillary fracture, left side, subsequent encounter for fracture with routine healing
|
|
S02.40DG
|
Maxillary fracture, left side, subsequent encounter for fracture with delayed healing
|
|
S02.40DK
|
Maxillary fracture, left side, subsequent encounter for fracture with nonunion
|
|
S02.40DS
|
Maxillary fracture, left side, sequela
|
|
S02.40EA
|
Zygomatic fracture, right side, initial encounter for closed fracture
|
|
S02.40EB
|
Zygomatic fracture, right side, initial encounter for open fracture
|
|
S02.40ED
|
Zygomatic fracture, right side, subsequent encounter for fracture with routine healing
|
|
S02.40EG
|
Zygomatic fracture, right side, subsequent encounter for fracture with delayed healing
|
|
S02.40EK
|
Zygomatic fracture, right side, subsequent encounter for fracture with nonunion
|
|
S02.40ES
|
Zygomatic fracture, right side, sequela
|
|
S02.40FA
|
Zygomatic fracture, left side, initial encounter for closed fracture
|
|
S02.40FB
|
Zygomatic fracture, left side, initial encounter for open fracture
|
|
S02.40FD
|
Zygomatic fracture, left side, subsequent encounter for fracture with routine healing
|
|
S02.40FG
|
Zygomatic fracture, left side, subsequent encounter for fracture with delayed healing
|
|
S02.40FK
|
Zygomatic fracture, left side, subsequent encounter for fracture with nonunion
|
|
S02.40FS
|
Zygomatic fracture, left side, sequela
|
|
S02.411A
|
LeFort I fracture, initial encounter for closed fracture
|
|
S02.411B
|
LeFort I fracture, initial encounter for open fracture
|
|
S02.411D
|
LeFort I fracture, subsequent encounter for fracture with routine healing
|
|
S02.411G
|
LeFort I fracture, subsequent encounter for fracture with delayed healing
|
|
S02.411K
|
LeFort I fracture, subsequent encounter for fracture with nonunion
|
|
S02.411S
|
LeFort I fracture, sequela
|
|
S02.412A
|
LeFort II fracture, initial encounter for closed fracture
|
|
S02.412B
|
LeFort II fracture, initial encounter for open fracture
|
|
S02.412D
|
LeFort II fracture, subsequent encounter for fracture with routine healing
|
|
S02.412G
|
LeFort II fracture, subsequent encounter for fracture with delayed healing
|
|
S02.412K
|
LeFort II fracture, subsequent encounter for fracture with nonunion
|
|
S02.412S
|
LeFort II fracture, sequela
|
|
S02.413A
|
LeFort III fracture, initial encounter for closed fracture
|
|
S02.413B
|
LeFort III fracture, initial encounter for open fracture
|
|
S02.413D
|
LeFort III fracture, subsequent encounter for fracture with routine healing
|
|
S02.413G
|
LeFort III fracture, subsequent encounter for fracture with delayed healing
|
|
S02.413K
|
LeFort III fracture, subsequent encounter for fracture with nonunion
|
|
S02.413S
|
LeFort III fracture, sequela
|
|
S02.42XA
|
Fracture of alveolus of maxilla, initial encounter for closed fracture
|
|
S02.42XB
|
Fracture of alveolus of maxilla, initial encounter for open fracture
|
|
S02.42XD
|
Fracture of alveolus of maxilla, subsequent encounter for fracture with routine healing
|
|
S02.42XG
|
Fracture of alveolus of maxilla, subsequent encounter for fracture with delayed healing
|
|
S02.42XK
|
Fracture of alveolus of maxilla, subsequent encounter for fracture with nonunion
|
|
S02.42XS
|
Fracture of alveolus of maxilla, sequela
|
|
S02.600A
|
Fracture of unspecified part of body of mandible, unspecified side, initial encounter for closed fracture
|
|
S02.600B
|
Fracture of unspecified part of body of mandible, unspecified side, initial encounter for open fracture
|
|
S02.600D
|
Fracture of unspecified part of body of mandible, unspecified side, subsequent encounter for fracture with routine healing
|
|
S02.600G
|
Fracture of unspecified part of body of mandible, unspecified side, subsequent encounter for fracture with delayed healing
|
|
S02.600K
|
Fracture of unspecified part of body of mandible, unspecified side, subsequent encounter for fracture with nonunion
|
|
S02.600S
|
Fracture of unspecified part of body of mandible, unspecified side, sequela
|
|
S02.601A
|
Fracture of unspecified part of body of right mandible, initial encounter for closed fracture
|
|
S02.601B
|
Fracture of unspecified part of body of right mandible, initial encounter for open fracture
|
|
S02.601D
|
Fracture of unspecified part of body of right mandible, subsequent encounter for fracture with routine healing
|
|
S02.601G
|
Fracture of unspecified part of body of right mandible, subsequent encounter for fracture with delayed healing
|
|
S02.601K
|
Fracture of unspecified part of body of right mandible, subsequent encounter for fracture with nonunion
|
|
S02.601S
|
Fracture of unspecified part of body of right mandible, sequela
|
|
S02.602A
|
Fracture of unspecified part of body of left mandible, initial encounter for closed fracture
|
|
S02.602B
|
Fracture of unspecified part of body of left mandible, initial encounter for open fracture
|
|
S02.602D
|
Fracture of unspecified part of body of left mandible, subsequent encounter for fracture with routine healing
|
|
S02.602G
|
Fracture of unspecified part of body of left mandible, subsequent encounter for fracture with delayed healing
|
|
S02.602K
|
Fracture of unspecified part of body of left mandible, subsequent encounter for fracture with nonunion
|
|
S02.602S
|
Fracture of unspecified part of body of left mandible, sequela
|
|
S02.609A
|
Fracture of mandible, unspecified, initial encounter for closed fracture
|
|
S02.609B
|
Fracture of mandible, unspecified, initial encounter for open fracture
|
|
S02.609D
|
Fracture of mandible, unspecified, subsequent encounter for fracture with routine healing
|
|
S02.609G
|
Fracture of mandible, unspecified, subsequent encounter for fracture with delayed healing
|
|
S02.609K
|
Fracture of mandible, unspecified, subsequent encounter for fracture with nonunion
|
|
S02.609S
|
Fracture of mandible, unspecified, sequela
|
|
S02.610A
|
Fracture of condylar process of mandible, unspecified side, initial encounter for closed fracture
|
|
S02.610B
|
Fracture of condylar process of mandible, unspecified side, initial encounter for open fracture
|
|
S02.610D
|
Fracture of condylar process of mandible, unspecified side, subsequent encounter for fracture with routine healing
|
|
S02.610G
|
Fracture of condylar process of mandible, unspecified side, subsequent encounter for fracture with delayed healing
|
|
S02.610K
|
Fracture of condylar process of mandible, unspecified side, subsequent encounter for fracture with nonunion
|
|
S02.610S
|
Fracture of condylar process of mandible, unspecified side, sequela
|
|
S02.611A
|
Fracture of condylar process of right mandible, initial encounter for closed fracture
|
|
S02.611B
|
Fracture of condylar process of right mandible, initial encounter for open fracture
|
|
S02.611D
|
Fracture of condylar process of right mandible, subsequent encounter for fracture with routine healing
|
|
S02.611G
|
Fracture of condylar process of right mandible, subsequent encounter for fracture with delayed healing
|
|
S02.611K
|
Fracture of condylar process of right mandible, subsequent encounter for fracture with nonunion
|
|
S02.611S
|
Fracture of condylar process of right mandible, sequela
|
|
S02.612A
|
Fracture of condylar process of left mandible, initial encounter for closed fracture
|
|
S02.612B
|
Fracture of condylar process of left mandible, initial encounter for open fracture
|
|
S02.612D
|
Fracture of condylar process of left mandible, subsequent encounter for fracture with routine healing
|
|
S02.612G
|
Fracture of condylar process of left mandible, subsequent encounter for fracture with delayed healing
|
|
S02.612K
|
Fracture of condylar process of left mandible, subsequent encounter for fracture with nonunion
|
|
S02.612S
|
Fracture of condylar process of left mandible, sequela
|
|
S02.620A
|
Fracture of subcondylar process of mandible, unspecified side, initial encounter for closed fracture
|
|
S02.620B
|
Fracture of subcondylar process of mandible, unspecified side, initial encounter for open fracture
|
|
S02.620D
|
Fracture of subcondylar process of mandible, unspecified side, subsequent encounter for fracture with routine healing
|
|
S02.620G
|
Fracture of subcondylar process of mandible, unspecified side, subsequent encounter for fracture with delayed healing
|
|
S02.620K
|
Fracture of subcondylar process of mandible, unspecified side, subsequent encounter for fracture with nonunion
|
|
S02.620S
|
Fracture of subcondylar process of mandible, unspecified side, sequela
|
|
S02.621A
|
Fracture of subcondylar process of right mandible, initial encounter for closed fracture
|
|
S02.621B
|
Fracture of subcondylar process of right mandible, initial encounter for open fracture
|
|
S02.621D
|
Fracture of subcondylar process of right mandible, subsequent encounter for fracture with routine healing
|
|
S02.621G
|
Fracture of subcondylar process of right mandible, subsequent encounter for fracture with delayed healing
|
|
S02.621K
|
Fracture of subcondylar process of right mandible, subsequent encounter for fracture with nonunion
|
|
S02.621S
|
Fracture of subcondylar process of right mandible, sequela
|
|
S02.622A
|
Fracture of subcondylar process of left mandible, initial encounter for closed fracture
|
|
S02.622B
|
Fracture of subcondylar process of left mandible, initial encounter for open fracture
|
|
S02.622D
|
Fracture of subcondylar process of left mandible, subsequent encounter for fracture with routine healing
|
|
S02.622G
|
Fracture of subcondylar process of left mandible, subsequent encounter for fracture with delayed healing
|
|
S02.622K
|
Fracture of subcondylar process of left mandible, subsequent encounter for fracture with nonunion
|
|
S02.622S
|
Fracture of subcondylar process of left mandible, sequela
|
|
S02.630A
|
Fracture of coronoid process of mandible, unspecified side, initial encounter for closed fracture
|
|
S02.630B
|
Fracture of coronoid process of mandible, unspecified side, initial encounter for open fracture
|
|
S02.630D
|
Fracture of coronoid process of mandible, unspecified side, subsequent encounter for fracture with routine healing
|
|
S02.630G
|
Fracture of coronoid process of mandible, unspecified side, subsequent encounter for fracture with delayed healing
|
|
S02.630K
|
Fracture of coronoid process of mandible, unspecified side, subsequent encounter for fracture with nonunion
|
|
S02.630S
|
Fracture of coronoid process of mandible, unspecified side, sequela
|
|
S02.631A
|
Fracture of coronoid process of right mandible, initial encounter for closed fracture
|
|
S02.631B
|
Fracture of coronoid process of right mandible, initial encounter for open fracture
|
|
S02.631D
|
Fracture of coronoid process of right mandible, subsequent encounter for fracture with routine healing
|
|
S02.631G
|
Fracture of coronoid process of right mandible, subsequent encounter for fracture with delayed healing
|
|
S02.631K
|
Fracture of coronoid process of right mandible, subsequent encounter for fracture with nonunion
|
|
S02.631S
|
Fracture of coronoid process of right mandible, sequela
|
|
S02.632A
|
Fracture of coronoid process of left mandible, initial encounter for closed fracture
|
|
S02.632B
|
Fracture of coronoid process of left mandible, initial encounter for open fracture
|
|
S02.632D
|
Fracture of coronoid process of left mandible, subsequent encounter for fracture with routine healing
|
|
S02.632G
|
Fracture of coronoid process of left mandible, subsequent encounter for fracture with delayed healing
|
|
S02.632K
|
Fracture of coronoid process of left mandible, subsequent encounter for fracture with nonunion
|
|
S02.632S
|
Fracture of coronoid process of left mandible, sequela
|
|
S02.640A
|
Fracture of ramus of mandible, unspecified side, initial encounter for closed fracture
|
|
S02.640B
|
Fracture of ramus of mandible, unspecified side, initial encounter for open fracture
|
|
S02.640D
|
Fracture of ramus of mandible, unspecified side, subsequent encounter for fracture with routine healing
|
|
S02.640G
|
Fracture of ramus of mandible, unspecified side, subsequent encounter for fracture with delayed healing
|
|
S02.640K
|
Fracture of ramus of mandible, unspecified side, subsequent encounter for fracture with nonunion
|
|
S02.640S
|
Fracture of ramus of mandible, unspecified side, sequela
|
|
S02.641A
|
Fracture of ramus of right mandible, initial encounter for closed fracture
|
|
S02.641B
|
Fracture of ramus of right mandible, initial encounter for open fracture
|
|
S02.641D
|
Fracture of ramus of right mandible, subsequent encounter for fracture with routine healing
|
|
S02.641G
|
Fracture of ramus of right mandible, subsequent encounter for fracture with delayed healing
|
|
S02.641K
|
Fracture of ramus of right mandible, subsequent encounter for fracture with nonunion
|
|
S02.641S
|
Fracture of ramus of right mandible, sequela
|
|
S02.642A
|
Fracture of ramus of left mandible, initial encounter for closed fracture
|
|
S02.642B
|
Fracture of ramus of left mandible, initial encounter for open fracture
|
|
S02.642D
|
Fracture of ramus of left mandible, subsequent encounter for fracture with routine healing
|
|
S02.642G
|
Fracture of ramus of left mandible, subsequent encounter for fracture with delayed healing
|
|
S02.642K
|
Fracture of ramus of left mandible, subsequent encounter for fracture with nonunion
|
|
S02.642S
|
Fracture of ramus of left mandible, sequela
|
|
S02.650A
|
Fracture of angle of mandible, unspecified side, initial encounter for closed fracture
|
|
S02.650B
|
Fracture of angle of mandible, unspecified side, initial encounter for open fracture
|
|
S02.650D
|
Fracture of angle of mandible, unspecified side, subsequent encounter for fracture with routine healing
|
|
S02.650G
|
Fracture of angle of mandible, unspecified side, subsequent encounter for fracture with delayed healing
|
|
S02.650K
|
Fracture of angle of mandible, unspecified side, subsequent encounter for fracture with nonunion
|
|
S02.650S
|
Fracture of angle of mandible, unspecified side, sequela
|
|
S02.651A
|
Fracture of angle of right mandible, initial encounter for closed fracture
|
|
S02.651B
|
Fracture of angle of right mandible, initial encounter for open fracture
|
|
S02.651D
|
Fracture of angle of right mandible, subsequent encounter for fracture with routine healing
|
|
S02.651G
|
Fracture of angle of right mandible, subsequent encounter for fracture with delayed healing
|
|
S02.651K
|
Fracture of angle of right mandible, subsequent encounter for fracture with nonunion
|
|
S02.651S
|
Fracture of angle of right mandible, sequela
|
|
S02.652A
|
Fracture of angle of left mandible, initial encounter for closed fracture
|
|
S02.652B
|
Fracture of angle of left mandible, initial encounter for open fracture
|
|
S02.652D
|
Fracture of angle of left mandible, subsequent encounter for fracture with routine healing
|
|
S02.652G
|
Fracture of angle of left mandible, subsequent encounter for fracture with delayed healing
|
|
S02.652K
|
Fracture of angle of left mandible, subsequent encounter for fracture with nonunion
|
|
S02.652S
|
Fracture of angle of left mandible, sequela
|
|
S02.66XA
|
Fracture of symphysis of mandible, initial encounter for closed fracture
|
|
S02.66XB
|
Fracture of symphysis of mandible, initial encounter for open fracture
|
|
S02.66XD
|
Fracture of symphysis of mandible, subsequent encounter for fracture with routine healing
|
|
S02.66XG
|
Fracture of symphysis of mandible, subsequent encounter for fracture with delayed healing
|
|
S02.66XK
|
Fracture of symphysis of mandible, subsequent encounter for fracture with nonunion
|
|
S02.66XS
|
Fracture of symphysis of mandible, sequela
|
|
S02.670A
|
Fracture of alveolus of mandible, unspecified side, initial encounter for closed fracture
|
|
S02.670B
|
Fracture of alveolus of mandible, unspecified side, initial encounter for open fracture
|
|
S02.670D
|
Fracture of alveolus of mandible, unspecified side, subsequent encounter for fracture with routine healing
|
|
S02.670G
|
Fracture of alveolus of mandible, unspecified side, subsequent encounter for fracture with delayed healing
|
|
S02.670K
|
Fracture of alveolus of mandible, unspecified side, subsequent encounter for fracture with nonunion
|
|
S02.670S
|
Fracture of alveolus of mandible, unspecified side, sequela
|
|
S02.671A
|
Fracture of alveolus of right mandible, initial encounter for closed fracture
|
|
S02.671B
|
Fracture of alveolus of right mandible, initial encounter for open fracture
|
|
S02.671D
|
Fracture of alveolus of right mandible, subsequent encounter for fracture with routine healing
|
|
S02.671G
|
Fracture of alveolus of right mandible, subsequent encounter for fracture with delayed healing
|
|
S02.671K
|
Fracture of alveolus of right mandible, subsequent encounter for fracture with nonunion
|
|
S02.671S
|
Fracture of alveolus of right mandible, sequela
|
|
S02.672A
|
Fracture of alveolus of left mandible, initial encounter for closed fracture
|
|
S02.672B
|
Fracture of alveolus of left mandible, initial encounter for open fracture
|
|
S02.672D
|
Fracture of alveolus of left mandible, subsequent encounter for fracture with routine healing
|
|
S02.672G
|
Fracture of alveolus of left mandible, subsequent encounter for fracture with delayed healing
|
|
S02.672K
|
Fracture of alveolus of left mandible, subsequent encounter for fracture with nonunion
|
|
S02.672S
|
Fracture of alveolus of left mandible, sequela
|
|
S02.69XA
|
Fracture of mandible of other specified site, initial encounter for closed fracture
|
|
S02.69XB
|
Fracture of mandible of other specified site, initial encounter for open fracture
|
|
S02.69XD
|
Fracture of mandible of other specified site, subsequent encounter for fracture with routine healing
|
|
S02.69XG
|
Fracture of mandible of other specified site, subsequent encounter for fracture with delayed healing
|
|
S02.69XK
|
Fracture of mandible of other specified site, subsequent encounter for fracture with nonunion
|
|
S02.69XS
|
Fracture of mandible of other specified site, sequela
|
|
S02.80XA
|
Fracture of other specified skull and facial bones, unspecified side, initial encounter for closed fracture
|
|
S02.80XB
|
Fracture of other specified skull and facial bones, unspecified side, initial encounter for open fracture
|
|
S02.80XD
|
Fracture of other specified skull and facial bones, unspecified side, subsequent encounter for fracture with routine healing
|
|
S02.80XG
|
Fracture of other specified skull and facial bones, unspecified side, subsequent encounter for fracture with delayed healing
|
|
S02.80XK
|
Fracture of other specified skull and facial bones, unspecified side, subsequent encounter for fracture with nonunion
|
|
S02.80XS
|
Fracture of other specified skull and facial bones, unspecified side, sequela
|
|
S02.81XA
|
Fracture of other specified skull and facial bones, right side, initial encounter for closed fracture
|
|
S02.81XB
|
Fracture of other specified skull and facial bones, right side, initial encounter for open fracture
|
|
S02.81XD
|
Fracture of other specified skull and facial bones, right side, subsequent encounter for fracture with routine healing
|
|
S02.81XG
|
Fracture of other specified skull and facial bones, right side, subsequent encounter for fracture with delayed healing
|
|
S02.81XK
|
Fracture of other specified skull and facial bones, right side, subsequent encounter for fracture with nonunion
|
|
S02.81XS
|
Fracture of other specified skull and facial bones, right side, sequela
|
|
S02.82XA
|
Fracture of other specified skull and facial bones, left side, initial encounter for closed fracture
|
|
S02.82XB
|
Fracture of other specified skull and facial bones, left side, initial encounter for open fracture
|
|
S02.82XD
|
Fracture of other specified skull and facial bones, left side, subsequent encounter for fracture with routine healing
|
|
S02.82XG
|
Fracture of other specified skull and facial bones, left side, subsequent encounter for fracture with delayed healing
|
|
S02.82XK
|
Fracture of other specified skull and facial bones, left side, subsequent encounter for fracture with nonunion
|
|
S02.82XS
|
Fracture of other specified skull and facial bones, left side, sequela
|
|
S02.831S
|
Fracture of medial orbital wall, right side, sequela
|
|
S02.832A
|
Fracture of medial orbital wall, left side, initial encounter for closed fracture
|
|
S02.832B
|
Fracture of medial orbital wall, left side, initial encounter for open fracture
|
|
S02.832D
|
Fracture of medial orbital wall, left side, subsequent encounter for fracture with routine healing
|
|
S02.832G
|
Fracture of medial orbital wall, left side, subsequent encounter for fracture with delayed healing
|
|
S02.832K
|
Fracture of medial orbital wall, left side, subsequent encounter for fracture with nonunion
|
|
S02.832S
|
Fracture of medial orbital wall, left side, sequela
|
|
S02.839A
|
Fracture of medial orbital wall, unspecified side, initial encounter for closed fracture
|
|
S02.839B
|
Fracture of medial orbital wall, unspecified side, initial encounter for open fracture
|
|
S02.839D
|
Fracture of medial orbital wall, unspecified side, subsequent encounter for fracture with routine healing
|
|
S02.839G
|
Fracture of medial orbital wall, unspecified side, subsequent encounter for fracture with delayed healing
|
|
S02.839K
|
Fracture of medial orbital wall, unspecified side, subsequent encounter for fracture with nonunion
|
|
S02.839S
|
Fracture of medial orbital wall, unspecified side, sequela
|
|
S02.841A
|
Fracture of lateral orbital wall, right side, initial encounter for closed fracture
|
|
S02.841B
|
Fracture of lateral orbital wall, right side, initial encounter for open fracture
|
|
S02.841D
|
Fracture of lateral orbital wall, right side, subsequent encounter for fracture with routine healing
|
|
S02.841G
|
Fracture of lateral orbital wall, right side, subsequent encounter for fracture with delayed healing
|
|
S02.841K
|
Fracture of lateral orbital wall, right side, subsequent encounter for fracture with nonunion
|
|
S02.841S
|
Fracture of lateral orbital wall, right side, sequela
|
|
S02.842A
|
Fracture of lateral orbital wall, left side, initial encounter for closed fracture
|
|
S02.842B
|
Fracture of lateral orbital wall, left side, initial encounter for open fracture
|
|
S02.842D
|
Fracture of lateral orbital wall, left side, subsequent encounter for fracture with routine healing
|
|
S02.842G
|
Fracture of lateral orbital wall, left side, subsequent encounter for fracture with delayed healing
|
|
S02.842K
|
Fracture of lateral orbital wall, left side, subsequent encounter for fracture with nonunion
|
|
S02.842S
|
Fracture of lateral orbital wall, left side, sequela
|
|
S02.849A
|
Fracture of lateral orbital wall, unspecified side, initial encounter for closed fracture
|
|
S02.849B
|
Fracture of lateral orbital wall, unspecified side, initial encounter for open fracture
|
|
S02.849D
|
Fracture of lateral orbital wall, unspecified side, subsequent encounter for fracture with routine healing
|
|
S02.849G
|
Fracture of lateral orbital wall, unspecified side, subsequent encounter for fracture with delayed healing
|
|
S02.849K
|
Fracture of lateral orbital wall, unspecified side, subsequent encounter for fracture with nonunion
|
|
S02.849S
|
Fracture of lateral orbital wall, unspecified side, sequela
|
|
S02.85XA
|
Fracture of orbit, unspecified, initial encounter for closed fracture
|
|
S02.85XB
|
Fracture of orbit, unspecified, initial encounter for open fracture
|
|
S02.85XD
|
Fracture of orbit, unspecified, subsequent encounter for fracture with routine healing
|
|
S02.85XG
|
Fracture of orbit, unspecified, subsequent encounter for fracture with delayed healing
|
|
S02.85XK
|
Fracture of orbit, unspecified, subsequent encounter for fracture with nonunion
|
|
S02.85XS
|
Fracture of orbit, unspecified, sequela
|
|
S02.91XA
|
Unspecified fracture of skull, initial encounter for closed fracture
|
|
S02.91XB
|
Unspecified fracture of skull, initial encounter for open fracture
|
|
S02.91XD
|
Unspecified fracture of skull, subsequent encounter for fracture with routine healing
|
|
S02.91XG
|
Unspecified fracture of skull, subsequent encounter for fracture with delayed healing
|
|
S02.91XK
|
Unspecified fracture of skull, subsequent encounter for fracture with nonunion
|
|
S02.91XS
|
Unspecified fracture of skull, sequela
|
|
S02.92XA
|
Unspecified fracture of facial bones, initial encounter for closed fracture
|
|
S02.92XB
|
Unspecified fracture of facial bones, initial encounter for open fracture
|
|
S02.92XD
|
Unspecified fracture of facial bones, subsequent encounter for fracture with routine healing
|
|
S02.92XG
|
Unspecified fracture of facial bones, subsequent encounter for fracture with delayed healing
|
|
S02.92XK
|
Unspecified fracture of facial bones, subsequent encounter for fracture with nonunion
|
|
S02.92XS
|
Unspecified fracture of facial bones, sequela
|
|
S04.011A
|
Injury of optic nerve, right eye, initial encounter
|
|
S04.011D
|
Injury of optic nerve, right eye, subsequent encounter
|
|
S04.011S
|
Injury of optic nerve, right eye, sequela
|
|
S04.012A
|
Injury of optic nerve, left eye, initial encounter
|
|
S04.012D
|
Injury of optic nerve, left eye, subsequent encounter
|
|
S04.012S
|
Injury of optic nerve, left eye, sequela
|
|
S04.02XA
|
Injury of optic chiasm, initial encounter
|
|
S04.02XD
|
Injury of optic chiasm, subsequent encounter
|
|
S04.02XS
|
Injury of optic chiasm, sequela
|
|
S04.031A
|
Injury of optic tract and pathways, right side, initial encounter
|
|
S04.031D
|
Injury of optic tract and pathways, right side, subsequent encounter
|
|
S04.031S
|
Injury of optic tract and pathways, right side, sequela
|
|
S04.032A
|
Injury of optic tract and pathways, left side, initial encounter
|
|
S04.032D
|
Injury of optic tract and pathways, left side, subsequent encounter
|
|
S04.032S
|
Injury of optic tract and pathways, left side, sequela
|
|
S04.041A
|
Injury of visual cortex, right side, initial encounter
|
|
S04.041D
|
Injury of visual cortex, right side, subsequent encounter
|
|
S04.041S
|
Injury of visual cortex, right side, sequela
|
|
S04.042A
|
Injury of visual cortex, left side, initial encounter
|
|
S04.042D
|
Injury of visual cortex, left side, subsequent encounter
|
|
S04.042S
|
Injury of visual cortex, left side, sequela
|
|
S04.11XA
|
Injury of oculomotor nerve, right side, initial encounter
|
|
S04.11XD
|
Injury of oculomotor nerve, right side, subsequent encounter
|
|
S04.11XS
|
Injury of oculomotor nerve, right side, sequela
|
|
S04.12XA
|
Injury of oculomotor nerve, left side, initial encounter
|
|
S04.12XD
|
Injury of oculomotor nerve, left side, subsequent encounter
|
|
S04.12XS
|
Injury of oculomotor nerve, left side, sequela
|
|
S04.21XA
|
Injury of trochlear nerve, right side, initial encounter
|
|
S04.21XD
|
Injury of trochlear nerve, right side, subsequent encounter
|
|
S04.21XS
|
Injury of trochlear nerve, right side, sequela
|
|
S04.22XA
|
Injury of trochlear nerve, left side, initial encounter
|
|
S04.22XD
|
Injury of trochlear nerve, left side, subsequent encounter
|
|
S04.22XS
|
Injury of trochlear nerve, left side, sequela
|
|
S04.31XA
|
Injury of trigeminal nerve, right side, initial encounter
|
|
S04.31XD
|
Injury of trigeminal nerve, right side, subsequent encounter
|
|
S04.31XS
|
Injury of trigeminal nerve, right side, sequela
|
|
S04.32XA
|
Injury of trigeminal nerve, left side, initial encounter
|
|
S04.32XD
|
Injury of trigeminal nerve, left side, subsequent encounter
|
|
S04.32XS
|
Injury of trigeminal nerve, left side, sequela
|
|
S04.41XA
|
Injury of abducent nerve, right side, initial encounter
|
|
S04.41XD
|
Injury of abducent nerve, right side, subsequent encounter
|
|
S04.41XS
|
Injury of abducent nerve, right side, sequela
|
|
S04.42XA
|
Injury of abducent nerve, left side, initial encounter
|
|
S04.42XD
|
Injury of abducent nerve, left side, subsequent encounter
|
|
S04.42XS
|
Injury of abducent nerve, left side, sequela
|
|
S04.51XA
|
Injury of facial nerve, right side, initial encounter
|
|
S04.51XD
|
Injury of facial nerve, right side, subsequent encounter
|
|
S04.51XS
|
Injury of facial nerve, right side, sequela
|
|
S04.52XA
|
Injury of facial nerve, left side, initial encounter
|
|
S04.52XD
|
Injury of facial nerve, left side, subsequent encounter
|
|
S04.52XS
|
Injury of facial nerve, left side, sequela
|
|
S04.61XA
|
Injury of acoustic nerve, right side, initial encounter
|
|
S04.61XD
|
Injury of acoustic nerve, right side, subsequent encounter
|
|
S04.61XS
|
Injury of acoustic nerve, right side, sequela
|
|
S04.62XA
|
Injury of acoustic nerve, left side, initial encounter
|
|
S04.62XD
|
Injury of acoustic nerve, left side, subsequent encounter
|
|
S04.62XS
|
Injury of acoustic nerve, left side, sequela
|
|
S04.71XA
|
Injury of accessory nerve, right side, initial encounter
|
|
S04.71XD
|
Injury of accessory nerve, right side, subsequent encounter
|
|
S04.71XS
|
Injury of accessory nerve, right side, sequela
|
|
S04.72XA
|
Injury of accessory nerve, left side, initial encounter
|
|
S04.72XD
|
Injury of accessory nerve, left side, subsequent encounter
|
|
S04.72XS
|
Injury of accessory nerve, left side, sequela
|
|
S04.811A
|
Injury of olfactory [1st ] nerve, right side, initial encounter
|
|
S04.811D
|
Injury of olfactory [1st ] nerve, right side, subsequent encounter
|
|
S04.811S
|
Injury of olfactory [1st ] nerve, right side, sequela
|
|
S04.812A
|
Injury of olfactory [1st ] nerve, left side, initial encounter
|
|
S04.812D
|
Injury of olfactory [1st ] nerve, left side, subsequent encounter
|
|
S04.812S
|
Injury of olfactory [1st ] nerve, left side, sequela
|
|
S04.891A
|
Injury of other cranial nerves, right side, initial encounter
|
|
S04.891D
|
Injury of other cranial nerves, right side, subsequent encounter
|
|
S04.891S
|
Injury of other cranial nerves, right side, sequela
|
|
S04.892A
|
Injury of other cranial nerves, left side, initial encounter
|
|
S04.892D
|
Injury of other cranial nerves, left side, subsequent encounter
|
|
S04.892S
|
Injury of other cranial nerves, left side, sequela
|
|
S06.0X0A
|
Concussion without loss of consciousness, initial encounter
|
|
S06.0X0D
|
Concussion without loss of consciousness, subsequent encounter
|
|
S06.0X0S
|
Concussion without loss of consciousness, sequela
|
|
S06.0X1A
|
Concussion with loss of consciousness of 30 minutes or less, initial encounter
|
|
S06.0X1D
|
Concussion with loss of consciousness of 30 minutes or less, subsequent encounter
|
|
S06.0X1S
|
Concussion with loss of consciousness of 30 minutes or less, sequela
|
|
S06.0XAA
|
Concussion with loss of consciousness status unknown, initial encounter
|
|
S06.0XAD
|
Concussion with loss of consciousness status unknown, subsequent encounter
|
|
S06.0XAS
|
Concussion with loss of consciousness status unknown, sequela
|
|
S06.0X9A
|
Concussion with loss of consciousness of unspecified duration, initial encounter
|
|
S06.0X9D
|
Concussion with loss of consciousness of unspecified duration, subsequent encounter
|
|
S06.0X9S
|
Concussion with loss of consciousness of unspecified duration, sequela
|
|
S06.1X0A
|
Traumatic cerebral edema without loss of consciousness, initial encounter
|
|
S06.1X0D
|
Traumatic cerebral edema without loss of consciousness, subsequent encounter
|
|
S06.1X0S
|
Traumatic cerebral edema without loss of consciousness, sequela
|
|
S06.1X1A
|
Traumatic cerebral edema with loss of consciousness of 30 minutes or less, initial encounter
|
|
S06.1X1D
|
Traumatic cerebral edema with loss of consciousness of 30 minutes or less, subsequent encounter
|
|
S06.1X1S
|
Traumatic cerebral edema with loss of consciousness of 30 minutes or less, sequela
|
|
S06.1X2A
|
Traumatic cerebral edema with loss of consciousness of 31 minutes to 59 minutes, initial encounter
|
|
S06.1X2D
|
Traumatic cerebral edema with loss of consciousness of 31 minutes to 59 minutes, subsequent encounter
|
|
S06.1X2S
|
Traumatic cerebral edema with loss of consciousness of 31 minutes to 59 minutes, sequela
|
|
S06.1X3A
|
Traumatic cerebral edema with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter
|
|
S06.1X3D
|
Traumatic cerebral edema with loss of consciousness of 1 hour to 5 hours 59 minutes, subsequent encounter
|
|
S06.1X3S
|
Traumatic cerebral edema with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela
|
|
S06.1X4A
|
Traumatic cerebral edema with loss of consciousness of 6 hours to 24 hours, initial encounter
|
|
S06.1X4D
|
Traumatic cerebral edema with loss of consciousness of 6 hours to 24 hours, subsequent encounter
|
|
S06.1X4S
|
Traumatic cerebral edema with loss of consciousness of 6 hours to 24 hours, sequela
|
|
S06.1X5A
|
Traumatic cerebral edema with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter
|
|
S06.1X5D
|
Traumatic cerebral edema with loss of consciousness greater than 24 hours with return to pre-existing conscious level, subsequent encounter
|
|
S06.1X5S
|
Traumatic cerebral edema with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela
|
|
S06.1X6A
|
Traumatic cerebral edema with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter
|
|
S06.1X6D
|
Traumatic cerebral edema with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, subsequent encounter
|
|
S06.1X6S
|
Traumatic cerebral edema with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela
|
|
S06.1XAA
|
Traumatic cerebral edema with loss of consciousness status unknown, initial encounter
|
|
S06.1XAD
|
Traumatic cerebral edema with loss of consciousness status unknown, subsequent encounter
|
|
S06.1XAS
|
Traumatic cerebral edema with loss of consciousness status unknown, sequela
|
|
S06.1X9A
|
Traumatic cerebral edema with loss of consciousness of unspecified duration, initial encounter
|
|
S06.1X9D
|
Traumatic cerebral edema with loss of consciousness of unspecified duration, subsequent encounter
|
|
S06.1X9S
|
Traumatic cerebral edema with loss of consciousness of unspecified duration, sequela
|
|
S06.2X0A
|
Diffuse traumatic brain injury without loss of consciousness, initial encounter
|
|
S06.2X0D
|
Diffuse traumatic brain injury without loss of consciousness, subsequent encounter
|
|
S06.2X0S
|
Diffuse traumatic brain injury without loss of consciousness, sequela
|
|
S06.2X1A
|
Diffuse traumatic brain injury with loss of consciousness of 30 minutes or less, initial encounter
|
|
S06.2X1D
|
Diffuse traumatic brain injury with loss of consciousness of 30 minutes or less, subsequent encounter
|
|
S06.2X1S
|
Diffuse traumatic brain injury with loss of consciousness of 30 minutes or less, sequela
|
|
S06.2X2A
|
Diffuse traumatic brain injury with loss of consciousness of 31 minutes to 59 minutes, initial encounter
|
|
S06.2X2D
|
Diffuse traumatic brain injury with loss of consciousness of 31 minutes to 59 minutes, subsequent encounter
|
|
S06.2X2S
|
Diffuse traumatic brain injury with loss of consciousness of 31 minutes to 59 minutes, sequela
|
|
S06.2X3A
|
Diffuse traumatic brain injury with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter
|
|
S06.2X3D
|
Diffuse traumatic brain injury with loss of consciousness of 1 hour to 5 hours 59 minutes, subsequent encounter
|
|
S06.2X3S
|
Diffuse traumatic brain injury with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela
|
|
S06.2X4A
|
Diffuse traumatic brain injury with loss of consciousness of 6 hours to 24 hours, initial encounter
|
|
S06.2X4D
|
Diffuse traumatic brain injury with loss of consciousness of 6 hours to 24 hours, subsequent encounter
|
|
S06.2X4S
|
Diffuse traumatic brain injury with loss of consciousness of 6 hours to 24 hours, sequela
|
|
S06.2X5A
|
Diffuse traumatic brain injury with loss of consciousness greater than 24 hours with return to pre-existing conscious levels, initial encounter
|
|
S06.2X5D
|
Diffuse traumatic brain injury with loss of consciousness greater than 24 hours with return to pre-existing conscious levels, subsequent encounter
|
|
S06.2X5S
|
Diffuse traumatic brain injury with loss of consciousness greater than 24 hours with return to pre-existing conscious levels, sequela
|
|
S06.2X6A
|
Diffuse traumatic brain injury with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter
|
|
S06.2X6D
|
Diffuse traumatic brain injury with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, subsequent encounter
|
|
S06.2X6S
|
Diffuse traumatic brain injury with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela
|
|
S06.2XAA
|
Diffuse traumatic brain injury with loss of consciousness status unknown, initial encounter
|
|
S06.2XAD
|
Diffuse traumatic brain injury with loss of consciousness status unknown, subsequent encounter
|
|
S06.2XAS
|
Diffuse traumatic brain injury with loss of consciousness status unknown, sequela
|
|
S06.2X9A
|
Diffuse traumatic brain injury with loss of consciousness of unspecified duration, initial encounter
|
|
S06.2X9D
|
Diffuse traumatic brain injury with loss of consciousness of unspecified duration, subsequent encounter
|
|
S06.2X9S
|
Diffuse traumatic brain injury with loss of consciousness of unspecified duration, sequela
|
|
S06.300A
|
Unspecified focal traumatic brain injury without loss of consciousness, initial encounter
|
|
S06.300D
|
Unspecified focal traumatic brain injury without loss of consciousness, subsequent encounter
|
|
S06.300S
|
Unspecified focal traumatic brain injury without loss of consciousness, sequela
|
|
S06.301A
|
Unspecified focal traumatic brain injury with loss of consciousness of 30 minutes or less, initial encounter
|
|
S06.301D
|
Unspecified focal traumatic brain injury with loss of consciousness of 30 minutes or less, subsequent encounter
|
|
S06.301S
|
Unspecified focal traumatic brain injury with loss of consciousness of 30 minutes or less, sequela
|
|
S06.302A
|
Unspecified focal traumatic brain injury with loss of consciousness of 31 minutes to 59 minutes, initial encounter
|
|
S06.302D
|
Unspecified focal traumatic brain injury with loss of consciousness of 31 minutes to 59 minutes, subsequent encounter
|
|
S06.302S
|
Unspecified focal traumatic brain injury with loss of consciousness of 31 minutes to 59 minutes, sequela
|
|
S06.303A
|
Unspecified focal traumatic brain injury with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter
|
|
S06.303D
|
Unspecified focal traumatic brain injury with loss of consciousness of 1 hour to 5 hours 59 minutes, subsequent encounter
|
|
S06.303S
|
Unspecified focal traumatic brain injury with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela
|
|
S06.304A
|
Unspecified focal traumatic brain injury with loss of consciousness of 6 hours to 24 hours, initial encounter
|
|
S06.304D
|
Unspecified focal traumatic brain injury with loss of consciousness of 6 hours to 24 hours, subsequent encounter
|
|
S06.304S
|
Unspecified focal traumatic brain injury with loss of consciousness of 6 hours to 24 hours, sequela
|
|
S06.305A
|
Unspecified focal traumatic brain injury with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter
|
|
S06.305D
|
Unspecified focal traumatic brain injury with loss of consciousness greater than 24 hours with return to pre-existing conscious level, subsequent encounter
|
|
S06.305S
|
Unspecified focal traumatic brain injury with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela
|
|
S06.306A
|
Unspecified focal traumatic brain injury with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter
|
|
S06.306D
|
Unspecified focal traumatic brain injury with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, subsequent encounter
|
|
S06.306S
|
Unspecified focal traumatic brain injury with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela
|
|
S06.309A
|
Unspecified focal traumatic brain injury with loss of consciousness of unspecified duration, initial encounter
|
|
S06.309D
|
Unspecified focal traumatic brain injury with loss of consciousness of unspecified duration, subsequent encounter
|
|
S06.309S
|
Unspecified focal traumatic brain injury with loss of consciousness of unspecified duration, sequela
|
|
S06.310A
|
Contusion and laceration of right cerebrum without loss of consciousness, initial encounter
|
|
S06.310D
|
Contusion and laceration of right cerebrum without loss of consciousness, subsequent encounter
|
|
S06.310S
|
Contusion and laceration of right cerebrum without loss of consciousness, sequela
|
|
S06.311A
|
Contusion and laceration of right cerebrum with loss of consciousness of 30 minutes or less, initial encounter
|
|
S06.311D
|
Contusion and laceration of right cerebrum with loss of consciousness of 30 minutes or less, subsequent encounter
|
|
S06.311S
|
Contusion and laceration of right cerebrum with loss of consciousness of 30 minutes or less, sequela
|
|
S06.312A
|
Contusion and laceration of right cerebrum with loss of consciousness of 31 minutes to 59 minutes, initial encounter
|
|
S06.312D
|
Contusion and laceration of right cerebrum with loss of consciousness of 31 minutes to 59 minutes, subsequent encounter
|
|
S06.312S
|
Contusion and laceration of right cerebrum with loss of consciousness of 31 minutes to 59 minutes, sequela
|
|
S06.313A
|
Contusion and laceration of right cerebrum with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter
|
|
S06.313D
|
Contusion and laceration of right cerebrum with loss of consciousness of 1 hour to 5 hours 59 minutes, subsequent encounter
|
|
S06.313S
|
Contusion and laceration of right cerebrum with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela
|
|
S06.314A
|
Contusion and laceration of right cerebrum with loss of consciousness of 6 hours to 24 hours, initial encounter
|
|
S06.314D
|
Contusion and laceration of right cerebrum with loss of consciousness of 6 hours to 24 hours, subsequent encounter
|
|
S06.314S
|
Contusion and laceration of right cerebrum with loss of consciousness of 6 hours to 24 hours, sequela
|
|
S06.315A
|
Contusion and laceration of right cerebrum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter
|
|
S06.315D
|
Contusion and laceration of right cerebrum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, subsequent encounter
|
|
S06.315S
|
Contusion and laceration of right cerebrum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela
|
|
S06.316A
|
Contusion and laceration of right cerebrum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter
|
|
S06.316D
|
Contusion and laceration of right cerebrum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, subsequent encounter
|
|
S06.316S
|
Contusion and laceration of right cerebrum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela
|
|
S06.31AA
|
Contusion and laceration of right cerebrum with loss of consciousness status unknown, initial encounter
|
|
S06.31AD
|
Contusion and laceration of right cerebrum with loss of consciousness status unknown, subsequent encounter
|
|
S06.31AS
|
Contusion and laceration of right cerebrum with loss of consciousness status unknown, sequela
|
|
S06.319A
|
Contusion and laceration of right cerebrum with loss of consciousness of unspecified duration, initial encounter
|
|
S06.319D
|
Contusion and laceration of right cerebrum with loss of consciousness of unspecified duration, subsequent encounter
|
|
S06.319S
|
Contusion and laceration of right cerebrum with loss of consciousness of unspecified duration, sequela
|
|
S06.320A
|
Contusion and laceration of left cerebrum without loss of consciousness, initial encounter
|
|
S06.320D
|
Contusion and laceration of left cerebrum without loss of consciousness, subsequent encounter
|
|
S06.320S
|
Contusion and laceration of left cerebrum without loss of consciousness, sequela
|
|
S06.321A
|
Contusion and laceration of left cerebrum with loss of consciousness of 30 minutes or less, initial encounter
|
|
S06.321D
|
Contusion and laceration of left cerebrum with loss of consciousness of 30 minutes or less, subsequent encounter
|
|
S06.321S
|
Contusion and laceration of left cerebrum with loss of consciousness of 30 minutes or less, sequela
|
|
S06.322A
|
Contusion and laceration of left cerebrum with loss of consciousness of 31 minutes to 59 minutes, initial encounter
|
|
S06.322D
|
Contusion and laceration of left cerebrum with loss of consciousness of 31 minutes to 59 minutes, subsequent encounter
|
|
S06.322S
|
Contusion and laceration of left cerebrum with loss of consciousness of 31 minutes to 59 minutes, sequela
|
|
S06.323A
|
Contusion and laceration of left cerebrum with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter
|
|
S06.323D
|
Contusion and laceration of left cerebrum with loss of consciousness of 1 hour to 5 hours 59 minutes, subsequent encounter
|
|
S06.323S
|
Contusion and laceration of left cerebrum with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela
|
|
S06.324A
|
Contusion and laceration of left cerebrum with loss of consciousness of 6 hours to 24 hours, initial encounter
|
|
S06.324D
|
Contusion and laceration of left cerebrum with loss of consciousness of 6 hours to 24 hours, subsequent encounter
|
|
S06.324S
|
Contusion and laceration of left cerebrum with loss of consciousness of 6 hours to 24 hours, sequela
|
|
S06.325A
|
Contusion and laceration of left cerebrum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter
|
|
S06.325D
|
Contusion and laceration of left cerebrum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, subsequent encounter
|
|
S06.325S
|
Contusion and laceration of left cerebrum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela
|
|
S06.326A
|
Contusion and laceration of left cerebrum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter
|
|
S06.326D
|
Contusion and laceration of left cerebrum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, subsequent encounter
|
|
S06.326S
|
Contusion and laceration of left cerebrum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela
|
|
S06.32AA
|
Contusion and laceration of left cerebrum with loss of consciousness status unknown, initial encounter
|
|
S06.32AD
|
Contusion and laceration of left cerebrum with loss of consciousness status unknown, subsequent encounter
|
|
S06.32AS
|
Contusion and laceration of left cerebrum with loss of consciousness status unknown, sequela
|
|
S06.329A
|
Contusion and laceration of left cerebrum with loss of consciousness of unspecified duration, initial encounter
|
|
S06.329D
|
Contusion and laceration of left cerebrum with loss of consciousness of unspecified duration, subsequent encounter
|
|
S06.329S
|
Contusion and laceration of left cerebrum with loss of consciousness of unspecified duration, sequela
|
|
S06.330A
|
Contusion and laceration of cerebrum, unspecified, without loss of consciousness, initial encounter
|
|
S06.330D
|
Contusion and laceration of cerebrum, unspecified, without loss of consciousness, subsequent encounter
|
|
S06.330S
|
Contusion and laceration of cerebrum, unspecified, without loss of consciousness, sequela
|
|
S06.331A
|
Contusion and laceration of cerebrum, unspecified, with loss of consciousness of 30 minutes or less, initial encounter
|
|
S06.331D
|
Contusion and laceration of cerebrum, unspecified, with loss of consciousness of 30 minutes or less, subsequent encounter
|
|
S06.331S
|
Contusion and laceration of cerebrum, unspecified, with loss of consciousness of 30 minutes or less, sequela
|
|
S06.332A
|
Contusion and laceration of cerebrum, unspecified, with loss of consciousness of 31 minutes to 59 minutes, initial encounter
|
|
S06.332D
|
Contusion and laceration of cerebrum, unspecified, with loss of consciousness of 31 minutes to 59 minutes, subsequent encounter
|
|
S06.332S
|
Contusion and laceration of cerebrum, unspecified, with loss of consciousness of 31 minutes to 59 minutes, sequela
|
|
S06.333A
|
Contusion and laceration of cerebrum, unspecified, with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter
|
|
S06.333D
|
Contusion and laceration of cerebrum, unspecified, with loss of consciousness of 1 hour to 5 hours 59 minutes, subsequent encounter
|
|
S06.333S
|
Contusion and laceration of cerebrum, unspecified, with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela
|
|
S06.334A
|
Contusion and laceration of cerebrum, unspecified, with loss of consciousness of 6 hours to 24 hours, initial encounter
|
|
S06.334D
|
Contusion and laceration of cerebrum, unspecified, with loss of consciousness of 6 hours to 24 hours, subsequent encounter
|
|
S06.334S
|
Contusion and laceration of cerebrum, unspecified, with loss of consciousness of 6 hours to 24 hours, sequela
|
|
S06.335A
|
Contusion and laceration of cerebrum, unspecified, with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter
|
|
S06.335D
|
Contusion and laceration of cerebrum, unspecified, with loss of consciousness greater than 24 hours with return to pre-existing conscious level, subsequent encounter
|
|
S06.335S
|
Contusion and laceration of cerebrum, unspecified, with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela
|
|
S06.336A
|
Contusion and laceration of cerebrum, unspecified, with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter
|
|
S06.336D
|
Contusion and laceration of cerebrum, unspecified, with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, subsequent encounter
|
|
S06.336S
|
Contusion and laceration of cerebrum, unspecified, with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela
|
|
S06.33AA
|
Contusion and laceration of cerebrum, unspecified, with loss of consciousness status unknown, initial encounter
|
|
S06.33AD
|
Contusion and laceration of cerebrum, unspecified, with loss of consciousness status unknown, subsequent encounter
|
|
S06.33AS
|
Contusion and laceration of cerebrum, unspecified, with loss of consciousness status unknown, sequela
|
|
S06.339A
|
Contusion and laceration of cerebrum, unspecified, with loss of consciousness of unspecified duration, initial encounter
|
|
S06.339D
|
Contusion and laceration of cerebrum, unspecified, with loss of consciousness of unspecified duration, subsequent encounter
|
|
S06.339S
|
Contusion and laceration of cerebrum, unspecified, with loss of consciousness of unspecified duration, sequela
|
|
S06.340A
|
Traumatic hemorrhage of right cerebrum without loss of consciousness, initial encounter
|
|
S06.340D
|
Traumatic hemorrhage of right cerebrum without loss of consciousness, subsequent encounter
|
|
S06.340S
|
Traumatic hemorrhage of right cerebrum without loss of consciousness, sequela
|
|
S06.341A
|
Traumatic hemorrhage of right cerebrum with loss of consciousness of 30 minutes or less, initial encounter
|
|
S06.341D
|
Traumatic hemorrhage of right cerebrum with loss of consciousness of 30 minutes or less, subsequent encounter
|
|
S06.341S
|
Traumatic hemorrhage of right cerebrum with loss of consciousness of 30 minutes or less, sequela
|
|
S06.342A
|
Traumatic hemorrhage of right cerebrum with loss of consciousness of 31 minutes to 59 minutes, initial encounter
|
|
S06.342D
|
Traumatic hemorrhage of right cerebrum with loss of consciousness of 31 minutes to 59 minutes, subsequent encounter
|
|
S06.342S
|
Traumatic hemorrhage of right cerebrum with loss of consciousness of 31 minutes to 59 minutes, sequela
|
|
S06.343A
|
Traumatic hemorrhage of right cerebrum with loss of consciousness of 1 hours to 5 hours 59 minutes, initial encounter
|
|
S06.343D
|
Traumatic hemorrhage of right cerebrum with loss of consciousness of 1 hours to 5 hours 59 minutes, subsequent encounter
|
|
S06.343S
|
Traumatic hemorrhage of right cerebrum with loss of consciousness of 1 hours to 5 hours 59 minutes, sequela
|
|
S06.344A
|
Traumatic hemorrhage of right cerebrum with loss of consciousness of 6 hours to 24 hours, initial encounter
|
|
S06.344D
|
Traumatic hemorrhage of right cerebrum with loss of consciousness of 6 hours to 24 hours, subsequent encounter
|
|
S06.344S
|
Traumatic hemorrhage of right cerebrum with loss of consciousness of 6 hours to 24 hours, sequela
|
|
S06.345A
|
Traumatic hemorrhage of right cerebrum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter
|
|
S06.345D
|
Traumatic hemorrhage of right cerebrum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, subsequent encounter
|
|
S06.345S
|
Traumatic hemorrhage of right cerebrum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela
|
|
S06.346A
|
Traumatic hemorrhage of right cerebrum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter
|
|
S06.346D
|
Traumatic hemorrhage of right cerebrum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, subsequent encounter
|
|
S06.346S
|
Traumatic hemorrhage of right cerebrum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela
|
|
S06.34AA
|
Traumatic hemorrhage of right cerebrum with loss of consciousness status unknown, initial encounter
|
|
S06.34AD
|
Traumatic hemorrhage of right cerebrum with loss of consciousness status unknown, subsequent encounter
|
|
S06.34AS
|
Traumatic hemorrhage of right cerebrum with loss of consciousness status unknown, sequela
|
|
S06.349A
|
Traumatic hemorrhage of right cerebrum with loss of consciousness of unspecified duration, initial encounter
|
|
S06.349D
|
Traumatic hemorrhage of right cerebrum with loss of consciousness of unspecified duration, subsequent encounter
|
|
S06.349S
|
Traumatic hemorrhage of right cerebrum with loss of consciousness of unspecified duration, sequela
|
|
S06.350A
|
Traumatic hemorrhage of left cerebrum without loss of consciousness, initial encounter
|
|
S06.350D
|
Traumatic hemorrhage of left cerebrum without loss of consciousness, subsequent encounter
|
|
S06.350S
|
Traumatic hemorrhage of left cerebrum without loss of consciousness, sequela
|
|
S06.351A
|
Traumatic hemorrhage of left cerebrum with loss of consciousness of 30 minutes or less, initial encounter
|
|
S06.351D
|
Traumatic hemorrhage of left cerebrum with loss of consciousness of 30 minutes or less, subsequent encounter
|
|
S06.351S
|
Traumatic hemorrhage of left cerebrum with loss of consciousness of 30 minutes or less, sequela
|
|
S06.352A
|
Traumatic hemorrhage of left cerebrum with loss of consciousness of 31 minutes to 59 minutes, initial encounter
|
|
S06.352D
|
Traumatic hemorrhage of left cerebrum with loss of consciousness of 31 minutes to 59 minutes, subsequent encounter
|
|
S06.352S
|
Traumatic hemorrhage of left cerebrum with loss of consciousness of 31 minutes to 59 minutes, sequela
|
|
S06.353A
|
Traumatic hemorrhage of left cerebrum with loss of consciousness of 1 hours to 5 hours 59 minutes, initial encounter
|
|
S06.353D
|
Traumatic hemorrhage of left cerebrum with loss of consciousness of 1 hours to 5 hours 59 minutes, subsequent encounter
|
|
S06.353S
|
Traumatic hemorrhage of left cerebrum with loss of consciousness of 1 hours to 5 hours 59 minutes, sequela
|
|
S06.354A
|
Traumatic hemorrhage of left cerebrum with loss of consciousness of 6 hours to 24 hours, initial encounter
|
|
S06.354D
|
Traumatic hemorrhage of left cerebrum with loss of consciousness of 6 hours to 24 hours, subsequent encounter
|
|
S06.354S
|
Traumatic hemorrhage of left cerebrum with loss of consciousness of 6 hours to 24 hours, sequela
|
|
S06.355A
|
Traumatic hemorrhage of left cerebrum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter
|
|
S06.355D
|
Traumatic hemorrhage of left cerebrum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, subsequent encounter
|
|
S06.355S
|
Traumatic hemorrhage of left cerebrum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela
|
|
S06.356A
|
Traumatic hemorrhage of left cerebrum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter
|
|
S06.356D
|
Traumatic hemorrhage of left cerebrum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, subsequent encounter
|
|
S06.356S
|
Traumatic hemorrhage of left cerebrum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela
|
|
S06.35AA
|
Traumatic hemorrhage of left cerebrum with loss of consciousness status unknown, initial encounter
|
|
S06.35AD
|
Traumatic hemorrhage of left cerebrum with loss of consciousness status unknown, subsequent encounter
|
|
S06.35AS
|
Traumatic hemorrhage of left cerebrum with loss of consciousness status unknown, sequela
|
|
S06.359A
|
Traumatic hemorrhage of left cerebrum with loss of consciousness of unspecified duration, initial encounter
|
|
S06.359D
|
Traumatic hemorrhage of left cerebrum with loss of consciousness of unspecified duration, subsequent encounter
|
|
S06.359S
|
Traumatic hemorrhage of left cerebrum with loss of consciousness of unspecified duration, sequela
|
|
S06.360A
|
Traumatic hemorrhage of cerebrum, unspecified, without loss of consciousness, initial encounter
|
|
S06.360D
|
Traumatic hemorrhage of cerebrum, unspecified, without loss of consciousness, subsequent encounter
|
|
S06.360S
|
Traumatic hemorrhage of cerebrum, unspecified, without loss of consciousness, sequela
|
|
S06.361A
|
Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of 30 minutes or less, initial encounter
|
|
S06.361D
|
Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of 30 minutes or less, subsequent encounter
|
|
S06.361S
|
Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of 30 minutes or less, sequela
|
|
S06.362A
|
Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of 31 minutes to 59 minutes, initial encounter
|
|
S06.362D
|
Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of 31 minutes to 59 minutes, subsequent encounter
|
|
S06.362S
|
Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of 31 minutes to 59 minutes, sequela
|
|
S06.363A
|
Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of 1 hours to 5 hours 59 minutes, initial encounter
|
|
S06.363D
|
Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of 1 hours to 5 hours 59 minutes, subsequent encounter
|
|
S06.363S
|
Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of 1 hours to 5 hours 59 minutes, sequela
|
|
S06.364A
|
Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of 6 hours to 24 hours, initial encounter
|
|
S06.364D
|
Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of 6 hours to 24 hours, subsequent encounter
|
|
S06.364S
|
Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of 6 hours to 24 hours, sequela
|
|
S06.365A
|
Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter
|
|
S06.365D
|
Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness greater than 24 hours with return to pre-existing conscious level, subsequent encounter
|
|
S06.365S
|
Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela
|
|
S06.366A
|
Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter
|
|
S06.366D
|
Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, subsequent encounter
|
|
S06.366S
|
Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela
|
|
S06.36AA
|
Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness status unknown, initial encounter
|
|
S06.36AD
|
Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness status unknown, subsequent encounter
|
|
S06.36AS
|
Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness status unknown, sequela
|
|
S06.369A
|
Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of unspecified duration, initial encounter
|
|
S06.369D
|
Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of unspecified duration, subsequent encounter
|
|
S06.369S
|
Traumatic hemorrhage of cerebrum, unspecified, with loss of consciousness of unspecified duration, sequela
|
|
S06.370A
|
Contusion, laceration, and hemorrhage of cerebellum without loss of consciousness, initial encounter
|
|
S06.370D
|
Contusion, laceration, and hemorrhage of cerebellum without loss of consciousness, subsequent encounter
|
|
S06.370S
|
Contusion, laceration, and hemorrhage of cerebellum without loss of consciousness, sequela
|
|
S06.371A
|
Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness of 30 minutes or less, initial encounter
|
|
S06.371D
|
Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness of 30 minutes or less, subsequent encounter
|
|
S06.371S
|
Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness of 30 minutes or less, sequela
|
|
S06.372A
|
Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness of 31 minutes to 59 minutes, initial encounter
|
|
S06.372D
|
Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness of 31 minutes to 59 minutes, subsequent encounter
|
|
S06.372S
|
Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness of 31 minutes to 59 minutes, sequela
|
|
S06.373A
|
Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter
|
|
S06.373D
|
Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness of 1 hour to 5 hours 59 minutes, subsequent encounter
|
|
S06.373S
|
Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela
|
|
S06.374A
|
Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness of 6 hours to 24 hours, initial encounter
|
|
S06.374D
|
Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness of 6 hours to 24 hours, subsequent encounter
|
|
S06.374S
|
Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness of 6 hours to 24 hours, sequela
|
|
S06.375A
|
Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter
|
|
S06.375D
|
Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, subsequent encounter
|
|
S06.375S
|
Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela
|
|
S06.376A
|
Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter
|
|
S06.376D
|
Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, subsequent encounter
|
|
S06.376S
|
Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela
|
|
S06.37AA
|
Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness status unknown, initial encounter
|
|
S06.37AD
|
Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness status unknown, subsequent encounter
|
|
S06.37AS
|
Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness status unknown, sequela
|
|
S06.379A
|
Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness of unspecified duration, initial encounter
|
|
S06.379D
|
Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness of unspecified duration, subsequent encounter
|
|
S06.379S
|
Contusion, laceration, and hemorrhage of cerebellum with loss of consciousness of unspecified duration, sequela
|
|
S06.380A
|
Contusion, laceration, and hemorrhage of brainstem without loss of consciousness, initial encounter
|
|
S06.380D
|
Contusion, laceration, and hemorrhage of brainstem without loss of consciousness, subsequent encounter
|
|
S06.380S
|
Contusion, laceration, and hemorrhage of brainstem without loss of consciousness, sequela
|
|
S06.381A
|
Contusion, laceration, and hemorrhage of brainstem with loss of consciousness of 30 minutes or less, initial encounter
|
|
S06.381D
|
Contusion, laceration, and hemorrhage of brainstem with loss of consciousness of 30 minutes or less, subsequent encounter
|
|
S06.381S
|
Contusion, laceration, and hemorrhage of brainstem with loss of consciousness of 30 minutes or less, sequela
|
|
S06.382A
|
Contusion, laceration, and hemorrhage of brainstem with loss of consciousness of 31 minutes to 59 minutes, initial encounter
|
|
S06.382D
|
Contusion, laceration, and hemorrhage of brainstem with loss of consciousness of 31 minutes to 59 minutes, subsequent encounter
|
|
S06.382S
|
Contusion, laceration, and hemorrhage of brainstem with loss of consciousness of 31 minutes to 59 minutes, sequela
|
|
S06.383A
|
Contusion, laceration, and hemorrhage of brainstem with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter
|
|
S06.383D
|
Contusion, laceration, and hemorrhage of brainstem with loss of consciousness of 1 hour to 5 hours 59 minutes, subsequent encounter
|
|
S06.383S
|
Contusion, laceration, and hemorrhage of brainstem with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela
|
|
S06.384A
|
Contusion, laceration, and hemorrhage of brainstem with loss of consciousness of 6 hours to 24 hours, initial encounter
|
|
S06.384D
|
Contusion, laceration, and hemorrhage of brainstem with loss of consciousness of 6 hours to 24 hours, subsequent encounter
|
|
S06.384S
|
Contusion, laceration, and hemorrhage of brainstem with loss of consciousness of 6 hours to 24 hours, sequela
|
|
S06.385A
|
Contusion, laceration, and hemorrhage of brainstem with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter
|
|
S06.385D
|
Contusion, laceration, and hemorrhage of brainstem with loss of consciousness greater than 24 hours with return to pre-existing conscious level, subsequent encounter
|
|
S06.385S
|
Contusion, laceration, and hemorrhage of brainstem with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela
|
|
S06.386A
|
Contusion, laceration, and hemorrhage of brainstem with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter
|
|
S06.386D
|
Contusion, laceration, and hemorrhage of brainstem with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, subsequent encounter
|
|
S06.386S
|
Contusion, laceration, and hemorrhage of brainstem with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela
|
|
S06.38AA
|
Contusion, laceration, and hemorrhage of brainstem with loss of consciousness status unknown, initial encounter
|
|
S06.38AD
|
Contusion, laceration, and hemorrhage of brainstem with loss of consciousness status unknown, subsequent encounter
|
|
S06.38AS
|
Contusion, laceration, and hemorrhage of brainstem with loss of consciousness status unknown, sequela
|
|
S06.389A
|
Contusion, laceration, and hemorrhage of brainstem with loss of consciousness of unspecified duration, initial encounter
|
|
S06.389D
|
Contusion, laceration, and hemorrhage of brainstem with loss of consciousness of unspecified duration, subsequent encounter
|
|
S06.389S
|
Contusion, laceration, and hemorrhage of brainstem with loss of consciousness of unspecified duration, sequela
|
|
S06.4X0A
|
Epidural hemorrhage without loss of consciousness, initial encounter
|
|
S06.4X0D
|
Epidural hemorrhage without loss of consciousness, subsequent encounter
|
|
S06.4X0S
|
Epidural hemorrhage without loss of consciousness, sequela
|
|
S06.4X1A
|
Epidural hemorrhage with loss of consciousness of 30 minutes or less, initial encounter
|
|
S06.4X1D
|
Epidural hemorrhage with loss of consciousness of 30 minutes or less, subsequent encounter
|
|
S06.4X1S
|
Epidural hemorrhage with loss of consciousness of 30 minutes or less, sequela
|
|
S06.4X2A
|
Epidural hemorrhage with loss of consciousness of 31 minutes to 59 minutes, initial encounter
|
|
S06.4X2D
|
Epidural hemorrhage with loss of consciousness of 31 minutes to 59 minutes, subsequent encounter
|
|
S06.4X2S
|
Epidural hemorrhage with loss of consciousness of 31 minutes to 59 minutes, sequela
|
|
S06.4X3A
|
Epidural hemorrhage with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter
|
|
S06.4X3D
|
Epidural hemorrhage with loss of consciousness of 1 hour to 5 hours 59 minutes, subsequent encounter
|
|
S06.4X3S
|
Epidural hemorrhage with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela
|
|
S06.4X4A
|
Epidural hemorrhage with loss of consciousness of 6 hours to 24 hours, initial encounter
|
|
S06.4X4D
|
Epidural hemorrhage with loss of consciousness of 6 hours to 24 hours, subsequent encounter
|
|
S06.4X4S
|
Epidural hemorrhage with loss of consciousness of 6 hours to 24 hours, sequela
|
|
S06.4X5A
|
Epidural hemorrhage with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter
|
|
S06.4X5D
|
Epidural hemorrhage with loss of consciousness greater than 24 hours with return to pre-existing conscious level, subsequent encounter
|
|
S06.4X5S
|
Epidural hemorrhage with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela
|
|
S06.4X6A
|
Epidural hemorrhage with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter
|
|
S06.4X6D
|
Epidural hemorrhage with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, subsequent encounter
|
|
S06.4X6S
|
Epidural hemorrhage with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela
|
|
S06.4XAA
|
Epidural hemorrhage with loss of consciousness status unknown, initial encounter
|
|
S06.4XAD
|
Epidural hemorrhage with loss of consciousness status unknown, subsequent encounter
|
|
S06.4XAS
|
Epidural hemorrhage with loss of consciousness status unknown, sequela
|
|
S06.4X9A
|
Epidural hemorrhage with loss of consciousness of unspecified duration, initial encounter
|
|
S06.4X9D
|
Epidural hemorrhage with loss of consciousness of unspecified duration, subsequent encounter
|
|
S06.4X9S
|
Epidural hemorrhage with loss of consciousness of unspecified duration, sequela
|
|
S06.5X0A
|
Traumatic subdural hemorrhage without loss of consciousness, initial encounter
|
|
S06.5X0D
|
Traumatic subdural hemorrhage without loss of consciousness, subsequent encounter
|
|
S06.5X0S
|
Traumatic subdural hemorrhage without loss of consciousness, sequela
|
|
S06.5X1A
|
Traumatic subdural hemorrhage with loss of consciousness of 30 minutes or less, initial encounter
|
|
S06.5X1D
|
Traumatic subdural hemorrhage with loss of consciousness of 30 minutes or less, subsequent encounter
|
|
S06.5X1S
|
Traumatic subdural hemorrhage with loss of consciousness of 30 minutes or less, sequela
|
|
S06.5X2A
|
Traumatic subdural hemorrhage with loss of consciousness of 31 minutes to 59 minutes, initial encounter
|
|
S06.5X2D
|
Traumatic subdural hemorrhage with loss of consciousness of 31 minutes to 59 minutes, subsequent encounter
|
|
S06.5X2S
|
Traumatic subdural hemorrhage with loss of consciousness of 31 minutes to 59 minutes, sequela
|
|
S06.5X3A
|
Traumatic subdural hemorrhage with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter
|
|
S06.5X3D
|
Traumatic subdural hemorrhage with loss of consciousness of 1 hour to 5 hours 59 minutes, subsequent encounter
|
|
S06.5X3S
|
Traumatic subdural hemorrhage with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela
|
|
S06.5X4A
|
Traumatic subdural hemorrhage with loss of consciousness of 6 hours to 24 hours, initial encounter
|
|
S06.5X4D
|
Traumatic subdural hemorrhage with loss of consciousness of 6 hours to 24 hours, subsequent encounter
|
|
S06.5X4S
|
Traumatic subdural hemorrhage with loss of consciousness of 6 hours to 24 hours, sequela
|
|
S06.5X5A
|
Traumatic subdural hemorrhage with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter
|
|
S06.5X5D
|
Traumatic subdural hemorrhage with loss of consciousness greater than 24 hours with return to pre-existing conscious level, subsequent encounter
|
|
S06.5X5S
|
Traumatic subdural hemorrhage with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela
|
|
S06.5X6A
|
Traumatic subdural hemorrhage with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter
|
|
S06.5X6D
|
Traumatic subdural hemorrhage with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, subsequent encounter
|
|
S06.5X6S
|
Traumatic subdural hemorrhage with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela
|
|
S06.5XAA
|
Traumatic subdural hemorrhage with loss of consciousness status unknown, initial encounter
|
|
S06.5XAD
|
Traumatic subdural hemorrhage with loss of consciousness status unknown, subsequent encounter
|
|
S06.5XAS
|
Traumatic subdural hemorrhage with loss of consciousness status unknown, sequela
|
|
S06.5X9A
|
Traumatic subdural hemorrhage with loss of consciousness of unspecified duration, initial encounter
|
|
S06.5X9D
|
Traumatic subdural hemorrhage with loss of consciousness of unspecified duration, subsequent encounter
|
|
S06.5X9S
|
Traumatic subdural hemorrhage with loss of consciousness of unspecified duration, sequela
|
|
S06.6X0A
|
Traumatic subarachnoid hemorrhage without loss of consciousness, initial encounter
|
|
S06.6X0D
|
Traumatic subarachnoid hemorrhage without loss of consciousness, subsequent encounter
|
|
S06.6X0S
|
Traumatic subarachnoid hemorrhage without loss of consciousness, sequela
|
|
S06.6X1A
|
Traumatic subarachnoid hemorrhage with loss of consciousness of 30 minutes or less, initial encounter
|
|
S06.6X1D
|
Traumatic subarachnoid hemorrhage with loss of consciousness of 30 minutes or less, subsequent encounter
|
|
S06.6X1S
|
Traumatic subarachnoid hemorrhage with loss of consciousness of 30 minutes or less, sequela
|
|
S06.6X2A
|
Traumatic subarachnoid hemorrhage with loss of consciousness of 31 minutes to 59 minutes, initial encounter
|
|
S06.6X2D
|
Traumatic subarachnoid hemorrhage with loss of consciousness of 31 minutes to 59 minutes, subsequent encounter
|
|
S06.6X2S
|
Traumatic subarachnoid hemorrhage with loss of consciousness of 31 minutes to 59 minutes, sequela
|
|
S06.6X3A
|
Traumatic subarachnoid hemorrhage with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter
|
|
S06.6X3D
|
Traumatic subarachnoid hemorrhage with loss of consciousness of 1 hour to 5 hours 59 minutes, subsequent encounter
|
|
S06.6X3S
|
Traumatic subarachnoid hemorrhage with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela
|
|
S06.6X4A
|
Traumatic subarachnoid hemorrhage with loss of consciousness of 6 hours to 24 hours, initial encounter
|
|
S06.6X4D
|
Traumatic subarachnoid hemorrhage with loss of consciousness of 6 hours to 24 hours, subsequent encounter
|
|
S06.6X4S
|
Traumatic subarachnoid hemorrhage with loss of consciousness of 6 hours to 24 hours, sequela
|
|
S06.6X5A
|
Traumatic subarachnoid hemorrhage with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter
|
|
S06.6X5D
|
Traumatic subarachnoid hemorrhage with loss of consciousness greater than 24 hours with return to pre-existing conscious level, subsequent encounter
|
|
S06.6X5S
|
Traumatic subarachnoid hemorrhage with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela
|
|
S06.6X6A
|
Traumatic subarachnoid hemorrhage with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter
|
|
S06.6X6D
|
Traumatic subarachnoid hemorrhage with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, subsequent encounter
|
|
S06.6X6S
|
Traumatic subarachnoid hemorrhage with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela
|
|
S06.6XAA
|
Traumatic subarachnoid hemorrhage with loss of consciousness status unknown, initial encounter
|
|
S06.6XAD
|
Traumatic subarachnoid hemorrhage with loss of consciousness status unknown, subsequent encounter
|
|
S06.6XAS
|
Traumatic subarachnoid hemorrhage with loss of consciousness status unknown, sequela
|
|
S06.6X9A
|
Traumatic subarachnoid hemorrhage with loss of consciousness of unspecified duration, initial encounter
|
|
S06.6X9D
|
Traumatic subarachnoid hemorrhage with loss of consciousness of unspecified duration, subsequent encounter
|
|
S06.6X9S
|
Traumatic subarachnoid hemorrhage with loss of consciousness of unspecified duration, sequela
|
|
S06.810A
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified without loss of consciousness, initial encounter
|
|
S06.810D
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified without loss of consciousness, subsequent encounter
|
|
S06.810S
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified without loss of consciousness, sequela
|
|
S06.811A
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 30 minutes or less, initial encounter
|
|
S06.811D
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 30 minutes or less, subsequent encounter
|
|
S06.811S
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 30 minutes or less, sequela
|
|
S06.812A
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 31 minutes to 59 minutes, initial encounter
|
|
S06.812D
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 31 minutes to 59 minutes, subsequent encounter
|
|
S06.812S
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 31 minutes to 59 minutes, sequela
|
|
S06.813A
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter
|
|
S06.813D
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 1 hour to 5 hours 59 minutes, subsequent encounter
|
|
S06.813S
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela
|
|
S06.814A
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 6 hours to 24 hours, initial encounter
|
|
S06.814D
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 6 hours to 24 hours, subsequent encounter
|
|
S06.814S
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 6 hours to 24 hours, sequela
|
|
S06.815A
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter
|
|
S06.815D
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness greater than 24 hours with return to pre-existing conscious level, subsequent encounter
|
|
S06.815S
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela
|
|
S06.816A
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter
|
|
S06.816D
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, subsequent encounter
|
|
S06.816S
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela
|
|
S06.81AA
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness status unknown, initial encounter
|
|
S06.81AD
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness status unknown, subsequent encounter
|
|
S06.81AS
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness status unknown, sequela
|
|
S06.819A
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of unspecified duration, initial encounter
|
|
S06.819D
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of unspecified duration, subsequent encounter
|
|
S06.819S
|
Injury of right internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of unspecified duration, sequela
|
|
S06.820A
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified without loss of consciousness, initial encounter
|
|
S06.820D
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified without loss of consciousness, subsequent encounter
|
|
S06.820S
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified without loss of consciousness, sequela
|
|
S06.821A
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 30 minutes or less, initial encounter
|
|
S06.821D
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 30 minutes or less, subsequent encounter
|
|
S06.821S
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 30 minutes or less, sequela
|
|
S06.822A
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 31 minutes to 59 minutes, initial encounter
|
|
S06.822D
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 31 minutes to 59 minutes, subsequent encounter
|
|
S06.822S
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 31 minutes to 59 minutes, sequela
|
|
S06.823A
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter
|
|
S06.823D
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 1 hour to 5 hours 59 minutes, subsequent encounter
|
|
S06.823S
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela
|
|
S06.824A
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 6 hours to 24 hours, initial encounter
|
|
S06.824D
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 6 hours to 24 hours, subsequent encounter
|
|
S06.824S
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of 6 hours to 24 hours, sequela
|
|
S06.825A
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter
|
|
S06.825D
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness greater than 24 hours with return to pre-existing conscious level, subsequent encounter
|
|
S06.825S
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela
|
|
S06.826A
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter
|
|
S06.826D
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, subsequent encounter
|
|
S06.826S
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela
|
|
S06.82AA
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness status unknown, initial encounter
|
|
S06.82AD
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness status unknown, subsequent encounter
|
|
S06.82AS
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness status unknown, sequela
|
|
S06.829A
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of unspecified duration, initial encounter
|
|
S06.829D
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of unspecified duration, subsequent encounter
|
|
S06.829S
|
Injury of left internal carotid artery, intracranial portion, not elsewhere classified with loss of consciousness of unspecified duration, sequela
|
|
S06.8A0A
|
Primary blast injury of brain, not elsewhere classified without loss of consciousness, initial encounter
|
|
S06.8A0D
|
Primary blast injury of brain, not elsewhere classified without loss of consciousness, subsequent encounter
|
|
S06.8A0S
|
Primary blast injury of brain, not elsewhere classified without loss of consciousness, sequela
|
|
S06.8A1A
|
Primary blast injury of brain, not elsewhere classified with loss of consciousness of 30 minutes or less, initial encounter
|
|
S06.8A1D
|
Primary blast injury of brain, not elsewhere classified with loss of consciousness of 30 minutes or less, subsequent encounter
|
|
S06.8A1S
|
Primary blast injury of brain, not elsewhere classified with loss of consciousness of 30 minutes or less, sequela
|
|
S06.8A2A
|
Primary blast injury of brain, not elsewhere classified with loss of consciousness of 31 minutes to 59 minutes, initial encounter
|
|
S06.8A2D
|
Primary blast injury of brain, not elsewhere classified with loss of consciousness of 31 minutes to 59 minutes, subsequent encounter
|
|
S06.8A2S
|
Primary blast injury of brain, not elsewhere classified with loss of consciousness of 31 minutes to 59 minutes, sequela
|
|
S06.8A3A
|
Primary blast injury of brain, not elsewhere classified with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter
|
|
S06.8A3D
|
Primary blast injury of brain, not elsewhere classified with loss of consciousness of 1 hour to 5 hours 59 minutes, subsequent encounter
|
|
S06.8A3S
|
Primary blast injury of brain, not elsewhere classified with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela
|
|
S06.8A4A
|
Primary blast injury of brain, not elsewhere classified with loss of consciousness of 6 hours to 24 hours, initial encounter
|
|
S06.8A4D
|
Primary blast injury of brain, not elsewhere classified with loss of consciousness of 6 hours to 24 hours, subsequent encounter
|
|
S06.8A4S
|
Primary blast injury of brain, not elsewhere classified with loss of consciousness of 6 hours to 24 hours, sequela
|
|
S06.8A5A
|
Primary blast injury of brain, not elsewhere classified with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter
|
|
S06.8A5D
|
Primary blast injury of brain, not elsewhere classified with loss of consciousness greater than 24 hours with return to pre-existing conscious level, subsequent encounter
|
|
S06.8A5S
|
Primary blast injury of brain, not elsewhere classified with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela
|
|
S06.8A6A
|
Primary blast injury of brain, not elsewhere classified with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter
|
|
S06.8A6D
|
Primary blast injury of brain, not elsewhere classified with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, subsequent encounter
|
|
S06.8A6S
|
Primary blast injury of brain, not elsewhere classified with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela
|
|
S06.8A7A
|
Primary blast injury of brain, not elsewhere classified with loss of consciousness of any duration with death due to brain injury prior to regaining consciousness, initial encounter
|
|
S06.8A8A
|
Primary blast injury of brain, not elsewhere classified with loss of consciousness of any duration with death due to other cause prior to regaining consciousness, initial encounter
|
|
S06.8AAA
|
Primary blast injury of brain, not elsewhere classified with loss of consciousness status unknown, initial encounter
|
|
S06.8AAD
|
Primary blast injury of brain, not elsewhere classified with loss of consciousness status unknown, subsequent encounter
|
|
S06.8AAS
|
Primary blast injury of brain, not elsewhere classified with loss of consciousness status unknown, sequela
|
|
S06.8A9A
|
Primary blast injury of brain, not elsewhere classified with loss of consciousness of unspecified duration, initial encounter
|
|
S06.8A9D
|
Primary blast injury of brain, not elsewhere classified with loss of consciousness of unspecified duration, subsequent encounter
|
|
S06.8A9S
|
Primary blast injury of brain, not elsewhere classified with loss of consciousness of unspecified duration, sequela
|
|
S06.890A
|
Other specified intracranial injury without loss of consciousness, initial encounter
|
|
S06.890D
|
Other specified intracranial injury without loss of consciousness, subsequent encounter
|
|
S06.890S
|
Other specified intracranial injury without loss of consciousness, sequela
|
|
S06.891A
|
Other specified intracranial injury with loss of consciousness of 30 minutes or less, initial encounter
|
|
S06.891D
|
Other specified intracranial injury with loss of consciousness of 30 minutes or less, subsequent encounter
|
|
S06.891S
|
Other specified intracranial injury with loss of consciousness of 30 minutes or less, sequela
|
|
S06.892A
|
Other specified intracranial injury with loss of consciousness of 31 minutes to 59 minutes, initial encounter
|
|
S06.892D
|
Other specified intracranial injury with loss of consciousness of 31 minutes to 59 minutes, subsequent encounter
|
|
S06.892S
|
Other specified intracranial injury with loss of consciousness of 31 minutes to 59 minutes, sequela
|
|
S06.893A
|
Other specified intracranial injury with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter
|
|
S06.893D
|
Other specified intracranial injury with loss of consciousness of 1 hour to 5 hours 59 minutes, subsequent encounter
|
|
S06.893S
|
Other specified intracranial injury with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela
|
|
S06.894A
|
Other specified intracranial injury with loss of consciousness of 6 hours to 24 hours, initial encounter
|
|
S06.894D
|
Other specified intracranial injury with loss of consciousness of 6 hours to 24 hours, subsequent encounter
|
|
S06.894S
|
Other specified intracranial injury with loss of consciousness of 6 hours to 24 hours, sequela
|
|
S06.895A
|
Other specified intracranial injury with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter
|
|
S06.895D
|
Other specified intracranial injury with loss of consciousness greater than 24 hours with return to pre-existing conscious level, subsequent encounter
|
|
S06.895S
|
Other specified intracranial injury with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela
|
|
S06.896A
|
Other specified intracranial injury with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter
|
|
S06.896D
|
Other specified intracranial injury with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, subsequent encounter
|
|
S06.896S
|
Other specified intracranial injury with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela
|
|
S06.89AA
|
Other specified intracranial injury with loss of consciousness status unknown, initial encounter
|
|
S06.89AD
|
Other specified intracranial injury with loss of consciousness status unknown, subsequent encounter
|
|
S06.89AS
|
Other specified intracranial injury with loss of consciousness status unknown, sequela
|
|
S06.899A
|
Other specified intracranial injury with loss of consciousness of unspecified duration, initial encounter
|
|
S06.899D
|
Other specified intracranial injury with loss of consciousness of unspecified duration, subsequent encounter
|
|
S06.899S
|
Other specified intracranial injury with loss of consciousness of unspecified duration, sequela
|
|
S06.9X0A
|
Unspecified intracranial injury without loss of consciousness, initial encounter
|
|
S06.9X0D
|
Unspecified intracranial injury without loss of consciousness, subsequent encounter
|
|
S06.9X0S
|
Unspecified intracranial injury without loss of consciousness, sequela
|
|
S06.9X1A
|
Unspecified intracranial injury with loss of consciousness of 30 minutes or less, initial encounter
|
|
S06.9X1D
|
Unspecified intracranial injury with loss of consciousness of 30 minutes or less, subsequent encounter
|
|
S06.9X1S
|
Unspecified intracranial injury with loss of consciousness of 30 minutes or less, sequela
|
|
S06.9X2A
|
Unspecified intracranial injury with loss of consciousness of 31 minutes to 59 minutes, initial encounter
|
|
S06.9X2D
|
Unspecified intracranial injury with loss of consciousness of 31 minutes to 59 minutes, subsequent encounter
|
|
S06.9X2S
|
Unspecified intracranial injury with loss of consciousness of 31 minutes to 59 minutes, sequela
|
|
S06.9X3A
|
Unspecified intracranial injury with loss of consciousness of 1 hour to 5 hours 59 minutes, initial encounter
|
|
S06.9X3D
|
Unspecified intracranial injury with loss of consciousness of 1 hour to 5 hours 59 minutes, subsequent encounter
|
|
S06.9X3S
|
Unspecified intracranial injury with loss of consciousness of 1 hour to 5 hours 59 minutes, sequela
|
|
S06.9X4A
|
Unspecified intracranial injury with loss of consciousness of 6 hours to 24 hours, initial encounter
|
|
S06.9X4D
|
Unspecified intracranial injury with loss of consciousness of 6 hours to 24 hours, subsequent encounter
|
|
S06.9X4S
|
Unspecified intracranial injury with loss of consciousness of 6 hours to 24 hours, sequela
|
|
S06.9X5A
|
Unspecified intracranial injury with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter
|
|
S06.9X5D
|
Unspecified intracranial injury with loss of consciousness greater than 24 hours with return to pre-existing conscious level, subsequent encounter
|
|
S06.9X5S
|
Unspecified intracranial injury with loss of consciousness greater than 24 hours with return to pre-existing conscious level, sequela
|
|
S06.9X6A
|
Unspecified intracranial injury with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, initial encounter
|
|
S06.9X6D
|
Unspecified intracranial injury with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, subsequent encounter
|
|
S06.9X6S
|
Unspecified intracranial injury with loss of consciousness greater than 24 hours without return to pre-existing conscious level with patient surviving, sequela
|
|
S06.9X9A
|
Unspecified intracranial injury with loss of consciousness of unspecified duration, initial encounter
|
|
S06.9X9D
|
Unspecified intracranial injury with loss of consciousness of unspecified duration, subsequent encounter
|
|
S06.9X9S
|
Unspecified intracranial injury with loss of consciousness of unspecified duration, sequela
|
|
S06.A0XA
|
Traumatic brain compression without herniation, initial encounter
|
|
S06.A0XD
|
Traumatic brain compression without herniation, subsequent encounter
|
|
S06.A0XS
|
Traumatic brain compression without herniation, sequela
|
|
S06.A1XA
|
Traumatic brain compression with herniation, initial encounter
|
|
S06.A1XD
|
Traumatic brain compression with herniation, subsequent encounter
|
|
S06.A1XS
|
Traumatic brain compression with herniation, sequela
|
|
S09.19XA
|
Other specified injury of muscle and tendon of head, initial encounter
|
|
S09.19XD
|
Other specified injury of muscle and tendon of head, subsequent encounter
|
|
S09.19XS
|
Other specified injury of muscle and tendon of head, sequela
|
|
S09.8XXA
|
Other specified injuries of head, initial encounter
|
|
S09.8XXD
|
Other specified injuries of head, subsequent encounter
|
|
S09.8XXS
|
Other specified injuries of head, sequela
|
|
S09.90XA
|
Unspecified injury of head, initial encounter
|
|
S09.90XD
|
Unspecified injury of head, subsequent encounter
|
|
S09.90XS
|
Unspecified injury of head, sequela
|
|
T40.0X1A
|
Poisoning by opium, accidental (unintentional), initial encounter
|
|
T40.0X1D
|
Poisoning by opium, accidental (unintentional), subsequent encounter
|
|
T40.0X1S
|
Poisoning by opium, accidental (unintentional), sequela
|
|
T40.0X2A
|
Poisoning by opium, intentional self-harm, initial encounter
|
|
T40.0X2D
|
Poisoning by opium, intentional self-harm, subsequent encounter
|
|
T40.0X2S
|
Poisoning by opium, intentional self-harm, sequela
|
|
T40.0X3A
|
Poisoning by opium, assault, initial encounter
|
|
T40.0X3D
|
Poisoning by opium, assault, subsequent encounter
|
|
T40.0X3S
|
Poisoning by opium, assault, sequela
|
|
T40.0X4A
|
Poisoning by opium, undetermined, initial encounter
|
|
T40.0X4D
|
Poisoning by opium, undetermined, subsequent encounter
|
|
T40.0X4S
|
Poisoning by opium, undetermined, sequela
|
|
T40.0X5A
|
Adverse effect of opium, initial encounter
|
|
T40.0X5D
|
Adverse effect of opium, subsequent encounter
|
|
T40.0X5S
|
Adverse effect of opium, sequela
|
|
T40.1X1A
|
Poisoning by heroin, accidental (unintentional), initial encounter
|
|
T40.1X1D
|
Poisoning by heroin, accidental (unintentional), subsequent encounter
|
|
T40.1X1S
|
Poisoning by heroin, accidental (unintentional), sequela
|
|
T40.1X2A
|
Poisoning by heroin, intentional self-harm, initial encounter
|
|
T40.1X2D
|
Poisoning by heroin, intentional self-harm, subsequent encounter
|
|
T40.1X2S
|
Poisoning by heroin, intentional self-harm, sequela
|
|
T40.1X3A
|
Poisoning by heroin, assault, initial encounter
|
|
T40.1X3D
|
Poisoning by heroin, assault, subsequent encounter
|
|
T40.1X3S
|
Poisoning by heroin, assault, sequela
|
|
T40.1X4A
|
Poisoning by heroin, undetermined, initial encounter
|
|
T40.1X4D
|
Poisoning by heroin, undetermined, subsequent encounter
|
|
T40.1X4S
|
Poisoning by heroin, undetermined, sequela
|
|
T40.2X1A
|
Poisoning by other opioids, accidental (unintentional), initial encounter
|
|
T40.2X1D
|
Poisoning by other opioids, accidental (unintentional), subsequent encounter
|
|
T40.2X1S
|
Poisoning by other opioids, accidental (unintentional), sequela
|
|
T40.2X2A
|
Poisoning by other opioids, intentional self-harm, initial encounter
|
|
T40.2X2D
|
Poisoning by other opioids, intentional self-harm, subsequent encounter
|
|
T40.2X2S
|
Poisoning by other opioids, intentional self-harm, sequela
|
|
T40.2X3A
|
Poisoning by other opioids, assault, initial encounter
|
|
T40.2X3D
|
Poisoning by other opioids, assault, subsequent encounter
|
|
T40.2X3S
|
Poisoning by other opioids, assault, sequela
|
|
T40.2X4A
|
Poisoning by other opioids, undetermined, initial encounter
|
|
T40.2X4D
|
Poisoning by other opioids, undetermined, subsequent encounter
|
|
T40.2X4S
|
Poisoning by other opioids, undetermined, sequela
|
|
T40.2X5A
|
Adverse effect of other opioids, initial encounter
|
|
T40.2X5D
|
Adverse effect of other opioids, subsequent encounter
|
|
T40.2X5S
|
Adverse effect of other opioids, sequela
|
|
T40.3X1A
|
Poisoning by methadone, accidental (unintentional), initial encounter
|
|
T40.3X1D
|
Poisoning by methadone, accidental (unintentional), subsequent encounter
|
|
T40.3X1S
|
Poisoning by methadone, accidental (unintentional), sequela
|
|
T40.3X2A
|
Poisoning by methadone, intentional self-harm, initial encounter
|
|
T40.3X2D
|
Poisoning by methadone, intentional self-harm, subsequent encounter
|
|
T40.3X2S
|
Poisoning by methadone, intentional self-harm, sequela
|
|
T40.3X3A
|
Poisoning by methadone, assault, initial encounter
|
|
T40.3X3D
|
Poisoning by methadone, assault, subsequent encounter
|
|
T40.3X3S
|
Poisoning by methadone, assault, sequela
|
|
T40.3X4A
|
Poisoning by methadone, undetermined, initial encounter
|
|
T40.3X4D
|
Poisoning by methadone, undetermined, subsequent encounter
|
|
T40.3X4S
|
Poisoning by methadone, undetermined, sequela
|
|
T40.3X5A
|
Adverse effect of methadone, initial encounter
|
|
T40.3X5D
|
Adverse effect of methadone, subsequent encounter
|
|
T40.3X5S
|
Adverse effect of methadone, sequela
|
|
T40.491A
|
Poisoning by other synthetic narcotics, accidental (unintentional), initial encounter
|
|
T40.491D
|
Poisoning by other synthetic narcotics, accidental (unintentional), subsequent encounter
|
|
T40.491S
|
Poisoning by other synthetic narcotics, accidental (unintentional), sequela
|
|
T40.492A
|
Poisoning by other synthetic narcotics, intentional self-harm, initial encounter
|
|
T40.492D
|
Poisoning by other synthetic narcotics, intentional self-harm, subsequent encounter
|
|
T40.492S
|
Poisoning by other synthetic narcotics, intentional self-harm, sequela
|
|
T40.493A
|
Poisoning by other synthetic narcotics, assault, initial encounter
|
|
T40.493D
|
Poisoning by other synthetic narcotics, assault, subsequent encounter
|
|
T40.493S
|
Poisoning by other synthetic narcotics, assault, sequela
|
|
T40.494A
|
Poisoning by other synthetic narcotics, undetermined, initial encounter
|
|
T40.494D
|
Poisoning by other synthetic narcotics, undetermined, subsequent encounter
|
|
T40.494S
|
Poisoning by other synthetic narcotics, undetermined, sequela
|
|
T40.495A
|
Adverse effect of other synthetic narcotics, initial encounter
|
|
T40.495D
|
Adverse effect of other synthetic narcotics, subsequent encounter
|
|
T40.495S
|
Adverse effect of other synthetic narcotics, sequela
|
|
T40.5X1A
|
Poisoning by cocaine, accidental (unintentional), initial encounter
|
|
T40.5X1D
|
Poisoning by cocaine, accidental (unintentional), subsequent encounter
|
|
T40.5X1S
|
Poisoning by cocaine, accidental (unintentional), sequela
|
|
T40.5X2A
|
Poisoning by cocaine, intentional self-harm, initial encounter
|
|
T40.5X2D
|
Poisoning by cocaine, intentional self-harm, subsequent encounter
|
|
T40.5X2S
|
Poisoning by cocaine, intentional self-harm, sequela
|
|
T40.5X3A
|
Poisoning by cocaine, assault, initial encounter
|
|
T40.5X3D
|
Poisoning by cocaine, assault, subsequent encounter
|
|
T40.5X3S
|
Poisoning by cocaine, assault, sequela
|
|
T40.5X4A
|
Poisoning by cocaine, undetermined, initial encounter
|
|
T40.5X4D
|
Poisoning by cocaine, undetermined, subsequent encounter
|
|
T40.5X4S
|
Poisoning by cocaine, undetermined, sequela
|
|
T40.5X5A
|
Adverse effect of cocaine, initial encounter
|
|
T40.5X5D
|
Adverse effect of cocaine, subsequent encounter
|
|
T40.5X5S
|
Adverse effect of cocaine, sequela
|
|
T40.601A
|
Poisoning by unspecified narcotics, accidental (unintentional), initial encounter
|
|
T40.601D
|
Poisoning by unspecified narcotics, accidental (unintentional), subsequent encounter
|
|
T40.601S
|
Poisoning by unspecified narcotics, accidental (unintentional), sequela
|
|
T40.602A
|
Poisoning by unspecified narcotics, intentional self-harm, initial encounter
|
|
T40.602D
|
Poisoning by unspecified narcotics, intentional self-harm, subsequent encounter
|
|
T40.602S
|
Poisoning by unspecified narcotics, intentional self-harm, sequela
|
|
T40.603A
|
Poisoning by unspecified narcotics, assault, initial encounter
|
|
T40.603D
|
Poisoning by unspecified narcotics, assault, subsequent encounter
|
|
T40.603S
|
Poisoning by unspecified narcotics, assault, sequela
|
|
T40.604A
|
Poisoning by unspecified narcotics, undetermined, initial encounter
|
|
T40.604D
|
Poisoning by unspecified narcotics, undetermined, subsequent encounter
|
|
T40.604S
|
Poisoning by unspecified narcotics, undetermined, sequela
|
|
T40.605A
|
Adverse effect of unspecified narcotics, initial encounter
|
|
T40.605D
|
Adverse effect of unspecified narcotics, subsequent encounter
|
|
T40.605S
|
Adverse effect of unspecified narcotics, sequela
|
|
T40.691A
|
Poisoning by other narcotics, accidental (unintentional), initial encounter
|
|
T40.691D
|
Poisoning by other narcotics, accidental (unintentional), subsequent encounter
|
|
T40.691S
|
Poisoning by other narcotics, accidental (unintentional), sequela
|
|
T40.692A
|
Poisoning by other narcotics, intentional self-harm, initial encounter
|
|
T40.692D
|
Poisoning by other narcotics, intentional self-harm, subsequent encounter
|
|
T40.692S
|
Poisoning by other narcotics, intentional self-harm, sequela
|
|
T40.693A
|
Poisoning by other narcotics, assault, initial encounter
|
|
T40.693D
|
Poisoning by other narcotics, assault, subsequent encounter
|
|
T40.693S
|
Poisoning by other narcotics, assault, sequela
|
|
T40.694A
|
Poisoning by other narcotics, undetermined, initial encounter
|
|
T40.694D
|
Poisoning by other narcotics, undetermined, subsequent encounter
|
|
T40.694S
|
Poisoning by other narcotics, undetermined, sequela
|
|
T40.695A
|
Adverse effect of other narcotics, initial encounter
|
|
T40.695D
|
Adverse effect of other narcotics, subsequent encounter
|
|
T40.695S
|
Adverse effect of other narcotics, sequela
|
|
T40.711A
|
Poisoning by cannabis, accidental (unintentional), initial encounter
|
|
T40.711D
|
Poisoning by cannabis, accidental (unintentional), subsequent encounter
|
|
T40.711S
|
Poisoning by cannabis, accidental (unintentional), sequela
|
|
T40.712A
|
Poisoning by cannabis, intentional self-harm, initial encounter
|
|
T40.712D
|
Poisoning by cannabis, intentional self-harm, subsequent encounter
|
|
T40.712S
|
Poisoning by cannabis, intentional self-harm, sequela
|
|
T40.713A
|
Poisoning by cannabis, assault, initial encounter
|
|
T40.713D
|
Poisoning by cannabis, assault, subsequent encounter
|
|
T40.713S
|
Poisoning by cannabis, assault, sequela
|
|
T40.715A
|
Adverse effect of cannabis, initial encounter
|
|
T40.715D
|
Adverse effect of cannabis, subsequent encounter
|
|
T40.715S
|
Adverse effect of cannabis, sequela
|
|
T40.721A
|
Poisoning by synthetic cannabinoids, accidental (unintentional), initial encounter
|
|
T40.721D
|
Poisoning by synthetic cannabinoids, accidental (unintentional), subsequent encounter
|
|
T40.721S
|
Poisoning by synthetic cannabinoids, accidental (unintentional), sequela
|
|
T40.722A
|
Poisoning by synthetic cannabinoids, intentional self-harm, initial encounter
|
|
T40.722D
|
Poisoning by synthetic cannabinoids, intentional self-harm, subsequent encounter
|
|
T40.722S
|
Poisoning by synthetic cannabinoids, intentional self-harm, sequela
|
|
T40.723A
|
Poisoning by synthetic cannabinoids, assault, initial encounter
|
|
T40.723D
|
Poisoning by synthetic cannabinoids, assault, subsequent encounter
|
|
T40.723S
|
Poisoning by synthetic cannabinoids, assault, sequela
|
|
T40.725A
|
Adverse effect of synthetic cannabinoids, initial encounter
|
|
T40.725D
|
Adverse effect of synthetic cannabinoids, subsequent encounter
|
|
T40.725S
|
Adverse effect of synthetic cannabinoids, sequela
|
|
T40.8X1A
|
Poisoning by lysergide [LSD], accidental (unintentional), initial encounter
|
|
T40.8X1D
|
Poisoning by lysergide [LSD], accidental (unintentional), subsequent encounter
|
|
T40.8X1S
|
Poisoning by lysergide [LSD], accidental (unintentional), sequela
|
|
T40.8X2A
|
Poisoning by lysergide [LSD], intentional self-harm, initial encounter
|
|
T40.8X2D
|
Poisoning by lysergide [LSD], intentional self-harm, subsequent encounter
|
|
T40.8X2S
|
Poisoning by lysergide [LSD], intentional self-harm, sequela
|
|
T40.8X3A
|
Poisoning by lysergide [LSD], assault, initial encounter
|
|
T40.8X3D
|
Poisoning by lysergide [LSD], assault, subsequent encounter
|
|
T40.8X3S
|
Poisoning by lysergide [LSD], assault, sequela
|
|
T40.8X4A
|
Poisoning by lysergide [LSD], undetermined, initial encounter
|
|
T40.8X4D
|
Poisoning by lysergide [LSD], undetermined, subsequent encounter
|
|
T40.8X4S
|
Poisoning by lysergide [LSD], undetermined, sequela
|
|
T40.901A
|
Poisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional), initial encounter
|
|
T40.901D
|
Poisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional), subsequent encounter
|
|
T40.901S
|
Poisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional), sequela
|
|
T40.902A
|
Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm, initial encounter
|
|
T40.902D
|
Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm, subsequent encounter
|
|
T40.902S
|
Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm, sequela
|
|
T40.903A
|
Poisoning by unspecified psychodysleptics [hallucinogens], assault, initial encounter
|
|
T40.903D
|
Poisoning by unspecified psychodysleptics [hallucinogens], assault, subsequent encounter
|
|
T40.903S
|
Poisoning by unspecified psychodysleptics [hallucinogens], assault, sequela
|
|
T40.904A
|
Poisoning by unspecified psychodysleptics [hallucinogens], undetermined, initial encounter
|
|
T40.904D
|
Poisoning by unspecified psychodysleptics [hallucinogens], undetermined, subsequent encounter
|
|
T40.904S
|
Poisoning by unspecified psychodysleptics [hallucinogens], undetermined, sequela
|
|
T40.905A
|
Adverse effect of unspecified psychodysleptics [hallucinogens], initial encounter
|
|
T40.905D
|
Adverse effect of unspecified psychodysleptics [hallucinogens], subsequent encounter
|
|
T40.905S
|
Adverse effect of unspecified psychodysleptics [hallucinogens], sequela
|
|
T40.991A
|
Poisoning by other psychodysleptics [hallucinogens], accidental (unintentional), initial encounter
|
|
T40.991D
|
Poisoning by other psychodysleptics [hallucinogens], accidental (unintentional), subsequent encounter
|
|
T40.991S
|
Poisoning by other psychodysleptics [hallucinogens], accidental (unintentional), sequela
|
|
T40.992A
|
Poisoning by other psychodysleptics [hallucinogens], intentional self-harm, initial encounter
|
|
T40.992D
|
Poisoning by other psychodysleptics [hallucinogens], intentional self-harm, subsequent encounter
|
|
T40.992S
|
Poisoning by other psychodysleptics [hallucinogens], intentional self-harm, sequela
|
|
T40.993A
|
Poisoning by other psychodysleptics [hallucinogens], assault, initial encounter
|
|
T40.993D
|
Poisoning by other psychodysleptics [hallucinogens], assault, subsequent encounter
|
|
T40.993S
|
Poisoning by other psychodysleptics [hallucinogens], assault, sequela
|
|
T40.994A
|
Poisoning by other psychodysleptics [hallucinogens], undetermined, initial encounter
|
|
T40.994D
|
Poisoning by other psychodysleptics [hallucinogens], undetermined, subsequent encounter
|
|
T40.994S
|
Poisoning by other psychodysleptics [hallucinogens], undetermined, sequela
|
|
T40.995A
|
Adverse effect of other psychodysleptics [hallucinogens], initial encounter
|
|
T40.995D
|
Adverse effect of other psychodysleptics [hallucinogens], subsequent encounter
|
|
T40.995S
|
Adverse effect of other psychodysleptics [hallucinogens], sequela
|
|
T41.0X1A
|
Poisoning by inhaled anesthetics, accidental (unintentional), initial encounter
|
|
T41.0X1D
|
Poisoning by inhaled anesthetics, accidental (unintentional), subsequent encounter
|
|
T41.0X1S
|
Poisoning by inhaled anesthetics, accidental (unintentional), sequela
|
|
T41.0X2A
|
Poisoning by inhaled anesthetics, intentional self-harm, initial encounter
|
|
T41.0X2D
|
Poisoning by inhaled anesthetics, intentional self-harm, subsequent encounter
|
|
T41.0X2S
|
Poisoning by inhaled anesthetics, intentional self-harm, sequela
|
|
T41.0X3A
|
Poisoning by inhaled anesthetics, assault, initial encounter
|
|
T41.0X3D
|
Poisoning by inhaled anesthetics, assault, subsequent encounter
|
|
T41.0X3S
|
Poisoning by inhaled anesthetics, assault, sequela
|
|
T41.0X4A
|
Poisoning by inhaled anesthetics, undetermined, initial encounter
|
|
T41.0X4D
|
Poisoning by inhaled anesthetics, undetermined, subsequent encounter
|
|
T41.0X4S
|
Poisoning by inhaled anesthetics, undetermined, sequela
|
|
T41.0X5A
|
Adverse effect of inhaled anesthetics, initial encounter
|
|
T41.0X5D
|
Adverse effect of inhaled anesthetics, subsequent encounter
|
|
T41.0X5S
|
Adverse effect of inhaled anesthetics, sequela
|
|
T41.1X1A
|
Poisoning by intravenous anesthetics, accidental (unintentional), initial encounter
|
|
T41.1X1D
|
Poisoning by intravenous anesthetics, accidental (unintentional), subsequent encounter
|
|
T41.1X1S
|
Poisoning by intravenous anesthetics, accidental (unintentional), sequela
|
|
T41.1X2A
|
Poisoning by intravenous anesthetics, intentional self-harm, initial encounter
|
|
T41.1X2D
|
Poisoning by intravenous anesthetics, intentional self-harm, subsequent encounter
|
|
T41.1X2S
|
Poisoning by intravenous anesthetics, intentional self-harm, sequela
|
|
T41.1X3A
|
Poisoning by intravenous anesthetics, assault, initial encounter
|
|
T41.1X3D
|
Poisoning by intravenous anesthetics, assault, subsequent encounter
|
|
T41.1X3S
|
Poisoning by intravenous anesthetics, assault, sequela
|
|
T41.1X4A
|
Poisoning by intravenous anesthetics, undetermined, initial encounter
|
|
T41.1X4D
|
Poisoning by intravenous anesthetics, undetermined, subsequent encounter
|
|
T41.1X4S
|
Poisoning by intravenous anesthetics, undetermined, sequela
|
|
T41.1X5A
|
Adverse effect of intravenous anesthetics, initial encounter
|
|
T41.1X5D
|
Adverse effect of intravenous anesthetics, subsequent encounter
|
|
T41.1X5S
|
Adverse effect of intravenous anesthetics, sequela
|
|
T41.201A
|
Poisoning by unspecified general anesthetics, accidental (unintentional), initial encounter
|
|
T41.201D
|
Poisoning by unspecified general anesthetics, accidental (unintentional), subsequent encounter
|
|
T41.201S
|
Poisoning by unspecified general anesthetics, accidental (unintentional), sequela
|
|
T41.202A
|
Poisoning by unspecified general anesthetics, intentional self-harm, initial encounter
|
|
T41.202D
|
Poisoning by unspecified general anesthetics, intentional self-harm, subsequent encounter
|
|
T41.202S
|
Poisoning by unspecified general anesthetics, intentional self-harm, sequela
|
|
T41.203A
|
Poisoning by unspecified general anesthetics, assault, initial encounter
|
|
T41.203D
|
Poisoning by unspecified general anesthetics, assault, subsequent encounter
|
|
T41.203S
|
Poisoning by unspecified general anesthetics, assault, sequela
|
|
T41.204A
|
Poisoning by unspecified general anesthetics, undetermined, initial encounter
|
|
T41.204D
|
Poisoning by unspecified general anesthetics, undetermined, subsequent encounter
|
|
T41.204S
|
Poisoning by unspecified general anesthetics, undetermined, sequela
|
|
T41.205A
|
Adverse effect of unspecified general anesthetics, initial encounter
|
|
T41.205D
|
Adverse effect of unspecified general anesthetics, subsequent encounter
|
|
T41.205S
|
Adverse effect of unspecified general anesthetics, sequela
|
|
T41.206A
|
Underdosing of unspecified general anesthetics, initial encounter
|
|
T41.206D
|
Underdosing of unspecified general anesthetics, subsequent encounter
|
|
T41.206S
|
Underdosing of unspecified general anesthetics, sequela
|
|
T41.291A
|
Poisoning by other general anesthetics, accidental (unintentional), initial encounter
|
|
T41.291D
|
Poisoning by other general anesthetics, accidental (unintentional), subsequent encounter
|
|
T41.291S
|
Poisoning by other general anesthetics, accidental (unintentional), sequela
|
|
T41.292A
|
Poisoning by other general anesthetics, intentional self-harm, initial encounter
|
|
T41.292D
|
Poisoning by other general anesthetics, intentional self-harm, subsequent encounter
|
|
T41.292S
|
Poisoning by other general anesthetics, intentional self-harm, sequela
|
|
T41.293A
|
Poisoning by other general anesthetics, assault, initial encounter
|
|
T41.293D
|
Poisoning by other general anesthetics, assault, subsequent encounter
|
|
T41.293S
|
Poisoning by other general anesthetics, assault, sequela
|
|
T41.294A
|
Poisoning by other general anesthetics, undetermined, initial encounter
|
|
T41.294D
|
Poisoning by other general anesthetics, undetermined, subsequent encounter
|
|
T41.294S
|
Poisoning by other general anesthetics, undetermined, sequela
|
|
T41.295A
|
Adverse effect of other general anesthetics, initial encounter
|
|
T41.295D
|
Adverse effect of other general anesthetics, subsequent encounter
|
|
T41.295S
|
Adverse effect of other general anesthetics, sequela
|
|
T41.3X1A
|
Poisoning by local anesthetics, accidental (unintentional), initial encounter
|
|
T41.3X1D
|
Poisoning by local anesthetics, accidental (unintentional), subsequent encounter
|
|
T41.3X1S
|
Poisoning by local anesthetics, accidental (unintentional), sequela
|
|
T41.3X2A
|
Poisoning by local anesthetics, intentional self-harm, initial encounter
|
|
T41.3X2D
|
Poisoning by local anesthetics, intentional self-harm, subsequent encounter
|
|
T41.3X2S
|
Poisoning by local anesthetics, intentional self-harm, sequela
|
|
T41.3X3A
|
Poisoning by local anesthetics, assault, initial encounter
|
|
T41.3X3D
|
Poisoning by local anesthetics, assault, subsequent encounter
|
|
T41.3X3S
|
Poisoning by local anesthetics, assault, sequela
|
|
T41.3X4A
|
Poisoning by local anesthetics, undetermined, initial encounter
|
|
T41.3X4D
|
Poisoning by local anesthetics, undetermined, subsequent encounter
|
|
T41.3X4S
|
Poisoning by local anesthetics, undetermined, sequela
|
|
T41.3X5A
|
Adverse effect of local anesthetics, initial encounter
|
|
T41.3X5D
|
Adverse effect of local anesthetics, subsequent encounter
|
|
T41.3X5S
|
Adverse effect of local anesthetics, sequela
|
|
T41.41XA
|
Poisoning by unspecified anesthetic, accidental (unintentional), initial encounter
|
|
T41.41XD
|
Poisoning by unspecified anesthetic, accidental (unintentional), subsequent encounter
|
|
T41.41XS
|
Poisoning by unspecified anesthetic, accidental (unintentional), sequela
|
|
T41.42XA
|
Poisoning by unspecified anesthetic, intentional self-harm, initial encounter
|
|
T41.42XD
|
Poisoning by unspecified anesthetic, intentional self-harm, subsequent encounter
|
|
T41.42XS
|
Poisoning by unspecified anesthetic, intentional self-harm, sequela
|
|
T41.43XA
|
Poisoning by unspecified anesthetic, assault, initial encounter
|
|
T41.43XD
|
Poisoning by unspecified anesthetic, assault, subsequent encounter
|
|
T41.43XS
|
Poisoning by unspecified anesthetic, assault, sequela
|
|
T41.44XA
|
Poisoning by unspecified anesthetic, undetermined, initial encounter
|
|
T41.44XD
|
Poisoning by unspecified anesthetic, undetermined, subsequent encounter
|
|
T41.44XS
|
Poisoning by unspecified anesthetic, undetermined, sequela
|
|
T41.45XA
|
Adverse effect of unspecified anesthetic, initial encounter
|
|
T41.45XD
|
Adverse effect of unspecified anesthetic, subsequent encounter
|
|
T41.45XS
|
Adverse effect of unspecified anesthetic, sequela
|
|
T41.5X1A
|
Poisoning by therapeutic gases, accidental (unintentional), initial encounter
|
|
T41.5X1D
|
Poisoning by therapeutic gases, accidental (unintentional), subsequent encounter
|
|
T41.5X1S
|
Poisoning by therapeutic gases, accidental (unintentional), sequela
|
|
T41.5X2A
|
Poisoning by therapeutic gases, intentional self-harm, initial encounter
|
|
T41.5X2D
|
Poisoning by therapeutic gases, intentional self-harm, subsequent encounter
|
|
T41.5X2S
|
Poisoning by therapeutic gases, intentional self-harm, sequela
|
|
T41.5X3A
|
Poisoning by therapeutic gases, assault, initial encounter
|
|
T41.5X3D
|
Poisoning by therapeutic gases, assault, subsequent encounter
|
|
T41.5X3S
|
Poisoning by therapeutic gases, assault, sequela
|
|
T41.5X4A
|
Poisoning by therapeutic gases, undetermined, initial encounter
|
|
T41.5X4D
|
Poisoning by therapeutic gases, undetermined, subsequent encounter
|
|
T41.5X4S
|
Poisoning by therapeutic gases, undetermined, sequela
|
|
T41.5X5A
|
Adverse effect of therapeutic gases, initial encounter
|
|
T41.5X5D
|
Adverse effect of therapeutic gases, subsequent encounter
|
|
T41.5X5S
|
Adverse effect of therapeutic gases, sequela
|
|
T41.5X6A
|
Underdosing of therapeutic gases, initial encounter
|
|
T41.5X6D
|
Underdosing of therapeutic gases, subsequent encounter
|
|
T41.5X6S
|
Underdosing of therapeutic gases, sequela
|
|
T42.0X1A
|
Poisoning by hydantoin derivatives, accidental (unintentional), initial encounter
|
|
T42.0X1D
|
Poisoning by hydantoin derivatives, accidental (unintentional), subsequent encounter
|
|
T42.0X1S
|
Poisoning by hydantoin derivatives, accidental (unintentional), sequela
|
|
T42.0X2A
|
Poisoning by hydantoin derivatives, intentional self-harm, initial encounter
|
|
T42.0X2D
|
Poisoning by hydantoin derivatives, intentional self-harm, subsequent encounter
|
|
T42.0X2S
|
Poisoning by hydantoin derivatives, intentional self-harm, sequela
|
|
T42.0X3A
|
Poisoning by hydantoin derivatives, assault, initial encounter
|
|
T42.0X3D
|
Poisoning by hydantoin derivatives, assault, subsequent encounter
|
|
T42.0X3S
|
Poisoning by hydantoin derivatives, assault, sequela
|
|
T42.0X4A
|
Poisoning by hydantoin derivatives, undetermined, initial encounter
|
|
T42.0X4D
|
Poisoning by hydantoin derivatives, undetermined, subsequent encounter
|
|
T42.0X4S
|
Poisoning by hydantoin derivatives, undetermined, sequela
|
|
T42.0X5A
|
Adverse effect of hydantoin derivatives, initial encounter
|
|
T42.0X5D
|
Adverse effect of hydantoin derivatives, subsequent encounter
|
|
T42.0X5S
|
Adverse effect of hydantoin derivatives, sequela
|
|
T42.0X6A
|
Underdosing of hydantoin derivatives, initial encounter
|
|
T42.0X6D
|
Underdosing of hydantoin derivatives, subsequent encounter
|
|
T42.0X6S
|
Underdosing of hydantoin derivatives, sequela
|
|
T42.1X1A
|
Poisoning by iminostilbenes, accidental (unintentional), initial encounter
|
|
T42.1X1D
|
Poisoning by iminostilbenes, accidental (unintentional), subsequent encounter
|
|
T42.1X1S
|
Poisoning by iminostilbenes, accidental (unintentional), sequela
|
|
T42.1X2A
|
Poisoning by iminostilbenes, intentional self-harm, initial encounter
|
|
T42.1X2D
|
Poisoning by iminostilbenes, intentional self-harm, subsequent encounter
|
|
T42.1X2S
|
Poisoning by iminostilbenes, intentional self-harm, sequela
|
|
T42.1X3A
|
Poisoning by iminostilbenes, assault, initial encounter
|
|
T42.1X3D
|
Poisoning by iminostilbenes, assault, subsequent encounter
|
|
T42.1X3S
|
Poisoning by iminostilbenes, assault, sequela
|
|
T42.1X4A
|
Poisoning by iminostilbenes, undetermined, initial encounter
|
|
T42.1X4D
|
Poisoning by iminostilbenes, undetermined, subsequent encounter
|
|
T42.1X4S
|
Poisoning by iminostilbenes, undetermined, sequela
|
|
T42.1X5A
|
Adverse effect of iminostilbenes, initial encounter
|
|
T42.1X5D
|
Adverse effect of iminostilbenes, subsequent encounter
|
|
T42.1X5S
|
Adverse effect of iminostilbenes, sequela
|
|
T42.1X6A
|
Underdosing of iminostilbenes, initial encounter
|
|
T42.1X6D
|
Underdosing of iminostilbenes, subsequent encounter
|
|
T42.1X6S
|
Underdosing of iminostilbenes, sequela
|
|
T42.2X1A
|
Poisoning by succinimides and oxazolidinediones, accidental (unintentional), initial encounter
|
|
T42.2X1D
|
Poisoning by succinimides and oxazolidinediones, accidental (unintentional), subsequent encounter
|
|
T42.2X1S
|
Poisoning by succinimides and oxazolidinediones, accidental (unintentional), sequela
|
|
T42.2X2A
|
Poisoning by succinimides and oxazolidinediones, intentional self-harm, initial encounter
|
|
T42.2X2D
|
Poisoning by succinimides and oxazolidinediones, intentional self-harm, subsequent encounter
|
|
T42.2X2S
|
Poisoning by succinimides and oxazolidinediones, intentional self-harm, sequela
|
|
T42.2X3A
|
Poisoning by succinimides and oxazolidinediones, assault, initial encounter
|
|
T42.2X3D
|
Poisoning by succinimides and oxazolidinediones, assault, subsequent encounter
|
|
T42.2X3S
|
Poisoning by succinimides and oxazolidinediones, assault, sequela
|
|
T42.2X4A
|
Poisoning by succinimides and oxazolidinediones, undetermined, initial encounter
|
|
T42.2X4D
|
Poisoning by succinimides and oxazolidinediones, undetermined, subsequent encounter
|
|
T42.2X4S
|
Poisoning by succinimides and oxazolidinediones, undetermined, sequela
|
|
T42.2X5A
|
Adverse effect of succinimides and oxazolidinediones, initial encounter
|
|
T42.2X5D
|
Adverse effect of succinimides and oxazolidinediones, subsequent encounter
|
|
T42.2X5S
|
Adverse effect of succinimides and oxazolidinediones, sequela
|
|
T42.2X6A
|
Underdosing of succinimides and oxazolidinediones, initial encounter
|
|
T42.2X6D
|
Underdosing of succinimides and oxazolidinediones, subsequent encounter
|
|
T42.2X6S
|
Underdosing of succinimides and oxazolidinediones, sequela
|
|
T42.3X1A
|
Poisoning by barbiturates, accidental (unintentional), initial encounter
|
|
T42.3X1D
|
Poisoning by barbiturates, accidental (unintentional), subsequent encounter
|
|
T42.3X1S
|
Poisoning by barbiturates, accidental (unintentional), sequela
|
|
T42.3X2A
|
Poisoning by barbiturates, intentional self-harm, initial encounter
|
|
T42.3X2D
|
Poisoning by barbiturates, intentional self-harm, subsequent encounter
|
|
T42.3X2S
|
Poisoning by barbiturates, intentional self-harm, sequela
|
|
T42.3X3A
|
Poisoning by barbiturates, assault, initial encounter
|
|
T42.3X3D
|
Poisoning by barbiturates, assault, subsequent encounter
|
|
T42.3X3S
|
Poisoning by barbiturates, assault, sequela
|
|
T42.3X4A
|
Poisoning by barbiturates, undetermined, initial encounter
|
|
T42.3X4D
|
Poisoning by barbiturates, undetermined, subsequent encounter
|
|
T42.3X4S
|
Poisoning by barbiturates, undetermined, sequela
|
|
T42.3X5A
|
Adverse effect of barbiturates, initial encounter
|
|
T42.3X5D
|
Adverse effect of barbiturates, subsequent encounter
|
|
T42.3X5S
|
Adverse effect of barbiturates, sequela
|
|
T42.3X6A
|
Underdosing of barbiturates, initial encounter
|
|
T42.3X6D
|
Underdosing of barbiturates, subsequent encounter
|
|
T42.3X6S
|
Underdosing of barbiturates, sequela
|
|
T42.4X1A
|
Poisoning by benzodiazepines, accidental (unintentional), initial encounter
|
|
T42.4X1D
|
Poisoning by benzodiazepines, accidental (unintentional), subsequent encounter
|
|
T42.4X1S
|
Poisoning by benzodiazepines, accidental (unintentional), sequela
|
|
T42.4X2A
|
Poisoning by benzodiazepines, intentional self-harm, initial encounter
|
|
T42.4X2D
|
Poisoning by benzodiazepines, intentional self-harm, subsequent encounter
|
|
T42.4X2S
|
Poisoning by benzodiazepines, intentional self-harm, sequela
|
|
T42.4X3A
|
Poisoning by benzodiazepines, assault, initial encounter
|
|
T42.4X3D
|
Poisoning by benzodiazepines, assault, subsequent encounter
|
|
T42.4X3S
|
Poisoning by benzodiazepines, assault, sequela
|
|
T42.4X4A
|
Poisoning by benzodiazepines, undetermined, initial encounter
|
|
T42.4X4D
|
Poisoning by benzodiazepines, undetermined, subsequent encounter
|
|
T42.4X4S
|
Poisoning by benzodiazepines, undetermined, sequela
|
|
T42.4X5A
|
Adverse effect of benzodiazepines, initial encounter
|
|
T42.4X5D
|
Adverse effect of benzodiazepines, subsequent encounter
|
|
T42.4X5S
|
Adverse effect of benzodiazepines, sequela
|
|
T42.5X1A
|
Poisoning by mixed antiepileptics, accidental (unintentional), initial encounter
|
|
T42.5X1D
|
Poisoning by mixed antiepileptics, accidental (unintentional), subsequent encounter
|
|
T42.5X1S
|
Poisoning by mixed antiepileptics, accidental (unintentional), sequela
|
|
T42.5X2A
|
Poisoning by mixed antiepileptics, intentional self-harm, initial encounter
|
|
T42.5X2D
|
Poisoning by mixed antiepileptics, intentional self-harm, subsequent encounter
|
|
T42.5X2S
|
Poisoning by mixed antiepileptics, intentional self-harm, sequela
|
|
T42.5X3A
|
Poisoning by mixed antiepileptics, assault, initial encounter
|
|
T42.5X3D
|
Poisoning by mixed antiepileptics, assault, subsequent encounter
|
|
T42.5X3S
|
Poisoning by mixed antiepileptics, assault, sequela
|
|
T42.5X4A
|
Poisoning by mixed antiepileptics, undetermined, initial encounter
|
|
T42.5X4D
|
Poisoning by mixed antiepileptics, undetermined, subsequent encounter
|
|
T42.5X4S
|
Poisoning by mixed antiepileptics, undetermined, sequela
|
|
T42.5X5A
|
Adverse effect of mixed antiepileptics, initial encounter
|
|
T42.5X5D
|
Adverse effect of mixed antiepileptics, subsequent encounter
|
|
T42.5X5S
|
Adverse effect of mixed antiepileptics, sequela
|
|
T42.5X6A
|
Underdosing of mixed antiepileptics, initial encounter
|
|
T42.5X6D
|
Underdosing of mixed antiepileptics, subsequent encounter
|
|
T42.5X6S
|
Underdosing of mixed antiepileptics, sequela
|
|
T42.6X1A
|
Poisoning by other antiepileptic and sedative-hypnotic drugs, accidental (unintentional), initial encounter
|
|
T42.6X1D
|
Poisoning by other antiepileptic and sedative-hypnotic drugs, accidental (unintentional), subsequent encounter
|
|
T42.6X1S
|
Poisoning by other antiepileptic and sedative-hypnotic drugs, accidental (unintentional), sequela
|
|
T42.6X2A
|
Poisoning by other antiepileptic and sedative-hypnotic drugs, intentional self-harm, initial encounter
|
|
T42.6X2D
|
Poisoning by other antiepileptic and sedative-hypnotic drugs, intentional self-harm, subsequent encounter
|
|
T42.6X2S
|
Poisoning by other antiepileptic and sedative-hypnotic drugs, intentional self-harm, sequela
|
|
T42.6X3A
|
Poisoning by other antiepileptic and sedative-hypnotic drugs, assault, initial encounter
|
|
T42.6X3D
|
Poisoning by other antiepileptic and sedative-hypnotic drugs, assault, subsequent encounter
|
|
T42.6X3S
|
Poisoning by other antiepileptic and sedative-hypnotic drugs, assault, sequela
|
|
T42.6X4A
|
Poisoning by other antiepileptic and sedative-hypnotic drugs, undetermined, initial encounter
|
|
T42.6X4D
|
Poisoning by other antiepileptic and sedative-hypnotic drugs, undetermined, subsequent encounter
|
|
T42.6X4S
|
Poisoning by other antiepileptic and sedative-hypnotic drugs, undetermined, sequela
|
|
T42.6X5A
|
Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter
|
|
T42.6X5D
|
Adverse effect of other antiepileptic and sedative-hypnotic drugs, subsequent encounter
|
|
T42.6X5S
|
Adverse effect of other antiepileptic and sedative-hypnotic drugs, sequela
|
|
T42.6X6A
|
Underdosing of other antiepileptic and sedative-hypnotic drugs, initial encounter
|
|
T42.6X6D
|
Underdosing of other antiepileptic and sedative-hypnotic drugs, subsequent encounter
|
|
T42.6X6S
|
Underdosing of other antiepileptic and sedative-hypnotic drugs, sequela
|
|
T42.71XA
|
Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, accidental (unintentional), initial encounter
|
|
T42.71XD
|
Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, accidental (unintentional), subsequent encounter
|
|
T42.71XS
|
Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, accidental (unintentional), sequela
|
|
T42.72XA
|
Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, intentional self-harm, initial encounter
|
|
T42.72XD
|
Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, intentional self-harm, subsequent encounter
|
|
T42.72XS
|
Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, intentional self-harm, sequela
|
|
T42.73XA
|
Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, assault, initial encounter
|
|
T42.73XD
|
Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, assault, subsequent encounter
|
|
T42.73XS
|
Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, assault, sequela
|
|
T42.74XA
|
Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, undetermined, initial encounter
|
|
T42.74XD
|
Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, undetermined, subsequent encounter
|
|
T42.74XS
|
Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, undetermined, sequela
|
|
T42.75XA
|
Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter
|
|
T42.75XD
|
Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, subsequent encounter
|
|
T42.75XS
|
Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, sequela
|
|
T42.76XA
|
Underdosing of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter
|
|
T42.76XD
|
Underdosing of unspecified antiepileptic and sedative-hypnotic drugs, subsequent encounter
|
|
T42.76XS
|
Underdosing of unspecified antiepileptic and sedative-hypnotic drugs, sequela
|
|
T42.8X1A
|
Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, accidental (unintentional), initial encounter
|
|
T42.8X1D
|
Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, accidental (unintentional), subsequent encounter
|
|
T42.8X1S
|
Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, accidental (unintentional), sequela
|
|
T42.8X2A
|
Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, intentional self-harm, initial encounter
|
|
T42.8X2D
|
Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, intentional self-harm, subsequent encounter
|
|
T42.8X2S
|
Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, intentional self-harm, sequela
|
|
T42.8X3A
|
Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, assault, initial encounter
|
|
T42.8X3D
|
Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, assault, subsequent encounter
|
|
T42.8X3S
|
Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, assault, sequela
|
|
T42.8X4A
|
Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, undetermined, initial encounter
|
|
T42.8X4D
|
Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, undetermined, subsequent encounter
|
|
T42.8X4S
|
Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, undetermined, sequela
|
|
T42.8X5A
|
Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter
|
|
T42.8X5D
|
Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, subsequent encounter
|
|
T42.8X5S
|
Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, sequela
|
|
T42.8X6A
|
Underdosing of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter
|
|
T42.8X6D
|
Underdosing of antiparkinsonism drugs and other central muscle-tone depressants, subsequent encounter
|
|
T42.8X6S
|
Underdosing of antiparkinsonism drugs and other central muscle-tone depressants, sequela
|
|
T43.011A
|
Poisoning by tricyclic antidepressants, accidental (unintentional), initial encounter
|
|
T43.011D
|
Poisoning by tricyclic antidepressants, accidental (unintentional), subsequent encounter
|
|
T43.011S
|
Poisoning by tricyclic antidepressants, accidental (unintentional), sequela
|
|
T43.012A
|
Poisoning by tricyclic antidepressants, intentional self-harm, initial encounter
|
|
T43.012D
|
Poisoning by tricyclic antidepressants, intentional self-harm, subsequent encounter
|
|
T43.012S
|
Poisoning by tricyclic antidepressants, intentional self-harm, sequela
|
|
T43.013A
|
Poisoning by tricyclic antidepressants, assault, initial encounter
|
|
T43.013D
|
Poisoning by tricyclic antidepressants, assault, subsequent encounter
|
|
T43.013S
|
Poisoning by tricyclic antidepressants, assault, sequela
|
|
T43.014A
|
Poisoning by tricyclic antidepressants, undetermined, initial encounter
|
|
T43.014D
|
Poisoning by tricyclic antidepressants, undetermined, subsequent encounter
|
|
T43.014S
|
Poisoning by tricyclic antidepressants, undetermined, sequela
|
|
T43.015A
|
Adverse effect of tricyclic antidepressants, initial encounter
|
|
T43.015D
|
Adverse effect of tricyclic antidepressants, subsequent encounter
|
|
T43.015S
|
Adverse effect of tricyclic antidepressants, sequela
|
|
T43.021A
|
Poisoning by tetracyclic antidepressants, accidental (unintentional), initial encounter
|
|
T43.021D
|
Poisoning by tetracyclic antidepressants, accidental (unintentional), subsequent encounter
|
|
T43.021S
|
Poisoning by tetracyclic antidepressants, accidental (unintentional), sequela
|
|
T43.022A
|
Poisoning by tetracyclic antidepressants, intentional self-harm, initial encounter
|
|
T43.022D
|
Poisoning by tetracyclic antidepressants, intentional self-harm, subsequent encounter
|
|
T43.022S
|
Poisoning by tetracyclic antidepressants, intentional self-harm, sequela
|
|
T43.023A
|
Poisoning by tetracyclic antidepressants, assault, initial encounter
|
|
T43.023D
|
Poisoning by tetracyclic antidepressants, assault, subsequent encounter
|
|
T43.023S
|
Poisoning by tetracyclic antidepressants, assault, sequela
|
|
T43.024A
|
Poisoning by tetracyclic antidepressants, undetermined, initial encounter
|
|
T43.024D
|
Poisoning by tetracyclic antidepressants, undetermined, subsequent encounter
|
|
T43.024S
|
Poisoning by tetracyclic antidepressants, undetermined, sequela
|
|
T43.025A
|
Adverse effect of tetracyclic antidepressants, initial encounter
|
|
T43.025D
|
Adverse effect of tetracyclic antidepressants, subsequent encounter
|
|
T43.025S
|
Adverse effect of tetracyclic antidepressants, sequela
|
|
T43.1X1A
|
Poisoning by monoamine-oxidase-inhibitor antidepressants, accidental (unintentional), initial encounter
|
|
T43.1X1D
|
Poisoning by monoamine-oxidase-inhibitor antidepressants, accidental (unintentional), subsequent encounter
|
|
T43.1X1S
|
Poisoning by monoamine-oxidase-inhibitor antidepressants, accidental (unintentional), sequela
|
|
T43.1X2A
|
Poisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm, initial encounter
|
|
T43.1X2D
|
Poisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm, subsequent encounter
|
|
T43.1X2S
|
Poisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm, sequela
|
|
T43.1X3A
|
Poisoning by monoamine-oxidase-inhibitor antidepressants, assault, initial encounter
|
|
T43.1X3D
|
Poisoning by monoamine-oxidase-inhibitor antidepressants, assault, subsequent encounter
|
|
T43.1X3S
|
Poisoning by monoamine-oxidase-inhibitor antidepressants, assault, sequela
|
|
T43.1X4A
|
Poisoning by monoamine-oxidase-inhibitor antidepressants, undetermined, initial encounter
|
|
T43.1X4D
|
Poisoning by monoamine-oxidase-inhibitor antidepressants, undetermined, subsequent encounter
|
|
T43.1X4S
|
Poisoning by monoamine-oxidase-inhibitor antidepressants, undetermined, sequela
|
|
T43.1X5A
|
Adverse effect of monoamine-oxidase-inhibitor antidepressants, initial encounter
|
|
T43.1X5D
|
Adverse effect of monoamine-oxidase-inhibitor antidepressants, subsequent encounter
|
|
T43.1X5S
|
Adverse effect of monoamine-oxidase-inhibitor antidepressants, sequela
|
|
T43.1X6A
|
Underdosing of monoamine-oxidase-inhibitor antidepressants, initial encounter
|
|
T43.1X6D
|
Underdosing of monoamine-oxidase-inhibitor antidepressants, subsequent encounter
|
|
T43.1X6S
|
Underdosing of monoamine-oxidase-inhibitor antidepressants, sequela
|
|
T43.201A
|
Poisoning by unspecified antidepressants, accidental (unintentional), initial encounter
|
|
T43.201D
|
Poisoning by unspecified antidepressants, accidental (unintentional), subsequent encounter
|
|
T43.201S
|
Poisoning by unspecified antidepressants, accidental (unintentional), sequela
|
|
T43.202A
|
Poisoning by unspecified antidepressants, intentional self-harm, initial encounter
|
|
T43.202D
|
Poisoning by unspecified antidepressants, intentional self-harm, subsequent encounter
|
|
T43.202S
|
Poisoning by unspecified antidepressants, intentional self-harm, sequela
|
|
T43.203A
|
Poisoning by unspecified antidepressants, assault, initial encounter
|
|
T43.203D
|
Poisoning by unspecified antidepressants, assault, subsequent encounter
|
|
T43.203S
|
Poisoning by unspecified antidepressants, assault, sequela
|
|
T43.204A
|
Poisoning by unspecified antidepressants, undetermined, initial encounter
|
|
T43.204D
|
Poisoning by unspecified antidepressants, undetermined, subsequent encounter
|
|
T43.204S
|
Poisoning by unspecified antidepressants, undetermined, sequela
|
|
T43.205A
|
Adverse effect of unspecified antidepressants, initial encounter
|
|
T43.205D
|
Adverse effect of unspecified antidepressants, subsequent encounter
|
|
T43.205S
|
Adverse effect of unspecified antidepressants, sequela
|
|
T43.211A
|
Poisoning by selective serotonin and norepinephrine reuptake inhibitors, accidental (unintentional), initial encounter
|
|
T43.211D
|
Poisoning by selective serotonin and norepinephrine reuptake inhibitors, accidental (unintentional), subsequent encounter
|
|
T43.211S
|
Poisoning by selective serotonin and norepinephrine reuptake inhibitors, accidental (unintentional), sequela
|
|
T43.212A
|
Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, initial encounter
|
|
T43.212D
|
Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, subsequent encounter
|
|
T43.212S
|
Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, sequela
|
|
T43.213A
|
Poisoning by selective serotonin and norepinephrine reuptake inhibitors, assault, initial encounter
|
|
T43.213D
|
Poisoning by selective serotonin and norepinephrine reuptake inhibitors, assault, subsequent encounter
|
|
T43.213S
|
Poisoning by selective serotonin and norepinephrine reuptake inhibitors, assault, sequela
|
|
T43.214A
|
Poisoning by selective serotonin and norepinephrine reuptake inhibitors, undetermined, initial encounter
|
|
T43.214D
|
Poisoning by selective serotonin and norepinephrine reuptake inhibitors, undetermined, subsequent encounter
|
|
T43.214S
|
Poisoning by selective serotonin and norepinephrine reuptake inhibitors, undetermined, sequela
|
|
T43.215A
|
Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter
|
|
T43.215D
|
Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter
|
|
T43.215S
|
Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, sequela
|
|
T43.221A
|
Poisoning by selective serotonin reuptake inhibitors, accidental (unintentional), initial encounter
|
|
T43.221D
|
Poisoning by selective serotonin reuptake inhibitors, accidental (unintentional), subsequent encounter
|
|
T43.221S
|
Poisoning by selective serotonin reuptake inhibitors, accidental (unintentional), sequela
|
|
T43.222A
|
Poisoning by selective serotonin reuptake inhibitors, intentional self-harm, initial encounter
|
|
T43.222D
|
Poisoning by selective serotonin reuptake inhibitors, intentional self-harm, subsequent encounter
|
|
T43.222S
|
Poisoning by selective serotonin reuptake inhibitors, intentional self-harm, sequela
|
|
T43.223A
|
Poisoning by selective serotonin reuptake inhibitors, assault, initial encounter
|
|
T43.223D
|
Poisoning by selective serotonin reuptake inhibitors, assault, subsequent encounter
|
|
T43.223S
|
Poisoning by selective serotonin reuptake inhibitors, assault, sequela
|
|
T43.224A
|
Poisoning by selective serotonin reuptake inhibitors, undetermined, initial encounter
|
|
T43.224D
|
Poisoning by selective serotonin reuptake inhibitors, undetermined, subsequent encounter
|
|
T43.224S
|
Poisoning by selective serotonin reuptake inhibitors, undetermined, sequela
|
|
T43.225A
|
Adverse effect of selective serotonin reuptake inhibitors, initial encounter
|
|
T43.225D
|
Adverse effect of selective serotonin reuptake inhibitors, subsequent encounter
|
|
T43.225S
|
Adverse effect of selective serotonin reuptake inhibitors, sequela
|
|
T43.226A
|
Underdosing of selective serotonin reuptake inhibitors, initial encounter
|
|
T43.226D
|
Underdosing of selective serotonin reuptake inhibitors, subsequent encounter
|
|
T43.226S
|
Underdosing of selective serotonin reuptake inhibitors, sequela
|
|
T43.291A
|
Poisoning by other antidepressants, accidental (unintentional), initial encounter
|
|
T43.291D
|
Poisoning by other antidepressants, accidental (unintentional), subsequent encounter
|
|
T43.291S
|
Poisoning by other antidepressants, accidental (unintentional), sequela
|
|
T43.292A
|
Poisoning by other antidepressants, intentional self-harm, initial encounter
|
|
T43.292D
|
Poisoning by other antidepressants, intentional self-harm, subsequent encounter
|
|
T43.292S
|
Poisoning by other antidepressants, intentional self-harm, sequela
|
|
T43.293A
|
Poisoning by other antidepressants, assault, initial encounter
|
|
T43.293D
|
Poisoning by other antidepressants, assault, subsequent encounter
|
|
T43.293S
|
Poisoning by other antidepressants, assault, sequela
|
|
T43.294A
|
Poisoning by other antidepressants, undetermined, initial encounter
|
|
T43.294D
|
Poisoning by other antidepressants, undetermined, subsequent encounter
|
|
T43.294S
|
Poisoning by other antidepressants, undetermined, sequela
|
|
T43.295A
|
Adverse effect of other antidepressants, initial encounter
|
|
T43.295D
|
Adverse effect of other antidepressants, subsequent encounter
|
|
T43.295S
|
Adverse effect of other antidepressants, sequela
|
|
T43.3X1A
|
Poisoning by phenothiazine antipsychotics and neuroleptics, accidental (unintentional), initial encounter
|
|
T43.3X1D
|
Poisoning by phenothiazine antipsychotics and neuroleptics, accidental (unintentional), subsequent encounter
|
|
T43.3X1S
|
Poisoning by phenothiazine antipsychotics and neuroleptics, accidental (unintentional), sequela
|
|
T43.3X2A
|
Poisoning by phenothiazine antipsychotics and neuroleptics, intentional self-harm, initial encounter
|
|
T43.3X2D
|
Poisoning by phenothiazine antipsychotics and neuroleptics, intentional self-harm, subsequent encounter
|
|
T43.3X2S
|
Poisoning by phenothiazine antipsychotics and neuroleptics, intentional self-harm, sequela
|
|
T43.3X3A
|
Poisoning by phenothiazine antipsychotics and neuroleptics, assault, initial encounter
|
|
T43.3X3D
|
Poisoning by phenothiazine antipsychotics and neuroleptics, assault, subsequent encounter
|
|
T43.3X3S
|
Poisoning by phenothiazine antipsychotics and neuroleptics, assault, sequela
|
|
T43.3X4A
|
Poisoning by phenothiazine antipsychotics and neuroleptics, undetermined, initial encounter
|
|
T43.3X4D
|
Poisoning by phenothiazine antipsychotics and neuroleptics, undetermined, subsequent encounter
|
|
T43.3X4S
|
Poisoning by phenothiazine antipsychotics and neuroleptics, undetermined, sequela
|
|
T43.3X5A
|
Adverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter
|
|
T43.3X5D
|
Adverse effect of phenothiazine antipsychotics and neuroleptics, subsequent encounter
|
|
T43.3X5S
|
Adverse effect of phenothiazine antipsychotics and neuroleptics, sequela
|
|
T43.3X6A
|
Underdosing of phenothiazine antipsychotics and neuroleptics, initial encounter
|
|
T43.3X6D
|
Underdosing of phenothiazine antipsychotics and neuroleptics, subsequent encounter
|
|
T43.3X6S
|
Underdosing of phenothiazine antipsychotics and neuroleptics, sequela
|
|
T43.4X1A
|
Poisoning by butyrophenone and thiothixene neuroleptics, accidental (unintentional), initial encounter
|
|
T43.4X1D
|
Poisoning by butyrophenone and thiothixene neuroleptics, accidental (unintentional), subsequent encounter
|
|
T43.4X1S
|
Poisoning by butyrophenone and thiothixene neuroleptics, accidental (unintentional), sequela
|
|
T43.4X2A
|
Poisoning by butyrophenone and thiothixene neuroleptics, intentional self-harm, initial encounter
|
|
T43.4X2D
|
Poisoning by butyrophenone and thiothixene neuroleptics, intentional self-harm, subsequent encounter
|
|
T43.4X2S
|
Poisoning by butyrophenone and thiothixene neuroleptics, intentional self-harm, sequela
|
|
T43.4X3A
|
Poisoning by butyrophenone and thiothixene neuroleptics, assault, initial encounter
|
|
T43.4X3D
|
Poisoning by butyrophenone and thiothixene neuroleptics, assault, subsequent encounter
|
|
T43.4X3S
|
Poisoning by butyrophenone and thiothixene neuroleptics, assault, sequela
|
|
T43.4X4A
|
Poisoning by butyrophenone and thiothixene neuroleptics, undetermined, initial encounter
|
|
T43.4X4D
|
Poisoning by butyrophenone and thiothixene neuroleptics, undetermined, subsequent encounter
|
|
T43.4X4S
|
Poisoning by butyrophenone and thiothixene neuroleptics, undetermined, sequela
|
|
T43.4X5A
|
Adverse effect of butyrophenone and thiothixene neuroleptics, initial encounter
|
|
T43.4X5D
|
Adverse effect of butyrophenone and thiothixene neuroleptics, subsequent encounter
|
|
T43.4X5S
|
Adverse effect of butyrophenone and thiothixene neuroleptics, sequela
|
|
T43.4X6A
|
Underdosing of butyrophenone and thiothixene neuroleptics, initial encounter
|
|
T43.4X6D
|
Underdosing of butyrophenone and thiothixene neuroleptics, subsequent encounter
|
|
T43.4X6S
|
Underdosing of butyrophenone and thiothixene neuroleptics, sequela
|
|
T43.501A
|
Poisoning by unspecified antipsychotics and neuroleptics, accidental (unintentional), initial encounter
|
|
T43.501D
|
Poisoning by unspecified antipsychotics and neuroleptics, accidental (unintentional), subsequent encounter
|
|
T43.501S
|
Poisoning by unspecified antipsychotics and neuroleptics, accidental (unintentional), sequela
|
|
T43.502A
|
Poisoning by unspecified antipsychotics and neuroleptics, intentional self-harm, initial encounter
|
|
T43.502D
|
Poisoning by unspecified antipsychotics and neuroleptics, intentional self-harm, subsequent encounter
|
|
T43.502S
|
Poisoning by unspecified antipsychotics and neuroleptics, intentional self-harm, sequela
|
|
T43.503A
|
Poisoning by unspecified antipsychotics and neuroleptics, assault, initial encounter
|
|
T43.503D
|
Poisoning by unspecified antipsychotics and neuroleptics, assault, subsequent encounter
|
|
T43.503S
|
Poisoning by unspecified antipsychotics and neuroleptics, assault, sequela
|
|
T43.504A
|
Poisoning by unspecified antipsychotics and neuroleptics, undetermined, initial encounter
|
|
T43.504D
|
Poisoning by unspecified antipsychotics and neuroleptics, undetermined, subsequent encounter
|
|
T43.504S
|
Poisoning by unspecified antipsychotics and neuroleptics, undetermined, sequela
|
|
T43.505A
|
Adverse effect of unspecified antipsychotics and neuroleptics, initial encounter
|
|
T43.505D
|
Adverse effect of unspecified antipsychotics and neuroleptics, subsequent encounter
|
|
T43.505S
|
Adverse effect of unspecified antipsychotics and neuroleptics, sequela
|
|
T43.506A
|
Underdosing of unspecified antipsychotics and neuroleptics, initial encounter
|
|
T43.506D
|
Underdosing of unspecified antipsychotics and neuroleptics, subsequent encounter
|
|
T43.506S
|
Underdosing of unspecified antipsychotics and neuroleptics, sequela
|
|
T43.591A
|
Poisoning by other antipsychotics and neuroleptics, accidental (unintentional), initial encounter
|
|
T43.591D
|
Poisoning by other antipsychotics and neuroleptics, accidental (unintentional), subsequent encounter
|
|
T43.591S
|
Poisoning by other antipsychotics and neuroleptics, accidental (unintentional), sequela
|
|
T43.592A
|
Poisoning by other antipsychotics and neuroleptics, intentional self-harm, initial encounter
|
|
T43.592D
|
Poisoning by other antipsychotics and neuroleptics, intentional self-harm, subsequent encounter
|
|
T43.592S
|
Poisoning by other antipsychotics and neuroleptics, intentional self-harm, sequela
|
|
T43.593A
|
Poisoning by other antipsychotics and neuroleptics, assault, initial encounter
|
|
T43.593D
|
Poisoning by other antipsychotics and neuroleptics, assault, subsequent encounter
|
|
T43.593S
|
Poisoning by other antipsychotics and neuroleptics, assault, sequela
|
|
T43.594A
|
Poisoning by other antipsychotics and neuroleptics, undetermined, initial encounter
|
|
T43.594D
|
Poisoning by other antipsychotics and neuroleptics, undetermined, subsequent encounter
|
|
T43.594S
|
Poisoning by other antipsychotics and neuroleptics, undetermined, sequela
|
|
T43.595A
|
Adverse effect of other antipsychotics and neuroleptics, initial encounter
|
|
T43.595D
|
Adverse effect of other antipsychotics and neuroleptics, subsequent encounter
|
|
T43.595S
|
Adverse effect of other antipsychotics and neuroleptics, sequela
|
|
T43.596A
|
Underdosing of other antipsychotics and neuroleptics, initial encounter
|
|
T43.596D
|
Underdosing of other antipsychotics and neuroleptics, subsequent encounter
|
|
T43.596S
|
Underdosing of other antipsychotics and neuroleptics, sequela
|
|
T43.601A
|
Poisoning by unspecified psychostimulants, accidental (unintentional), initial encounter
|
|
T43.601D
|
Poisoning by unspecified psychostimulants, accidental (unintentional), subsequent encounter
|
|
T43.601S
|
Poisoning by unspecified psychostimulants, accidental (unintentional), sequela
|
|
T43.602A
|
Poisoning by unspecified psychostimulants, intentional self-harm, initial encounter
|
|
T43.602D
|
Poisoning by unspecified psychostimulants, intentional self-harm, subsequent encounter
|
|
T43.602S
|
Poisoning by unspecified psychostimulants, intentional self-harm, sequela
|
|
T43.603A
|
Poisoning by unspecified psychostimulants, assault, initial encounter
|
|
T43.603D
|
Poisoning by unspecified psychostimulants, assault, subsequent encounter
|
|
T43.603S
|
Poisoning by unspecified psychostimulants, assault, sequela
|
|
T43.604A
|
Poisoning by unspecified psychostimulants, undetermined, initial encounter
|
|
T43.604D
|
Poisoning by unspecified psychostimulants, undetermined, subsequent encounter
|
|
T43.604S
|
Poisoning by unspecified psychostimulants, undetermined, sequela
|
|
T43.605A
|
Adverse effect of unspecified psychostimulants, initial encounter
|
|
T43.605D
|
Adverse effect of unspecified psychostimulants, subsequent encounter
|
|
T43.605S
|
Adverse effect of unspecified psychostimulants, sequela
|
|
T43.606A
|
Underdosing of unspecified psychostimulants, initial encounter
|
|
T43.606D
|
Underdosing of unspecified psychostimulants, subsequent encounter
|
|
T43.606S
|
Underdosing of unspecified psychostimulants, sequela
|
|
T43.611A
|
Poisoning by caffeine, accidental (unintentional), initial encounter
|
|
T43.611D
|
Poisoning by caffeine, accidental (unintentional), subsequent encounter
|
|
T43.611S
|
Poisoning by caffeine, accidental (unintentional), sequela
|
|
T43.612A
|
Poisoning by caffeine, intentional self-harm, initial encounter
|
|
T43.612D
|
Poisoning by caffeine, intentional self-harm, subsequent encounter
|
|
T43.612S
|
Poisoning by caffeine, intentional self-harm, sequela
|
|
T43.613A
|
Poisoning by caffeine, assault, initial encounter
|
|
T43.613D
|
Poisoning by caffeine, assault, subsequent encounter
|
|
T43.613S
|
Poisoning by caffeine, assault, sequela
|
|
T43.614A
|
Poisoning by caffeine, undetermined, initial encounter
|
|
T43.614D
|
Poisoning by caffeine, undetermined, subsequent encounter
|
|
T43.614S
|
Poisoning by caffeine, undetermined, sequela
|
|
T43.615A
|
Adverse effect of caffeine, initial encounter
|
|
T43.615D
|
Adverse effect of caffeine, subsequent encounter
|
|
T43.615S
|
Adverse effect of caffeine, sequela
|
|
T43.621A
|
Poisoning by amphetamines, accidental (unintentional), initial encounter
|
|
T43.621D
|
Poisoning by amphetamines, accidental (unintentional), subsequent encounter
|
|
T43.621S
|
Poisoning by amphetamines, accidental (unintentional), sequela
|
|
T43.622A
|
Poisoning by amphetamines, intentional self-harm, initial encounter
|
|
T43.622D
|
Poisoning by amphetamines, intentional self-harm, subsequent encounter
|
|
T43.622S
|
Poisoning by amphetamines, intentional self-harm, sequela
|
|
T43.623A
|
Poisoning by amphetamines, assault, initial encounter
|
|
T43.623D
|
Poisoning by amphetamines, assault, subsequent encounter
|
|
T43.623S
|
Poisoning by amphetamines, assault, sequela
|
|
T43.624A
|
Poisoning by amphetamines, undetermined, initial encounter
|
|
T43.624D
|
Poisoning by amphetamines, undetermined, subsequent encounter
|
|
T43.624S
|
Poisoning by amphetamines, undetermined, sequela
|
|
T43.625A
|
Adverse effect of amphetamines, initial encounter
|
|
T43.625D
|
Adverse effect of amphetamines, subsequent encounter
|
|
T43.625S
|
Adverse effect of amphetamines, sequela
|
|
T43.631A
|
Poisoning by methylphenidate, accidental (unintentional), initial encounter
|
|
T43.631D
|
Poisoning by methylphenidate, accidental (unintentional), subsequent encounter
|
|
T43.631S
|
Poisoning by methylphenidate, accidental (unintentional), sequela
|
|
T43.632A
|
Poisoning by methylphenidate, intentional self-harm, initial encounter
|
|
T43.632D
|
Poisoning by methylphenidate, intentional self-harm, subsequent encounter
|
|
T43.632S
|
Poisoning by methylphenidate, intentional self-harm, sequela
|
|
T43.633A
|
Poisoning by methylphenidate, assault, initial encounter
|
|
T43.633D
|
Poisoning by methylphenidate, assault, subsequent encounter
|
|
T43.633S
|
Poisoning by methylphenidate, assault, sequela
|
|
T43.634A
|
Poisoning by methylphenidate, undetermined, initial encounter
|
|
T43.634D
|
Poisoning by methylphenidate, undetermined, subsequent encounter
|
|
T43.634S
|
Poisoning by methylphenidate, undetermined, sequela
|
|
T43.635A
|
Adverse effect of methylphenidate, initial encounter
|
|
T43.635D
|
Adverse effect of methylphenidate, subsequent encounter
|
|
T43.635S
|
Adverse effect of methylphenidate, sequela
|
|
T43.691A
|
Poisoning by other psychostimulants, accidental (unintentional), initial encounter
|
|
T43.691D
|
Poisoning by other psychostimulants, accidental (unintentional), subsequent encounter
|
|
T43.691S
|
Poisoning by other psychostimulants, accidental (unintentional), sequela
|
|
T43.692A
|
Poisoning by other psychostimulants, intentional self-harm, initial encounter
|
|
T43.692D
|
Poisoning by other psychostimulants, intentional self-harm, subsequent encounter
|
|
T43.692S
|
Poisoning by other psychostimulants, intentional self-harm, sequela
|
|
T43.693A
|
Poisoning by other psychostimulants, assault, initial encounter
|
|
T43.693D
|
Poisoning by other psychostimulants, assault, subsequent encounter
|
|
T43.693S
|
Poisoning by other psychostimulants, assault, sequela
|
|
T43.694A
|
Poisoning by other psychostimulants, undetermined, initial encounter
|
|
T43.694D
|
Poisoning by other psychostimulants, undetermined, subsequent encounter
|
|
T43.694S
|
Poisoning by other psychostimulants, undetermined, sequela
|
|
T43.695A
|
Adverse effect of other psychostimulants, initial encounter
|
|
T43.695D
|
Adverse effect of other psychostimulants, subsequent encounter
|
|
T43.695S
|
Adverse effect of other psychostimulants, sequela
|
|
T43.696A
|
Underdosing of other psychostimulants, initial encounter
|
|
T43.696D
|
Underdosing of other psychostimulants, subsequent encounter
|
|
T43.696S
|
Underdosing of other psychostimulants, sequela
|
|
T43.8X1A
|
Poisoning by other psychotropic drugs, accidental (unintentional), initial encounter
|
|
T43.8X1D
|
Poisoning by other psychotropic drugs, accidental (unintentional), subsequent encounter
|
|
T43.8X1S
|
Poisoning by other psychotropic drugs, accidental (unintentional), sequela
|
|
T43.8X2A
|
Poisoning by other psychotropic drugs, intentional self-harm, initial encounter
|
|
T43.8X2D
|
Poisoning by other psychotropic drugs, intentional self-harm, subsequent encounter
|
|
T43.8X2S
|
Poisoning by other psychotropic drugs, intentional self-harm, sequela
|
|
T43.8X3A
|
Poisoning by other psychotropic drugs, assault, initial encounter
|
|
T43.8X3D
|
Poisoning by other psychotropic drugs, assault, subsequent encounter
|
|
T43.8X3S
|
Poisoning by other psychotropic drugs, assault, sequela
|
|
T43.8X4A
|
Poisoning by other psychotropic drugs, undetermined, initial encounter
|
|
T43.8X4D
|
Poisoning by other psychotropic drugs, undetermined, subsequent encounter
|
|
T43.8X4S
|
Poisoning by other psychotropic drugs, undetermined, sequela
|
|
T43.8X5A
|
Adverse effect of other psychotropic drugs, initial encounter
|
|
T43.8X5D
|
Adverse effect of other psychotropic drugs, subsequent encounter
|
|
T43.8X5S
|
Adverse effect of other psychotropic drugs, sequela
|
|
T43.8X6A
|
Underdosing of other psychotropic drugs, initial encounter
|
|
T43.8X6D
|
Underdosing of other psychotropic drugs, subsequent encounter
|
|
T43.8X6S
|
Underdosing of other psychotropic drugs, sequela
|
|
T43.91XA
|
Poisoning by unspecified psychotropic drug, accidental (unintentional), initial encounter
|
|
T43.91XD
|
Poisoning by unspecified psychotropic drug, accidental (unintentional), subsequent encounter
|
|
T43.91XS
|
Poisoning by unspecified psychotropic drug, accidental (unintentional), sequela
|
|
T43.92XA
|
Poisoning by unspecified psychotropic drug, intentional self-harm, initial encounter
|
|
T43.92XD
|
Poisoning by unspecified psychotropic drug, intentional self-harm, subsequent encounter
|
|
T43.92XS
|
Poisoning by unspecified psychotropic drug, intentional self-harm, sequela
|
|
T43.93XA
|
Poisoning by unspecified psychotropic drug, assault, initial encounter
|
|
T43.93XD
|
Poisoning by unspecified psychotropic drug, assault, subsequent encounter
|
|
T43.93XS
|
Poisoning by unspecified psychotropic drug, assault, sequela
|
|
T43.94XA
|
Poisoning by unspecified psychotropic drug, undetermined, initial encounter
|
|
T43.94XD
|
Poisoning by unspecified psychotropic drug, undetermined, subsequent encounter
|
|
T43.94XS
|
Poisoning by unspecified psychotropic drug, undetermined, sequela
|
|
T43.95XA
|
Adverse effect of unspecified psychotropic drug, initial encounter
|
|
T43.95XD
|
Adverse effect of unspecified psychotropic drug, subsequent encounter
|
|
T43.95XS
|
Adverse effect of unspecified psychotropic drug, sequela
|
|
T43.96XA
|
Underdosing of unspecified psychotropic drug, initial encounter
|
|
T43.96XD
|
Underdosing of unspecified psychotropic drug, subsequent encounter
|
|
T43.96XS
|
Underdosing of unspecified psychotropic drug, sequela
|
|
T44.0X1A
|
Poisoning by anticholinesterase agents, accidental (unintentional), initial encounter
|
|
T44.0X1D
|
Poisoning by anticholinesterase agents, accidental (unintentional), subsequent encounter
|
|
T44.0X1S
|
Poisoning by anticholinesterase agents, accidental (unintentional), sequela
|
|
T44.0X2A
|
Poisoning by anticholinesterase agents, intentional self-harm, initial encounter
|
|
T44.0X2D
|
Poisoning by anticholinesterase agents, intentional self-harm, subsequent encounter
|
|
T44.0X2S
|
Poisoning by anticholinesterase agents, intentional self-harm, sequela
|
|
T44.0X3A
|
Poisoning by anticholinesterase agents, assault, initial encounter
|
|
T44.0X3D
|
Poisoning by anticholinesterase agents, assault, subsequent encounter
|
|
T44.0X3S
|
Poisoning by anticholinesterase agents, assault, sequela
|
|
T44.0X4A
|
Poisoning by anticholinesterase agents, undetermined, initial encounter
|
|
T44.0X4D
|
Poisoning by anticholinesterase agents, undetermined, subsequent encounter
|
|
T44.0X4S
|
Poisoning by anticholinesterase agents, undetermined, sequela
|
|
T44.0X5A
|
Adverse effect of anticholinesterase agents, initial encounter
|
|
T44.0X5D
|
Adverse effect of anticholinesterase agents, subsequent encounter
|
|
T44.0X5S
|
Adverse effect of anticholinesterase agents, sequela
|
|
T44.0X6A
|
Underdosing of anticholinesterase agents, initial encounter
|
|
T44.0X6D
|
Underdosing of anticholinesterase agents, subsequent encounter
|
|
T44.0X6S
|
Underdosing of anticholinesterase agents, sequela
|
|
T44.1X1A
|
Poisoning by other parasympathomimetics [cholinergics], accidental (unintentional), initial encounter
|
|
T44.1X1D
|
Poisoning by other parasympathomimetics [cholinergics], accidental (unintentional), subsequent encounter
|
|
T44.1X1S
|
Poisoning by other parasympathomimetics [cholinergics], accidental (unintentional), sequela
|
|
T44.1X2A
|
Poisoning by other parasympathomimetics [cholinergics], intentional self-harm, initial encounter
|
|
T44.1X2D
|
Poisoning by other parasympathomimetics [cholinergics], intentional self-harm, subsequent encounter
|
|
T44.1X2S
|
Poisoning by other parasympathomimetics [cholinergics], intentional self-harm, sequela
|
|
T44.1X3A
|
Poisoning by other parasympathomimetics [cholinergics], assault, initial encounter
|
|
T44.1X3D
|
Poisoning by other parasympathomimetics [cholinergics], assault, subsequent encounter
|
|
T44.1X3S
|
Poisoning by other parasympathomimetics [cholinergics], assault, sequela
|
|
T44.1X4A
|
Poisoning by other parasympathomimetics [cholinergics], undetermined, initial encounter
|
|
T44.1X4D
|
Poisoning by other parasympathomimetics [cholinergics], undetermined, subsequent encounter
|
|
T44.1X4S
|
Poisoning by other parasympathomimetics [cholinergics], undetermined, sequela
|
|
T44.1X5A
|
Adverse effect of other parasympathomimetics [cholinergics], initial encounter
|
|
T44.1X5D
|
Adverse effect of other parasympathomimetics [cholinergics], subsequent encounter
|
|
T44.1X5S
|
Adverse effect of other parasympathomimetics [cholinergics], sequela
|
|
T44.1X6A
|
Underdosing of other parasympathomimetics [cholinergics], initial encounter
|
|
T44.1X6D
|
Underdosing of other parasympathomimetics [cholinergics], subsequent encounter
|
|
T44.1X6S
|
Underdosing of other parasympathomimetics [cholinergics], sequela
|
|
T44.2X1A
|
Poisoning by ganglionic blocking drugs, accidental (unintentional), initial encounter
|
|
T44.2X1D
|
Poisoning by ganglionic blocking drugs, accidental (unintentional), subsequent encounter
|
|
T44.2X1S
|
Poisoning by ganglionic blocking drugs, accidental (unintentional), sequela
|
|
T44.2X2A
|
Poisoning by ganglionic blocking drugs, intentional self-harm, initial encounter
|
|
T44.2X2D
|
Poisoning by ganglionic blocking drugs, intentional self-harm, subsequent encounter
|
|
T44.2X2S
|
Poisoning by ganglionic blocking drugs, intentional self-harm, sequela
|
|
T44.2X3A
|
Poisoning by ganglionic blocking drugs, assault, initial encounter
|
|
T44.2X3D
|
Poisoning by ganglionic blocking drugs, assault, subsequent encounter
|
|
T44.2X3S
|
Poisoning by ganglionic blocking drugs, assault, sequela
|
|
T44.2X4A
|
Poisoning by ganglionic blocking drugs, undetermined, initial encounter
|
|
T44.2X4D
|
Poisoning by ganglionic blocking drugs, undetermined, subsequent encounter
|
|
T44.2X4S
|
Poisoning by ganglionic blocking drugs, undetermined, sequela
|
|
T44.2X5A
|
Adverse effect of ganglionic blocking drugs, initial encounter
|
|
T44.2X5D
|
Adverse effect of ganglionic blocking drugs, subsequent encounter
|
|
T44.2X5S
|
Adverse effect of ganglionic blocking drugs, sequela
|
|
T44.2X6A
|
Underdosing of ganglionic blocking drugs, initial encounter
|
|
T44.2X6D
|
Underdosing of ganglionic blocking drugs, subsequent encounter
|
|
T44.2X6S
|
Underdosing of ganglionic blocking drugs, sequela
|
|
T44.3X1A
|
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), initial encounter
|
|
T44.3X1D
|
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), subsequent encounter
|
|
T44.3X1S
|
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), sequela
|
|
T44.3X2A
|
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, initial encounter
|
|
T44.3X2D
|
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, subsequent encounter
|
|
T44.3X2S
|
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, sequela
|
|
T44.3X3A
|
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, initial encounter
|
|
T44.3X3D
|
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, subsequent encounter
|
|
T44.3X3S
|
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, sequela
|
|
T44.3X4A
|
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, initial encounter
|
|
T44.3X4D
|
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, subsequent encounter
|
|
T44.3X4S
|
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, sequela
|
|
T44.3X5A
|
Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter
|
|
T44.3X5D
|
Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter
|
|
T44.3X5S
|
Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela
|
|
T44.3X6A
|
Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter
|
|
T44.3X6D
|
Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter
|
|
T44.3X6S
|
Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela
|
|
T44.4X1A
|
Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), initial encounter
|
|
T44.4X1D
|
Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), subsequent encounter
|
|
T44.4X1S
|
Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), sequela
|
|
T44.4X2A
|
Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, initial encounter
|
|
T44.4X2D
|
Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, subsequent encounter
|
|
T44.4X2S
|
Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, sequela
|
|
T44.4X3A
|
Poisoning by predominantly alpha-adrenoreceptor agonists, assault, initial encounter
|
|
T44.4X3D
|
Poisoning by predominantly alpha-adrenoreceptor agonists, assault, subsequent encounter
|
|
T44.4X3S
|
Poisoning by predominantly alpha-adrenoreceptor agonists, assault, sequela
|
|
T44.4X4A
|
Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, initial encounter
|
|
T44.4X4D
|
Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, subsequent encounter
|
|
T44.4X4S
|
Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, sequela
|
|
T44.4X5A
|
Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter
|
|
T44.4X5D
|
Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter
|
|
T44.4X5S
|
Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela
|
|
T44.4X6A
|
Underdosing of predominantly alpha-adrenoreceptor agonists, initial encounter
|
|
T44.4X6D
|
Underdosing of predominantly alpha-adrenoreceptor agonists, subsequent encounter
|
|
T44.4X6S
|
Underdosing of predominantly alpha-adrenoreceptor agonists, sequela
|
|
T44.5X1A
|
Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), initial encounter
|
|
T44.5X1D
|
Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), subsequent encounter
|
|
T44.5X1S
|
Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), sequela
|
|
T44.5X2A
|
Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, initial encounter
|
|
T44.5X2D
|
Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, subsequent encounter
|
|
T44.5X2S
|
Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, sequela
|
|
T44.5X3A
|
Poisoning by predominantly beta-adrenoreceptor agonists, assault, initial encounter
|
|
T44.5X3D
|
Poisoning by predominantly beta-adrenoreceptor agonists, assault, subsequent encounter
|
|
T44.5X3S
|
Poisoning by predominantly beta-adrenoreceptor agonists, assault, sequela
|
|
T44.5X4A
|
Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, initial encounter
|
|
T44.5X4D
|
Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, subsequent encounter
|
|
T44.5X4S
|
Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, sequela
|
|
T44.5X5A
|
Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter
|
|
T44.5X5D
|
Adverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter
|
|
T44.5X5S
|
Adverse effect of predominantly beta-adrenoreceptor agonists, sequela
|
|
T44.6X1A
|
Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), initial encounter
|
|
T44.6X1D
|
Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), subsequent encounter
|
|
T44.6X1S
|
Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), sequela
|
|
T44.6X2A
|
Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, initial encounter
|
|
T44.6X2D
|
Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, subsequent encounter
|
|
T44.6X2S
|
Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, sequela
|
|
T44.6X3A
|
Poisoning by alpha-adrenoreceptor antagonists, assault, initial encounter
|
|
T44.6X3D
|
Poisoning by alpha-adrenoreceptor antagonists, assault, subsequent encounter
|
|
T44.6X3S
|
Poisoning by alpha-adrenoreceptor antagonists, assault, sequela
|
|
T44.6X4A
|
Poisoning by alpha-adrenoreceptor antagonists, undetermined, initial encounter
|
|
T44.6X4D
|
Poisoning by alpha-adrenoreceptor antagonists, undetermined, subsequent encounter
|
|
T44.6X4S
|
Poisoning by alpha-adrenoreceptor antagonists, undetermined, sequela
|
|
T44.6X5A
|
Adverse effect of alpha-adrenoreceptor antagonists, initial encounter
|
|
T44.6X5D
|
Adverse effect of alpha-adrenoreceptor antagonists, subsequent encounter
|
|
T44.6X5S
|
Adverse effect of alpha-adrenoreceptor antagonists, sequela
|
|
T44.6X6A
|
Underdosing of alpha-adrenoreceptor antagonists, initial encounter
|
|
T44.6X6D
|
Underdosing of alpha-adrenoreceptor antagonists, subsequent encounter
|
|
T44.6X6S
|
Underdosing of alpha-adrenoreceptor antagonists, sequela
|
|
T44.7X1A
|
Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional), initial encounter
|
|
T44.7X1D
|
Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional), subsequent encounter
|
|
T44.7X1S
|
Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional), sequela
|
|
T44.7X2A
|
Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, initial encounter
|
|
T44.7X2D
|
Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, subsequent encounter
|
|
T44.7X2S
|
Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, sequela
|
|
T44.7X3A
|
Poisoning by beta-adrenoreceptor antagonists, assault, initial encounter
|
|
T44.7X3D
|
Poisoning by beta-adrenoreceptor antagonists, assault, subsequent encounter
|
|
T44.7X3S
|
Poisoning by beta-adrenoreceptor antagonists, assault, sequela
|
|
T44.7X4A
|
Poisoning by beta-adrenoreceptor antagonists, undetermined, initial encounter
|
|
T44.7X4D
|
Poisoning by beta-adrenoreceptor antagonists, undetermined, subsequent encounter
|
|
T44.7X4S
|
Poisoning by beta-adrenoreceptor antagonists, undetermined, sequela
|
|
T44.7X5A
|
Adverse effect of beta-adrenoreceptor antagonists, initial encounter
|
|
T44.7X5D
|
Adverse effect of beta-adrenoreceptor antagonists, subsequent encounter
|
|
T44.7X5S
|
Adverse effect of beta-adrenoreceptor antagonists, sequela
|
|
T44.7X6A
|
Underdosing of beta-adrenoreceptor antagonists, initial encounter
|
|
T44.7X6D
|
Underdosing of beta-adrenoreceptor antagonists, subsequent encounter
|
|
T44.7X6S
|
Underdosing of beta-adrenoreceptor antagonists, sequela
|
|
T44.8X1A
|
Poisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional), initial encounter
|
|
T44.8X1D
|
Poisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional), subsequent encounter
|
|
T44.8X1S
|
Poisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional), sequela
|
|
T44.8X2A
|
Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, initial encounter
|
|
T44.8X2D
|
Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, subsequent encounter
|
|
T44.8X2S
|
Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, sequela
|
|
T44.8X3A
|
Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, initial encounter
|
|
T44.8X3D
|
Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, subsequent encounter
|
|
T44.8X3S
|
Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, sequela
|
|
T44.8X4A
|
Poisoning by centrally-acting and adrenergic-neuron-blocking agents, undetermined, initial encounter
|
|
T44.8X4D
|
Poisoning by centrally-acting and adrenergic-neuron-blocking agents, undetermined, subsequent encounter
|
|
T44.8X4S
|
Poisoning by centrally-acting and adrenergic-neuron-blocking agents, undetermined, sequela
|
|
T44.8X5A
|
Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter
|
|
T44.8X5D
|
Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter
|
|
T44.8X5S
|
Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, sequela
|
|
T44.8X6A
|
Underdosing of centrally-acting and adrenergic-neuron-blocking agents, initial encounter
|
|
T44.8X6D
|
Underdosing of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter
|
|
T44.8X6S
|
Underdosing of centrally-acting and adrenergic-neuron-blocking agents, sequela
|
|
T44.901A
|
Poisoning by unspecified drugs primarily affecting the autonomic nervous system, accidental (unintentional), initial encounter
|
|
T44.901D
|
Poisoning by unspecified drugs primarily affecting the autonomic nervous system, accidental (unintentional), subsequent encounter
|
|
T44.901S
|
Poisoning by unspecified drugs primarily affecting the autonomic nervous system, accidental (unintentional), sequela
|
|
T44.902A
|
Poisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm, initial encounter
|
|
T44.902D
|
Poisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm, subsequent encounter
|
|
T44.902S
|
Poisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm, sequela
|
|
T44.903A
|
Poisoning by unspecified drugs primarily affecting the autonomic nervous system, assault, initial encounter
|
|
T44.903D
|
Poisoning by unspecified drugs primarily affecting the autonomic nervous system, assault, subsequent encounter
|
|
T44.903S
|
Poisoning by unspecified drugs primarily affecting the autonomic nervous system, assault, sequela
|
|
T44.904A
|
Poisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined, initial encounter
|
|
T44.904D
|
Poisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined, subsequent encounter
|
|
T44.904S
|
Poisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined, sequela
|
|
T44.905A
|
Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, initial encounter
|
|
T44.905D
|
Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter
|
|
T44.905S
|
Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, sequela
|
|
T44.906A
|
Underdosing of unspecified drugs primarily affecting the autonomic nervous system, initial encounter
|
|
T44.906D
|
Underdosing of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter
|
|
T44.906S
|
Underdosing of unspecified drugs primarily affecting the autonomic nervous system, sequela
|
|
T44.991A
|
Poisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional), initial encounter
|
|
T44.991D
|
Poisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional), subsequent encounter
|
|
T44.991S
|
Poisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional), sequela
|
|
T44.992A
|
Poisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm, initial encounter
|
|
T44.992D
|
Poisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm, subsequent encounter
|
|
T44.992S
|
Poisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm, sequela
|
|
T44.993A
|
Poisoning by other drug primarily affecting the autonomic nervous system, assault, initial encounter
|
|
T44.993D
|
Poisoning by other drug primarily affecting the autonomic nervous system, assault, subsequent encounter
|
|
T44.993S
|
Poisoning by other drug primarily affecting the autonomic nervous system, assault, sequela
|
|
T44.994A
|
Poisoning by other drug primarily affecting the autonomic nervous system, undetermined, initial encounter
|
|
T44.994D
|
Poisoning by other drug primarily affecting the autonomic nervous system, undetermined, subsequent encounter
|
|
T44.994S
|
Poisoning by other drug primarily affecting the autonomic nervous system, undetermined, sequela
|
|
T44.995A
|
Adverse effect of other drug primarily affecting the autonomic nervous system, initial encounter
|
|
T44.995D
|
Adverse effect of other drug primarily affecting the autonomic nervous system, subsequent encounter
|
|
T44.995S
|
Adverse effect of other drug primarily affecting the autonomic nervous system, sequela
|
|
T44.996A
|
Underdosing of other drug primarily affecting the autonomic nervous system, initial encounter
|
|
T44.996D
|
Underdosing of other drug primarily affecting the autonomic nervous system, subsequent encounter
|
|
T44.996S
|
Underdosing of other drug primarily affecting the autonomic nervous system, sequela
|
|
T45.0X1A
|
Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), initial encounter
|
|
T45.0X1D
|
Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), subsequent encounter
|
|
T45.0X1S
|
Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), sequela
|
|
T45.0X2A
|
Poisoning by antiallergic and antiemetic drugs, intentional self-harm, initial encounter
|
|
T45.0X2D
|
Poisoning by antiallergic and antiemetic drugs, intentional self-harm, subsequent encounter
|
|
T45.0X2S
|
Poisoning by antiallergic and antiemetic drugs, intentional self-harm, sequela
|
|
T45.0X3A
|
Poisoning by antiallergic and antiemetic drugs, assault, initial encounter
|
|
T45.0X3D
|
Poisoning by antiallergic and antiemetic drugs, assault, subsequent encounter
|
|
T45.0X3S
|
Poisoning by antiallergic and antiemetic drugs, assault, sequela
|
|
T45.0X4A
|
Poisoning by antiallergic and antiemetic drugs, undetermined, initial encounter
|
|
T45.0X4D
|
Poisoning by antiallergic and antiemetic drugs, undetermined, subsequent encounter
|
|
T45.0X4S
|
Poisoning by antiallergic and antiemetic drugs, undetermined, sequela
|
|
T45.0X5A
|
Adverse effect of antiallergic and antiemetic drugs, initial encounter
|
|
T45.0X5D
|
Adverse effect of antiallergic and antiemetic drugs, subsequent encounter
|
|
T45.0X5S
|
Adverse effect of antiallergic and antiemetic drugs, sequela
|
|
T45.1X1A
|
Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial encounter
|
|
T45.1X1D
|
Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), subsequent encounter
|
|
T45.1X1S
|
Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), sequela
|
|
T45.1X2A
|
Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, initial encounter
|
|
T45.1X2D
|
Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, subsequent encounter
|
|
T45.1X2S
|
Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, sequela
|
|
T45.1X3A
|
Poisoning by antineoplastic and immunosuppressive drugs, assault, initial encounter
|
|
T45.1X3D
|
Poisoning by antineoplastic and immunosuppressive drugs, assault, subsequent encounter
|
|
T45.1X3S
|
Poisoning by antineoplastic and immunosuppressive drugs, assault, sequela
|
|
T45.1X4A
|
Poisoning by antineoplastic and immunosuppressive drugs, undetermined, initial encounter
|
|
T45.1X4D
|
Poisoning by antineoplastic and immunosuppressive drugs, undetermined, subsequent encounter
|
|
T45.1X4S
|
Poisoning by antineoplastic and immunosuppressive drugs, undetermined, sequela
|
|
T45.1X5A
|
Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
|
|
T45.1X5D
|
Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter
|
|
T45.1X5S
|
Adverse effect of antineoplastic and immunosuppressive drugs, sequela
|
|
T45.1X6A
|
Underdosing of antineoplastic and immunosuppressive drugs, initial encounter
|
|
T45.1X6D
|
Underdosing of antineoplastic and immunosuppressive drugs, subsequent encounter
|
|
T45.1X6S
|
Underdosing of antineoplastic and immunosuppressive drugs, sequela
|
|
T45.2X1A
|
Poisoning by vitamins, accidental (unintentional), initial encounter
|
|
T45.2X1D
|
Poisoning by vitamins, accidental (unintentional), subsequent encounter
|
|
T45.2X1S
|
Poisoning by vitamins, accidental (unintentional), sequela
|
|
T45.2X2A
|
Poisoning by vitamins, intentional self-harm, initial encounter
|
|
T45.2X2D
|
Poisoning by vitamins, intentional self-harm, subsequent encounter
|
|
T45.2X2S
|
Poisoning by vitamins, intentional self-harm, sequela
|
|
T45.2X3A
|
Poisoning by vitamins, assault, initial encounter
|
|
T45.2X3D
|
Poisoning by vitamins, assault, subsequent encounter
|
|
T45.2X3S
|
Poisoning by vitamins, assault, sequela
|
|
T45.2X4A
|
Poisoning by vitamins, undetermined, initial encounter
|
|
T45.2X4D
|
Poisoning by vitamins, undetermined, subsequent encounter
|
|
T45.2X4S
|
Poisoning by vitamins, undetermined, sequela
|
|
T45.2X5A
|
Adverse effect of vitamins, initial encounter
|
|
T45.2X5D
|
Adverse effect of vitamins, subsequent encounter
|
|
T45.2X5S
|
Adverse effect of vitamins, sequela
|
|
T45.3X1A
|
Poisoning by enzymes, accidental (unintentional), initial encounter
|
|
T45.3X1D
|
Poisoning by enzymes, accidental (unintentional), subsequent encounter
|
|
T45.3X1S
|
Poisoning by enzymes, accidental (unintentional), sequela
|
|
T45.3X2A
|
Poisoning by enzymes, intentional self-harm, initial encounter
|
|
T45.3X2D
|
Poisoning by enzymes, intentional self-harm, subsequent encounter
|
|
T45.3X2S
|
Poisoning by enzymes, intentional self-harm, sequela
|
|
T45.3X3A
|
Poisoning by enzymes, assault, initial encounter
|
|
T45.3X3D
|
Poisoning by enzymes, assault, subsequent encounter
|
|
T45.3X3S
|
Poisoning by enzymes, assault, sequela
|
|
T45.3X4A
|
Poisoning by enzymes, undetermined, initial encounter
|
|
T45.3X4D
|
Poisoning by enzymes, undetermined, subsequent encounter
|
|
T45.3X4S
|
Poisoning by enzymes, undetermined, sequela
|
|
T45.3X5A
|
Adverse effect of enzymes, initial encounter
|
|
T45.3X5D
|
Adverse effect of enzymes, subsequent encounter
|
|
T45.3X5S
|
Adverse effect of enzymes, sequela
|
|
T45.3X6A
|
Underdosing of enzymes, initial encounter
|
|
T45.3X6D
|
Underdosing of enzymes, subsequent encounter
|
|
T45.3X6S
|
Underdosing of enzymes, sequela
|
|
T45.4X1A
|
Poisoning by iron and its compounds, accidental (unintentional), initial encounter
|
|
T45.4X1D
|
Poisoning by iron and its compounds, accidental (unintentional), subsequent encounter
|
|
T45.4X1S
|
Poisoning by iron and its compounds, accidental (unintentional), sequela
|
|
T45.4X2A
|
Poisoning by iron and its compounds, intentional self-harm, initial encounter
|
|
T45.4X2D
|
Poisoning by iron and its compounds, intentional self-harm, subsequent encounter
|
|
T45.4X2S
|
Poisoning by iron and its compounds, intentional self-harm, sequela
|
|
T45.4X3A
|
Poisoning by iron and its compounds, assault, initial encounter
|
|
T45.4X3D
|
Poisoning by iron and its compounds, assault, subsequent encounter
|
|
T45.4X3S
|
Poisoning by iron and its compounds, assault, sequela
|
|
T45.4X4A
|
Poisoning by iron and its compounds, undetermined, initial encounter
|
|
T45.4X4D
|
Poisoning by iron and its compounds, undetermined, subsequent encounter
|
|
T45.4X4S
|
Poisoning by iron and its compounds, undetermined, sequela
|
|
T45.4X5A
|
Adverse effect of iron and its compounds, initial encounter
|
|
T45.4X5D
|
Adverse effect of iron and its compounds, subsequent encounter
|
|
T45.4X5S
|
Adverse effect of iron and its compounds, sequela
|
|
T45.511A
|
Poisoning by anticoagulants, accidental (unintentional), initial encounter
|
|
T45.511D
|
Poisoning by anticoagulants, accidental (unintentional), subsequent encounter
|
|
T45.511S
|
Poisoning by anticoagulants, accidental (unintentional), sequela
|
|
T45.512A
|
Poisoning by anticoagulants, intentional self-harm, initial encounter
|
|
T45.512D
|
Poisoning by anticoagulants, intentional self-harm, subsequent encounter
|
|
T45.512S
|
Poisoning by anticoagulants, intentional self-harm, sequela
|
|
T45.513A
|
Poisoning by anticoagulants, assault, initial encounter
|
|
T45.513D
|
Poisoning by anticoagulants, assault, subsequent encounter
|
|
T45.513S
|
Poisoning by anticoagulants, assault, sequela
|
|
T45.514A
|
Poisoning by anticoagulants, undetermined, initial encounter
|
|
T45.514D
|
Poisoning by anticoagulants, undetermined, subsequent encounter
|
|
T45.514S
|
Poisoning by anticoagulants, undetermined, sequela
|
|
T45.515A
|
Adverse effect of anticoagulants, initial encounter
|
|
T45.515D
|
Adverse effect of anticoagulants, subsequent encounter
|
|
T45.515S
|
Adverse effect of anticoagulants, sequela
|
|
T45.516A
|
Underdosing of anticoagulants, initial encounter
|
|
T45.516D
|
Underdosing of anticoagulants, subsequent encounter
|
|
T45.516S
|
Underdosing of anticoagulants, sequela
|
|
T45.521A
|
Poisoning by antithrombotic drugs, accidental (unintentional), initial encounter
|
|
T45.521D
|
Poisoning by antithrombotic drugs, accidental (unintentional), subsequent encounter
|
|
T45.521S
|
Poisoning by antithrombotic drugs, accidental (unintentional), sequela
|
|
T45.522A
|
Poisoning by antithrombotic drugs, intentional self-harm, initial encounter
|
|
T45.522D
|
Poisoning by antithrombotic drugs, intentional self-harm, subsequent encounter
|
|
T45.522S
|
Poisoning by antithrombotic drugs, intentional self-harm, sequela
|
|
T45.523A
|
Poisoning by antithrombotic drugs, assault, initial encounter
|
|
T45.523D
|
Poisoning by antithrombotic drugs, assault, subsequent encounter
|
|
T45.523S
|
Poisoning by antithrombotic drugs, assault, sequela
|
|
T45.524A
|
Poisoning by antithrombotic drugs, undetermined, initial encounter
|
|
T45.524D
|
Poisoning by antithrombotic drugs, undetermined, subsequent encounter
|
|
T45.524S
|
Poisoning by antithrombotic drugs, undetermined, sequela
|
|
T45.525A
|
Adverse effect of antithrombotic drugs, initial encounter
|
|
T45.525D
|
Adverse effect of antithrombotic drugs, subsequent encounter
|
|
T45.525S
|
Adverse effect of antithrombotic drugs, sequela
|
|
T45.526A
|
Underdosing of antithrombotic drugs, initial encounter
|
|
T45.526D
|
Underdosing of antithrombotic drugs, subsequent encounter
|
|
T45.526S
|
Underdosing of antithrombotic drugs, sequela
|
|
T45.601A
|
Poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), initial encounter
|
|
T45.601D
|
Poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), subsequent encounter
|
|
T45.601S
|
Poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), sequela
|
|
T45.602A
|
Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, initial encounter
|
|
T45.602D
|
Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, subsequent encounter
|
|
T45.602S
|
Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, sequela
|
|
T45.603A
|
Poisoning by unspecified fibrinolysis-affecting drugs, assault, initial encounter
|
|
T45.603D
|
Poisoning by unspecified fibrinolysis-affecting drugs, assault, subsequent encounter
|
|
T45.603S
|
Poisoning by unspecified fibrinolysis-affecting drugs, assault, sequela
|
|
T45.604A
|
Poisoning by unspecified fibrinolysis-affecting drugs, undetermined, initial encounter
|
|
T45.604D
|
Poisoning by unspecified fibrinolysis-affecting drugs, undetermined, subsequent encounter
|
|
T45.604S
|
Poisoning by unspecified fibrinolysis-affecting drugs, undetermined, sequela
|
|
T45.605A
|
Adverse effect of unspecified fibrinolysis-affecting drugs, initial encounter
|
|
T45.605D
|
Adverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounter
|
|
T45.605S
|
Adverse effect of unspecified fibrinolysis-affecting drugs, sequela
|
|
T45.606A
|
Underdosing of unspecified fibrinolysis-affecting drugs, initial encounter
|
|
T45.606D
|
Underdosing of unspecified fibrinolysis-affecting drugs, subsequent encounter
|
|
T45.606S
|
Underdosing of unspecified fibrinolysis-affecting drugs, sequela
|
|
T45.611A
|
Poisoning by thrombolytic drug, accidental (unintentional), initial encounter
|
|
T45.611D
|
Poisoning by thrombolytic drug, accidental (unintentional), subsequent encounter
|
|
T45.611S
|
Poisoning by thrombolytic drug, accidental (unintentional), sequela
|
|
T45.612A
|
Poisoning by thrombolytic drug, intentional self-harm, initial encounter
|
|
T45.612D
|
Poisoning by thrombolytic drug, intentional self-harm, subsequent encounter
|
|
T45.612S
|
Poisoning by thrombolytic drug, intentional self-harm, sequela
|
|
T45.613A
|
Poisoning by thrombolytic drug, assault, initial encounter
|
|
T45.613D
|
Poisoning by thrombolytic drug, assault, subsequent encounter
|
|
T45.613S
|
Poisoning by thrombolytic drug, assault, sequela
|
|
T45.614A
|
Poisoning by thrombolytic drug, undetermined, initial encounter
|
|
T45.614D
|
Poisoning by thrombolytic drug, undetermined, subsequent encounter
|
|
T45.614S
|
Poisoning by thrombolytic drug, undetermined, sequela
|
|
T45.615A
|
Adverse effect of thrombolytic drugs, initial encounter
|
|
T45.615D
|
Adverse effect of thrombolytic drugs, subsequent encounter
|
|
T45.615S
|
Adverse effect of thrombolytic drugs, sequela
|
|
T45.616A
|
Underdosing of thrombolytic drugs, initial encounter
|
|
T45.616D
|
Underdosing of thrombolytic drugs, subsequent encounter
|
|
T45.616S
|
Underdosing of thrombolytic drugs, sequela
|
|
T45.621A
|
Poisoning by hemostatic drug, accidental (unintentional), initial encounter
|
|
T45.621D
|
Poisoning by hemostatic drug, accidental (unintentional), subsequent encounter
|
|
T45.621S
|
Poisoning by hemostatic drug, accidental (unintentional), sequela
|
|
T45.622A
|
Poisoning by hemostatic drug, intentional self-harm, initial encounter
|
|
T45.622D
|
Poisoning by hemostatic drug, intentional self-harm, subsequent encounter
|
|
T45.622S
|
Poisoning by hemostatic drug, intentional self-harm, sequela
|
|
T45.623A
|
Poisoning by hemostatic drug, assault, initial encounter
|
|
T45.623D
|
Poisoning by hemostatic drug, assault, subsequent encounter
|
|
T45.623S
|
Poisoning by hemostatic drug, assault, sequela
|
|
T45.624A
|
Poisoning by hemostatic drug, undetermined, initial encounter
|
|
T45.624D
|
Poisoning by hemostatic drug, undetermined, subsequent encounter
|
|
T45.624S
|
Poisoning by hemostatic drug, undetermined, sequela
|
|
T45.625A
|
Adverse effect of hemostatic drug, initial encounter
|
|
T45.625D
|
Adverse effect of hemostatic drug, subsequent encounter
|
|
T45.625S
|
Adverse effect of hemostatic drug, sequela
|
|
T45.626A
|
Underdosing of hemostatic drugs, initial encounter
|
|
T45.626D
|
Underdosing of hemostatic drugs, subsequent encounter
|
|
T45.626S
|
Underdosing of hemostatic drugs, sequela
|
|
T45.691A
|
Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional), initial encounter
|
|
T45.691D
|
Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional), subsequent encounter
|
|
T45.691S
|
Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional), sequela
|
|
T45.692A
|
Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, initial encounter
|
|
T45.692D
|
Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, subsequent encounter
|
|
T45.692S
|
Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, sequela
|
|
T45.693A
|
Poisoning by other fibrinolysis-affecting drugs, assault, initial encounter
|
|
T45.693D
|
Poisoning by other fibrinolysis-affecting drugs, assault, subsequent encounter
|
|
T45.693S
|
Poisoning by other fibrinolysis-affecting drugs, assault, sequela
|
|
T45.694A
|
Poisoning by other fibrinolysis-affecting drugs, undetermined, initial encounter
|
|
T45.694D
|
Poisoning by other fibrinolysis-affecting drugs, undetermined, subsequent encounter
|
|
T45.694S
|
Poisoning by other fibrinolysis-affecting drugs, undetermined, sequela
|
|
T45.695A
|
Adverse effect of other fibrinolysis-affecting drugs, initial encounter
|
|
T45.695D
|
Adverse effect of other fibrinolysis-affecting drugs, subsequent encounter
|
|
T45.695S
|
Adverse effect of other fibrinolysis-affecting drugs, sequela
|
|
T45.696A
|
Underdosing of other fibrinolysis-affecting drugs, initial encounter
|
|
T45.696D
|
Underdosing of other fibrinolysis-affecting drugs, subsequent encounter
|
|
T45.696S
|
Underdosing of other fibrinolysis-affecting drugs, sequela
|
|
T45.7X1A
|
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), initial encounter
|
|
T45.7X1D
|
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), subsequent encounter
|
|
T45.7X1S
|
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), sequela
|
|
T45.7X2A
|
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, initial encounter
|
|
T45.7X2D
|
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, subsequent encounter
|
|
T45.7X2S
|
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, sequela
|
|
T45.7X3A
|
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, initial encounter
|
|
T45.7X3D
|
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, subsequent encounter
|
|
T45.7X3S
|
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, sequela
|
|
T45.7X4A
|
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, initial encounter
|
|
T45.7X4D
|
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, subsequent encounter
|
|
T45.7X4S
|
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, sequela
|
|
T45.7X5A
|
Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter
|
|
T45.7X5D
|
Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter
|
|
T45.7X5S
|
Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela
|
|
T45.7X6A
|
Underdosing of anticoagulant antagonist, vitamin K and other coagulants, initial encounter
|
|
T45.7X6D
|
Underdosing of anticoagulant antagonist, vitamin K and other coagulants, subsequent encounter
|
|
T45.7X6S
|
Underdosing of anticoagulant antagonist, vitamin K and other coagulants, sequela
|
|
T45.8X1A
|
Poisoning by other primarily systemic and hematological agents, accidental (unintentional), initial encounter
|
|
T45.8X1D
|
Poisoning by other primarily systemic and hematological agents, accidental (unintentional), subsequent encounter
|
|
T45.8X1S
|
Poisoning by other primarily systemic and hematological agents, accidental (unintentional), sequela
|
|
T45.8X2A
|
Poisoning by other primarily systemic and hematological agents, intentional self-harm, initial encounter
|
|
T45.8X2D
|
Poisoning by other primarily systemic and hematological agents, intentional self-harm, subsequent encounter
|
|
T45.8X2S
|
Poisoning by other primarily systemic and hematological agents, intentional self-harm, sequela
|
|
T45.8X3A
|
Poisoning by other primarily systemic and hematological agents, assault, initial encounter
|
|
T45.8X3D
|
Poisoning by other primarily systemic and hematological agents, assault, subsequent encounter
|
|
T45.8X3S
|
Poisoning by other primarily systemic and hematological agents, assault, sequela
|
|
T45.8X4A
|
Poisoning by other primarily systemic and hematological agents, undetermined, initial encounter
|
|
T45.8X4D
|
Poisoning by other primarily systemic and hematological agents, undetermined, subsequent encounter
|
|
T45.8X4S
|
Poisoning by other primarily systemic and hematological agents, undetermined, sequela
|
|
T45.8X5A
|
Adverse effect of other primarily systemic and hematological agents, initial encounter
|
|
T45.8X5D
|
Adverse effect of other primarily systemic and hematological agents, subsequent encounter
|
|
T45.8X5S
|
Adverse effect of other primarily systemic and hematological agents, sequela
|
|
T45.8X6A
|
Underdosing of other primarily systemic and hematological agents, initial encounter
|
|
T45.8X6D
|
Underdosing of other primarily systemic and hematological agents, subsequent encounter
|
|
T45.8X6S
|
Underdosing of other primarily systemic and hematological agents, sequela
|
|
T45.91XA
|
Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), initial encounter
|
|
T45.91XD
|
Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), subsequent encounter
|
|
T45.91XS
|
Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), sequela
|
|
T45.92XA
|
Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, initial encounter
|
|
T45.92XD
|
Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, subsequent encounter
|
|
T45.92XS
|
Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, sequela
|
|
T45.93XA
|
Poisoning by unspecified primarily systemic and hematological agent, assault, initial encounter
|
|
T45.93XD
|
Poisoning by unspecified primarily systemic and hematological agent, assault, subsequent encounter
|
|
T45.93XS
|
Poisoning by unspecified primarily systemic and hematological agent, assault, sequela
|
|
T45.94XA
|
Poisoning by unspecified primarily systemic and hematological agent, undetermined, initial encounter
|
|
T45.94XD
|
Poisoning by unspecified primarily systemic and hematological agent, undetermined, subsequent encounter
|
|
T45.94XS
|
Poisoning by unspecified primarily systemic and hematological agent, undetermined, sequela
|
|
T45.95XA
|
Adverse effect of unspecified primarily systemic and hematological agent, initial encounter
|
|
T45.95XD
|
Adverse effect of unspecified primarily systemic and hematological agent, subsequent encounter
|
|
T45.95XS
|
Adverse effect of unspecified primarily systemic and hematological agent, sequela
|
|
T45.96XA
|
Underdosing of unspecified primarily systemic and hematological agent, initial encounter
|
|
T45.96XD
|
Underdosing of unspecified primarily systemic and hematological agent, subsequent encounter
|
|
T45.96XS
|
Underdosing of unspecified primarily systemic and hematological agent, sequela
|
|
T46.0X1A
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter
|
|
T46.0X1D
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), subsequent encounter
|
|
T46.0X1S
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), sequela
|
|
T46.0X2A
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter
|
|
T46.0X2D
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, subsequent encounter
|
|
T46.0X2S
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, sequela
|
|
T46.0X3A
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter
|
|
T46.0X3D
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, subsequent encounter
|
|
T46.0X3S
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, sequela
|
|
T46.0X4A
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, initial encounter
|
|
T46.0X4D
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, subsequent encounter
|
|
T46.0X4S
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, sequela
|
|
T46.0X5A
|
Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
|
|
T46.0X5D
|
Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
|
|
T46.0X5S
|
Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela
|
|
T46.0X6A
|
Underdosing of cardiac-stimulant glycosides and drugs of similar action, initial encounter
|
|
T46.0X6D
|
Underdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
|
|
T46.0X6S
|
Underdosing of cardiac-stimulant glycosides and drugs of similar action, sequela
|
|
T46.1X1A
|
Poisoning by calcium-channel blockers, accidental (unintentional), initial encounter
|
|
T46.1X1D
|
Poisoning by calcium-channel blockers, accidental (unintentional), subsequent encounter
|
|
T46.1X1S
|
Poisoning by calcium-channel blockers, accidental (unintentional), sequela
|
|
T46.1X2A
|
Poisoning by calcium-channel blockers, intentional self-harm, initial encounter
|
|
T46.1X2D
|
Poisoning by calcium-channel blockers, intentional self-harm, subsequent encounter
|
|
T46.1X2S
|
Poisoning by calcium-channel blockers, intentional self-harm, sequela
|
|
T46.1X3A
|
Poisoning by calcium-channel blockers, assault, initial encounter
|
|
T46.1X3D
|
Poisoning by calcium-channel blockers, assault, subsequent encounter
|
|
T46.1X3S
|
Poisoning by calcium-channel blockers, assault, sequela
|
|
T46.1X4A
|
Poisoning by calcium-channel blockers, undetermined, initial encounter
|
|
T46.1X4D
|
Poisoning by calcium-channel blockers, undetermined, subsequent encounter
|
|
T46.1X4S
|
Poisoning by calcium-channel blockers, undetermined, sequela
|
|
T46.1X5A
|
Adverse effect of calcium-channel blockers, initial encounter
|
|
T46.1X5D
|
Adverse effect of calcium-channel blockers, subsequent encounter
|
|
T46.1X5S
|
Adverse effect of calcium-channel blockers, sequela
|
|
T46.1X6A
|
Underdosing of calcium-channel blockers, initial encounter
|
|
T46.1X6D
|
Underdosing of calcium-channel blockers, subsequent encounter
|
|
T46.1X6S
|
Underdosing of calcium-channel blockers, sequela
|
|
T46.2X1A
|
Poisoning by other antidysrhythmic drugs, accidental (unintentional), initial encounter
|
|
T46.2X1D
|
Poisoning by other antidysrhythmic drugs, accidental (unintentional), subsequent encounter
|
|
T46.2X1S
|
Poisoning by other antidysrhythmic drugs, accidental (unintentional), sequela
|
|
T46.2X2A
|
Poisoning by other antidysrhythmic drugs, intentional self-harm, initial encounter
|
|
T46.2X2D
|
Poisoning by other antidysrhythmic drugs, intentional self-harm, subsequent encounter
|
|
T46.2X2S
|
Poisoning by other antidysrhythmic drugs, intentional self-harm, sequela
|
|
T46.2X3A
|
Poisoning by other antidysrhythmic drugs, assault, initial encounter
|
|
T46.2X3D
|
Poisoning by other antidysrhythmic drugs, assault, subsequent encounter
|
|
T46.2X3S
|
Poisoning by other antidysrhythmic drugs, assault, sequela
|
|
T46.2X4A
|
Poisoning by other antidysrhythmic drugs, undetermined, initial encounter
|
|
T46.2X4D
|
Poisoning by other antidysrhythmic drugs, undetermined, subsequent encounter
|
|
T46.2X4S
|
Poisoning by other antidysrhythmic drugs, undetermined, sequela
|
|
T46.2X5A
|
Adverse effect of other antidysrhythmic drugs, initial encounter
|
|
T46.2X5D
|
Adverse effect of other antidysrhythmic drugs, subsequent encounter
|
|
T46.2X5S
|
Adverse effect of other antidysrhythmic drugs, sequela
|
|
T46.2X6A
|
Underdosing of other antidysrhythmic drugs, initial encounter
|
|
T46.2X6D
|
Underdosing of other antidysrhythmic drugs, subsequent encounter
|
|
T46.2X6S
|
Underdosing of other antidysrhythmic drugs, sequela
|
|
T46.3X1A
|
Poisoning by coronary vasodilators, accidental (unintentional), initial encounter
|
|
T46.3X1D
|
Poisoning by coronary vasodilators, accidental (unintentional), subsequent encounter
|
|
T46.3X1S
|
Poisoning by coronary vasodilators, accidental (unintentional), sequela
|
|
T46.3X2A
|
Poisoning by coronary vasodilators, intentional self-harm, initial encounter
|
|
T46.3X2D
|
Poisoning by coronary vasodilators, intentional self-harm, subsequent encounter
|
|
T46.3X2S
|
Poisoning by coronary vasodilators, intentional self-harm, sequela
|
|
T46.3X3A
|
Poisoning by coronary vasodilators, assault, initial encounter
|
|
T46.3X3D
|
Poisoning by coronary vasodilators, assault, subsequent encounter
|
|
T46.3X3S
|
Poisoning by coronary vasodilators, assault, sequela
|
|
T46.3X4A
|
Poisoning by coronary vasodilators, undetermined, initial encounter
|
|
T46.3X4D
|
Poisoning by coronary vasodilators, undetermined, subsequent encounter
|
|
T46.3X4S
|
Poisoning by coronary vasodilators, undetermined, sequela
|
|
T46.3X5A
|
Adverse effect of coronary vasodilators, initial encounter
|
|
T46.3X5D
|
Adverse effect of coronary vasodilators, subsequent encounter
|
|
T46.3X5S
|
Adverse effect of coronary vasodilators, sequela
|
|
T46.3X6A
|
Underdosing of coronary vasodilators, initial encounter
|
|
T46.3X6D
|
Underdosing of coronary vasodilators, subsequent encounter
|
|
T46.3X6S
|
Underdosing of coronary vasodilators, sequela
|
|
T46.4X1A
|
Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter
|
|
T46.4X1D
|
Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), subsequent encounter
|
|
T46.4X1S
|
Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), sequela
|
|
T46.4X2A
|
Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, initial encounter
|
|
T46.4X2D
|
Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, subsequent encounter
|
|
T46.4X2S
|
Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, sequela
|
|
T46.4X3A
|
Poisoning by angiotensin-converting-enzyme inhibitors, assault, initial encounter
|
|
T46.4X3D
|
Poisoning by angiotensin-converting-enzyme inhibitors, assault, subsequent encounter
|
|
T46.4X3S
|
Poisoning by angiotensin-converting-enzyme inhibitors, assault, sequela
|
|
T46.4X4A
|
Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, initial encounter
|
|
T46.4X4D
|
Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, subsequent encounter
|
|
T46.4X4S
|
Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, sequela
|
|
T46.4X5A
|
Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
|
|
T46.4X5D
|
Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter
|
|
T46.4X5S
|
Adverse effect of angiotensin-converting-enzyme inhibitors, sequela
|
|
T46.4X6A
|
Underdosing of angiotensin-converting-enzyme inhibitors, initial encounter
|
|
T46.4X6D
|
Underdosing of angiotensin-converting-enzyme inhibitors, subsequent encounter
|
|
T46.4X6S
|
Underdosing of angiotensin-converting-enzyme inhibitors, sequela
|
|
T46.5X1A
|
Poisoning by other antihypertensive drugs, accidental (unintentional), initial encounter
|
|
T46.5X1D
|
Poisoning by other antihypertensive drugs, accidental (unintentional), subsequent encounter
|
|
T46.5X1S
|
Poisoning by other antihypertensive drugs, accidental (unintentional), sequela
|
|
T46.5X2A
|
Poisoning by other antihypertensive drugs, intentional self-harm, initial encounter
|
|
T46.5X2D
|
Poisoning by other antihypertensive drugs, intentional self-harm, subsequent encounter
|
|
T46.5X2S
|
Poisoning by other antihypertensive drugs, intentional self-harm, sequela
|
|
T46.5X3A
|
Poisoning by other antihypertensive drugs, assault, initial encounter
|
|
T46.5X3D
|
Poisoning by other antihypertensive drugs, assault, subsequent encounter
|
|
T46.5X3S
|
Poisoning by other antihypertensive drugs, assault, sequela
|
|
T46.5X4A
|
Poisoning by other antihypertensive drugs, undetermined, initial encounter
|
|
T46.5X4D
|
Poisoning by other antihypertensive drugs, undetermined, subsequent encounter
|
|
T46.5X4S
|
Poisoning by other antihypertensive drugs, undetermined, sequela
|
|
T46.5X5A
|
Adverse effect of other antihypertensive drugs, initial encounter
|
|
T46.5X5D
|
Adverse effect of other antihypertensive drugs, subsequent encounter
|
|
T46.5X5S
|
Adverse effect of other antihypertensive drugs, sequela
|
|
T46.5X6A
|
Underdosing of other antihypertensive drugs, initial encounter
|
|
T46.5X6D
|
Underdosing of other antihypertensive drugs, subsequent encounter
|
|
T46.5X6S
|
Underdosing of other antihypertensive drugs, sequela
|
|
T46.6X1A
|
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), initial encounter
|
|
T46.6X1D
|
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), subsequent encounter
|
|
T46.6X1S
|
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), sequela
|
|
T46.6X2A
|
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, initial encounter
|
|
T46.6X2D
|
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, subsequent encounter
|
|
T46.6X2S
|
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, sequela
|
|
T46.6X3A
|
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, initial encounter
|
|
T46.6X3D
|
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, subsequent encounter
|
|
T46.6X3S
|
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, sequela
|
|
T46.6X4A
|
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, initial encounter
|
|
T46.6X4D
|
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, subsequent encounter
|
|
T46.6X4S
|
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, sequela
|
|
T46.6X5A
|
Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
|
|
T46.6X5D
|
Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
|
|
T46.6X5S
|
Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela
|
|
T46.6X6A
|
Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
|
|
T46.6X6D
|
Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
|
|
T46.6X6S
|
Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, sequela
|
|
T46.7X1A
|
Poisoning by peripheral vasodilators, accidental (unintentional), initial encounter
|
|
T46.7X1D
|
Poisoning by peripheral vasodilators, accidental (unintentional), subsequent encounter
|
|
T46.7X1S
|
Poisoning by peripheral vasodilators, accidental (unintentional), sequela
|
|
T46.7X2A
|
Poisoning by peripheral vasodilators, intentional self-harm, initial encounter
|
|
T46.7X2D
|
Poisoning by peripheral vasodilators, intentional self-harm, subsequent encounter
|
|
T46.7X2S
|
Poisoning by peripheral vasodilators, intentional self-harm, sequela
|
|
T46.7X3A
|
Poisoning by peripheral vasodilators, assault, initial encounter
|
|
T46.7X3D
|
Poisoning by peripheral vasodilators, assault, subsequent encounter
|
|
T46.7X3S
|
Poisoning by peripheral vasodilators, assault, sequela
|
|
T46.7X4A
|
Poisoning by peripheral vasodilators, undetermined, initial encounter
|
|
T46.7X4D
|
Poisoning by peripheral vasodilators, undetermined, subsequent encounter
|
|
T46.7X4S
|
Poisoning by peripheral vasodilators, undetermined, sequela
|
|
T46.7X5A
|
Adverse effect of peripheral vasodilators, initial encounter
|
|
T46.7X5D
|
Adverse effect of peripheral vasodilators, subsequent encounter
|
|
T46.7X5S
|
Adverse effect of peripheral vasodilators, sequela
|
|
T46.7X6A
|
Underdosing of peripheral vasodilators, initial encounter
|
|
T46.7X6D
|
Underdosing of peripheral vasodilators, subsequent encounter
|
|
T46.7X6S
|
Underdosing of peripheral vasodilators, sequela
|
|
T46.8X1A
|
Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial encounter
|
|
T46.8X1D
|
Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), subsequent encounter
|
|
T46.8X1S
|
Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), sequela
|
|
T46.8X2A
|
Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounter
|
|
T46.8X2D
|
Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, subsequent encounter
|
|
T46.8X2S
|
Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequela
|
|
T46.8X3A
|
Poisoning by antivaricose drugs, including sclerosing agents, assault, initial encounter
|
|
T46.8X3D
|
Poisoning by antivaricose drugs, including sclerosing agents, assault, subsequent encounter
|
|
T46.8X3S
|
Poisoning by antivaricose drugs, including sclerosing agents, assault, sequela
|
|
T46.8X4A
|
Poisoning by antivaricose drugs, including sclerosing agents, undetermined, initial encounter
|
|
T46.8X4D
|
Poisoning by antivaricose drugs, including sclerosing agents, undetermined, subsequent encounter
|
|
T46.8X4S
|
Poisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela
|
|
T46.8X5A
|
Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter
|
|
T46.8X5D
|
Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter
|
|
T46.8X5S
|
Adverse effect of antivaricose drugs, including sclerosing agents, sequela
|
|
T46.901A
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
|
|
T46.901D
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter
|
|
T46.901S
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), sequela
|
|
T46.902A
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
|
|
T46.902D
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter
|
|
T46.902S
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, sequela
|
|
T46.903A
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, initial encounter
|
|
T46.903D
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, subsequent encounter
|
|
T46.903S
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, sequela
|
|
T46.904A
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, initial encounter
|
|
T46.904D
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, subsequent encounter
|
|
T46.904S
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, sequela
|
|
T46.905A
|
Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter
|
|
T46.905D
|
Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
|
|
T46.905S
|
Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela
|
|
T46.906A
|
Underdosing of unspecified agents primarily affecting the cardiovascular system, initial encounter
|
|
T46.906D
|
Underdosing of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
|
|
T46.906S
|
Underdosing of unspecified agents primarily affecting the cardiovascular system, sequela
|
|
T46.991A
|
Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
|
|
T46.991D
|
Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter
|
|
T46.991S
|
Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), sequela
|
|
T46.992A
|
Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
|
|
T46.992D
|
Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter
|
|
T46.992S
|
Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, sequela
|
|
T46.993A
|
Poisoning by other agents primarily affecting the cardiovascular system, assault, initial encounter
|
|
T46.993D
|
Poisoning by other agents primarily affecting the cardiovascular system, assault, subsequent encounter
|
|
T46.993S
|
Poisoning by other agents primarily affecting the cardiovascular system, assault, sequela
|
|
T46.994A
|
Poisoning by other agents primarily affecting the cardiovascular system, undetermined, initial encounter
|
|
T46.994D
|
Poisoning by other agents primarily affecting the cardiovascular system, undetermined, subsequent encounter
|
|
T46.994S
|
Poisoning by other agents primarily affecting the cardiovascular system, undetermined, sequela
|
|
T46.995A
|
Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter
|
|
T46.995D
|
Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter
|
|
T46.995S
|
Adverse effect of other agents primarily affecting the cardiovascular system, sequela
|
|
T46.996A
|
Underdosing of other agents primarily affecting the cardiovascular system, initial encounter
|
|
T46.996D
|
Underdosing of other agents primarily affecting the cardiovascular system, subsequent encounter
|
|
T46.996S
|
Underdosing of other agents primarily affecting the cardiovascular system, sequela
|
|
T47.0X1A
|
Poisoning by histamine H2-receptor blockers, accidental (unintentional), initial encounter
|
|
T47.0X1D
|
Poisoning by histamine H2-receptor blockers, accidental (unintentional), subsequent encounter
|
|
T47.0X1S
|
Poisoning by histamine H2-receptor blockers, accidental (unintentional), sequela
|
|
T47.0X2A
|
Poisoning by histamine H2-receptor blockers, intentional self-harm, initial encounter
|
|
T47.0X2D
|
Poisoning by histamine H2-receptor blockers, intentional self-harm, subsequent encounter
|
|
T47.0X2S
|
Poisoning by histamine H2-receptor blockers, intentional self-harm, sequela
|
|
T47.0X3A
|
Poisoning by histamine H2-receptor blockers, assault, initial encounter
|
|
T47.0X3D
|
Poisoning by histamine H2-receptor blockers, assault, subsequent encounter
|
|
T47.0X3S
|
Poisoning by histamine H2-receptor blockers, assault, sequela
|
|
T47.0X4A
|
Poisoning by histamine H2-receptor blockers, undetermined, initial encounter
|
|
T47.0X4D
|
Poisoning by histamine H2-receptor blockers, undetermined, subsequent encounter
|
|
T47.0X4S
|
Poisoning by histamine H2-receptor blockers, undetermined, sequela
|
|
T47.0X5A
|
Adverse effect of histamine H2-receptor blockers, initial encounter
|
|
T47.0X5D
|
Adverse effect of histamine H2-receptor blockers, subsequent encounter
|
|
T47.0X5S
|
Adverse effect of histamine H2-receptor blockers, sequela
|
|
T47.1X1A
|
Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), initial encounter
|
|
T47.1X1D
|
Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), subsequent encounter
|
|
T47.1X1S
|
Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), sequela
|
|
T47.1X2A
|
Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, initial encounter
|
|
T47.1X2D
|
Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, subsequent encounter
|
|
T47.1X2S
|
Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, sequela
|
|
T47.1X3A
|
Poisoning by other antacids and anti-gastric-secretion drugs, assault, initial encounter
|
|
T47.1X3D
|
Poisoning by other antacids and anti-gastric-secretion drugs, assault, subsequent encounter
|
|
T47.1X3S
|
Poisoning by other antacids and anti-gastric-secretion drugs, assault, sequela
|
|
T47.1X4A
|
Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, initial encounter
|
|
T47.1X4D
|
Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, subsequent encounter
|
|
T47.1X4S
|
Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, sequela
|
|
T47.1X5A
|
Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter
|
|
T47.1X5D
|
Adverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter
|
|
T47.1X5S
|
Adverse effect of other antacids and anti-gastric-secretion drugs, sequela
|
|
T47.2X1A
|
Poisoning by stimulant laxatives, accidental (unintentional), initial encounter
|
|
T47.2X1D
|
Poisoning by stimulant laxatives, accidental (unintentional), subsequent encounter
|
|
T47.2X1S
|
Poisoning by stimulant laxatives, accidental (unintentional), sequela
|
|
T47.2X2A
|
Poisoning by stimulant laxatives, intentional self-harm, initial encounter
|
|
T47.2X2D
|
Poisoning by stimulant laxatives, intentional self-harm, subsequent encounter
|
|
T47.2X2S
|
Poisoning by stimulant laxatives, intentional self-harm, sequela
|
|
T47.2X3A
|
Poisoning by stimulant laxatives, assault, initial encounter
|
|
T47.2X3D
|
Poisoning by stimulant laxatives, assault, subsequent encounter
|
|
T47.2X3S
|
Poisoning by stimulant laxatives, assault, sequela
|
|
T47.2X4A
|
Poisoning by stimulant laxatives, undetermined, initial encounter
|
|
T47.2X4D
|
Poisoning by stimulant laxatives, undetermined, subsequent encounter
|
|
T47.2X4S
|
Poisoning by stimulant laxatives, undetermined, sequela
|
|
T47.2X5A
|
Adverse effect of stimulant laxatives, initial encounter
|
|
T47.2X5D
|
Adverse effect of stimulant laxatives, subsequent encounter
|
|
T47.2X5S
|
Adverse effect of stimulant laxatives, sequela
|
|
T47.3X1A
|
Poisoning by saline and osmotic laxatives, accidental (unintentional), initial encounter
|
|
T47.3X1D
|
Poisoning by saline and osmotic laxatives, accidental (unintentional), subsequent encounter
|
|
T47.3X1S
|
Poisoning by saline and osmotic laxatives, accidental (unintentional), sequela
|
|
T47.3X2A
|
Poisoning by saline and osmotic laxatives, intentional self-harm, initial encounter
|
|
T47.3X2D
|
Poisoning by saline and osmotic laxatives, intentional self-harm, subsequent encounter
|
|
T47.3X2S
|
Poisoning by saline and osmotic laxatives, intentional self-harm, sequela
|
|
T47.3X3A
|
Poisoning by saline and osmotic laxatives, assault, initial encounter
|
|
T47.3X3D
|
Poisoning by saline and osmotic laxatives, assault, subsequent encounter
|
|
T47.3X3S
|
Poisoning by saline and osmotic laxatives, assault, sequela
|
|
T47.3X4A
|
Poisoning by saline and osmotic laxatives, undetermined, initial encounter
|
|
T47.3X4D
|
Poisoning by saline and osmotic laxatives, undetermined, subsequent encounter
|
|
T47.3X4S
|
Poisoning by saline and osmotic laxatives, undetermined, sequela
|
|
T47.3X5A
|
Adverse effect of saline and osmotic laxatives, initial encounter
|
|
T47.3X5D
|
Adverse effect of saline and osmotic laxatives, subsequent encounter
|
|
T47.3X5S
|
Adverse effect of saline and osmotic laxatives, sequela
|
|
T47.4X1A
|
Poisoning by other laxatives, accidental (unintentional), initial encounter
|
|
T47.4X1D
|
Poisoning by other laxatives, accidental (unintentional), subsequent encounter
|
|
T47.4X1S
|
Poisoning by other laxatives, accidental (unintentional), sequela
|
|
T47.4X2A
|
Poisoning by other laxatives, intentional self-harm, initial encounter
|
|
T47.4X2D
|
Poisoning by other laxatives, intentional self-harm, subsequent encounter
|
|
T47.4X2S
|
Poisoning by other laxatives, intentional self-harm, sequela
|
|
T47.4X3A
|
Poisoning by other laxatives, assault, initial encounter
|
|
T47.4X3D
|
Poisoning by other laxatives, assault, subsequent encounter
|
|
T47.4X3S
|
Poisoning by other laxatives, assault, sequela
|
|
T47.4X4A
|
Poisoning by other laxatives, undetermined, initial encounter
|
|
T47.4X4D
|
Poisoning by other laxatives, undetermined, subsequent encounter
|
|
T47.4X4S
|
Poisoning by other laxatives, undetermined, sequela
|
|
T47.4X5A
|
Adverse effect of other laxatives, initial encounter
|
|
T47.4X5D
|
Adverse effect of other laxatives, subsequent encounter
|
|
T47.4X5S
|
Adverse effect of other laxatives, sequela
|
|
T47.5X1A
|
Poisoning by digestants, accidental (unintentional), initial encounter
|
|
T47.5X1D
|
Poisoning by digestants, accidental (unintentional), subsequent encounter
|
|
T47.5X1S
|
Poisoning by digestants, accidental (unintentional), sequela
|
|
T47.5X2A
|
Poisoning by digestants, intentional self-harm, initial encounter
|
|
T47.5X2D
|
Poisoning by digestants, intentional self-harm, subsequent encounter
|
|
T47.5X2S
|
Poisoning by digestants, intentional self-harm, sequela
|
|
T47.5X3A
|
Poisoning by digestants, assault, initial encounter
|
|
T47.5X3D
|
Poisoning by digestants, assault, subsequent encounter
|
|
T47.5X3S
|
Poisoning by digestants, assault, sequela
|
|
T47.5X4A
|
Poisoning by digestants, undetermined, initial encounter
|
|
T47.5X4D
|
Poisoning by digestants, undetermined, subsequent encounter
|
|
T47.5X4S
|
Poisoning by digestants, undetermined, sequela
|
|
T47.5X5A
|
Adverse effect of digestants, initial encounter
|
|
T47.5X5D
|
Adverse effect of digestants, subsequent encounter
|
|
T47.5X5S
|
Adverse effect of digestants, sequela
|
|
T47.6X1A
|
Poisoning by antidiarrheal drugs, accidental (unintentional), initial encounter
|
|
T47.6X1D
|
Poisoning by antidiarrheal drugs, accidental (unintentional), subsequent encounter
|
|
T47.6X1S
|
Poisoning by antidiarrheal drugs, accidental (unintentional), sequela
|
|
T47.6X2A
|
Poisoning by antidiarrheal drugs, intentional self-harm, initial encounter
|
|
T47.6X2D
|
Poisoning by antidiarrheal drugs, intentional self-harm, subsequent encounter
|
|
T47.6X2S
|
Poisoning by antidiarrheal drugs, intentional self-harm, sequela
|
|
T47.6X3A
|
Poisoning by antidiarrheal drugs, assault, initial encounter
|
|
T47.6X3D
|
Poisoning by antidiarrheal drugs, assault, subsequent encounter
|
|
T47.6X3S
|
Poisoning by antidiarrheal drugs, assault, sequela
|
|
T47.6X4A
|
Poisoning by antidiarrheal drugs, undetermined, initial encounter
|
|
T47.6X4D
|
Poisoning by antidiarrheal drugs, undetermined, subsequent encounter
|
|
T47.6X4S
|
Poisoning by antidiarrheal drugs, undetermined, sequela
|
|
T47.6X5A
|
Adverse effect of antidiarrheal drugs, initial encounter
|
|
T47.6X5D
|
Adverse effect of antidiarrheal drugs, subsequent encounter
|
|
T47.6X5S
|
Adverse effect of antidiarrheal drugs, sequela
|
|
T47.7X1A
|
Poisoning by emetics, accidental (unintentional), initial encounter
|
|
T47.7X1D
|
Poisoning by emetics, accidental (unintentional), subsequent encounter
|
|
T47.7X1S
|
Poisoning by emetics, accidental (unintentional), sequela
|
|
T47.7X2A
|
Poisoning by emetics, intentional self-harm, initial encounter
|
|
T47.7X2D
|
Poisoning by emetics, intentional self-harm, subsequent encounter
|
|
T47.7X2S
|
Poisoning by emetics, intentional self-harm, sequela
|
|
T47.7X3A
|
Poisoning by emetics, assault, initial encounter
|
|
T47.7X3D
|
Poisoning by emetics, assault, subsequent encounter
|
|
T47.7X3S
|
Poisoning by emetics, assault, sequela
|
|
T47.7X4A
|
Poisoning by emetics, undetermined, initial encounter
|
|
T47.7X4D
|
Poisoning by emetics, undetermined, subsequent encounter
|
|
T47.7X4S
|
Poisoning by emetics, undetermined, sequela
|
|
T47.7X5A
|
Adverse effect of emetics, initial encounter
|
|
T47.7X5D
|
Adverse effect of emetics, subsequent encounter
|
|
T47.7X5S
|
Adverse effect of emetics, sequela
|
|
T47.8X1A
|
Poisoning by other agents primarily affecting gastrointestinal system, accidental (unintentional), initial encounter
|
|
T47.8X1D
|
Poisoning by other agents primarily affecting gastrointestinal system, accidental (unintentional), subsequent encounter
|
|
T47.8X1S
|
Poisoning by other agents primarily affecting gastrointestinal system, accidental (unintentional), sequela
|
|
T47.8X2A
|
Poisoning by other agents primarily affecting gastrointestinal system, intentional self-harm, initial encounter
|
|
T47.8X2D
|
Poisoning by other agents primarily affecting gastrointestinal system, intentional self-harm, subsequent encounter
|
|
T47.8X2S
|
Poisoning by other agents primarily affecting gastrointestinal system, intentional self-harm, sequela
|
|
T47.8X3A
|
Poisoning by other agents primarily affecting gastrointestinal system, assault, initial encounter
|
|
T47.8X3D
|
Poisoning by other agents primarily affecting gastrointestinal system, assault, subsequent encounter
|
|
T47.8X3S
|
Poisoning by other agents primarily affecting gastrointestinal system, assault, sequela
|
|
T47.8X4A
|
Poisoning by other agents primarily affecting gastrointestinal system, undetermined, initial encounter
|
|
T47.8X4D
|
Poisoning by other agents primarily affecting gastrointestinal system, undetermined, subsequent encounter
|
|
T47.8X4S
|
Poisoning by other agents primarily affecting gastrointestinal system, undetermined, sequela
|
|
T47.8X5A
|
Adverse effect of other agents primarily affecting gastrointestinal system, initial encounter
|
|
T47.8X5D
|
Adverse effect of other agents primarily affecting gastrointestinal system, subsequent encounter
|
|
T47.8X5S
|
Adverse effect of other agents primarily affecting gastrointestinal system, sequela
|
|
T47.91XA
|
Poisoning by unspecified agents primarily affecting the gastrointestinal system, accidental (unintentional), initial encounter
|
|
T47.91XD
|
Poisoning by unspecified agents primarily affecting the gastrointestinal system, accidental (unintentional), subsequent encounter
|
|
T47.91XS
|
Poisoning by unspecified agents primarily affecting the gastrointestinal system, accidental (unintentional), sequela
|
|
T47.92XA
|
Poisoning by unspecified agents primarily affecting the gastrointestinal system, intentional self-harm, initial encounter
|
|
T47.92XD
|
Poisoning by unspecified agents primarily affecting the gastrointestinal system, intentional self-harm, subsequent encounter
|
|
T47.92XS
|
Poisoning by unspecified agents primarily affecting the gastrointestinal system, intentional self-harm, sequela
|
|
T47.93XA
|
Poisoning by unspecified agents primarily affecting the gastrointestinal system, assault, initial encounter
|
|
T47.93XD
|
Poisoning by unspecified agents primarily affecting the gastrointestinal system, assault, subsequent encounter
|
|
T47.93XS
|
Poisoning by unspecified agents primarily affecting the gastrointestinal system, assault, sequela
|
|
T47.94XA
|
Poisoning by unspecified agents primarily affecting the gastrointestinal system, undetermined, initial encounter
|
|
T47.94XD
|
Poisoning by unspecified agents primarily affecting the gastrointestinal system, undetermined, subsequent encounter
|
|
T47.94XS
|
Poisoning by unspecified agents primarily affecting the gastrointestinal system, undetermined, sequela
|
|
T47.95XA
|
Adverse effect of unspecified agents primarily affecting the gastrointestinal system, initial encounter
|
|
T47.95XD
|
Adverse effect of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter
|
|
T47.95XS
|
Adverse effect of unspecified agents primarily affecting the gastrointestinal system, sequela
|
|
T48.0X1A
|
Poisoning by oxytocic drugs, accidental (unintentional), initial encounter
|
|
T48.0X1D
|
Poisoning by oxytocic drugs, accidental (unintentional), subsequent encounter
|
|
T48.0X1S
|
Poisoning by oxytocic drugs, accidental (unintentional), sequela
|
|
T48.0X2A
|
Poisoning by oxytocic drugs, intentional self-harm, initial encounter
|
|
T48.0X2D
|
Poisoning by oxytocic drugs, intentional self-harm, subsequent encounter
|
|
T48.0X2S
|
Poisoning by oxytocic drugs, intentional self-harm, sequela
|
|
T48.0X3A
|
Poisoning by oxytocic drugs, assault, initial encounter
|
|
T48.0X3D
|
Poisoning by oxytocic drugs, assault, subsequent encounter
|
|
T48.0X3S
|
Poisoning by oxytocic drugs, assault, sequela
|
|
T48.0X4A
|
Poisoning by oxytocic drugs, undetermined, initial encounter
|
|
T48.0X4D
|
Poisoning by oxytocic drugs, undetermined, subsequent encounter
|
|
T48.0X4S
|
Poisoning by oxytocic drugs, undetermined, sequela
|
|
T48.0X5A
|
Adverse effect of oxytocic drugs, initial encounter
|
|
T48.0X5D
|
Adverse effect of oxytocic drugs, subsequent encounter
|
|
T48.0X5S
|
Adverse effect of oxytocic drugs, sequela
|
|
T48.1X1A
|
Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], accidental (unintentional), initial encounter
|
|
T48.1X1D
|
Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], accidental (unintentional), subsequent encounter
|
|
T48.1X1S
|
Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], accidental (unintentional), sequela
|
|
T48.1X2A
|
Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], intentional self-harm, initial encounter
|
|
T48.1X2D
|
Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], intentional self-harm, subsequent encounter
|
|
T48.1X2S
|
Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], intentional self-harm, sequela
|
|
T48.1X3A
|
Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], assault, initial encounter
|
|
T48.1X3D
|
Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], assault, subsequent encounter
|
|
T48.1X3S
|
Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], assault, sequela
|
|
T48.1X4A
|
Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], undetermined, initial encounter
|
|
T48.1X4D
|
Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], undetermined, subsequent encounter
|
|
T48.1X4S
|
Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], undetermined, sequela
|
|
T48.1X5A
|
Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter
|
|
T48.1X5D
|
Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter
|
|
T48.1X5S
|
Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], sequela
|
|
T48.201A
|
Poisoning by unspecified drugs acting on muscles, accidental (unintentional), initial encounter
|
|
T48.201D
|
Poisoning by unspecified drugs acting on muscles, accidental (unintentional), subsequent encounter
|
|
T48.201S
|
Poisoning by unspecified drugs acting on muscles, accidental (unintentional), sequela
|
|
T48.202A
|
Poisoning by unspecified drugs acting on muscles, intentional self-harm, initial encounter
|
|
T48.202D
|
Poisoning by unspecified drugs acting on muscles, intentional self-harm, subsequent encounter
|
|
T48.202S
|
Poisoning by unspecified drugs acting on muscles, intentional self-harm, sequela
|
|
T48.203A
|
Poisoning by unspecified drugs acting on muscles, assault, initial encounter
|
|
T48.203D
|
Poisoning by unspecified drugs acting on muscles, assault, subsequent encounter
|
|
T48.203S
|
Poisoning by unspecified drugs acting on muscles, assault, sequela
|
|
T48.204A
|
Poisoning by unspecified drugs acting on muscles, undetermined, initial encounter
|
|
T48.204D
|
Poisoning by unspecified drugs acting on muscles, undetermined, subsequent encounter
|
|
T48.204S
|
Poisoning by unspecified drugs acting on muscles, undetermined, sequela
|
|
T48.205A
|
Adverse effect of unspecified drugs acting on muscles, initial encounter
|
|
T48.205D
|
Adverse effect of unspecified drugs acting on muscles, subsequent encounter
|
|
T48.205S
|
Adverse effect of unspecified drugs acting on muscles, sequela
|
|
T48.291A
|
Poisoning by other drugs acting on muscles, accidental (unintentional), initial encounter
|
|
T48.291D
|
Poisoning by other drugs acting on muscles, accidental (unintentional), subsequent encounter
|
|
T48.291S
|
Poisoning by other drugs acting on muscles, accidental (unintentional), sequela
|
|
T48.292A
|
Poisoning by other drugs acting on muscles, intentional self-harm, initial encounter
|
|
T48.292D
|
Poisoning by other drugs acting on muscles, intentional self-harm, subsequent encounter
|
|
T48.292S
|
Poisoning by other drugs acting on muscles, intentional self-harm, sequela
|
|
T48.293A
|
Poisoning by other drugs acting on muscles, assault, initial encounter
|
|
T48.293D
|
Poisoning by other drugs acting on muscles, assault, subsequent encounter
|
|
T48.293S
|
Poisoning by other drugs acting on muscles, assault, sequela
|
|
T48.294A
|
Poisoning by other drugs acting on muscles, undetermined, initial encounter
|
|
T48.294D
|
Poisoning by other drugs acting on muscles, undetermined, subsequent encounter
|
|
T48.294S
|
Poisoning by other drugs acting on muscles, undetermined, sequela
|
|
T48.295A
|
Adverse effect of other drugs acting on muscles, initial encounter
|
|
T48.295D
|
Adverse effect of other drugs acting on muscles, subsequent encounter
|
|
T48.295S
|
Adverse effect of other drugs acting on muscles, sequela
|
|
T48.3X1A
|
Poisoning by antitussives, accidental (unintentional), initial encounter
|
|
T48.3X1D
|
Poisoning by antitussives, accidental (unintentional), subsequent encounter
|
|
T48.3X1S
|
Poisoning by antitussives, accidental (unintentional), sequela
|
|
T48.3X2A
|
Poisoning by antitussives, intentional self-harm, initial encounter
|
|
T48.3X2D
|
Poisoning by antitussives, intentional self-harm, subsequent encounter
|
|
T48.3X2S
|
Poisoning by antitussives, intentional self-harm, sequela
|
|
T48.3X3A
|
Poisoning by antitussives, assault, initial encounter
|
|
T48.3X3D
|
Poisoning by antitussives, assault, subsequent encounter
|
|
T48.3X3S
|
Poisoning by antitussives, assault, sequela
|
|
T48.3X4A
|
Poisoning by antitussives, undetermined, initial encounter
|
|
T48.3X4D
|
Poisoning by antitussives, undetermined, subsequent encounter
|
|
T48.3X4S
|
Poisoning by antitussives, undetermined, sequela
|
|
T48.3X5A
|
Adverse effect of antitussives, initial encounter
|
|
T48.3X5D
|
Adverse effect of antitussives, subsequent encounter
|
|
T48.3X5S
|
Adverse effect of antitussives, sequela
|
|
T48.4X1A
|
Poisoning by expectorants, accidental (unintentional), initial encounter
|
|
T48.4X1D
|
Poisoning by expectorants, accidental (unintentional), subsequent encounter
|
|
T48.4X1S
|
Poisoning by expectorants, accidental (unintentional), sequela
|
|
T48.4X2A
|
Poisoning by expectorants, intentional self-harm, initial encounter
|
|
T48.4X2D
|
Poisoning by expectorants, intentional self-harm, subsequent encounter
|
|
T48.4X2S
|
Poisoning by expectorants, intentional self-harm, sequela
|
|
T48.4X3A
|
Poisoning by expectorants, assault, initial encounter
|
|
T48.4X3D
|
Poisoning by expectorants, assault, subsequent encounter
|
|
T48.4X3S
|
Poisoning by expectorants, assault, sequela
|
|
T48.4X4A
|
Poisoning by expectorants, undetermined, initial encounter
|
|
T48.4X4D
|
Poisoning by expectorants, undetermined, subsequent encounter
|
|
T48.4X4S
|
Poisoning by expectorants, undetermined, sequela
|
|
T48.4X5A
|
Adverse effect of expectorants, initial encounter
|
|
T48.4X5D
|
Adverse effect of expectorants, subsequent encounter
|
|
T48.4X5S
|
Adverse effect of expectorants, sequela
|
|
T48.5X1A
|
Poisoning by other anti-common-cold drugs, accidental (unintentional), initial encounter
|
|
T48.5X1D
|
Poisoning by other anti-common-cold drugs, accidental (unintentional), subsequent encounter
|
|
T48.5X1S
|
Poisoning by other anti-common-cold drugs, accidental (unintentional), sequela
|
|
T48.5X2A
|
Poisoning by other anti-common-cold drugs, intentional self-harm, initial encounter
|
|
T48.5X2D
|
Poisoning by other anti-common-cold drugs, intentional self-harm, subsequent encounter
|
|
T48.5X2S
|
Poisoning by other anti-common-cold drugs, intentional self-harm, sequela
|
|
T48.5X3A
|
Poisoning by other anti-common-cold drugs, assault, initial encounter
|
|
T48.5X3D
|
Poisoning by other anti-common-cold drugs, assault, subsequent encounter
|
|
T48.5X3S
|
Poisoning by other anti-common-cold drugs, assault, sequela
|
|
T48.5X4A
|
Poisoning by other anti-common-cold drugs, undetermined, initial encounter
|
|
T48.5X4D
|
Poisoning by other anti-common-cold drugs, undetermined, subsequent encounter
|
|
T48.5X4S
|
Poisoning by other anti-common-cold drugs, undetermined, sequela
|
|
T48.5X5A
|
Adverse effect of other anti-common-cold drugs, initial encounter
|
|
T48.5X5D
|
Adverse effect of other anti-common-cold drugs, subsequent encounter
|
|
T48.5X5S
|
Adverse effect of other anti-common-cold drugs, sequela
|
|
T48.6X1A
|
Poisoning by antiasthmatics, accidental (unintentional), initial encounter
|
|
T48.6X1D
|
Poisoning by antiasthmatics, accidental (unintentional), subsequent encounter
|
|
T48.6X1S
|
Poisoning by antiasthmatics, accidental (unintentional), sequela
|
|
T48.6X2A
|
Poisoning by antiasthmatics, intentional self-harm, initial encounter
|
|
T48.6X2D
|
Poisoning by antiasthmatics, intentional self-harm, subsequent encounter
|
|
T48.6X2S
|
Poisoning by antiasthmatics, intentional self-harm, sequela
|
|
T48.6X3A
|
Poisoning by antiasthmatics, assault, initial encounter
|
|
T48.6X3D
|
Poisoning by antiasthmatics, assault, subsequent encounter
|
|
T48.6X3S
|
Poisoning by antiasthmatics, assault, sequela
|
|
T48.6X4A
|
Poisoning by antiasthmatics, undetermined, initial encounter
|
|
T48.6X4D
|
Poisoning by antiasthmatics, undetermined, subsequent encounter
|
|
T48.6X4S
|
Poisoning by antiasthmatics, undetermined, sequela
|
|
T48.6X5A
|
Adverse effect of antiasthmatics, initial encounter
|
|
T48.6X5D
|
Adverse effect of antiasthmatics, subsequent encounter
|
|
T48.6X5S
|
Adverse effect of antiasthmatics, sequela
|
|
T48.6X6A
|
Underdosing of antiasthmatics, initial encounter
|
|
T48.6X6D
|
Underdosing of antiasthmatics, subsequent encounter
|
|
T48.6X6S
|
Underdosing of antiasthmatics, sequela
|
|
T48.901A
|
Poisoning by unspecified agents primarily acting on the respiratory system, accidental (unintentional), initial encounter
|
|
T48.901D
|
Poisoning by unspecified agents primarily acting on the respiratory system, accidental (unintentional), subsequent encounter
|
|
T48.901S
|
Poisoning by unspecified agents primarily acting on the respiratory system, accidental (unintentional), sequela
|
|
T48.902A
|
Poisoning by unspecified agents primarily acting on the respiratory system, intentional self-harm, initial encounter
|
|
T48.902D
|
Poisoning by unspecified agents primarily acting on the respiratory system, intentional self-harm, subsequent encounter
|
|
T48.902S
|
Poisoning by unspecified agents primarily acting on the respiratory system, intentional self-harm, sequela
|
|
T48.903A
|
Poisoning by unspecified agents primarily acting on the respiratory system, assault, initial encounter
|
|
T48.903D
|
Poisoning by unspecified agents primarily acting on the respiratory system, assault, subsequent encounter
|
|
T48.903S
|
Poisoning by unspecified agents primarily acting on the respiratory system, assault, sequela
|
|
T48.904A
|
Poisoning by unspecified agents primarily acting on the respiratory system, undetermined, initial encounter
|
|
T48.904D
|
Poisoning by unspecified agents primarily acting on the respiratory system, undetermined, subsequent encounter
|
|
T48.904S
|
Poisoning by unspecified agents primarily acting on the respiratory system, undetermined, sequela
|
|
T48.905A
|
Adverse effect of unspecified agents primarily acting on the respiratory system, initial encounter
|
|
T48.905D
|
Adverse effect of unspecified agents primarily acting on the respiratory system, subsequent encounter
|
|
T48.905S
|
Adverse effect of unspecified agents primarily acting on the respiratory system, sequela
|
|
T48.906A
|
Underdosing of unspecified agents primarily acting on the respiratory system, initial encounter
|
|
T48.906D
|
Underdosing of unspecified agents primarily acting on the respiratory system, subsequent encounter
|
|
T48.906S
|
Underdosing of unspecified agents primarily acting on the respiratory system, sequela
|
|
T48.991A
|
Poisoning by other agents primarily acting on the respiratory system, accidental (unintentional), initial encounter
|
|
T48.991D
|
Poisoning by other agents primarily acting on the respiratory system, accidental (unintentional), subsequent encounter
|
|
T48.991S
|
Poisoning by other agents primarily acting on the respiratory system, accidental (unintentional), sequela
|
|
T48.992A
|
Poisoning by other agents primarily acting on the respiratory system, intentional self-harm, initial encounter
|
|
T48.992D
|
Poisoning by other agents primarily acting on the respiratory system, intentional self-harm, subsequent encounter
|
|
T48.992S
|
Poisoning by other agents primarily acting on the respiratory system, intentional self-harm, sequela
|
|
T48.993A
|
Poisoning by other agents primarily acting on the respiratory system, assault, initial encounter
|
|
T48.993D
|
Poisoning by other agents primarily acting on the respiratory system, assault, subsequent encounter
|
|
T48.993S
|
Poisoning by other agents primarily acting on the respiratory system, assault, sequela
|
|
T48.994A
|
Poisoning by other agents primarily acting on the respiratory system, undetermined, initial encounter
|
|
T48.994D
|
Poisoning by other agents primarily acting on the respiratory system, undetermined, subsequent encounter
|
|
T48.994S
|
Poisoning by other agents primarily acting on the respiratory system, undetermined, sequela
|
|
T48.995A
|
Adverse effect of other agents primarily acting on the respiratory system, initial encounter
|
|
T48.995D
|
Adverse effect of other agents primarily acting on the respiratory system, subsequent encounter
|
|
T48.995S
|
Adverse effect of other agents primarily acting on the respiratory system, sequela
|
|
T48.996A
|
Underdosing of other agents primarily acting on the respiratory system, initial encounter
|
|
T48.996D
|
Underdosing of other agents primarily acting on the respiratory system, subsequent encounter
|
|
T48.996S
|
Underdosing of other agents primarily acting on the respiratory system, sequela
|
|
T49.0X1A
|
Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, accidental (unintentional), initial encounter
|
|
T49.0X1D
|
Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, accidental (unintentional), subsequent encounter
|
|
T49.0X1S
|
Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, accidental (unintentional), sequela
|
|
T49.0X2A
|
Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, intentional self-harm, initial encounter
|
|
T49.0X2D
|
Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, intentional self-harm, subsequent encounter
|
|
T49.0X2S
|
Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, intentional self-harm, sequela
|
|
T49.0X3A
|
Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, assault, initial encounter
|
|
T49.0X3D
|
Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, assault, subsequent encounter
|
|
T49.0X3S
|
Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, assault, sequela
|
|
T49.0X4A
|
Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, undetermined, initial encounter
|
|
T49.0X4D
|
Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, undetermined, subsequent encounter
|
|
T49.0X4S
|
Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, undetermined, sequela
|
|
T49.0X5A
|
Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter
|
|
T49.0X5D
|
Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter
|
|
T49.0X5S
|
Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, sequela
|
|
T49.0X6A
|
Underdosing of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter
|
|
T49.0X6D
|
Underdosing of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter
|
|
T49.0X6S
|
Underdosing of local antifungal, anti-infective and anti-inflammatory drugs, sequela
|
|
T49.1X1A
|
Poisoning by antipruritics, accidental (unintentional), initial encounter
|
|
T49.1X1D
|
Poisoning by antipruritics, accidental (unintentional), subsequent encounter
|
|
T49.1X1S
|
Poisoning by antipruritics, accidental (unintentional), sequela
|
|
T49.1X2A
|
Poisoning by antipruritics, intentional self-harm, initial encounter
|
|
T49.1X2D
|
Poisoning by antipruritics, intentional self-harm, subsequent encounter
|
|
T49.1X2S
|
Poisoning by antipruritics, intentional self-harm, sequela
|
|
T49.1X3A
|
Poisoning by antipruritics, assault, initial encounter
|
|
T49.1X3D
|
Poisoning by antipruritics, assault, subsequent encounter
|
|
T49.1X3S
|
Poisoning by antipruritics, assault, sequela
|
|
T49.1X4A
|
Poisoning by antipruritics, undetermined, initial encounter
|
|
T49.1X4D
|
Poisoning by antipruritics, undetermined, subsequent encounter
|
|
T49.1X4S
|
Poisoning by antipruritics, undetermined, sequela
|
|
T49.1X5A
|
Adverse effect of antipruritics, initial encounter
|
|
T49.1X5D
|
Adverse effect of antipruritics, subsequent encounter
|
|
T49.1X5S
|
Adverse effect of antipruritics, sequela
|
|
T49.2X1A
|
Poisoning by local astringents and local detergents, accidental (unintentional), initial encounter
|
|
T49.2X1D
|
Poisoning by local astringents and local detergents, accidental (unintentional), subsequent encounter
|
|
T49.2X1S
|
Poisoning by local astringents and local detergents, accidental (unintentional), sequela
|
|
T49.2X2A
|
Poisoning by local astringents and local detergents, intentional self-harm, initial encounter
|
|
T49.2X2D
|
Poisoning by local astringents and local detergents, intentional self-harm, subsequent encounter
|
|
T49.2X2S
|
Poisoning by local astringents and local detergents, intentional self-harm, sequela
|
|
T49.2X3A
|
Poisoning by local astringents and local detergents, assault, initial encounter
|
|
T49.2X3D
|
Poisoning by local astringents and local detergents, assault, subsequent encounter
|
|
T49.2X3S
|
Poisoning by local astringents and local detergents, assault, sequela
|
|
T49.2X4A
|
Poisoning by local astringents and local detergents, undetermined, initial encounter
|
|
T49.2X4D
|
Poisoning by local astringents and local detergents, undetermined, subsequent encounter
|
|
T49.2X4S
|
Poisoning by local astringents and local detergents, undetermined, sequela
|
|
T49.2X5A
|
Adverse effect of local astringents and local detergents, initial encounter
|
|
T49.2X5D
|
Adverse effect of local astringents and local detergents, subsequent encounter
|
|
T49.2X5S
|
Adverse effect of local astringents and local detergents, sequela
|
|
T49.3X1A
|
Poisoning by emollients, demulcents and protectants, accidental (unintentional), initial encounter
|
|
T49.3X1D
|
Poisoning by emollients, demulcents and protectants, accidental (unintentional), subsequent encounter
|
|
T49.3X1S
|
Poisoning by emollients, demulcents and protectants, accidental (unintentional), sequela
|
|
T49.3X2A
|
Poisoning by emollients, demulcents and protectants, intentional self-harm, initial encounter
|
|
T49.3X2D
|
Poisoning by emollients, demulcents and protectants, intentional self-harm, subsequent encounter
|
|
T49.3X2S
|
Poisoning by emollients, demulcents and protectants, intentional self-harm, sequela
|
|
T49.3X3A
|
Poisoning by emollients, demulcents and protectants, assault, initial encounter
|
|
T49.3X3D
|
Poisoning by emollients, demulcents and protectants, assault, subsequent encounter
|
|
T49.3X3S
|
Poisoning by emollients, demulcents and protectants, assault, sequela
|
|
T49.3X4A
|
Poisoning by emollients, demulcents and protectants, undetermined, initial encounter
|
|
T49.3X4D
|
Poisoning by emollients, demulcents and protectants, undetermined, subsequent encounter
|
|
T49.3X4S
|
Poisoning by emollients, demulcents and protectants, undetermined, sequela
|
|
T49.3X5A
|
Adverse effect of emollients, demulcents and protectants, initial encounter
|
|
T49.3X5D
|
Adverse effect of emollients, demulcents and protectants, subsequent encounter
|
|
T49.3X5S
|
Adverse effect of emollients, demulcents and protectants, sequela
|
|
T49.3X6A
|
Underdosing of emollients, demulcents and protectants, initial encounter
|
|
T49.3X6D
|
Underdosing of emollients, demulcents and protectants, subsequent encounter
|
|
T49.3X6S
|
Underdosing of emollients, demulcents and protectants, sequela
|
|
T49.4X1A
|
Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, accidental (unintentional), initial encounter
|
|
T49.4X1D
|
Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, accidental (unintentional), subsequent encounter
|
|
T49.4X1S
|
Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, accidental (unintentional), sequela
|
|
T49.4X2A
|
Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, intentional self-harm, initial encounter
|
|
T49.4X2D
|
Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, intentional self-harm, subsequent encounter
|
|
T49.4X2S
|
Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, intentional self-harm, sequela
|
|
T49.4X3A
|
Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, assault, initial encounter
|
|
T49.4X3D
|
Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, assault, subsequent encounter
|
|
T49.4X3S
|
Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, assault, sequela
|
|
T49.4X4A
|
Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, undetermined, initial encounter
|
|
T49.4X4D
|
Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, undetermined, subsequent encounter
|
|
T49.4X4S
|
Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, undetermined, sequela
|
|
T49.4X5A
|
Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter
|
|
T49.4X5D
|
Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter
|
|
T49.4X5S
|
Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela
|
|
T49.5X1A
|
Poisoning by ophthalmological drugs and preparations, accidental (unintentional), initial encounter
|
|
T49.5X1D
|
Poisoning by ophthalmological drugs and preparations, accidental (unintentional), subsequent encounter
|
|
T49.5X1S
|
Poisoning by ophthalmological drugs and preparations, accidental (unintentional), sequela
|
|
T49.5X2A
|
Poisoning by ophthalmological drugs and preparations, intentional self-harm, initial encounter
|
|
T49.5X2D
|
Poisoning by ophthalmological drugs and preparations, intentional self-harm, subsequent encounter
|
|
T49.5X2S
|
Poisoning by ophthalmological drugs and preparations, intentional self-harm, sequela
|
|
T49.5X3A
|
Poisoning by ophthalmological drugs and preparations, assault, initial encounter
|
|
T49.5X3D
|
Poisoning by ophthalmological drugs and preparations, assault, subsequent encounter
|
|
T49.5X3S
|
Poisoning by ophthalmological drugs and preparations, assault, sequela
|
|
T49.5X4A
|
Poisoning by ophthalmological drugs and preparations, undetermined, initial encounter
|
|
T49.5X4D
|
Poisoning by ophthalmological drugs and preparations, undetermined, subsequent encounter
|
|
T49.5X4S
|
Poisoning by ophthalmological drugs and preparations, undetermined, sequela
|
|
T49.5X5A
|
Adverse effect of ophthalmological drugs and preparations, initial encounter
|
|
T49.5X5D
|
Adverse effect of ophthalmological drugs and preparations, subsequent encounter
|
|
T49.5X5S
|
Adverse effect of ophthalmological drugs and preparations, sequela
|
|
T49.6X1A
|
Poisoning by otorhinolaryngological drugs and preparations, accidental (unintentional), initial encounter
|
|
T49.6X1D
|
Poisoning by otorhinolaryngological drugs and preparations, accidental (unintentional), subsequent encounter
|
|
T49.6X1S
|
Poisoning by otorhinolaryngological drugs and preparations, accidental (unintentional), sequela
|
|
T49.6X2A
|
Poisoning by otorhinolaryngological drugs and preparations, intentional self-harm, initial encounter
|
|
T49.6X2D
|
Poisoning by otorhinolaryngological drugs and preparations, intentional self-harm, subsequent encounter
|
|
T49.6X2S
|
Poisoning by otorhinolaryngological drugs and preparations, intentional self-harm, sequela
|
|
T49.6X3A
|
Poisoning by otorhinolaryngological drugs and preparations, assault, initial encounter
|
|
T49.6X3D
|
Poisoning by otorhinolaryngological drugs and preparations, assault, subsequent encounter
|
|
T49.6X3S
|
Poisoning by otorhinolaryngological drugs and preparations, assault, sequela
|
|
T49.6X4A
|
Poisoning by otorhinolaryngological drugs and preparations, undetermined, initial encounter
|
|
T49.6X4D
|
Poisoning by otorhinolaryngological drugs and preparations, undetermined, subsequent encounter
|
|
T49.6X4S
|
Poisoning by otorhinolaryngological drugs and preparations, undetermined, sequela
|
|
T49.6X5A
|
Adverse effect of otorhinolaryngological drugs and preparations, initial encounter
|
|
T49.6X5D
|
Adverse effect of otorhinolaryngological drugs and preparations, subsequent encounter
|
|
T49.6X5S
|
Adverse effect of otorhinolaryngological drugs and preparations, sequela
|
|
T49.7X1A
|
Poisoning by dental drugs, topically applied, accidental (unintentional), initial encounter
|
|
T49.7X1D
|
Poisoning by dental drugs, topically applied, accidental (unintentional), subsequent encounter
|
|
T49.7X1S
|
Poisoning by dental drugs, topically applied, accidental (unintentional), sequela
|
|
T49.7X2A
|
Poisoning by dental drugs, topically applied, intentional self-harm, initial encounter
|
|
T49.7X2D
|
Poisoning by dental drugs, topically applied, intentional self-harm, subsequent encounter
|
|
T49.7X2S
|
Poisoning by dental drugs, topically applied, intentional self-harm, sequela
|
|
T49.7X3A
|
Poisoning by dental drugs, topically applied, assault, initial encounter
|
|
T49.7X3D
|
Poisoning by dental drugs, topically applied, assault, subsequent encounter
|
|
T49.7X3S
|
Poisoning by dental drugs, topically applied, assault, sequela
|
|
T49.7X4A
|
Poisoning by dental drugs, topically applied, undetermined, initial encounter
|
|
T49.7X4D
|
Poisoning by dental drugs, topically applied, undetermined, subsequent encounter
|
|
T49.7X4S
|
Poisoning by dental drugs, topically applied, undetermined, sequela
|
|
T49.7X5A
|
Adverse effect of dental drugs, topically applied, initial encounter
|
|
T49.7X5D
|
Adverse effect of dental drugs, topically applied, subsequent encounter
|
|
T49.7X5S
|
Adverse effect of dental drugs, topically applied, sequela
|
|
T49.8X1A
|
Poisoning by other topical agents, accidental (unintentional), initial encounter
|
|
T49.8X1D
|
Poisoning by other topical agents, accidental (unintentional), subsequent encounter
|
|
T49.8X1S
|
Poisoning by other topical agents, accidental (unintentional), sequela
|
|
T49.8X2A
|
Poisoning by other topical agents, intentional self-harm, initial encounter
|
|
T49.8X2D
|
Poisoning by other topical agents, intentional self-harm, subsequent encounter
|
|
T49.8X2S
|
Poisoning by other topical agents, intentional self-harm, sequela
|
|
T49.8X3A
|
Poisoning by other topical agents, assault, initial encounter
|
|
T49.8X3D
|
Poisoning by other topical agents, assault, subsequent encounter
|
|
T49.8X3S
|
Poisoning by other topical agents, assault, sequela
|
|
T49.8X4A
|
Poisoning by other topical agents, undetermined, initial encounter
|
|
T49.8X4D
|
Poisoning by other topical agents, undetermined, subsequent encounter
|
|
T49.8X4S
|
Poisoning by other topical agents, undetermined, sequela
|
|
T49.8X5A
|
Adverse effect of other topical agents, initial encounter
|
|
T49.8X5D
|
Adverse effect of other topical agents, subsequent encounter
|
|
T49.8X5S
|
Adverse effect of other topical agents, sequela
|
|
T49.91XA
|
Poisoning by unspecified topical agent, accidental (unintentional), initial encounter
|
|
T49.91XD
|
Poisoning by unspecified topical agent, accidental (unintentional), subsequent encounter
|
|
T49.91XS
|
Poisoning by unspecified topical agent, accidental (unintentional), sequela
|
|
T49.92XA
|
Poisoning by unspecified topical agent, intentional self-harm, initial encounter
|
|
T49.92XD
|
Poisoning by unspecified topical agent, intentional self-harm, subsequent encounter
|
|
T49.92XS
|
Poisoning by unspecified topical agent, intentional self-harm, sequela
|
|
T49.93XA
|
Poisoning by unspecified topical agent, assault, initial encounter
|
|
T49.93XD
|
Poisoning by unspecified topical agent, assault, subsequent encounter
|
|
T49.93XS
|
Poisoning by unspecified topical agent, assault, sequela
|
|
T49.94XA
|
Poisoning by unspecified topical agent, undetermined, initial encounter
|
|
T49.94XD
|
Poisoning by unspecified topical agent, undetermined, subsequent encounter
|
|
T49.94XS
|
Poisoning by unspecified topical agent, undetermined, sequela
|
|
T49.95XA
|
Adverse effect of unspecified topical agent, initial encounter
|
|
T49.95XD
|
Adverse effect of unspecified topical agent, subsequent encounter
|
|
T49.95XS
|
Adverse effect of unspecified topical agent, sequela
|
|
T50.0X1A
|
Poisoning by mineralocorticoids and their antagonists, accidental (unintentional), initial encounter
|
|
T50.0X1D
|
Poisoning by mineralocorticoids and their antagonists, accidental (unintentional), subsequent encounter
|
|
T50.0X1S
|
Poisoning by mineralocorticoids and their antagonists, accidental (unintentional), sequela
|
|
T50.0X2A
|
Poisoning by mineralocorticoids and their antagonists, intentional self-harm, initial encounter
|
|
T50.0X2D
|
Poisoning by mineralocorticoids and their antagonists, intentional self-harm, subsequent encounter
|
|
T50.0X2S
|
Poisoning by mineralocorticoids and their antagonists, intentional self-harm, sequela
|
|
T50.0X3A
|
Poisoning by mineralocorticoids and their antagonists, assault, initial encounter
|
|
T50.0X3D
|
Poisoning by mineralocorticoids and their antagonists, assault, subsequent encounter
|
|
T50.0X3S
|
Poisoning by mineralocorticoids and their antagonists, assault, sequela
|
|
T50.0X4A
|
Poisoning by mineralocorticoids and their antagonists, undetermined, initial encounter
|
|
T50.0X4D
|
Poisoning by mineralocorticoids and their antagonists, undetermined, subsequent encounter
|
|
T50.0X4S
|
Poisoning by mineralocorticoids and their antagonists, undetermined, sequela
|
|
T50.0X5A
|
Adverse effect of mineralocorticoids and their antagonists, initial encounter
|
|
T50.0X5D
|
Adverse effect of mineralocorticoids and their antagonists, subsequent encounter
|
|
T50.0X5S
|
Adverse effect of mineralocorticoids and their antagonists, sequela
|
|
T50.0X6A
|
Underdosing of mineralocorticoids and their antagonists, initial encounter
|
|
T50.0X6D
|
Underdosing of mineralocorticoids and their antagonists, subsequent encounter
|
|
T50.0X6S
|
Underdosing of mineralocorticoids and their antagonists, sequela
|
|
T50.1X1A
|
Poisoning by loop [high-ceiling] diuretics, accidental (unintentional), initial encounter
|
|
T50.1X1D
|
Poisoning by loop [high-ceiling] diuretics, accidental (unintentional), subsequent encounter
|
|
T50.1X1S
|
Poisoning by loop [high-ceiling] diuretics, accidental (unintentional), sequela
|
|
T50.1X2A
|
Poisoning by loop [high-ceiling] diuretics, intentional self-harm, initial encounter
|
|
T50.1X2D
|
Poisoning by loop [high-ceiling] diuretics, intentional self-harm, subsequent encounter
|
|
T50.1X2S
|
Poisoning by loop [high-ceiling] diuretics, intentional self-harm, sequela
|
|
T50.1X3A
|
Poisoning by loop [high-ceiling] diuretics, assault, initial encounter
|
|
T50.1X3D
|
Poisoning by loop [high-ceiling] diuretics, assault, subsequent encounter
|
|
T50.1X3S
|
Poisoning by loop [high-ceiling] diuretics, assault, sequela
|
|
T50.1X4A
|
Poisoning by loop [high-ceiling] diuretics, undetermined, initial encounter
|
|
T50.1X4D
|
Poisoning by loop [high-ceiling] diuretics, undetermined, subsequent encounter
|
|
T50.1X4S
|
Poisoning by loop [high-ceiling] diuretics, undetermined, sequela
|
|
T50.1X5A
|
Adverse effect of loop [high-ceiling] diuretics, initial encounter
|
|
T50.1X5D
|
Adverse effect of loop [high-ceiling] diuretics, subsequent encounter
|
|
T50.1X5S
|
Adverse effect of loop [high-ceiling] diuretics, sequela
|
|
T50.1X6A
|
Underdosing of loop [high-ceiling] diuretics, initial encounter
|
|
T50.1X6D
|
Underdosing of loop [high-ceiling] diuretics, subsequent encounter
|
|
T50.1X6S
|
Underdosing of loop [high-ceiling] diuretics, sequela
|
|
T50.2X1A
|
Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, accidental (unintentional), initial encounter
|
|
T50.2X1D
|
Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, accidental (unintentional), subsequent encounter
|
|
T50.2X1S
|
Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, accidental (unintentional), sequela
|
|
T50.2X2A
|
Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-harm, initial encounter
|
|
T50.2X2D
|
Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-harm, subsequent encounter
|
|
T50.2X2S
|
Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-harm, sequela
|
|
T50.2X3A
|
Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, assault, initial encounter
|
|
T50.2X3D
|
Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, assault, subsequent encounter
|
|
T50.2X3S
|
Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, assault, sequela
|
|
T50.2X4A
|
Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, undetermined, initial encounter
|
|
T50.2X4D
|
Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, undetermined, subsequent encounter
|
|
T50.2X4S
|
Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, undetermined, sequela
|
|
T50.2X5A
|
Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
|
|
T50.2X5D
|
Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter
|
|
T50.2X5S
|
Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
|
|
T50.2X6A
|
Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
|
|
T50.2X6D
|
Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter
|
|
T50.2X6S
|
Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
|
|
T50.3X1A
|
Poisoning by electrolytic, caloric and water-balance agents, accidental (unintentional), initial encounter
|
|
T50.3X1D
|
Poisoning by electrolytic, caloric and water-balance agents, accidental (unintentional), subsequent encounter
|
|
T50.3X1S
|
Poisoning by electrolytic, caloric and water-balance agents, accidental (unintentional), sequela
|
|
T50.3X2A
|
Poisoning by electrolytic, caloric and water-balance agents, intentional self-harm, initial encounter
|
|
T50.3X2D
|
Poisoning by electrolytic, caloric and water-balance agents, intentional self-harm, subsequent encounter
|
|
T50.3X2S
|
Poisoning by electrolytic, caloric and water-balance agents, intentional self-harm, sequela
|
|
T50.3X3A
|
Poisoning by electrolytic, caloric and water-balance agents, assault, initial encounter
|
|
T50.3X3D
|
Poisoning by electrolytic, caloric and water-balance agents, assault, subsequent encounter
|
|
T50.3X3S
|
Poisoning by electrolytic, caloric and water-balance agents, assault, sequela
|
|
T50.3X4A
|
Poisoning by electrolytic, caloric and water-balance agents, undetermined, initial encounter
|
|
T50.3X4D
|
Poisoning by electrolytic, caloric and water-balance agents, undetermined, subsequent encounter
|
|
T50.3X4S
|
Poisoning by electrolytic, caloric and water-balance agents, undetermined, sequela
|
|
T50.3X5A
|
Adverse effect of electrolytic, caloric and water-balance agents, initial encounter
|
|
T50.3X5D
|
Adverse effect of electrolytic, caloric and water-balance agents, subsequent encounter
|
|
T50.3X5S
|
Adverse effect of electrolytic, caloric and water-balance agents, sequela
|
|
T50.3X6A
|
Underdosing of electrolytic, caloric and water-balance agents, initial encounter
|
|
T50.3X6D
|
Underdosing of electrolytic, caloric and water-balance agents, subsequent encounter
|
|
T50.3X6S
|
Underdosing of electrolytic, caloric and water-balance agents, sequela
|
|
T50.4X1A
|
Poisoning by drugs affecting uric acid metabolism, accidental (unintentional), initial encounter
|
|
T50.4X1D
|
Poisoning by drugs affecting uric acid metabolism, accidental (unintentional), subsequent encounter
|
|
T50.4X1S
|
Poisoning by drugs affecting uric acid metabolism, accidental (unintentional), sequela
|
|
T50.4X2A
|
Poisoning by drugs affecting uric acid metabolism, intentional self-harm, initial encounter
|
|
T50.4X2D
|
Poisoning by drugs affecting uric acid metabolism, intentional self-harm, subsequent encounter
|
|
T50.4X2S
|
Poisoning by drugs affecting uric acid metabolism, intentional self-harm, sequela
|
|
T50.4X3A
|
Poisoning by drugs affecting uric acid metabolism, assault, initial encounter
|
|
T50.4X3D
|
Poisoning by drugs affecting uric acid metabolism, assault, subsequent encounter
|
|
T50.4X3S
|
Poisoning by drugs affecting uric acid metabolism, assault, sequela
|
|
T50.4X4A
|
Poisoning by drugs affecting uric acid metabolism, undetermined, initial encounter
|
|
T50.4X4D
|
Poisoning by drugs affecting uric acid metabolism, undetermined, subsequent encounter
|
|
T50.4X4S
|
Poisoning by drugs affecting uric acid metabolism, undetermined, sequela
|
|
T50.4X5A
|
Adverse effect of drugs affecting uric acid metabolism, initial encounter
|
|
T50.4X5D
|
Adverse effect of drugs affecting uric acid metabolism, subsequent encounter
|
|
T50.4X5S
|
Adverse effect of drugs affecting uric acid metabolism, sequela
|
|
T50.4X6A
|
Underdosing of drugs affecting uric acid metabolism, initial encounter
|
|
T50.4X6D
|
Underdosing of drugs affecting uric acid metabolism, subsequent encounter
|
|
T50.4X6S
|
Underdosing of drugs affecting uric acid metabolism, sequela
|
|
T50.5X1A
|
Poisoning by appetite depressants, accidental (unintentional), initial encounter
|
|
T50.5X1D
|
Poisoning by appetite depressants, accidental (unintentional), subsequent encounter
|
|
T50.5X1S
|
Poisoning by appetite depressants, accidental (unintentional), sequela
|
|
T50.5X2A
|
Poisoning by appetite depressants, intentional self-harm, initial encounter
|
|
T50.5X2D
|
Poisoning by appetite depressants, intentional self-harm, subsequent encounter
|
|
T50.5X2S
|
Poisoning by appetite depressants, intentional self-harm, sequela
|
|
T50.5X3A
|
Poisoning by appetite depressants, assault, initial encounter
|
|
T50.5X3D
|
Poisoning by appetite depressants, assault, subsequent encounter
|
|
T50.5X3S
|
Poisoning by appetite depressants, assault, sequela
|
|
T50.5X4A
|
Poisoning by appetite depressants, undetermined, initial encounter
|
|
T50.5X4D
|
Poisoning by appetite depressants, undetermined, subsequent encounter
|
|
T50.5X4S
|
Poisoning by appetite depressants, undetermined, sequela
|
|
T50.5X5A
|
Adverse effect of appetite depressants, initial encounter
|
|
T50.5X5D
|
Adverse effect of appetite depressants, subsequent encounter
|
|
T50.5X5S
|
Adverse effect of appetite depressants, sequela
|
|
T50.6X1A
|
Poisoning by antidotes and chelating agents, accidental (unintentional), initial encounter
|
|
T50.6X1D
|
Poisoning by antidotes and chelating agents, accidental (unintentional), subsequent encounter
|
|
T50.6X1S
|
Poisoning by antidotes and chelating agents, accidental (unintentional), sequela
|
|
T50.6X2A
|
Poisoning by antidotes and chelating agents, intentional self-harm, initial encounter
|
|
T50.6X2D
|
Poisoning by antidotes and chelating agents, intentional self-harm, subsequent encounter
|
|
T50.6X2S
|
Poisoning by antidotes and chelating agents, intentional self-harm, sequela
|
|
T50.6X3A
|
Poisoning by antidotes and chelating agents, assault, initial encounter
|
|
T50.6X3D
|
Poisoning by antidotes and chelating agents, assault, subsequent encounter
|
|
T50.6X3S
|
Poisoning by antidotes and chelating agents, assault, sequela
|
|
T50.6X4A
|
Poisoning by antidotes and chelating agents, undetermined, initial encounter
|
|
T50.6X4D
|
Poisoning by antidotes and chelating agents, undetermined, subsequent encounter
|
|
T50.6X4S
|
Poisoning by antidotes and chelating agents, undetermined, sequela
|
|
T50.6X5A
|
Adverse effect of antidotes and chelating agents, initial encounter
|
|
T50.6X5D
|
Adverse effect of antidotes and chelating agents, subsequent encounter
|
|
T50.6X5S
|
Adverse effect of antidotes and chelating agents, sequela
|
|
T50.6X6A
|
Underdosing of antidotes and chelating agents, initial encounter
|
|
T50.6X6D
|
Underdosing of antidotes and chelating agents, subsequent encounter
|
|
T50.6X6S
|
Underdosing of antidotes and chelating agents, sequela
|
|
T50.7X1A
|
